id	sid	tid	token	lemma	pos
ajlm-2816	1	1	abstract	abstract	ADJ
ajlm-2816	1	2	introduction	introduction	NOUN
ajlm-2816	1	3	methods	method	NOUN
ajlm-2816	1	4	results	result	VERB
ajlm-2816	1	5	discussion	discussion	NOUN
ajlm-2816	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2816	1	7	references	reference	NOUN
ajlm-2816	1	8	about	about	ADP
ajlm-2816	1	9	the	the	DET
ajlm-2816	1	10	author(s	author(s	NOUN
ajlm-2816	1	11	)	)	PUNCT
ajlm-2816	1	12	temitope	temitope	NOUN
ajlm-2816	1	13	o.	o.	PROPN
ajlm-2816	1	14	obadare	obadare	PROPN
ajlm-2816	1	15	department	department	PROPN
ajlm-2816	1	16	of	of	ADP
ajlm-2816	1	17	medical	medical	ADJ
ajlm-2816	1	18	microbiology	microbiology	NOUN
ajlm-2816	1	19	and	and	CCONJ
ajlm-2816	1	20	parasitology	parasitology	NOUN
ajlm-2816	1	21	,	,	PUNCT
ajlm-2816	1	22	obafemi	obafemi	PROPN
ajlm-2816	1	23	awolowo	awolowo	PROPN
ajlm-2816	1	24	university	university	PROPN
ajlm-2816	1	25	teaching	teaching	NOUN
ajlm-2816	1	26	hospitals	hospital	NOUN
ajlm-2816	1	27	complex	complex	ADJ
ajlm-2816	1	28	,	,	PUNCT
ajlm-2816	1	29	ile	ile	PROPN
ajlm-2816	1	30	-	-	PUNCT
ajlm-2816	1	31	ife	ife	PROPN
ajlm-2816	1	32	,	,	PUNCT
ajlm-2816	1	33	nigeria	nigeria	PROPN
ajlm-2816	1	34	department	department	PROPN
ajlm-2816	1	35	of	of	ADP
ajlm-2816	1	36	medical	medical	ADJ
ajlm-2816	1	37	microbiology	microbiology	NOUN
ajlm-2816	1	38	and	and	CCONJ
ajlm-2816	1	39	parasitology	parasitology	NOUN
ajlm-2816	1	40	,	,	PUNCT
ajlm-2816	1	41	faculty	faculty	NOUN
ajlm-2816	1	42	of	of	ADP
ajlm-2816	1	43	basic	basic	ADJ
ajlm-2816	1	44	clinical	clinical	ADJ
ajlm-2816	1	45	sciences	science	NOUN
ajlm-2816	1	46	,	,	PUNCT
ajlm-2816	1	47	obafemi	obafemi	ADP
ajlm-2816	1	48	awolowo	awolowo	PROPN
ajlm-2816	1	49	university	university	PROPN
ajlm-2816	1	50	,	,	PUNCT
ajlm-2816	1	51	ile	ile	PROPN
ajlm-2816	1	52	-	-	PUNCT
ajlm-2816	1	53	ife	ife	PROPN
ajlm-2816	1	54	,	,	PUNCT
ajlm-2816	1	55	nigeria	nigeria	PROPN
ajlm-2816	1	56	adeyemi	adeyemi	ADP
ajlm-2816	1	57	t.	t.	PROPN
ajlm-2816	1	58	adeyemo	adeyemo	PROPN
ajlm-2816	1	59	department	department	PROPN
ajlm-2816	1	60	of	of	ADP
ajlm-2816	1	61	medical	medical	ADJ
ajlm-2816	1	62	microbiology	microbiology	NOUN
ajlm-2816	1	63	and	and	CCONJ
ajlm-2816	1	64	parasitology	parasitology	NOUN
ajlm-2816	1	65	,	,	PUNCT
ajlm-2816	1	66	obafemi	obafemi	PROPN
ajlm-2816	1	67	awolowo	awolowo	PROPN
ajlm-2816	1	68	university	university	PROPN
ajlm-2816	1	69	teaching	teaching	NOUN
ajlm-2816	1	70	hospitals	hospital	NOUN
ajlm-2816	1	71	complex	complex	ADJ
ajlm-2816	1	72	,	,	PUNCT
ajlm-2816	1	73	ile	ile	PROPN
ajlm-2816	1	74	-	-	PUNCT
ajlm-2816	1	75	ife	ife	PROPN
ajlm-2816	1	76	,	,	PUNCT
ajlm-2816	1	77	nigeria	nigeria	PROPN
ajlm-2816	1	78	department	department	PROPN
ajlm-2816	1	79	of	of	ADP
ajlm-2816	1	80	medical	medical	ADJ
ajlm-2816	1	81	microbiology	microbiology	NOUN
ajlm-2816	1	82	and	and	CCONJ
ajlm-2816	1	83	parasitology	parasitology	NOUN
ajlm-2816	1	84	,	,	PUNCT
ajlm-2816	1	85	faculty	faculty	NOUN
ajlm-2816	1	86	of	of	ADP
ajlm-2816	1	87	basic	basic	ADJ
ajlm-2816	1	88	clinical	clinical	ADJ
ajlm-2816	1	89	sciences	science	NOUN
ajlm-2816	1	90	,	,	PUNCT
ajlm-2816	1	91	obafemi	obafemi	ADP
ajlm-2816	1	92	awolowo	awolowo	PROPN
ajlm-2816	1	93	university	university	PROPN
ajlm-2816	1	94	,	,	PUNCT
ajlm-2816	1	95	ile	ile	PROPN
ajlm-2816	1	96	-	-	PUNCT
ajlm-2816	1	97	ife	ife	PROPN
ajlm-2816	1	98	,	,	PUNCT
ajlm-2816	1	99	nigeria	nigeria	PROPN
ajlm-2816	1	100	oluwaseun	oluwaseun	PROPN
ajlm-2816	1	101	a.	a.	PROPN
ajlm-2816	1	102	ibrahim	ibrahim	PROPN
ajlm-2816	1	103	department	department	PROPN
ajlm-2816	1	104	of	of	ADP
ajlm-2816	1	105	medical	medical	ADJ
ajlm-2816	1	106	microbiology	microbiology	NOUN
ajlm-2816	1	107	and	and	CCONJ
ajlm-2816	1	108	parasitology	parasitology	NOUN
ajlm-2816	1	109	,	,	PUNCT
ajlm-2816	1	110	obafemi	obafemi	PROPN
ajlm-2816	1	111	awolowo	awolowo	PROPN
ajlm-2816	1	112	university	university	PROPN
ajlm-2816	1	113	teaching	teaching	NOUN
ajlm-2816	1	114	hospitals	hospital	NOUN
ajlm-2816	1	115	complex	complex	ADJ
ajlm-2816	1	116	,	,	PUNCT
ajlm-2816	1	117	ile	ile	PROPN
ajlm-2816	1	118	-	-	PUNCT
ajlm-2816	1	119	ife	ife	PROPN
ajlm-2816	1	120	,	,	PUNCT
ajlm-2816	1	121	nigeria	nigeria	PROPN
ajlm-2816	1	122	naheemot	naheemot	NOUN
ajlm-2816	1	123	o.	o.	PROPN
ajlm-2816	1	124	sule	sule	PROPN
ajlm-2816	1	125	department	department	PROPN
ajlm-2816	1	126	of	of	ADP
ajlm-2816	1	127	epidemiology	epidemiology	NOUN
ajlm-2816	1	128	,	,	PUNCT
ajlm-2816	1	129	faculty	faculty	NOUN
ajlm-2816	1	130	of	of	ADP
ajlm-2816	1	131	biostatistics	biostatistic	NOUN
ajlm-2816	1	132	and	and	CCONJ
ajlm-2816	1	133	occupational	occupational	ADJ
ajlm-2816	1	134	statistics	statistic	NOUN
ajlm-2816	1	135	,	,	PUNCT
ajlm-2816	1	136	mcgill	mcgill	PROPN
ajlm-2816	1	137	university	university	PROPN
ajlm-2816	1	138	,	,	PUNCT
ajlm-2816	1	139	montreal	montreal	PROPN
ajlm-2816	1	140	,	,	PUNCT
ajlm-2816	1	141	quebec	quebec	PROPN
ajlm-2816	1	142	,	,	PUNCT
ajlm-2816	1	143	canada	canada	PROPN
ajlm-2816	1	144	center	center	PROPN
ajlm-2816	1	145	for	for	ADP
ajlm-2816	1	146	clinical	clinical	ADJ
ajlm-2816	1	147	epidemiology	epidemiology	NOUN
ajlm-2816	1	148	,	,	PUNCT
ajlm-2816	1	149	lady	lady	PROPN
ajlm-2816	1	150	davis	davis	PROPN
ajlm-2816	1	151	institute	institute	PROPN
ajlm-2816	1	152	,	,	PUNCT
ajlm-2816	1	153	jewish	jewish	ADJ
ajlm-2816	1	154	general	general	ADJ
ajlm-2816	1	155	hospital	hospital	PROPN
ajlm-2816	1	156	,	,	PUNCT
ajlm-2816	1	157	montreal	montreal	PROPN
ajlm-2816	1	158	,	,	PUNCT
ajlm-2816	1	159	quebec	quebec	PROPN
ajlm-2816	1	160	,	,	PUNCT
ajlm-2816	1	161	canada	canada	PROPN
ajlm-2816	1	162	mayowa	mayowa	PROPN
ajlm-2816	1	163	m.	m.	PROPN
ajlm-2816	1	164	adeyemo	adeyemo	PROPN
ajlm-2816	1	165	department	department	PROPN
ajlm-2816	1	166	of	of	ADP
ajlm-2816	1	167	hematology	hematology	PROPN
ajlm-2816	1	168	,	,	PUNCT
ajlm-2816	1	169	pinderfields	pinderfield	VERB
ajlm-2816	1	170	general	general	ADJ
ajlm-2816	1	171	hospital	hospital	NOUN
ajlm-2816	1	172	,	,	PUNCT
ajlm-2816	1	173	mid	mid	PROPN
ajlm-2816	1	174	yorkshire	yorkshire	PROPN
ajlm-2816	1	175	nhs	nhs	PROPN
ajlm-2816	1	176	trusts	trust	NOUN
ajlm-2816	1	177	,	,	PUNCT
ajlm-2816	1	178	wakefield	wakefield	PROPN
ajlm-2816	1	179	,	,	PUNCT
ajlm-2816	1	180	united	united	PROPN
ajlm-2816	1	181	kingdom	kingdom	PROPN
ajlm-2816	1	182	olusegun	olusegun	PROPN
ajlm-2816	1	183	i.	i.	PROPN
ajlm-2816	1	184	alatise	alatise	PROPN
ajlm-2816	1	185	department	department	PROPN
ajlm-2816	1	186	of	of	ADP
ajlm-2816	1	187	surgery	surgery	NOUN
ajlm-2816	1	188	,	,	PUNCT
ajlm-2816	1	189	faculty	faculty	NOUN
ajlm-2816	1	190	of	of	ADP
ajlm-2816	1	191	clinical	clinical	ADJ
ajlm-2816	1	192	sciences	science	NOUN
ajlm-2816	1	193	,	,	PUNCT
ajlm-2816	1	194	obafemi	obafemi	ADP
ajlm-2816	1	195	awolowo	awolowo	PROPN
ajlm-2816	1	196	university	university	PROPN
ajlm-2816	1	197	,	,	PUNCT
ajlm-2816	1	198	ile	ile	PROPN
ajlm-2816	1	199	-	-	PUNCT
ajlm-2816	1	200	ife	ife	PROPN
ajlm-2816	1	201	,	,	PUNCT
ajlm-2816	1	202	nigeria	nigeria	PROPN
ajlm-2816	1	203	department	department	PROPN
ajlm-2816	1	204	of	of	ADP
ajlm-2816	1	205	general	general	ADJ
ajlm-2816	1	206	surgery	surgery	NOUN
ajlm-2816	1	207	,	,	PUNCT
ajlm-2816	1	208	obafemi	obafemi	ADP
ajlm-2816	1	209	awolowo	awolowo	PROPN
ajlm-2816	1	210	university	university	PROPN
ajlm-2816	1	211	,	,	PUNCT
ajlm-2816	1	212	teaching	teaching	NOUN
ajlm-2816	1	213	hospitals	hospital	NOUN
ajlm-2816	1	214	complex	complex	ADJ
ajlm-2816	1	215	,	,	PUNCT
ajlm-2816	1	216	ile	ile	PROPN
ajlm-2816	1	217	-	-	PUNCT
ajlm-2816	1	218	ife	ife	PROPN
ajlm-2816	1	219	,	,	PUNCT
ajlm-2816	1	220	nigeria	nigeria	PROPN
ajlm-2816	1	221	citation	citation	NOUN
ajlm-2816	1	222	obadare	obadare	VERB
ajlm-2816	1	223	to	to	PART
ajlm-2816	1	224	,	,	PUNCT
ajlm-2816	1	225	adeyemo	adeyemo	ADV
ajlm-2816	1	226	at	at	ADV
ajlm-2816	1	227	,	,	PUNCT
ajlm-2816	1	228	ibrahim	ibrahim	PROPN
ajlm-2816	1	229	oa	oa	PROPN
ajlm-2816	1	230	,	,	PUNCT
ajlm-2816	1	231	sule	sule	PROPN
ajlm-2816	1	232	no	no	PROPN
ajlm-2816	1	233	,	,	PUNCT
ajlm-2816	1	234	adeyemo	adeyemo	PROPN
ajlm-2816	1	235	mm	mm	INTJ
ajlm-2816	1	236	,	,	PUNCT
ajlm-2816	2	1	alatise	alatise	PROPN
ajlm-2816	2	2	oi	oi	INTJ
ajlm-2816	2	3	.	.	PUNCT
ajlm-2816	3	1	bacterial	bacterial	ADJ
ajlm-2816	3	2	agents	agent	NOUN
ajlm-2816	3	3	and	and	CCONJ
ajlm-2816	3	4	antibiotic	antibiotic	ADJ
ajlm-2816	3	5	resistance	resistance	NOUN
ajlm-2816	3	6	in	in	ADP
ajlm-2816	3	7	febrile	febrile	NOUN
ajlm-2816	3	8	neutropaenia	neutropaenia	NOUN
ajlm-2816	3	9	in	in	ADP
ajlm-2816	3	10	africa	africa	PROPN
ajlm-2816	3	11	:	:	PUNCT
ajlm-2816	3	12	a	a	DET
ajlm-2816	3	13	systematic	systematic	ADJ
ajlm-2816	3	14	review	review	NOUN
ajlm-2816	3	15	and	and	CCONJ
ajlm-2816	3	16	meta	meta	ADJ
ajlm-2816	3	17	-	-	PUNCT
ajlm-2816	3	18	analysis	analysis	NOUN
ajlm-2816	3	19	.	.	PUNCT
ajlm-2816	4	1	afr	afr	PROPN
ajlm-2816	4	2	j	j	PROPN
ajlm-2816	4	3	lab	lab	PROPN
ajlm-2816	4	4	med	med	PROPN
ajlm-2816	4	5	.	.	PUNCT
ajlm-2816	5	1	2025;14(1	2025;14(1	NUM
ajlm-2816	5	2	)	)	PUNCT
ajlm-2816	5	3	,	,	PUNCT
ajlm-2816	5	4	a2816	a2816	PROPN
ajlm-2816	5	5	.	.	PUNCT
ajlm-2816	5	6	https://doi.org/10.4102/ajlm.v14i1.2816	https://doi.org/10.4102/ajlm.v14i1.2816	PRON
ajlm-2816	6	1	note	note	VERB
ajlm-2816	6	2	:	:	PUNCT
ajlm-2816	6	3	additional	additional	ADJ
ajlm-2816	6	4	supporting	support	VERB
ajlm-2816	6	5	information	information	NOUN
ajlm-2816	6	6	is	be	AUX
ajlm-2816	6	7	available	available	ADJ
ajlm-2816	6	8	for	for	ADP
ajlm-2816	6	9	download	download	NOUN
ajlm-2816	6	10	alongside	alongside	ADP
ajlm-2816	6	11	the	the	DET
ajlm-2816	6	12	online	online	ADJ
ajlm-2816	6	13	version	version	NOUN
ajlm-2816	6	14	of	of	ADP
ajlm-2816	6	15	this	this	DET
ajlm-2816	6	16	article	article	NOUN
ajlm-2816	6	17	as	as	ADP
ajlm-2816	6	18	online	online	ADJ
ajlm-2816	6	19	supplementary	supplementary	ADJ
ajlm-2816	6	20	document	document	NOUN
ajlm-2816	6	21	1	1	NUM
ajlm-2816	6	22	.	.	PUNCT
ajlm-2816	6	23	review	review	NOUN
ajlm-2816	6	24	article	article	NOUN
ajlm-2816	6	25	bacterial	bacterial	ADJ
ajlm-2816	6	26	agents	agent	NOUN
ajlm-2816	6	27	and	and	CCONJ
ajlm-2816	6	28	antibiotic	antibiotic	ADJ
ajlm-2816	6	29	resistance	resistance	NOUN
ajlm-2816	6	30	in	in	ADP
ajlm-2816	6	31	febrile	febrile	NOUN
ajlm-2816	6	32	neutropaenia	neutropaenia	NOUN
ajlm-2816	6	33	in	in	ADP
ajlm-2816	6	34	africa	africa	PROPN
ajlm-2816	6	35	:	:	PUNCT
ajlm-2816	6	36	a	a	DET
ajlm-2816	6	37	systematic	systematic	ADJ
ajlm-2816	6	38	review	review	NOUN
ajlm-2816	6	39	and	and	CCONJ
ajlm-2816	6	40	meta	meta	ADJ
ajlm-2816	6	41	-	-	PUNCT
ajlm-2816	6	42	analysis	analysis	NOUN
ajlm-2816	6	43	temitope	temitope	NOUN
ajlm-2816	6	44	o.	o.	PROPN
ajlm-2816	6	45	obadare	obadare	PROPN
ajlm-2816	6	46	,	,	PUNCT
ajlm-2816	6	47	adeyemi	adeyemi	ADV
ajlm-2816	6	48	t.	t.	PROPN
ajlm-2816	6	49	adeyemo	adeyemo	NOUN
ajlm-2816	6	50	,	,	PUNCT
ajlm-2816	6	51	oluwaseun	oluwaseun	PROPN
ajlm-2816	6	52	a.	a.	PROPN
ajlm-2816	6	53	ibrahim	ibrahim	PROPN
ajlm-2816	6	54	,	,	PUNCT
ajlm-2816	6	55	naheemot	naheemot	NOUN
ajlm-2816	6	56	o.	o.	PROPN
ajlm-2816	6	57	sule	sule	PROPN
ajlm-2816	6	58	,	,	PUNCT
ajlm-2816	6	59	mayowa	mayowa	ADJ
ajlm-2816	6	60	m.	m.	NOUN
ajlm-2816	6	61	adeyemo	adeyemo	NOUN
ajlm-2816	6	62	,	,	PUNCT
ajlm-2816	6	63	olusegun	olusegun	PROPN
ajlm-2816	6	64	i.	i.	PROPN
ajlm-2816	6	65	alatise	alatise	PROPN
ajlm-2816	6	66	received	receive	VERB
ajlm-2816	6	67	:	:	PUNCT
ajlm-2816	6	68	25	25	NUM
ajlm-2816	6	69	mar	mar	PROPN
ajlm-2816	6	70	.	.	PROPN
ajlm-2816	6	71	2025	2025	NUM
ajlm-2816	6	72	;	;	PUNCT
ajlm-2816	6	73	accepted	accept	VERB
ajlm-2816	6	74	:	:	PUNCT
ajlm-2816	6	75	21	21	NUM
ajlm-2816	6	76	may	may	PROPN
ajlm-2816	6	77	2025	2025	NUM
ajlm-2816	6	78	;	;	PUNCT
ajlm-2816	6	79	published	publish	VERB
ajlm-2816	6	80	:	:	PUNCT
ajlm-2816	6	81	26	26	NUM
ajlm-2816	6	82	aug	aug	NOUN
ajlm-2816	6	83	.	.	PROPN
ajlm-2816	7	1	2025	2025	NUM
ajlm-2816	7	2	copyright	copyright	NOUN
ajlm-2816	7	3	:	:	PUNCT
ajlm-2816	7	4	©	©	PROPN
ajlm-2816	7	5	2025	2025	NUM
ajlm-2816	7	6	.	.	PUNCT
ajlm-2816	8	1	the	the	DET
ajlm-2816	8	2	author(s	author(s	PROPN
ajlm-2816	8	3	)	)	PUNCT
ajlm-2816	8	4	.	.	PUNCT
ajlm-2816	9	1	licensee	licensee	NOUN
ajlm-2816	9	2	:	:	PUNCT
ajlm-2816	9	3	aosis	aosis	NOUN
ajlm-2816	9	4	.	.	PUNCT
ajlm-2816	10	1	this	this	PRON
ajlm-2816	10	2	is	be	AUX
ajlm-2816	10	3	an	an	DET
ajlm-2816	10	4	open	open	ADJ
ajlm-2816	10	5	access	access	NOUN
ajlm-2816	10	6	article	article	NOUN
ajlm-2816	10	7	distributed	distribute	VERB
ajlm-2816	10	8	under	under	ADP
ajlm-2816	10	9	the	the	DET
ajlm-2816	10	10	terms	term	NOUN
ajlm-2816	10	11	of	of	ADP
ajlm-2816	10	12	the	the	DET
ajlm-2816	10	13	creative	creative	ADJ
ajlm-2816	10	14	commons	common	NOUN
ajlm-2816	10	15	attribution	attribution	NOUN
ajlm-2816	10	16	license	license	NOUN
ajlm-2816	10	17	,	,	PUNCT
ajlm-2816	10	18	which	which	PRON
ajlm-2816	10	19	permits	permit	VERB
ajlm-2816	10	20	unrestricted	unrestricted	ADJ
ajlm-2816	10	21	use	use	NOUN
ajlm-2816	10	22	,	,	PUNCT
ajlm-2816	10	23	distribution	distribution	NOUN
ajlm-2816	10	24	,	,	PUNCT
ajlm-2816	10	25	and	and	CCONJ
ajlm-2816	10	26	reproduction	reproduction	NOUN
ajlm-2816	10	27	in	in	ADP
ajlm-2816	10	28	any	any	DET
ajlm-2816	10	29	medium	medium	NOUN
ajlm-2816	10	30	,	,	PUNCT
ajlm-2816	10	31	provided	provide	VERB
ajlm-2816	10	32	the	the	DET
ajlm-2816	10	33	original	original	ADJ
ajlm-2816	10	34	work	work	NOUN
ajlm-2816	10	35	is	be	AUX
ajlm-2816	10	36	properly	properly	ADV
ajlm-2816	10	37	cited	cite	VERB
ajlm-2816	10	38	.	.	PUNCT
ajlm-2816	11	1	abstract	abstract	ADJ
ajlm-2816	11	2	background	background	NOUN
ajlm-2816	11	3	:	:	PUNCT
ajlm-2816	11	4	febrile	febrile	NOUN
ajlm-2816	11	5	neutropaenia	neutropaenia	NOUN
ajlm-2816	11	6	(	(	PUNCT
ajlm-2816	11	7	fn	fn	NOUN
ajlm-2816	11	8	)	)	PUNCT
ajlm-2816	11	9	is	be	AUX
ajlm-2816	11	10	an	an	DET
ajlm-2816	11	11	oncology	oncology	NOUN
ajlm-2816	11	12	emergency	emergency	NOUN
ajlm-2816	11	13	,	,	PUNCT
ajlm-2816	11	14	but	but	CCONJ
ajlm-2816	11	15	there	there	PRON
ajlm-2816	11	16	is	be	VERB
ajlm-2816	11	17	a	a	DET
ajlm-2816	11	18	paucity	paucity	NOUN
ajlm-2816	11	19	of	of	ADP
ajlm-2816	11	20	data	datum	NOUN
ajlm-2816	11	21	on	on	ADP
ajlm-2816	11	22	it	it	PRON
ajlm-2816	11	23	in	in	ADP
ajlm-2816	11	24	africa	africa	PROPN
ajlm-2816	11	25	.	.	PUNCT
ajlm-2816	12	1	aim	aim	VERB
ajlm-2816	12	2	:	:	PUNCT
ajlm-2816	13	1	this	this	DET
ajlm-2816	13	2	study	study	NOUN
ajlm-2816	13	3	aimed	aim	VERB
ajlm-2816	13	4	to	to	PART
ajlm-2816	13	5	review	review	VERB
ajlm-2816	13	6	and	and	CCONJ
ajlm-2816	13	7	aggregate	aggregate	VERB
ajlm-2816	13	8	data	datum	NOUN
ajlm-2816	13	9	on	on	ADP
ajlm-2816	13	10	fn	fn	NOUN
ajlm-2816	13	11	in	in	ADP
ajlm-2816	13	12	the	the	DET
ajlm-2816	13	13	context	context	NOUN
ajlm-2816	13	14	of	of	ADP
ajlm-2816	13	15	antibiotic	antibiotic	ADJ
ajlm-2816	13	16	resistance	resistance	NOUN
ajlm-2816	13	17	.	.	PUNCT
ajlm-2816	14	1	methods	method	NOUN
ajlm-2816	14	2	:	:	PUNCT
ajlm-2816	14	3	published	publish	VERB
ajlm-2816	14	4	original	original	ADJ
ajlm-2816	14	5	articles	article	NOUN
ajlm-2816	14	6	between	between	ADP
ajlm-2816	14	7	1991	1991	NUM
ajlm-2816	14	8	and	and	CCONJ
ajlm-2816	14	9	2024	2024	NUM
ajlm-2816	14	10	were	be	AUX
ajlm-2816	14	11	systematically	systematically	ADV
ajlm-2816	14	12	searched	search	VERB
ajlm-2816	14	13	in	in	ADP
ajlm-2816	14	14	google	google	PROPN
ajlm-2816	14	15	scholar	scholar	NOUN
ajlm-2816	14	16	,	,	PUNCT
ajlm-2816	14	17	pubmed	pubmed	PROPN
ajlm-2816	14	18	,	,	PUNCT
ajlm-2816	14	19	and	and	CCONJ
ajlm-2816	14	20	african	african	ADJ
ajlm-2816	14	21	journals	journal	NOUN
ajlm-2816	14	22	online	online	ADJ
ajlm-2816	14	23	databases	database	NOUN
ajlm-2816	14	24	(	(	PUNCT
ajlm-2816	14	25	grey	grey	PROPN
ajlm-2816	14	26	literature	literature	NOUN
ajlm-2816	14	27	excluded	exclude	VERB
ajlm-2816	14	28	)	)	PUNCT
ajlm-2816	14	29	.	.	PUNCT
ajlm-2816	15	1	‘	'	PUNCT
ajlm-2816	15	2	febrile	febrile	NOUN
ajlm-2816	15	3	neutropenia	neutropenia	NOUN
ajlm-2816	15	4	’	'	PUNCT
ajlm-2816	15	5	was	be	AUX
ajlm-2816	15	6	combined	combine	VERB
ajlm-2816	15	7	by	by	ADP
ajlm-2816	15	8	boolean	boolean	ADJ
ajlm-2816	15	9	terms	term	NOUN
ajlm-2816	15	10	‘	'	PUNCT
ajlm-2816	15	11	or	or	CCONJ
ajlm-2816	15	12	’	'	PUNCT
ajlm-2816	15	13	and	and	CCONJ
ajlm-2816	15	14	‘	'	PUNCT
ajlm-2816	15	15	and	and	CCONJ
ajlm-2816	15	16	’	'	PUNCT
ajlm-2816	15	17	with	with	ADP
ajlm-2816	15	18	individual	individual	ADJ
ajlm-2816	15	19	countries	country	NOUN
ajlm-2816	15	20	for	for	ADP
ajlm-2816	15	21	the	the	DET
ajlm-2816	15	22	searched	search	VERB
ajlm-2816	15	23	terms	term	NOUN
ajlm-2816	15	24	.	.	PUNCT
ajlm-2816	16	1	data	datum	NOUN
ajlm-2816	16	2	aggregation	aggregation	NOUN
ajlm-2816	16	3	on	on	ADP
ajlm-2816	16	4	bacteria	bacteria	NOUN
ajlm-2816	16	5	isolates	isolate	NOUN
ajlm-2816	16	6	and	and	CCONJ
ajlm-2816	16	7	antibiotics	antibiotic	NOUN
ajlm-2816	16	8	was	be	AUX
ajlm-2816	16	9	done	do	VERB
ajlm-2816	16	10	using	use	VERB
ajlm-2816	16	11	microsoft	microsoft	PROPN
ajlm-2816	16	12	excel	excel	PROPN
ajlm-2816	16	13	.	.	PUNCT
ajlm-2816	17	1	results	result	NOUN
ajlm-2816	17	2	:	:	PUNCT
ajlm-2816	17	3	of	of	ADP
ajlm-2816	17	4	16	16	NUM
ajlm-2816	17	5	637	637	NUM
ajlm-2816	17	6	articles	article	NOUN
ajlm-2816	17	7	retrieved	retrieve	VERB
ajlm-2816	17	8	,	,	PUNCT
ajlm-2816	17	9	15	15	NUM
ajlm-2816	17	10	(	(	PUNCT
ajlm-2816	17	11	from	from	ADP
ajlm-2816	17	12	nine	nine	NUM
ajlm-2816	17	13	countries	country	NOUN
ajlm-2816	17	14	)	)	PUNCT
ajlm-2816	17	15	with	with	ADP
ajlm-2816	17	16	1216	1216	NUM
ajlm-2816	17	17	non	non	ADJ
ajlm-2816	17	18	-	-	ADJ
ajlm-2816	17	19	duplicate	duplicate	ADJ
ajlm-2816	17	20	isolates	isolate	NOUN
ajlm-2816	17	21	were	be	AUX
ajlm-2816	17	22	included	include	VERB
ajlm-2816	17	23	in	in	ADP
ajlm-2816	17	24	the	the	DET
ajlm-2816	17	25	analyses	analysis	NOUN
ajlm-2816	17	26	after	after	ADP
ajlm-2816	17	27	exclusion	exclusion	NOUN
ajlm-2816	17	28	of	of	ADP
ajlm-2816	17	29	irrelevant	irrelevant	ADJ
ajlm-2816	17	30	and	and	CCONJ
ajlm-2816	17	31	duplicate	duplicate	ADJ
ajlm-2816	17	32	articles	article	NOUN
ajlm-2816	17	33	.	.	PUNCT
ajlm-2816	18	1	there	there	PRON
ajlm-2816	18	2	were	be	VERB
ajlm-2816	18	3	57.0	57.0	NUM
ajlm-2816	18	4	%	%	NOUN
ajlm-2816	18	5	(	(	PUNCT
ajlm-2816	18	6	698/1225	698/1225	NUM
ajlm-2816	18	7	)	)	PUNCT
ajlm-2816	18	8	gram	gram	NOUN
ajlm-2816	18	9	-	-	PUNCT
ajlm-2816	18	10	positive	positive	ADJ
ajlm-2816	18	11	and	and	CCONJ
ajlm-2816	18	12	43.3	43.3	NUM
ajlm-2816	18	13	%	%	NOUN
ajlm-2816	18	14	(	(	PUNCT
ajlm-2816	18	15	527/1225	527/1225	NUM
ajlm-2816	18	16	)	)	PUNCT
ajlm-2816	18	17	gram	gram	NOUN
ajlm-2816	18	18	-	-	PUNCT
ajlm-2816	18	19	negative	negative	ADJ
ajlm-2816	18	20	bacteria	bacteria	NOUN
ajlm-2816	18	21	.	.	PUNCT
ajlm-2816	19	1	aggregated	aggregate	VERB
ajlm-2816	19	2	resistance	resistance	NOUN
ajlm-2816	19	3	to	to	ADP
ajlm-2816	19	4	antibiotics	antibiotic	NOUN
ajlm-2816	19	5	for	for	ADP
ajlm-2816	19	6	gram	gram	NOUN
ajlm-2816	19	7	-	-	PUNCT
ajlm-2816	19	8	positive	positive	ADJ
ajlm-2816	19	9	bacteria	bacteria	NOUN
ajlm-2816	19	10	was	be	AUX
ajlm-2816	19	11	71.8	71.8	NUM
ajlm-2816	19	12	%	%	NOUN
ajlm-2816	19	13	(	(	PUNCT
ajlm-2816	19	14	163/227	163/227	PROPN
ajlm-2816	19	15	)	)	PUNCT
ajlm-2816	19	16	,	,	PUNCT
ajlm-2816	19	17	for	for	ADP
ajlm-2816	19	18	ampicillin	ampicillin	NOUN
ajlm-2816	19	19	,	,	PUNCT
ajlm-2816	19	20	74.3	74.3	NUM
ajlm-2816	19	21	%	%	NOUN
ajlm-2816	19	22	(	(	PUNCT
ajlm-2816	19	23	226/304	226/304	PROPN
ajlm-2816	19	24	)	)	PUNCT
ajlm-2816	19	25	,	,	PUNCT
ajlm-2816	19	26	for	for	ADP
ajlm-2816	19	27	cefoxitin	cefoxitin	NOUN
ajlm-2816	19	28	,	,	PUNCT
ajlm-2816	19	29	64.1	64.1	NUM
ajlm-2816	19	30	%	%	NOUN
ajlm-2816	19	31	(	(	PUNCT
ajlm-2816	19	32	25/39	25/39	NUM
ajlm-2816	19	33	)	)	PUNCT
ajlm-2816	19	34	,	,	PUNCT
ajlm-2816	19	35	and	and	CCONJ
ajlm-2816	19	36	54.0	54.0	NUM
ajlm-2816	19	37	%	%	NOUN
ajlm-2816	19	38	(	(	PUNCT
ajlm-2816	19	39	47/87	47/87	NUM
ajlm-2816	19	40	)	)	PUNCT
ajlm-2816	19	41	for	for	ADP
ajlm-2816	19	42	oxacillin	oxacillin	PROPN
ajlm-2816	19	43	,	,	PUNCT
ajlm-2816	19	44	while	while	SCONJ
ajlm-2816	19	45	that	that	PRON
ajlm-2816	19	46	of	of	ADP
ajlm-2816	19	47	gram	gram	NOUN
ajlm-2816	19	48	-	-	PUNCT
ajlm-2816	19	49	negative	negative	ADJ
ajlm-2816	19	50	bacteria	bacteria	NOUN
ajlm-2816	19	51	was	be	AUX
ajlm-2816	19	52	35.5	35.5	NUM
ajlm-2816	19	53	%	%	NOUN
ajlm-2816	19	54	(	(	PUNCT
ajlm-2816	19	55	184/519	184/519	NUM
ajlm-2816	19	56	)	)	PUNCT
ajlm-2816	19	57	for	for	ADP
ajlm-2816	19	58	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2816	19	59	,	,	PUNCT
ajlm-2816	19	60	60.6	60.6	NUM
ajlm-2816	19	61	%	%	NOUN
ajlm-2816	19	62	(	(	PUNCT
ajlm-2816	19	63	168/277	168/277	NUM
ajlm-2816	19	64	)	)	PUNCT
ajlm-2816	19	65	for	for	ADP
ajlm-2816	19	66	ceftriaxone	ceftriaxone	NOUN
ajlm-2816	19	67	,	,	PUNCT
ajlm-2816	19	68	65.9	65.9	NUM
ajlm-2816	19	69	%	%	NOUN
ajlm-2816	19	70	(	(	PUNCT
ajlm-2816	19	71	89/135	89/135	NUM
ajlm-2816	19	72	)	)	PUNCT
ajlm-2816	19	73	for	for	ADP
ajlm-2816	19	74	cefuroxime	cefuroxime	ADJ
ajlm-2816	19	75	,	,	PUNCT
ajlm-2816	19	76	and	and	CCONJ
ajlm-2816	19	77	38.2	38.2	NUM
ajlm-2816	19	78	%	%	NOUN
ajlm-2816	19	79	(	(	PUNCT
ajlm-2816	19	80	153/401	153/401	NUM
ajlm-2816	19	81	)	)	PUNCT
ajlm-2816	19	82	for	for	ADP
ajlm-2816	19	83	imipenem	imipenem	PROPN
ajlm-2816	19	84	.	.	PUNCT
ajlm-2816	20	1	staphylococcus	staphylococcus	PROPN
ajlm-2816	20	2	aureus	aureus	PROPN
ajlm-2816	20	3	had	have	VERB
ajlm-2816	20	4	68.8	68.8	NUM
ajlm-2816	20	5	%	%	NOUN
ajlm-2816	20	6	(	(	PUNCT
ajlm-2816	20	7	22/32	22/32	NUM
ajlm-2816	20	8	)	)	PUNCT
ajlm-2816	20	9	resistance	resistance	NOUN
ajlm-2816	20	10	to	to	ADP
ajlm-2816	20	11	oxacillin	oxacillin	PROPN
ajlm-2816	20	12	/	/	SYM
ajlm-2816	20	13	methicillin	methicillin	NOUN
ajlm-2816	20	14	and	and	CCONJ
ajlm-2816	20	15	10	10	NUM
ajlm-2816	20	16	%	%	NOUN
ajlm-2816	20	17	(	(	PUNCT
ajlm-2816	20	18	1/10	1/10	NUM
ajlm-2816	20	19	)	)	PUNCT
ajlm-2816	20	20	resistance	resistance	NOUN
ajlm-2816	20	21	to	to	ADP
ajlm-2816	20	22	vancomycin	vancomycin	PROPN
ajlm-2816	20	23	.	.	PUNCT
ajlm-2816	21	1	klebsiella	klebsiella	PROPN
ajlm-2816	21	2	spp	spp	PROPN
ajlm-2816	21	3	.	.	PROPN
ajlm-2816	21	4	was	be	AUX
ajlm-2816	21	5	50	50	NUM
ajlm-2816	21	6	%	%	NOUN
ajlm-2816	21	7	(	(	PUNCT
ajlm-2816	21	8	9/18	9/18	NUM
ajlm-2816	21	9	)	)	PUNCT
ajlm-2816	21	10	resistant	resistant	ADJ
ajlm-2816	21	11	to	to	ADP
ajlm-2816	21	12	quinolones	quinolone	NOUN
ajlm-2816	21	13	,	,	PUNCT
ajlm-2816	21	14	75.9	75.9	NUM
ajlm-2816	21	15	%	%	NOUN
ajlm-2816	21	16	(	(	PUNCT
ajlm-2816	21	17	22/29	22/29	NUM
ajlm-2816	21	18	)	)	PUNCT
ajlm-2816	21	19	resistant	resistant	ADJ
ajlm-2816	21	20	to	to	ADP
ajlm-2816	21	21	third	third	ADJ
ajlm-2816	21	22	-	-	PUNCT
ajlm-2816	21	23	generation	generation	NOUN
ajlm-2816	21	24	cephalosporins	cephalosporin	NOUN
ajlm-2816	21	25	,	,	PUNCT
ajlm-2816	21	26	and	and	CCONJ
ajlm-2816	21	27	25.0	25.0	NUM
ajlm-2816	21	28	%	%	NOUN
ajlm-2816	21	29	(	(	PUNCT
ajlm-2816	21	30	4/16	4/16	NUM
ajlm-2816	21	31	)	)	PUNCT
ajlm-2816	21	32	resistant	resistant	ADJ
ajlm-2816	21	33	to	to	ADP
ajlm-2816	21	34	carbapenems	carbapenem	NOUN
ajlm-2816	21	35	,	,	PUNCT
ajlm-2816	21	36	while	while	SCONJ
ajlm-2816	21	37	acinetobacter	acinetobacter	ADJ
ajlm-2816	21	38	spp	spp	NOUN
ajlm-2816	21	39	.	.	PUNCT
ajlm-2816	21	40	was	be	AUX
ajlm-2816	21	41	85.7	85.7	NUM
ajlm-2816	21	42	%	%	NOUN
ajlm-2816	21	43	(	(	PUNCT
ajlm-2816	21	44	6/7	6/7	NUM
ajlm-2816	21	45	)	)	PUNCT
ajlm-2816	21	46	resistant	resistant	ADJ
ajlm-2816	21	47	to	to	AUX
ajlm-2816	21	48	gentamycin	gentamycin	VERB
ajlm-2816	21	49	.	.	PUNCT
ajlm-2816	22	1	conclusion	conclusion	NOUN
ajlm-2816	22	2	:	:	PUNCT
ajlm-2816	22	3	this	this	DET
ajlm-2816	22	4	review	review	NOUN
ajlm-2816	22	5	highlighted	highlight	VERB
ajlm-2816	22	6	the	the	DET
ajlm-2816	22	7	paucity	paucity	NOUN
ajlm-2816	22	8	of	of	ADP
ajlm-2816	22	9	data	datum	NOUN
ajlm-2816	22	10	and	and	CCONJ
ajlm-2816	22	11	the	the	DET
ajlm-2816	22	12	emergence	emergence	NOUN
ajlm-2816	22	13	of	of	ADP
ajlm-2816	22	14	multidrug	multidrug	NOUN
ajlm-2816	22	15	resistance	resistance	NOUN
ajlm-2816	22	16	in	in	ADP
ajlm-2816	22	17	fn	fn	PROPN
ajlm-2816	22	18	in	in	ADP
ajlm-2816	22	19	africa	africa	PROPN
ajlm-2816	22	20	.	.	PUNCT
ajlm-2816	23	1	there	there	PRON
ajlm-2816	23	2	is	be	VERB
ajlm-2816	23	3	a	a	DET
ajlm-2816	23	4	need	need	NOUN
ajlm-2816	23	5	for	for	ADP
ajlm-2816	23	6	antibiotic	antibiotic	ADJ
ajlm-2816	23	7	-	-	PUNCT
ajlm-2816	23	8	resistance	resistance	NOUN
ajlm-2816	23	9	surveillance	surveillance	NOUN
ajlm-2816	23	10	and	and	CCONJ
ajlm-2816	23	11	antibiotic	antibiotic	ADJ
ajlm-2816	23	12	stewardship	stewardship	NOUN
ajlm-2816	23	13	to	to	PART
ajlm-2816	23	14	optimise	optimise	VERB
ajlm-2816	23	15	therapy	therapy	NOUN
ajlm-2816	23	16	in	in	ADP
ajlm-2816	23	17	fn	fn	PROPN
ajlm-2816	23	18	in	in	ADP
ajlm-2816	23	19	africa	africa	PROPN
ajlm-2816	23	20	.	.	PUNCT
ajlm-2816	24	1	what	what	PRON
ajlm-2816	24	2	this	this	DET
ajlm-2816	24	3	study	study	NOUN
ajlm-2816	24	4	adds	add	VERB
ajlm-2816	24	5	:	:	PUNCT
ajlm-2816	24	6	to	to	ADP
ajlm-2816	24	7	the	the	DET
ajlm-2816	24	8	best	good	ADJ
ajlm-2816	24	9	of	of	ADP
ajlm-2816	24	10	our	our	PRON
ajlm-2816	24	11	knowledge	knowledge	NOUN
ajlm-2816	24	12	,	,	PUNCT
ajlm-2816	24	13	this	this	PRON
ajlm-2816	24	14	is	be	AUX
ajlm-2816	24	15	the	the	DET
ajlm-2816	24	16	first	first	ADJ
ajlm-2816	24	17	systematic	systematic	ADJ
ajlm-2816	24	18	review	review	NOUN
ajlm-2816	24	19	of	of	ADP
ajlm-2816	24	20	fn	fn	PROPN
ajlm-2816	24	21	in	in	ADP
ajlm-2816	24	22	africa	africa	PROPN
ajlm-2816	24	23	in	in	ADP
ajlm-2816	24	24	the	the	DET
ajlm-2816	24	25	context	context	NOUN
ajlm-2816	24	26	of	of	ADP
ajlm-2816	24	27	available	available	ADJ
ajlm-2816	24	28	laboratory	laboratory	NOUN
ajlm-2816	24	29	resources	resource	NOUN
ajlm-2816	24	30	across	across	ADP
ajlm-2816	24	31	the	the	DET
ajlm-2816	24	32	african	african	ADJ
ajlm-2816	24	33	regions	region	NOUN
ajlm-2816	24	34	.	.	PUNCT
ajlm-2816	25	1	keywords	keyword	NOUN
ajlm-2816	25	2	:	:	PUNCT
ajlm-2816	25	3	febrile	febrile	NOUN
ajlm-2816	25	4	-	-	PUNCT
ajlm-2816	25	5	neutropaenia	neutropaenia	NOUN
ajlm-2816	25	6	;	;	PUNCT
ajlm-2816	25	7	bloodstream	bloodstream	NOUN
ajlm-2816	25	8	-	-	PUNCT
ajlm-2816	25	9	infection	infection	NOUN
ajlm-2816	25	10	;	;	PUNCT
ajlm-2816	25	11	bacterial	bacterial	ADJ
ajlm-2816	25	12	agents	agent	NOUN
ajlm-2816	25	13	;	;	PUNCT
ajlm-2816	25	14	multi	multi	ADJ
ajlm-2816	25	15	-	-	ADJ
ajlm-2816	25	16	drug	drug	ADJ
ajlm-2816	25	17	resistance	resistance	NOUN
ajlm-2816	25	18	;	;	PUNCT
ajlm-2816	25	19	africa	africa	PROPN
ajlm-2816	25	20	.	.	PUNCT
ajlm-2816	26	1	introduction	introduction	NOUN
ajlm-2816	26	2	cancer	cancer	NOUN
ajlm-2816	26	3	is	be	AUX
ajlm-2816	26	4	one	one	NUM
ajlm-2816	26	5	of	of	ADP
ajlm-2816	26	6	the	the	DET
ajlm-2816	26	7	leading	lead	VERB
ajlm-2816	26	8	causes	cause	NOUN
ajlm-2816	26	9	of	of	ADP
ajlm-2816	26	10	morbidity	morbidity	NOUN
ajlm-2816	26	11	and	and	CCONJ
ajlm-2816	26	12	mortality	mortality	NOUN
ajlm-2816	26	13	globally	globally	ADV
ajlm-2816	26	14	and	and	CCONJ
ajlm-2816	26	15	the	the	DET
ajlm-2816	26	16	fifth	fifth	ADJ
ajlm-2816	26	17	leading	leading	ADJ
ajlm-2816	26	18	cause	cause	NOUN
ajlm-2816	26	19	of	of	ADP
ajlm-2816	26	20	mortality	mortality	NOUN
ajlm-2816	26	21	in	in	ADP
ajlm-2816	26	22	africa.1	africa.1	NOUN
ajlm-2816	26	23	according	accord	VERB
ajlm-2816	26	24	to	to	ADP
ajlm-2816	26	25	rajesh	rajesh	PROPN
ajlm-2816	26	26	sharma	sharma	PROPN
ajlm-2816	26	27	and	and	CCONJ
ajlm-2816	26	28	colleagues	colleague	NOUN
ajlm-2816	26	29	using	use	VERB
ajlm-2816	26	30	the	the	DET
ajlm-2816	26	31	globocan	globocan	PROPN
ajlm-2816	26	32	2020	2020	NUM
ajlm-2816	26	33	estimate	estimate	NOUN
ajlm-2816	26	34	,	,	PUNCT
ajlm-2816	26	35	about	about	ADV
ajlm-2816	26	36	1.1	1.1	NUM
ajlm-2816	26	37	million	million	NUM
ajlm-2816	26	38	new	new	ADJ
ajlm-2816	26	39	cancer	cancer	NOUN
ajlm-2816	26	40	cases	case	NOUN
ajlm-2816	26	41	occurred	occur	VERB
ajlm-2816	26	42	in	in	ADP
ajlm-2816	26	43	2020	2020	NUM
ajlm-2816	26	44	,	,	PUNCT
ajlm-2816	26	45	with	with	SCONJ
ajlm-2816	26	46	over	over	ADP
ajlm-2816	26	47	700	700	NUM
ajlm-2816	26	48	000	000	NUM
ajlm-2816	26	49	mortalities	mortality	NOUN
ajlm-2816	26	50	in	in	ADP
ajlm-2816	26	51	africa.2	africa.2	PROPN
ajlm-2816	26	52	this	this	DET
ajlm-2816	26	53	figure	figure	NOUN
ajlm-2816	26	54	might	might	AUX
ajlm-2816	26	55	increase	increase	VERB
ajlm-2816	26	56	by	by	ADP
ajlm-2816	26	57	102	102	NUM
ajlm-2816	26	58	%	%	NOUN
ajlm-2816	26	59	to	to	ADP
ajlm-2816	26	60	2.12	2.12	NUM
ajlm-2816	26	61	million	million	NUM
ajlm-2816	26	62	annually	annually	ADV
ajlm-2816	26	63	by	by	ADP
ajlm-2816	26	64	2040	2040	NUM
ajlm-2816	26	65	,	,	PUNCT
ajlm-2816	26	66	with	with	ADP
ajlm-2816	26	67	an	an	DET
ajlm-2816	26	68	accompanying	accompanying	ADJ
ajlm-2816	26	69	doubled	double	VERB
ajlm-2816	26	70	mortality	mortality	NOUN
ajlm-2816	26	71	rate	rate	NOUN
ajlm-2816	26	72	if	if	SCONJ
ajlm-2816	26	73	nothing	nothing	PRON
ajlm-2816	26	74	is	be	AUX
ajlm-2816	26	75	done	do	VERB
ajlm-2816	26	76	to	to	PART
ajlm-2816	26	77	reverse	reverse	VERB
ajlm-2816	26	78	the	the	DET
ajlm-2816	26	79	trend.3	trend.3	NOUN
ajlm-2816	26	80	the	the	DET
ajlm-2816	26	81	lowand	lowand	ADJ
ajlm-2816	26	82	middle	middle	ADJ
ajlm-2816	26	83	-	-	PUNCT
ajlm-2816	26	84	income	income	NOUN
ajlm-2816	26	85	countries	country	NOUN
ajlm-2816	26	86	(	(	PUNCT
ajlm-2816	26	87	lmics	lmic	NOUN
ajlm-2816	26	88	)	)	PUNCT
ajlm-2816	26	89	bear	bear	VERB
ajlm-2816	26	90	the	the	DET
ajlm-2816	26	91	brunt	brunt	NOUN
ajlm-2816	26	92	of	of	ADP
ajlm-2816	26	93	cancer	cancer	NOUN
ajlm-2816	26	94	death	death	NOUN
ajlm-2816	26	95	,	,	PUNCT
ajlm-2816	26	96	with	with	ADP
ajlm-2816	26	97	overall	overall	ADJ
ajlm-2816	26	98	70	70	NUM
ajlm-2816	26	99	%	%	NOUN
ajlm-2816	26	100	of	of	ADP
ajlm-2816	26	101	mortality	mortality	NOUN
ajlm-2816	26	102	occurring	occur	VERB
ajlm-2816	26	103	in	in	ADP
ajlm-2816	26	104	these	these	DET
ajlm-2816	26	105	regions	region	NOUN
ajlm-2816	26	106	because	because	SCONJ
ajlm-2816	26	107	of	of	ADP
ajlm-2816	26	108	delayed	delayed	ADJ
ajlm-2816	26	109	diagnosis	diagnosis	NOUN
ajlm-2816	26	110	,	,	PUNCT
ajlm-2816	26	111	poor	poor	ADJ
ajlm-2816	26	112	health	health	NOUN
ajlm-2816	26	113	infrastructure	infrastructure	NOUN
ajlm-2816	26	114	for	for	ADP
ajlm-2816	26	115	cancer	cancer	NOUN
ajlm-2816	26	116	support	support	NOUN
ajlm-2816	26	117	,	,	PUNCT
ajlm-2816	26	118	scarcity	scarcity	NOUN
ajlm-2816	26	119	of	of	ADP
ajlm-2816	26	120	oncology	oncology	NOUN
ajlm-2816	26	121	specialists	specialist	NOUN
ajlm-2816	26	122	,	,	PUNCT
ajlm-2816	26	123	exorbitant	exorbitant	ADJ
ajlm-2816	26	124	cost	cost	NOUN
ajlm-2816	26	125	,	,	PUNCT
ajlm-2816	26	126	or	or	CCONJ
ajlm-2816	26	127	lack	lack	NOUN
ajlm-2816	26	128	of	of	ADP
ajlm-2816	26	129	access	access	NOUN
ajlm-2816	26	130	to	to	ADP
ajlm-2816	26	131	anti	anti	ADJ
ajlm-2816	26	132	-	-	ADJ
ajlm-2816	26	133	cancer	cancer	ADJ
ajlm-2816	26	134	chemotherapy.4	chemotherapy.4	PROPN
ajlm-2816	26	135	in	in	ADP
ajlm-2816	26	136	2011	2011	NUM
ajlm-2816	26	137	,	,	PUNCT
ajlm-2816	26	138	the	the	DET
ajlm-2816	26	139	brazzaville	brazzaville	PROPN
ajlm-2816	26	140	declaration	declaration	NOUN
ajlm-2816	26	141	on	on	ADP
ajlm-2816	26	142	non	non	ADJ
ajlm-2816	26	143	-	-	ADJ
ajlm-2816	26	144	communicable	communicable	ADJ
ajlm-2816	26	145	diseases	disease	NOUN
ajlm-2816	26	146	prevention	prevention	NOUN
ajlm-2816	26	147	and	and	CCONJ
ajlm-2816	26	148	control	control	NOUN
ajlm-2816	26	149	in	in	ADP
ajlm-2816	26	150	the	the	DET
ajlm-2816	26	151	world	world	NOUN
ajlm-2816	26	152	health	health	PROPN
ajlm-2816	26	153	organization	organization	NOUN
ajlm-2816	26	154	african	african	ADJ
ajlm-2816	26	155	region	region	NOUN
ajlm-2816	26	156	was	be	AUX
ajlm-2816	26	157	adopted	adopt	VERB
ajlm-2816	26	158	,	,	PUNCT
ajlm-2816	26	159	where	where	SCONJ
ajlm-2816	26	160	african	african	ADJ
ajlm-2816	26	161	countries	country	NOUN
ajlm-2816	26	162	acknowledged	acknowledge	VERB
ajlm-2816	26	163	non	non	ADJ
ajlm-2816	26	164	-	-	ADJ
ajlm-2816	26	165	communicable	communicable	ADJ
ajlm-2816	26	166	diseases	disease	NOUN
ajlm-2816	26	167	,	,	PUNCT
ajlm-2816	26	168	including	include	VERB
ajlm-2816	26	169	cancer	cancer	NOUN
ajlm-2816	26	170	,	,	PUNCT
ajlm-2816	26	171	as	as	SCONJ
ajlm-2816	26	172	public	public	ADJ
ajlm-2816	26	173	health	health	NOUN
ajlm-2816	26	174	issues	issue	NOUN
ajlm-2816	26	175	of	of	ADP
ajlm-2816	26	176	concern	concern	NOUN
ajlm-2816	26	177	,	,	PUNCT
ajlm-2816	26	178	but	but	CCONJ
ajlm-2816	26	179	national	national	ADJ
ajlm-2816	26	180	cancer	cancer	NOUN
ajlm-2816	26	181	control	control	PROPN
ajlm-2816	26	182	plans	plan	NOUN
ajlm-2816	26	183	have	have	AUX
ajlm-2816	26	184	been	be	AUX
ajlm-2816	26	185	poorly	poorly	ADV
ajlm-2816	26	186	funded	fund	VERB
ajlm-2816	26	187	and	and	CCONJ
ajlm-2816	26	188	coordinated.5	coordinated.5	PROPN
ajlm-2816	26	189	neutropaenia	neutropaenia	NOUN
ajlm-2816	26	190	is	be	AUX
ajlm-2816	26	191	an	an	DET
ajlm-2816	26	192	absolute	absolute	ADJ
ajlm-2816	26	193	neutrophil	neutrophil	ADJ
ajlm-2816	26	194	count	count	NOUN
ajlm-2816	26	195	of	of	ADP
ajlm-2816	26	196	less	less	ADJ
ajlm-2816	26	197	than	than	ADP
ajlm-2816	26	198	1.0	1.0	NUM
ajlm-2816	26	199	×	×	NOUN
ajlm-2816	26	200	109	109	NUM
ajlm-2816	26	201	cells	cell	NOUN
ajlm-2816	26	202	/	/	SYM
ajlm-2816	26	203	l	l	NOUN
ajlm-2816	26	204	in	in	ADP
ajlm-2816	26	205	individuals	individual	NOUN
ajlm-2816	26	206	of	of	ADP
ajlm-2816	26	207	central	central	ADJ
ajlm-2816	26	208	european	european	ADJ
ajlm-2816	26	209	descent	descent	NOUN
ajlm-2816	26	210	,	,	PUNCT
ajlm-2816	26	211	or	or	CCONJ
ajlm-2816	26	212	less	less	ADJ
ajlm-2816	26	213	than	than	ADP
ajlm-2816	26	214	1.2	1.2	NUM
ajlm-2816	26	215	×	×	NOUN
ajlm-2816	26	216	109	109	NUM
ajlm-2816	26	217	cells	cell	NOUN
ajlm-2816	26	218	/	/	SYM
ajlm-2816	26	219	l	l	NOUN
ajlm-2816	26	220	in	in	ADP
ajlm-2816	26	221	african	african	PROPN
ajlm-2816	26	222	people.6	people.6	PROPN
ajlm-2816	26	223	this	this	PRON
ajlm-2816	26	224	is	be	AUX
ajlm-2816	26	225	a	a	DET
ajlm-2816	26	226	common	common	ADJ
ajlm-2816	26	227	phenomenon	phenomenon	NOUN
ajlm-2816	26	228	in	in	ADP
ajlm-2816	26	229	patients	patient	NOUN
ajlm-2816	26	230	with	with	ADP
ajlm-2816	26	231	cancer	cancer	NOUN
ajlm-2816	26	232	because	because	SCONJ
ajlm-2816	26	233	of	of	ADP
ajlm-2816	26	234	complications	complication	NOUN
ajlm-2816	26	235	of	of	ADP
ajlm-2816	26	236	cytotoxic	cytotoxic	ADJ
ajlm-2816	26	237	chemotherapy	chemotherapy	NOUN
ajlm-2816	26	238	,	,	PUNCT
ajlm-2816	26	239	bone	bone	NOUN
ajlm-2816	26	240	marrow	marrow	NOUN
ajlm-2816	26	241	metastatic	metastatic	ADJ
ajlm-2816	26	242	replacement	replacement	NOUN
ajlm-2816	26	243	,	,	PUNCT
ajlm-2816	26	244	and	and	CCONJ
ajlm-2816	26	245	disruption	disruption	NOUN
ajlm-2816	26	246	of	of	ADP
ajlm-2816	26	247	haematopoiesis	haematopoiesis	NOUN
ajlm-2816	26	248	by	by	ADP
ajlm-2816	26	249	malignant	malignant	ADJ
ajlm-2816	26	250	cells	cell	NOUN
ajlm-2816	26	251	.	.	PUNCT
ajlm-2816	27	1	febrile	febrile	NOUN
ajlm-2816	27	2	neutropaenia	neutropaenia	PROPN
ajlm-2816	27	3	(	(	PUNCT
ajlm-2816	27	4	fn	fn	NOUN
ajlm-2816	27	5	)	)	PUNCT
ajlm-2816	27	6	is	be	AUX
ajlm-2816	27	7	defined	define	VERB
ajlm-2816	27	8	as	as	ADP
ajlm-2816	27	9	a	a	DET
ajlm-2816	27	10	single	single	ADJ
ajlm-2816	27	11	oral	oral	ADJ
ajlm-2816	27	12	temperature	temperature	NOUN
ajlm-2816	27	13	greater	great	ADJ
ajlm-2816	27	14	than	than	ADP
ajlm-2816	27	15	or	or	CCONJ
ajlm-2816	27	16	equal	equal	ADJ
ajlm-2816	27	17	to	to	ADP
ajlm-2816	27	18	101	101	NUM
ajlm-2816	27	19	°	°	NUM
ajlm-2816	27	20	f	f	X
ajlm-2816	27	21	(	(	PUNCT
ajlm-2816	27	22	38.3	38.3	NUM
ajlm-2816	27	23	°	°	NOUN
ajlm-2816	27	24	c	c	NOUN
ajlm-2816	27	25	)	)	PUNCT
ajlm-2816	27	26	,	,	PUNCT
ajlm-2816	27	27	or	or	CCONJ
ajlm-2816	27	28	a	a	DET
ajlm-2816	27	29	temperature	temperature	NOUN
ajlm-2816	27	30	greater	great	ADJ
ajlm-2816	27	31	than	than	ADP
ajlm-2816	27	32	or	or	CCONJ
ajlm-2816	27	33	equal	equal	ADJ
ajlm-2816	27	34	to	to	ADP
ajlm-2816	27	35	100.4	100.4	NUM
ajlm-2816	27	36	°	°	NOUN
ajlm-2816	27	37	f	f	X
ajlm-2816	27	38	(	(	PUNCT
ajlm-2816	27	39	38	38	NUM
ajlm-2816	27	40	°	°	NOUN
ajlm-2816	27	41	c	c	NOUN
ajlm-2816	27	42	)	)	PUNCT
ajlm-2816	27	43	for	for	ADP
ajlm-2816	27	44	at	at	ADV
ajlm-2816	27	45	least	least	ADV
ajlm-2816	27	46	an	an	PRON
ajlm-2816	27	47	hour	hour	NOUN
ajlm-2816	27	48	,	,	PUNCT
ajlm-2816	27	49	with	with	ADP
ajlm-2816	27	50	an	an	DET
ajlm-2816	27	51	absolute	absolute	ADJ
ajlm-2816	27	52	neutrophil	neutrophil	ADJ
ajlm-2816	27	53	count	count	NOUN
ajlm-2816	27	54	of	of	ADP
ajlm-2816	27	55	less	less	ADJ
ajlm-2816	27	56	than	than	ADP
ajlm-2816	27	57	1500	1500	NUM
ajlm-2816	27	58	cells	cell	NOUN
ajlm-2816	27	59	/	/	SYM
ajlm-2816	27	60	l.7	l.7	ADJ
ajlm-2816	27	61	febrile	febrile	NOUN
ajlm-2816	27	62	neutropaenia	neutropaenia	NOUN
ajlm-2816	27	63	is	be	AUX
ajlm-2816	27	64	an	an	DET
ajlm-2816	27	65	oncological	oncological	ADJ
ajlm-2816	27	66	emergency	emergency	NOUN
ajlm-2816	27	67	associated	associate	VERB
ajlm-2816	27	68	with	with	ADP
ajlm-2816	27	69	sepsis	sepsis	NOUN
ajlm-2816	27	70	,	,	PUNCT
ajlm-2816	27	71	high	high	ADJ
ajlm-2816	27	72	treatment	treatment	NOUN
ajlm-2816	27	73	cost	cost	NOUN
ajlm-2816	27	74	,	,	PUNCT
ajlm-2816	27	75	treatment	treatment	NOUN
ajlm-2816	27	76	delay	delay	NOUN
ajlm-2816	27	77	,	,	PUNCT
ajlm-2816	27	78	and	and	CCONJ
ajlm-2816	27	79	dose	dose	NOUN
ajlm-2816	27	80	reduction	reduction	NOUN
ajlm-2816	27	81	,	,	PUNCT
ajlm-2816	27	82	with	with	ADP
ajlm-2816	27	83	potential	potential	ADJ
ajlm-2816	27	84	compromise	compromise	NOUN
ajlm-2816	27	85	of	of	ADP
ajlm-2816	27	86	cure	cure	NOUN
ajlm-2816	27	87	in	in	ADP
ajlm-2816	27	88	the	the	DET
ajlm-2816	27	89	patient.8	patient.8	NOUN
ajlm-2816	27	90	the	the	DET
ajlm-2816	27	91	severity	severity	NOUN
ajlm-2816	27	92	and	and	CCONJ
ajlm-2816	27	93	incidence	incidence	NOUN
ajlm-2816	27	94	of	of	ADP
ajlm-2816	27	95	fn	fn	NOUN
ajlm-2816	27	96	are	be	AUX
ajlm-2816	27	97	dependent	dependent	ADJ
ajlm-2816	27	98	on	on	ADP
ajlm-2816	27	99	various	various	ADJ
ajlm-2816	27	100	factors	factor	NOUN
ajlm-2816	27	101	such	such	ADJ
ajlm-2816	27	102	as	as	ADP
ajlm-2816	27	103	the	the	DET
ajlm-2816	27	104	content	content	NOUN
ajlm-2816	27	105	of	of	ADP
ajlm-2816	27	106	the	the	DET
ajlm-2816	27	107	therapeutic	therapeutic	ADJ
ajlm-2816	27	108	chemotherapy	chemotherapy	NOUN
ajlm-2816	27	109	,	,	PUNCT
ajlm-2816	27	110	the	the	DET
ajlm-2816	27	111	cycle	cycle	NOUN
ajlm-2816	27	112	of	of	ADP
ajlm-2816	27	113	therapy	therapy	NOUN
ajlm-2816	27	114	,	,	PUNCT
ajlm-2816	27	115	age	age	NOUN
ajlm-2816	27	116	of	of	ADP
ajlm-2816	27	117	the	the	DET
ajlm-2816	27	118	patient	patient	NOUN
ajlm-2816	27	119	,	,	PUNCT
ajlm-2816	27	120	type	type	NOUN
ajlm-2816	27	121	of	of	ADP
ajlm-2816	27	122	malignancy	malignancy	NOUN
ajlm-2816	27	123	,	,	PUNCT
ajlm-2816	27	124	and	and	CCONJ
ajlm-2816	27	125	other	other	ADJ
ajlm-2816	27	126	comorbidities	comorbiditie	NOUN
ajlm-2816	27	127	of	of	ADP
ajlm-2816	27	128	the	the	DET
ajlm-2816	27	129	patients.9	patients.9	NOUN
ajlm-2816	27	130	the	the	DET
ajlm-2816	27	131	fn	fn	NOUN
ajlm-2816	27	132	annual	annual	ADJ
ajlm-2816	27	133	incidence	incidence	NOUN
ajlm-2816	27	134	in	in	ADP
ajlm-2816	27	135	the	the	DET
ajlm-2816	27	136	united	united	PROPN
ajlm-2816	27	137	kingdom	kingdom	PROPN
ajlm-2816	27	138	is	be	AUX
ajlm-2816	27	139	9.4	9.4	NUM
ajlm-2816	27	140	per	per	ADP
ajlm-2816	27	141	1000	1000	NUM
ajlm-2816	27	142	oncology	oncology	NOUN
ajlm-2816	27	143	admissions.10	admissions.10	NOUN
ajlm-2816	27	144	in	in	ADP
ajlm-2816	27	145	the	the	DET
ajlm-2816	27	146	united	united	PROPN
ajlm-2816	27	147	states	states	PROPN
ajlm-2816	27	148	,	,	PUNCT
ajlm-2816	27	149	the	the	DET
ajlm-2816	27	150	incidence	incidence	NOUN
ajlm-2816	27	151	of	of	ADP
ajlm-2816	27	152	fn	fn	NOUN
ajlm-2816	27	153	ranges	range	NOUN
ajlm-2816	27	154	from	from	ADP
ajlm-2816	27	155	7.83	7.83	NUM
ajlm-2816	27	156	cases	case	NOUN
ajlm-2816	27	157	per	per	ADP
ajlm-2816	27	158	1000	1000	NUM
ajlm-2816	27	159	(	(	PUNCT
ajlm-2816	27	160	solid	solid	ADJ
ajlm-2816	27	161	tumours	tumour	NOUN
ajlm-2816	27	162	)	)	PUNCT
ajlm-2816	27	163	to	to	ADP
ajlm-2816	27	164	43.3	43.3	NUM
ajlm-2816	27	165	cases	case	NOUN
ajlm-2816	27	166	per	per	ADP
ajlm-2816	27	167	1000	1000	NUM
ajlm-2816	27	168	(	(	PUNCT
ajlm-2816	27	169	haematological	haematological	ADJ
ajlm-2816	27	170	malignancies).11	malignancies).11	ADJ
ajlm-2816	27	171	the	the	DET
ajlm-2816	27	172	incidence	incidence	NOUN
ajlm-2816	27	173	of	of	ADP
ajlm-2816	27	174	mortality	mortality	NOUN
ajlm-2816	27	175	is	be	AUX
ajlm-2816	27	176	high	high	ADJ
ajlm-2816	27	177	in	in	ADP
ajlm-2816	27	178	patients	patient	NOUN
ajlm-2816	27	179	with	with	ADP
ajlm-2816	27	180	fn	fn	PROPN
ajlm-2816	27	181	,	,	PUNCT
ajlm-2816	27	182	ranging	range	VERB
ajlm-2816	27	183	from	from	ADP
ajlm-2816	27	184	50	50	NUM
ajlm-2816	27	185	%	%	NOUN
ajlm-2816	27	186	to	to	ADP
ajlm-2816	27	187	75%.12	75%.12	NUM
ajlm-2816	27	188	early	early	ADV
ajlm-2816	27	189	appropriate	appropriate	ADJ
ajlm-2816	27	190	prophylaxis	prophylaxis	ADJ
ajlm-2816	27	191	and	and	CCONJ
ajlm-2816	27	192	empiric	empiric	ADJ
ajlm-2816	27	193	antibiotic	antibiotic	ADJ
ajlm-2816	27	194	use	use	NOUN
ajlm-2816	27	195	have	have	AUX
ajlm-2816	27	196	significantly	significantly	ADV
ajlm-2816	27	197	contributed	contribute	VERB
ajlm-2816	27	198	to	to	ADP
ajlm-2816	27	199	reduced	reduce	VERB
ajlm-2816	27	200	morbidity	morbidity	NOUN
ajlm-2816	27	201	and	and	CCONJ
ajlm-2816	27	202	mortality	mortality	NOUN
ajlm-2816	27	203	in	in	ADP
ajlm-2816	27	204	patients	patient	NOUN
ajlm-2816	27	205	with	with	ADP
ajlm-2816	27	206	fn.8	fn.8	PROPN
ajlm-2816	27	207	however	however	ADV
ajlm-2816	27	208	,	,	PUNCT
ajlm-2816	27	209	the	the	DET
ajlm-2816	27	210	emergence	emergence	NOUN
ajlm-2816	27	211	of	of	ADP
ajlm-2816	27	212	multidrug	multidrug	NOUN
ajlm-2816	27	213	-	-	PUNCT
ajlm-2816	27	214	resistant	resistant	ADJ
ajlm-2816	27	215	(	(	PUNCT
ajlm-2816	27	216	mdr	mdr	NOUN
ajlm-2816	27	217	)	)	PUNCT
ajlm-2816	27	218	bacteria	bacteria	NOUN
ajlm-2816	27	219	from	from	ADP
ajlm-2816	27	220	misuse	misuse	NOUN
ajlm-2816	27	221	and	and	CCONJ
ajlm-2816	27	222	overuse	overuse	NOUN
ajlm-2816	27	223	of	of	ADP
ajlm-2816	27	224	antibiotics	antibiotic	NOUN
ajlm-2816	27	225	has	have	AUX
ajlm-2816	27	226	reduced	reduce	VERB
ajlm-2816	27	227	the	the	DET
ajlm-2816	27	228	effectiveness	effectiveness	NOUN
ajlm-2816	27	229	of	of	ADP
ajlm-2816	27	230	broad	broad	ADJ
ajlm-2816	27	231	-	-	PUNCT
ajlm-2816	27	232	spectrum	spectrum	NOUN
ajlm-2816	27	233	antibiotic	antibiotic	ADJ
ajlm-2816	27	234	use	use	NOUN
ajlm-2816	27	235	in	in	ADP
ajlm-2816	27	236	patients	patient	NOUN
ajlm-2816	27	237	with	with	ADP
ajlm-2816	27	238	fn.13	fn.13	PROPN
ajlm-2816	27	239	it	it	PRON
ajlm-2816	27	240	is	be	AUX
ajlm-2816	27	241	documented	document	VERB
ajlm-2816	27	242	that	that	SCONJ
ajlm-2816	27	243	many	many	ADJ
ajlm-2816	27	244	antibiotics	antibiotic	NOUN
ajlm-2816	27	245	used	use	VERB
ajlm-2816	27	246	in	in	ADP
ajlm-2816	27	247	cancer	cancer	NOUN
ajlm-2816	27	248	patients	patient	NOUN
ajlm-2816	27	249	are	be	AUX
ajlm-2816	27	250	inappropriate	inappropriate	ADJ
ajlm-2816	27	251	and	and	CCONJ
ajlm-2816	27	252	do	do	AUX
ajlm-2816	27	253	not	not	PART
ajlm-2816	27	254	follow	follow	VERB
ajlm-2816	27	255	evidence	evidence	NOUN
ajlm-2816	27	256	-	-	PUNCT
ajlm-2816	27	257	based	base	VERB
ajlm-2816	27	258	standard	standard	NOUN
ajlm-2816	27	259	guidelines.14	guidelines.14	NOUN
ajlm-2816	27	260	moreover	moreover	ADV
ajlm-2816	27	261	,	,	PUNCT
ajlm-2816	27	262	the	the	DET
ajlm-2816	27	263	increased	increase	VERB
ajlm-2816	27	264	frequency	frequency	NOUN
ajlm-2816	27	265	and	and	CCONJ
ajlm-2816	27	266	duration	duration	NOUN
ajlm-2816	27	267	of	of	ADP
ajlm-2816	27	268	contact	contact	NOUN
ajlm-2816	27	269	with	with	ADP
ajlm-2816	27	270	healthcare	healthcare	PROPN
ajlm-2816	27	271	settings	setting	NOUN
ajlm-2816	27	272	,	,	PUNCT
ajlm-2816	27	273	breached	breach	VERB
ajlm-2816	27	274	anatomical	anatomical	ADJ
ajlm-2816	27	275	barriers	barrier	NOUN
ajlm-2816	27	276	,	,	PUNCT
ajlm-2816	27	277	and	and	CCONJ
ajlm-2816	27	278	invasive	invasive	ADJ
ajlm-2816	27	279	procedures	procedure	NOUN
ajlm-2816	27	280	predispose	predispose	VERB
ajlm-2816	27	281	patients	patient	NOUN
ajlm-2816	27	282	with	with	ADP
ajlm-2816	27	283	fn	fn	NOUN
ajlm-2816	27	284	to	to	ADP
ajlm-2816	27	285	healthcare	healthcare	NOUN
ajlm-2816	27	286	-	-	PUNCT
ajlm-2816	27	287	associated	associate	VERB
ajlm-2816	27	288	infections	infection	NOUN
ajlm-2816	27	289	,	,	PUNCT
ajlm-2816	27	290	which	which	PRON
ajlm-2816	27	291	are	be	AUX
ajlm-2816	27	292	mostly	mostly	ADV
ajlm-2816	27	293	mdr	mdr	NOUN
ajlm-2816	27	294	pathogens	pathogen	NOUN
ajlm-2816	27	295	,	,	PUNCT
ajlm-2816	27	296	lower	low	ADJ
ajlm-2816	27	297	the	the	DET
ajlm-2816	27	298	survival	survival	NOUN
ajlm-2816	27	299	rate	rate	NOUN
ajlm-2816	27	300	in	in	ADP
ajlm-2816	27	301	patients	patient	NOUN
ajlm-2816	27	302	with	with	ADP
ajlm-2816	27	303	fn.13	fn.13	PROPN
ajlm-2816	27	304	the	the	DET
ajlm-2816	27	305	world	world	PROPN
ajlm-2816	27	306	health	health	PROPN
ajlm-2816	27	307	organization	organization	NOUN
ajlm-2816	27	308	predicts	predict	VERB
ajlm-2816	27	309	that	that	SCONJ
ajlm-2816	27	310	the	the	DET
ajlm-2816	27	311	incidence	incidence	NOUN
ajlm-2816	27	312	of	of	ADP
ajlm-2816	27	313	malignancy	malignancy	NOUN
ajlm-2816	27	314	would	would	AUX
ajlm-2816	27	315	increase	increase	VERB
ajlm-2816	27	316	by	by	ADP
ajlm-2816	27	317	48	48	NUM
ajlm-2816	27	318	%	%	NOUN
ajlm-2816	27	319	by	by	ADP
ajlm-2816	27	320	2030	2030	NUM
ajlm-2816	27	321	from	from	ADP
ajlm-2816	27	322	the	the	DET
ajlm-2816	27	323	previous	previous	ADJ
ajlm-2816	27	324	survey	survey	NOUN
ajlm-2816	27	325	in	in	ADP
ajlm-2816	27	326	2018	2018	NUM
ajlm-2816	27	327	in	in	ADP
ajlm-2816	27	328	lmics	lmic	NOUN
ajlm-2816	27	329	.	.	PUNCT
ajlm-2816	28	1	this	this	DET
ajlm-2816	28	2	estimate	estimate	NOUN
ajlm-2816	28	3	could	could	AUX
ajlm-2816	28	4	be	be	AUX
ajlm-2816	28	5	less	less	ADJ
ajlm-2816	28	6	than	than	ADP
ajlm-2816	28	7	the	the	DET
ajlm-2816	28	8	actual	actual	ADJ
ajlm-2816	28	9	value	value	NOUN
ajlm-2816	28	10	,	,	PUNCT
ajlm-2816	28	11	as	as	SCONJ
ajlm-2816	28	12	there	there	PRON
ajlm-2816	28	13	is	be	VERB
ajlm-2816	28	14	an	an	DET
ajlm-2816	28	15	underestimation	underestimation	NOUN
ajlm-2816	28	16	of	of	ADP
ajlm-2816	28	17	cancer	cancer	NOUN
ajlm-2816	28	18	in	in	ADP
ajlm-2816	28	19	africa	africa	PROPN
ajlm-2816	28	20	because	because	SCONJ
ajlm-2816	28	21	of	of	ADP
ajlm-2816	28	22	diagnostic	diagnostic	ADJ
ajlm-2816	28	23	capacity	capacity	NOUN
ajlm-2816	28	24	and	and	CCONJ
ajlm-2816	28	25	cancer	cancer	NOUN
ajlm-2816	28	26	reporting.15	reporting.15	NOUN
ajlm-2816	28	27	this	this	PRON
ajlm-2816	28	28	would	would	AUX
ajlm-2816	28	29	invariably	invariably	ADV
ajlm-2816	28	30	increase	increase	VERB
ajlm-2816	28	31	the	the	DET
ajlm-2816	28	32	number	number	NOUN
ajlm-2816	28	33	of	of	ADP
ajlm-2816	28	34	patients	patient	NOUN
ajlm-2816	28	35	with	with	ADP
ajlm-2816	28	36	fn	fn	PROPN
ajlm-2816	28	37	in	in	ADP
ajlm-2816	28	38	africa	africa	PROPN
ajlm-2816	28	39	.	.	PUNCT
ajlm-2816	29	1	unlike	unlike	ADP
ajlm-2816	29	2	the	the	DET
ajlm-2816	29	3	developed	develop	VERB
ajlm-2816	29	4	countries	country	NOUN
ajlm-2816	29	5	,	,	PUNCT
ajlm-2816	29	6	there	there	PRON
ajlm-2816	29	7	is	be	VERB
ajlm-2816	29	8	a	a	DET
ajlm-2816	29	9	dearth	dearth	NOUN
ajlm-2816	29	10	of	of	ADP
ajlm-2816	29	11	data	datum	NOUN
ajlm-2816	29	12	on	on	ADP
ajlm-2816	29	13	the	the	DET
ajlm-2816	29	14	epidemiology	epidemiology	NOUN
ajlm-2816	29	15	of	of	ADP
ajlm-2816	29	16	bacterial	bacterial	ADJ
ajlm-2816	29	17	pathogens	pathogen	NOUN
ajlm-2816	29	18	implicated	implicate	VERB
ajlm-2816	29	19	in	in	ADP
ajlm-2816	29	20	fn	fn	NOUN
ajlm-2816	29	21	and	and	CCONJ
ajlm-2816	29	22	their	their	PRON
ajlm-2816	29	23	antibiotic	antibiotic	ADJ
ajlm-2816	29	24	susceptibility	susceptibility	NOUN
ajlm-2816	29	25	in	in	ADP
ajlm-2816	29	26	africa	africa	PROPN
ajlm-2816	29	27	,	,	PUNCT
ajlm-2816	29	28	which	which	PRON
ajlm-2816	29	29	is	be	AUX
ajlm-2816	29	30	responsible	responsible	ADJ
ajlm-2816	29	31	for	for	ADP
ajlm-2816	29	32	the	the	DET
ajlm-2816	29	33	lag	lag	NOUN
ajlm-2816	29	34	in	in	ADP
ajlm-2816	29	35	the	the	DET
ajlm-2816	29	36	development	development	NOUN
ajlm-2816	29	37	of	of	ADP
ajlm-2816	29	38	treatment	treatment	NOUN
ajlm-2816	29	39	protocols	protocol	NOUN
ajlm-2816	29	40	in	in	ADP
ajlm-2816	29	41	many	many	ADJ
ajlm-2816	29	42	healthcare	healthcare	NOUN
ajlm-2816	29	43	facilities	facility	NOUN
ajlm-2816	29	44	in	in	ADP
ajlm-2816	29	45	many	many	ADJ
ajlm-2816	29	46	african	african	ADJ
ajlm-2816	29	47	countries	country	NOUN
ajlm-2816	29	48	.	.	PUNCT
ajlm-2816	30	1	in	in	ADP
ajlm-2816	30	2	addition	addition	NOUN
ajlm-2816	30	3	,	,	PUNCT
ajlm-2816	30	4	the	the	DET
ajlm-2816	30	5	role	role	NOUN
ajlm-2816	30	6	of	of	ADP
ajlm-2816	30	7	mdr	mdr	PROPN
ajlm-2816	30	8	,	,	PUNCT
ajlm-2816	30	9	as	as	ADV
ajlm-2816	30	10	well	well	ADV
ajlm-2816	30	11	as	as	ADP
ajlm-2816	30	12	its	its	PRON
ajlm-2816	30	13	implication	implication	NOUN
ajlm-2816	30	14	in	in	ADP
ajlm-2816	30	15	fn	fn	NOUN
ajlm-2816	30	16	,	,	PUNCT
ajlm-2816	30	17	has	have	AUX
ajlm-2816	30	18	not	not	PART
ajlm-2816	30	19	been	be	AUX
ajlm-2816	30	20	well	well	ADV
ajlm-2816	30	21	investigated	investigate	VERB
ajlm-2816	30	22	,	,	PUNCT
ajlm-2816	30	23	despite	despite	SCONJ
ajlm-2816	30	24	the	the	DET
ajlm-2816	30	25	high	high	ADJ
ajlm-2816	30	26	burden	burden	NOUN
ajlm-2816	30	27	of	of	ADP
ajlm-2816	30	28	infections	infection	NOUN
ajlm-2816	30	29	by	by	ADP
ajlm-2816	30	30	mdr	mdr	PROPN
ajlm-2816	30	31	pathogens	pathogen	NOUN
ajlm-2816	30	32	in	in	ADP
ajlm-2816	30	33	africa	africa	PROPN
ajlm-2816	30	34	,	,	PUNCT
ajlm-2816	30	35	with	with	ADP
ajlm-2816	30	36	challenges	challenge	NOUN
ajlm-2816	30	37	of	of	ADP
ajlm-2816	30	38	poor	poor	ADJ
ajlm-2816	30	39	infection	infection	NOUN
ajlm-2816	30	40	prevention	prevention	NOUN
ajlm-2816	30	41	and	and	CCONJ
ajlm-2816	30	42	control	control	NOUN
ajlm-2816	30	43	practices	practice	NOUN
ajlm-2816	30	44	,	,	PUNCT
ajlm-2816	30	45	indiscriminate	indiscriminate	ADJ
ajlm-2816	30	46	antibiotic	antibiotic	ADJ
ajlm-2816	30	47	use	use	NOUN
ajlm-2816	30	48	,	,	PUNCT
ajlm-2816	30	49	as	as	ADV
ajlm-2816	30	50	well	well	ADV
ajlm-2816	30	51	as	as	ADP
ajlm-2816	30	52	inadequate	inadequate	ADJ
ajlm-2816	30	53	diagnostic	diagnostic	ADJ
ajlm-2816	30	54	infrastructure	infrastructure	NOUN
ajlm-2816	30	55	.	.	PUNCT
ajlm-2816	31	1	this	this	DET
ajlm-2816	31	2	study	study	NOUN
ajlm-2816	31	3	aimed	aim	VERB
ajlm-2816	31	4	to	to	PART
ajlm-2816	31	5	review	review	VERB
ajlm-2816	31	6	the	the	DET
ajlm-2816	31	7	studies	study	NOUN
ajlm-2816	31	8	on	on	ADP
ajlm-2816	31	9	fn	fn	NOUN
ajlm-2816	31	10	conducted	conduct	VERB
ajlm-2816	31	11	in	in	ADP
ajlm-2816	31	12	africa	africa	PROPN
ajlm-2816	31	13	,	,	PUNCT
ajlm-2816	31	14	and	and	CCONJ
ajlm-2816	31	15	aggregate	aggregate	VERB
ajlm-2816	31	16	the	the	DET
ajlm-2816	31	17	data	datum	NOUN
ajlm-2816	31	18	to	to	PART
ajlm-2816	31	19	document	document	VERB
ajlm-2816	31	20	the	the	DET
ajlm-2816	31	21	patients	patient	NOUN
ajlm-2816	31	22	’	'	PUNCT
ajlm-2816	31	23	clinical	clinical	ADJ
ajlm-2816	31	24	parameters	parameter	NOUN
ajlm-2816	31	25	,	,	PUNCT
ajlm-2816	31	26	implicating	implicate	VERB
ajlm-2816	31	27	bloodstream	bloodstream	NOUN
ajlm-2816	31	28	bacteria	bacteria	NOUN
ajlm-2816	31	29	pathogens	pathogen	NOUN
ajlm-2816	31	30	and	and	CCONJ
ajlm-2816	31	31	their	their	PRON
ajlm-2816	31	32	pattern	pattern	NOUN
ajlm-2816	31	33	of	of	ADP
ajlm-2816	31	34	antibiotic	antibiotic	ADJ
ajlm-2816	31	35	resistance	resistance	NOUN
ajlm-2816	31	36	.	.	PUNCT
ajlm-2816	32	1	methods	method	NOUN
ajlm-2816	32	2	this	this	DET
ajlm-2816	32	3	systematic	systematic	ADJ
ajlm-2816	32	4	review	review	NOUN
ajlm-2816	32	5	was	be	AUX
ajlm-2816	32	6	performed	perform	VERB
ajlm-2816	32	7	according	accord	VERB
ajlm-2816	32	8	to	to	ADP
ajlm-2816	32	9	the	the	DET
ajlm-2816	32	10	guidelines	guideline	NOUN
ajlm-2816	32	11	provided	provide	VERB
ajlm-2816	32	12	by	by	ADP
ajlm-2816	32	13	the	the	DET
ajlm-2816	32	14	cochrane	cochrane	PROPN
ajlm-2816	32	15	handbook	handbook	NOUN
ajlm-2816	32	16	for	for	ADP
ajlm-2816	32	17	systematic	systematic	ADJ
ajlm-2816	32	18	reviews	review	NOUN
ajlm-2816	32	19	of	of	ADP
ajlm-2816	32	20	interventions	intervention	NOUN
ajlm-2816	32	21	and	and	CCONJ
ajlm-2816	32	22	reported	report	VERB
ajlm-2816	32	23	by	by	ADP
ajlm-2816	32	24	the	the	DET
ajlm-2816	32	25	preferred	preferred	ADJ
ajlm-2816	32	26	reporting	reporting	NOUN
ajlm-2816	32	27	items	item	NOUN
ajlm-2816	32	28	for	for	ADP
ajlm-2816	32	29	systematic	systematic	ADJ
ajlm-2816	32	30	reviews	review	NOUN
ajlm-2816	32	31	and	and	CCONJ
ajlm-2816	32	32	meta	meta	NOUN
ajlm-2816	32	33	-	-	PUNCT
ajlm-2816	32	34	analyses	analysis	NOUN
ajlm-2816	32	35	guidelines.16	guidelines.16	PROPN
ajlm-2816	32	36	data	datum	NOUN
ajlm-2816	32	37	sources	source	NOUN
ajlm-2816	32	38	and	and	CCONJ
ajlm-2816	32	39	search	search	NOUN
ajlm-2816	32	40	strategy	strategy	NOUN
ajlm-2816	32	41	google	google	PROPN
ajlm-2816	32	42	scholar	scholar	NOUN
ajlm-2816	32	43	,	,	PUNCT
ajlm-2816	32	44	pubmed	pubmed	PROPN
ajlm-2816	32	45	,	,	PUNCT
ajlm-2816	32	46	and	and	CCONJ
ajlm-2816	32	47	african	african	ADJ
ajlm-2816	32	48	journals	journal	NOUN
ajlm-2816	32	49	online	online	PROPN
ajlm-2816	32	50	library	library	NOUN
ajlm-2816	32	51	databases	database	NOUN
ajlm-2816	32	52	were	be	AUX
ajlm-2816	32	53	systematically	systematically	ADV
ajlm-2816	32	54	searched	search	VERB
ajlm-2816	32	55	using	use	VERB
ajlm-2816	32	56	relevant	relevant	ADJ
ajlm-2816	32	57	keywords	keyword	NOUN
ajlm-2816	32	58	(	(	PUNCT
ajlm-2816	32	59	and	and	CCONJ
ajlm-2816	32	60	indexed	indexed	ADJ
ajlm-2816	32	61	words	word	NOUN
ajlm-2816	32	62	)	)	PUNCT
ajlm-2816	32	63	combined	combine	VERB
ajlm-2816	32	64	by	by	ADP
ajlm-2816	32	65	boolean	boolean	ADJ
ajlm-2816	32	66	terms	term	NOUN
ajlm-2816	32	67	‘	'	PUNCT
ajlm-2816	32	68	or	or	CCONJ
ajlm-2816	32	69	’	'	PUNCT
ajlm-2816	32	70	and	and	CCONJ
ajlm-2816	32	71	‘	'	PUNCT
ajlm-2816	32	72	and	and	CCONJ
ajlm-2816	32	73	’	'	PUNCT
ajlm-2816	32	74	to	to	PART
ajlm-2816	32	75	form	form	VERB
ajlm-2816	32	76	a	a	DET
ajlm-2816	32	77	final	final	ADJ
ajlm-2816	32	78	search	search	NOUN
ajlm-2816	32	79	strategy	strategy	NOUN
ajlm-2816	32	80	.	.	PUNCT
ajlm-2816	33	1	the	the	DET
ajlm-2816	33	2	search	search	NOUN
ajlm-2816	33	3	term	term	NOUN
ajlm-2816	33	4	for	for	ADP
ajlm-2816	33	5	google	google	PROPN
ajlm-2816	33	6	scholar	scholar	NOUN
ajlm-2816	33	7	[	[	X
ajlm-2816	33	8	‘	'	PUNCT
ajlm-2816	33	9	febrile	febrile	ADJ
ajlm-2816	33	10	neutropenia	neutropenia	NOUN
ajlm-2816	33	11	or	or	CCONJ
ajlm-2816	33	12	neutropenia	neutropenia	ADJ
ajlm-2816	33	13	sepsis	sepsis	NOUN
ajlm-2816	33	14	and	and	CCONJ
ajlm-2816	33	15	antibiotic	antibiotic	ADJ
ajlm-2816	33	16	or	or	CCONJ
ajlm-2816	33	17	antibacterial	antibacterial	ADJ
ajlm-2816	33	18	or	or	CCONJ
ajlm-2816	33	19	antimicrobial	antimicrobial	ADJ
ajlm-2816	33	20	and	and	CCONJ
ajlm-2816	33	21	sensitivity	sensitivity	NOUN
ajlm-2816	33	22	or	or	CCONJ
ajlm-2816	33	23	resistance	resistance	NOUN
ajlm-2816	33	24	or	or	CCONJ
ajlm-2816	33	25	susceptibility	susceptibility	NOUN
ajlm-2816	33	26	and	and	CCONJ
ajlm-2816	33	27	the	the	DET
ajlm-2816	33	28	name	name	NOUN
ajlm-2816	33	29	of	of	ADP
ajlm-2816	33	30	the	the	DET
ajlm-2816	33	31	individual	individual	ADJ
ajlm-2816	33	32	african	african	ADJ
ajlm-2816	33	33	countries	country	NOUN
ajlm-2816	33	34	’	'	PUNCT
ajlm-2816	33	35	]	]	PUNCT
ajlm-2816	33	36	,	,	PUNCT
ajlm-2816	33	37	pubmed	pubme	VERB
ajlm-2816	33	38	[	[	X
ajlm-2816	33	39	‘	'	PUNCT
ajlm-2816	33	40	febrile	febrile	ADJ
ajlm-2816	33	41	neutropenia	neutropenia	NOUN
ajlm-2816	33	42	or	or	CCONJ
ajlm-2816	33	43	neutropenia	neutropenia	NOUN
ajlm-2816	33	44	sepsis	sepsis	NOUN
ajlm-2816	33	45	and	and	CCONJ
ajlm-2816	33	46	the	the	DET
ajlm-2816	33	47	name	name	NOUN
ajlm-2816	33	48	of	of	ADP
ajlm-2816	33	49	the	the	DET
ajlm-2816	33	50	individual	individual	ADJ
ajlm-2816	33	51	african	african	ADJ
ajlm-2816	33	52	countries	country	NOUN
ajlm-2816	33	53	’	'	PUNCT
ajlm-2816	33	54	]	]	PUNCT
ajlm-2816	33	55	,	,	PUNCT
ajlm-2816	33	56	african	african	ADJ
ajlm-2816	33	57	journals	journal	NOUN
ajlm-2816	33	58	online	online	PROPN
ajlm-2816	33	59	library	library	NOUN
ajlm-2816	33	60	[	[	X
ajlm-2816	33	61	‘	'	PUNCT
ajlm-2816	33	62	febrile	febrile	ADJ
ajlm-2816	33	63	neutropenia	neutropenia	NOUN
ajlm-2816	33	64	or	or	CCONJ
ajlm-2816	33	65	neutropenia	neutropenia	NOUN
ajlm-2816	33	66	sepsis	sepsis	NOUN
ajlm-2816	33	67	and	and	CCONJ
ajlm-2816	33	68	the	the	DET
ajlm-2816	33	69	name	name	NOUN
ajlm-2816	33	70	of	of	ADP
ajlm-2816	33	71	the	the	DET
ajlm-2816	33	72	individual	individual	ADJ
ajlm-2816	33	73	african	african	ADJ
ajlm-2816	33	74	countries	country	NOUN
ajlm-2816	33	75	’	'	PUNCT
ajlm-2816	33	76	]	]	PUNCT
ajlm-2816	33	77	were	be	AUX
ajlm-2816	33	78	tailored	tailor	VERB
ajlm-2816	33	79	to	to	ADP
ajlm-2816	33	80	each	each	DET
ajlm-2816	33	81	database	database	NOUN
ajlm-2816	33	82	,	,	PUNCT
ajlm-2816	33	83	with	with	ADP
ajlm-2816	33	84	year	year	NOUN
ajlm-2816	33	85	of	of	ADP
ajlm-2816	33	86	publication	publication	NOUN
ajlm-2816	33	87	restrictions	restriction	NOUN
ajlm-2816	33	88	from	from	ADP
ajlm-2816	33	89	january	january	PROPN
ajlm-2816	33	90	1991	1991	NUM
ajlm-2816	33	91	to	to	ADP
ajlm-2816	33	92	december	december	PROPN
ajlm-2816	33	93	2024	2024	NUM
ajlm-2816	33	94	for	for	ADP
ajlm-2816	33	95	optimised	optimise	VERB
ajlm-2816	33	96	performance	performance	NOUN
ajlm-2816	33	97	at	at	ADP
ajlm-2816	33	98	pulling	pull	VERB
ajlm-2816	33	99	out	out	ADP
ajlm-2816	33	100	original	original	ADJ
ajlm-2816	33	101	articles	article	NOUN
ajlm-2816	33	102	published	publish	VERB
ajlm-2816	33	103	in	in	ADP
ajlm-2816	33	104	africa	africa	PROPN
ajlm-2816	33	105	.	.	PUNCT
ajlm-2816	34	1	moreover	moreover	ADV
ajlm-2816	34	2	,	,	PUNCT
ajlm-2816	34	3	the	the	DET
ajlm-2816	34	4	references	reference	NOUN
ajlm-2816	34	5	of	of	ADP
ajlm-2816	34	6	the	the	DET
ajlm-2816	34	7	identified	identify	VERB
ajlm-2816	34	8	studies	study	NOUN
ajlm-2816	34	9	were	be	AUX
ajlm-2816	34	10	hand	hand	NOUN
ajlm-2816	34	11	-	-	PUNCT
ajlm-2816	34	12	searched	search	VERB
ajlm-2816	34	13	for	for	ADP
ajlm-2816	34	14	other	other	ADJ
ajlm-2816	34	15	relevant	relevant	ADJ
ajlm-2816	34	16	studies	study	NOUN
ajlm-2816	34	17	not	not	PART
ajlm-2816	34	18	pulled	pull	VERB
ajlm-2816	34	19	by	by	ADP
ajlm-2816	34	20	the	the	DET
ajlm-2816	34	21	searched	search	VERB
ajlm-2816	34	22	terms	term	NOUN
ajlm-2816	34	23	from	from	ADP
ajlm-2816	34	24	the	the	DET
ajlm-2816	34	25	databases	database	NOUN
ajlm-2816	34	26	.	.	PUNCT
ajlm-2816	35	1	selection	selection	NOUN
ajlm-2816	35	2	criteria	criterion	NOUN
ajlm-2816	35	3	studies	study	NOUN
ajlm-2816	35	4	included	include	VERB
ajlm-2816	35	5	in	in	ADP
ajlm-2816	35	6	the	the	DET
ajlm-2816	35	7	synthesis	synthesis	NOUN
ajlm-2816	35	8	of	of	ADP
ajlm-2816	35	9	this	this	DET
ajlm-2816	35	10	systematic	systematic	ADJ
ajlm-2816	35	11	review	review	NOUN
ajlm-2816	35	12	were	be	AUX
ajlm-2816	35	13	original	original	ADJ
ajlm-2816	35	14	observational	observational	ADJ
ajlm-2816	35	15	studies	study	NOUN
ajlm-2816	35	16	published	publish	VERB
ajlm-2816	35	17	in	in	ADP
ajlm-2816	35	18	peer	peer	NOUN
ajlm-2816	35	19	-	-	PUNCT
ajlm-2816	35	20	reviewed	review	VERB
ajlm-2816	35	21	journals	journal	NOUN
ajlm-2816	35	22	conducted	conduct	VERB
ajlm-2816	35	23	in	in	ADP
ajlm-2816	35	24	africa	africa	PROPN
ajlm-2816	35	25	on	on	ADP
ajlm-2816	35	26	fn	fn	PROPN
ajlm-2816	35	27	(	(	PUNCT
ajlm-2816	35	28	or	or	CCONJ
ajlm-2816	35	29	infection	infection	NOUN
ajlm-2816	35	30	in	in	ADP
ajlm-2816	35	31	oncology	oncology	NOUN
ajlm-2816	35	32	patients	patient	NOUN
ajlm-2816	35	33	with	with	ADP
ajlm-2816	35	34	fn	fn	PROPN
ajlm-2816	35	35	components	component	NOUN
ajlm-2816	35	36	)	)	PUNCT
ajlm-2816	35	37	,	,	PUNCT
ajlm-2816	35	38	which	which	PRON
ajlm-2816	35	39	included	include	VERB
ajlm-2816	35	40	a	a	DET
ajlm-2816	35	41	minimum	minimum	NOUN
ajlm-2816	35	42	of	of	ADP
ajlm-2816	35	43	blood	blood	NOUN
ajlm-2816	35	44	culture	culture	NOUN
ajlm-2816	35	45	results	result	VERB
ajlm-2816	35	46	with	with	ADP
ajlm-2816	35	47	or	or	CCONJ
ajlm-2816	35	48	without	without	ADP
ajlm-2816	35	49	susceptibility	susceptibility	NOUN
ajlm-2816	35	50	pattern	pattern	NOUN
ajlm-2816	35	51	,	,	PUNCT
ajlm-2816	35	52	with	with	ADP
ajlm-2816	35	53	availability	availability	NOUN
ajlm-2816	35	54	of	of	ADP
ajlm-2816	35	55	the	the	DET
ajlm-2816	35	56	full	full	ADJ
ajlm-2816	35	57	texts	text	NOUN
ajlm-2816	35	58	.	.	PUNCT
ajlm-2816	36	1	review	review	NOUN
ajlm-2816	36	2	articles	article	NOUN
ajlm-2816	36	3	,	,	PUNCT
ajlm-2816	36	4	letters	letter	NOUN
ajlm-2816	36	5	,	,	PUNCT
ajlm-2816	36	6	editorials	editorial	NOUN
ajlm-2816	36	7	,	,	PUNCT
ajlm-2816	36	8	case	case	NOUN
ajlm-2816	36	9	reports	report	NOUN
ajlm-2816	36	10	,	,	PUNCT
ajlm-2816	36	11	case	case	NOUN
ajlm-2816	36	12	series	series	NOUN
ajlm-2816	36	13	,	,	PUNCT
ajlm-2816	36	14	conference	conference	NOUN
ajlm-2816	36	15	summaries	summary	NOUN
ajlm-2816	36	16	/	/	SYM
ajlm-2816	36	17	abstracts	abstract	NOUN
ajlm-2816	36	18	,	,	PUNCT
ajlm-2816	36	19	clinical	clinical	ADJ
ajlm-2816	36	20	trials	trial	NOUN
ajlm-2816	36	21	and	and	CCONJ
ajlm-2816	36	22	articles	article	NOUN
ajlm-2816	36	23	not	not	PART
ajlm-2816	36	24	published	publish	VERB
ajlm-2816	36	25	in	in	ADP
ajlm-2816	36	26	the	the	DET
ajlm-2816	36	27	english	english	ADJ
ajlm-2816	36	28	language	language	NOUN
ajlm-2816	36	29	were	be	AUX
ajlm-2816	36	30	excluded	exclude	VERB
ajlm-2816	36	31	from	from	ADP
ajlm-2816	36	32	the	the	DET
ajlm-2816	36	33	synthesis	synthesis	NOUN
ajlm-2816	36	34	of	of	ADP
ajlm-2816	36	35	this	this	DET
ajlm-2816	36	36	review	review	NOUN
ajlm-2816	36	37	.	.	PUNCT
ajlm-2816	37	1	these	these	DET
ajlm-2816	37	2	selection	selection	NOUN
ajlm-2816	37	3	criteria	criterion	NOUN
ajlm-2816	37	4	were	be	AUX
ajlm-2816	37	5	predetermined	predetermine	VERB
ajlm-2816	37	6	by	by	ADP
ajlm-2816	37	7	all	all	DET
ajlm-2816	37	8	the	the	DET
ajlm-2816	37	9	authors	author	NOUN
ajlm-2816	37	10	before	before	ADP
ajlm-2816	37	11	the	the	DET
ajlm-2816	37	12	search	search	NOUN
ajlm-2816	37	13	.	.	PUNCT
ajlm-2816	38	1	the	the	DET
ajlm-2816	38	2	study	study	NOUN
ajlm-2816	38	3	’s	’s	PART
ajlm-2816	38	4	validity	validity	NOUN
ajlm-2816	38	5	was	be	AUX
ajlm-2816	38	6	ensured	ensure	VERB
ajlm-2816	38	7	by	by	ADP
ajlm-2816	38	8	strict	strict	ADJ
ajlm-2816	38	9	compliance	compliance	NOUN
ajlm-2816	38	10	with	with	ADP
ajlm-2816	38	11	the	the	DET
ajlm-2816	38	12	determined	determined	ADJ
ajlm-2816	38	13	selection	selection	NOUN
ajlm-2816	38	14	criteria	criterion	NOUN
ajlm-2816	38	15	.	.	PUNCT
ajlm-2816	39	1	study	study	NOUN
ajlm-2816	39	2	identification	identification	NOUN
ajlm-2816	39	3	and	and	CCONJ
ajlm-2816	39	4	article	article	NOUN
ajlm-2816	39	5	selection	selection	NOUN
ajlm-2816	39	6	a	a	DET
ajlm-2816	39	7	total	total	NOUN
ajlm-2816	39	8	of	of	ADP
ajlm-2816	39	9	16	16	NUM
ajlm-2816	39	10	637	637	NUM
ajlm-2816	39	11	articles	article	NOUN
ajlm-2816	39	12	were	be	AUX
ajlm-2816	39	13	pulled	pull	VERB
ajlm-2816	39	14	out	out	ADP
ajlm-2816	39	15	by	by	ADP
ajlm-2816	39	16	the	the	DET
ajlm-2816	39	17	search	search	NOUN
ajlm-2816	39	18	engines	engine	NOUN
ajlm-2816	39	19	from	from	ADP
ajlm-2816	39	20	the	the	DET
ajlm-2816	39	21	searched	search	VERB
ajlm-2816	39	22	databases	database	NOUN
ajlm-2816	39	23	.	.	PUNCT
ajlm-2816	40	1	upon	upon	SCONJ
ajlm-2816	40	2	screening	screen	VERB
ajlm-2816	40	3	by	by	ADP
ajlm-2816	40	4	titles	title	NOUN
ajlm-2816	40	5	,	,	PUNCT
ajlm-2816	40	6	16	16	NUM
ajlm-2816	40	7	570	570	NUM
ajlm-2816	40	8	were	be	AUX
ajlm-2816	40	9	found	find	VERB
ajlm-2816	40	10	to	to	PART
ajlm-2816	40	11	be	be	AUX
ajlm-2816	40	12	irrelevant	irrelevant	ADJ
ajlm-2816	40	13	based	base	VERB
ajlm-2816	40	14	on	on	ADP
ajlm-2816	40	15	the	the	DET
ajlm-2816	40	16	predetermined	predetermine	VERB
ajlm-2816	40	17	parameters	parameter	NOUN
ajlm-2816	40	18	for	for	ADP
ajlm-2816	40	19	this	this	DET
ajlm-2816	40	20	study	study	NOUN
ajlm-2816	40	21	.	.	PUNCT
ajlm-2816	41	1	the	the	DET
ajlm-2816	41	2	remaining	remain	VERB
ajlm-2816	41	3	67	67	NUM
ajlm-2816	41	4	articles	article	NOUN
ajlm-2816	41	5	were	be	AUX
ajlm-2816	41	6	screened	screen	VERB
ajlm-2816	41	7	using	use	VERB
ajlm-2816	41	8	mendeley	mendeley	NOUN
ajlm-2816	41	9	citation	citation	NOUN
ajlm-2816	41	10	manager	manager	NOUN
ajlm-2816	41	11	software	software	NOUN
ajlm-2816	41	12	(	(	PUNCT
ajlm-2816	41	13	elsevier	elsevier	NOUN
ajlm-2816	41	14	,	,	PUNCT
ajlm-2816	41	15	amsterdam	amsterdam	PROPN
ajlm-2816	41	16	,	,	PUNCT
ajlm-2816	41	17	netherlands	netherlands	PROPN
ajlm-2816	41	18	)	)	PUNCT
ajlm-2816	41	19	,	,	PUNCT
ajlm-2816	41	20	and	and	CCONJ
ajlm-2816	41	21	16	16	NUM
ajlm-2816	41	22	were	be	AUX
ajlm-2816	41	23	excluded	exclude	VERB
ajlm-2816	41	24	for	for	ADP
ajlm-2816	41	25	being	be	AUX
ajlm-2816	41	26	duplicates	duplicate	NOUN
ajlm-2816	41	27	.	.	PUNCT
ajlm-2816	42	1	twenty	twenty	NUM
ajlm-2816	42	2	-	-	PUNCT
ajlm-2816	42	3	eight	eight	NUM
ajlm-2816	42	4	articles	article	NOUN
ajlm-2816	42	5	were	be	AUX
ajlm-2816	42	6	further	far	ADV
ajlm-2816	42	7	excluded	exclude	VERB
ajlm-2816	42	8	after	after	ADP
ajlm-2816	42	9	screening	screen	VERB
ajlm-2816	42	10	of	of	ADP
ajlm-2816	42	11	the	the	DET
ajlm-2816	42	12	abstracts	abstract	NOUN
ajlm-2816	42	13	and	and	CCONJ
ajlm-2816	42	14	subsequent	subsequent	ADJ
ajlm-2816	42	15	sorting	sorting	NOUN
ajlm-2816	42	16	based	base	VERB
ajlm-2816	42	17	on	on	ADP
ajlm-2816	42	18	inclusion	inclusion	NOUN
ajlm-2816	42	19	criteria	criterion	NOUN
ajlm-2816	42	20	by	by	ADP
ajlm-2816	42	21	two	two	NUM
ajlm-2816	42	22	independent	independent	ADJ
ajlm-2816	42	23	reviewers	reviewer	NOUN
ajlm-2816	42	24	(	(	PUNCT
ajlm-2816	42	25	t.o.o	t.o.o	NOUN
ajlm-2816	42	26	.	.	PROPN
ajlm-2816	42	27	and	and	CCONJ
ajlm-2816	42	28	a.t.a	a.t.a	NOUN
ajlm-2816	42	29	.	.	PUNCT
ajlm-2816	42	30	)	)	PUNCT
ajlm-2816	42	31	.	.	PUNCT
ajlm-2816	43	1	where	where	SCONJ
ajlm-2816	43	2	there	there	PRON
ajlm-2816	43	3	was	be	VERB
ajlm-2816	43	4	disagreement	disagreement	NOUN
ajlm-2816	43	5	,	,	PUNCT
ajlm-2816	43	6	another	another	DET
ajlm-2816	43	7	reviewer	reviewer	NOUN
ajlm-2816	43	8	(	(	PUNCT
ajlm-2816	43	9	o.a.i	o.a.i	ADJ
ajlm-2816	43	10	)	)	PUNCT
ajlm-2816	43	11	was	be	AUX
ajlm-2816	43	12	brought	bring	VERB
ajlm-2816	43	13	in	in	ADP
ajlm-2816	43	14	to	to	PART
ajlm-2816	43	15	break	break	VERB
ajlm-2816	43	16	the	the	DET
ajlm-2816	43	17	tie	tie	NOUN
ajlm-2816	43	18	.	.	PUNCT
ajlm-2816	44	1	at	at	ADP
ajlm-2816	44	2	the	the	DET
ajlm-2816	44	3	end	end	NOUN
ajlm-2816	44	4	of	of	ADP
ajlm-2816	44	5	the	the	DET
ajlm-2816	44	6	process	process	NOUN
ajlm-2816	44	7	,	,	PUNCT
ajlm-2816	44	8	15	15	NUM
ajlm-2816	44	9	eligible	eligible	ADJ
ajlm-2816	44	10	articles	article	NOUN
ajlm-2816	44	11	were	be	AUX
ajlm-2816	44	12	selected	select	VERB
ajlm-2816	44	13	for	for	ADP
ajlm-2816	44	14	the	the	DET
ajlm-2816	44	15	final	final	ADJ
ajlm-2816	44	16	synthesis	synthesis	NOUN
ajlm-2816	44	17	.	.	PUNCT
ajlm-2816	45	1	the	the	DET
ajlm-2816	45	2	details	detail	NOUN
ajlm-2816	45	3	of	of	ADP
ajlm-2816	45	4	the	the	DET
ajlm-2816	45	5	preferred	preferred	ADJ
ajlm-2816	45	6	reporting	reporting	NOUN
ajlm-2816	45	7	items	item	NOUN
ajlm-2816	45	8	for	for	ADP
ajlm-2816	45	9	systematic	systematic	ADJ
ajlm-2816	45	10	reviews	review	NOUN
ajlm-2816	45	11	and	and	CCONJ
ajlm-2816	45	12	meta	meta	ADJ
ajlm-2816	45	13	-	-	PUNCT
ajlm-2816	45	14	analyses16	analyses16	NOUN
ajlm-2816	45	15	process	process	NOUN
ajlm-2816	45	16	for	for	ADP
ajlm-2816	45	17	the	the	DET
ajlm-2816	45	18	selection	selection	NOUN
ajlm-2816	45	19	are	be	AUX
ajlm-2816	45	20	documented	document	VERB
ajlm-2816	45	21	in	in	ADP
ajlm-2816	45	22	figure	figure	NOUN
ajlm-2816	45	23	1	1	NUM
ajlm-2816	45	24	.	.	PUNCT
ajlm-2816	46	1	figure	figure	NOUN
ajlm-2816	46	2	1	1	NUM
ajlm-2816	46	3	:	:	PUNCT
ajlm-2816	46	4	preferred	preferred	ADJ
ajlm-2816	46	5	reporting	reporting	NOUN
ajlm-2816	46	6	items	item	NOUN
ajlm-2816	46	7	for	for	ADP
ajlm-2816	46	8	systematic	systematic	ADJ
ajlm-2816	46	9	reviews	review	NOUN
ajlm-2816	46	10	and	and	CCONJ
ajlm-2816	46	11	meta	meta	ADJ
ajlm-2816	46	12	-	-	PUNCT
ajlm-2816	46	13	analyses	analysis	NOUN
ajlm-2816	46	14	flowchart	flowchart	NOUN
ajlm-2816	46	15	describing	describe	VERB
ajlm-2816	46	16	literature	literature	NOUN
ajlm-2816	46	17	search	search	NOUN
ajlm-2816	46	18	and	and	CCONJ
ajlm-2816	46	19	identification	identification	NOUN
ajlm-2816	46	20	of	of	ADP
ajlm-2816	46	21	articles	article	NOUN
ajlm-2816	46	22	on	on	ADP
ajlm-2816	46	23	febrile	febrile	NOUN
ajlm-2816	46	24	neutropenia	neutropenia	PROPN
ajlm-2816	46	25	in	in	ADP
ajlm-2816	46	26	africa	africa	PROPN
ajlm-2816	46	27	,	,	PUNCT
ajlm-2816	46	28	january	january	PROPN
ajlm-2816	46	29	1991	1991	NUM
ajlm-2816	46	30	–	–	PUNCT
ajlm-2816	46	31	december	december	PROPN
ajlm-2816	46	32	2024	2024	NUM
ajlm-2816	46	33	for	for	ADP
ajlm-2816	46	34	synthesis	synthesis	NOUN
ajlm-2816	46	35	.	.	PUNCT
ajlm-2816	47	1	data	datum	NOUN
ajlm-2816	47	2	extraction	extraction	NOUN
ajlm-2816	47	3	the	the	DET
ajlm-2816	47	4	relevant	relevant	ADJ
ajlm-2816	47	5	qualitative	qualitative	NOUN
ajlm-2816	47	6	and	and	CCONJ
ajlm-2816	47	7	quantitative	quantitative	ADJ
ajlm-2816	47	8	data	datum	NOUN
ajlm-2816	47	9	were	be	AUX
ajlm-2816	47	10	extracted	extract	VERB
ajlm-2816	47	11	from	from	ADP
ajlm-2816	47	12	the	the	DET
ajlm-2816	47	13	selected	select	VERB
ajlm-2816	47	14	articles	article	NOUN
ajlm-2816	47	15	using	use	VERB
ajlm-2816	47	16	a	a	DET
ajlm-2816	47	17	piloted	piloted	ADJ
ajlm-2816	47	18	microsoft	microsoft	PROPN
ajlm-2816	47	19	excel	excel	PROPN
ajlm-2816	47	20	worksheet	worksheet	PROPN
ajlm-2816	47	21	software	software	PROPN
ajlm-2816	47	22	(	(	PUNCT
ajlm-2816	47	23	microsoft	microsoft	PROPN
ajlm-2816	47	24	corporation	corporation	PROPN
ajlm-2816	47	25	,	,	PUNCT
ajlm-2816	47	26	redmond	redmond	PROPN
ajlm-2816	47	27	,	,	PUNCT
ajlm-2816	47	28	washington	washington	PROPN
ajlm-2816	47	29	,	,	PUNCT
ajlm-2816	47	30	united	united	PROPN
ajlm-2816	47	31	states	states	PROPN
ajlm-2816	47	32	)	)	PUNCT
ajlm-2816	47	33	individually	individually	ADV
ajlm-2816	47	34	by	by	ADP
ajlm-2816	47	35	two	two	NUM
ajlm-2816	47	36	investigators	investigator	NOUN
ajlm-2816	47	37	(	(	PUNCT
ajlm-2816	47	38	t.o.o	t.o.o	NOUN
ajlm-2816	47	39	.	.	PROPN
ajlm-2816	47	40	and	and	CCONJ
ajlm-2816	47	41	a.t.a	a.t.a	NOUN
ajlm-2816	47	42	.	.	PUNCT
ajlm-2816	47	43	)	)	PUNCT
ajlm-2816	47	44	.	.	PUNCT
ajlm-2816	48	1	qualitative	qualitative	ADJ
ajlm-2816	48	2	parameters	parameter	NOUN
ajlm-2816	48	3	extracted	extract	VERB
ajlm-2816	48	4	were	be	AUX
ajlm-2816	48	5	the	the	DET
ajlm-2816	48	6	study	study	NOUN
ajlm-2816	48	7	design	design	NOUN
ajlm-2816	48	8	,	,	PUNCT
ajlm-2816	48	9	location	location	NOUN
ajlm-2816	48	10	,	,	PUNCT
ajlm-2816	48	11	region	region	NOUN
ajlm-2816	48	12	of	of	ADP
ajlm-2816	48	13	africa	africa	PROPN
ajlm-2816	48	14	(	(	PUNCT
ajlm-2816	48	15	based	base	VERB
ajlm-2816	48	16	on	on	ADP
ajlm-2816	48	17	regional	regional	ADJ
ajlm-2816	48	18	grouping	grouping	NOUN
ajlm-2816	48	19	by	by	ADP
ajlm-2816	48	20	the	the	DET
ajlm-2816	48	21	african	african	PROPN
ajlm-2816	48	22	union	union	PROPN
ajlm-2816	48	23	;	;	PUNCT
ajlm-2816	48	24	https://au.int/en/member_states/countryprofiles2	https://au.int/en/member_states/countryprofiles2	PROPN
ajlm-2816	48	25	)	)	PUNCT
ajlm-2816	48	26	,	,	PUNCT
ajlm-2816	48	27	duration	duration	NOUN
ajlm-2816	48	28	of	of	ADP
ajlm-2816	48	29	study	study	NOUN
ajlm-2816	48	30	(	(	PUNCT
ajlm-2816	48	31	in	in	ADP
ajlm-2816	48	32	months	month	NOUN
ajlm-2816	48	33	)	)	PUNCT
ajlm-2816	48	34	,	,	PUNCT
ajlm-2816	48	35	study	study	NOUN
ajlm-2816	48	36	time	time	NOUN
ajlm-2816	48	37	frame	frame	NOUN
ajlm-2816	48	38	,	,	PUNCT
ajlm-2816	48	39	sampled	sample	VERB
ajlm-2816	48	40	population	population	NOUN
ajlm-2816	48	41	,	,	PUNCT
ajlm-2816	48	42	blood	blood	NOUN
ajlm-2816	48	43	culture	culture	NOUN
ajlm-2816	48	44	system	system	NOUN
ajlm-2816	48	45	,	,	PUNCT
ajlm-2816	48	46	and	and	CCONJ
ajlm-2816	48	47	the	the	DET
ajlm-2816	48	48	technique	technique	NOUN
ajlm-2816	48	49	for	for	ADP
ajlm-2816	48	50	bacteria	bacteria	NOUN
ajlm-2816	48	51	identification	identification	NOUN
ajlm-2816	48	52	and	and	CCONJ
ajlm-2816	48	53	antibiotic	antibiotic	ADJ
ajlm-2816	48	54	susceptibility	susceptibility	NOUN
ajlm-2816	48	55	pattern	pattern	NOUN
ajlm-2816	48	56	of	of	ADP
ajlm-2816	48	57	the	the	DET
ajlm-2816	48	58	bacteria	bacteria	NOUN
ajlm-2816	48	59	associated	associate	VERB
ajlm-2816	48	60	with	with	ADP
ajlm-2816	48	61	fn	fn	PROPN
ajlm-2816	48	62	.	.	PUNCT
ajlm-2816	49	1	the	the	DET
ajlm-2816	49	2	quantitative	quantitative	ADJ
ajlm-2816	49	3	data	datum	NOUN
ajlm-2816	49	4	extracted	extract	VERB
ajlm-2816	49	5	were	be	AUX
ajlm-2816	49	6	the	the	DET
ajlm-2816	49	7	number	number	NOUN
ajlm-2816	49	8	of	of	ADP
ajlm-2816	49	9	patients	patient	NOUN
ajlm-2816	49	10	,	,	PUNCT
ajlm-2816	49	11	the	the	DET
ajlm-2816	49	12	number	number	NOUN
ajlm-2816	49	13	of	of	ADP
ajlm-2816	49	14	isolates	isolate	NOUN
ajlm-2816	49	15	obtained	obtain	VERB
ajlm-2816	49	16	from	from	ADP
ajlm-2816	49	17	the	the	DET
ajlm-2816	49	18	blood	blood	NOUN
ajlm-2816	49	19	culture	culture	NOUN
ajlm-2816	49	20	,	,	PUNCT
ajlm-2816	49	21	the	the	DET
ajlm-2816	49	22	proportion	proportion	NOUN
ajlm-2816	49	23	of	of	ADP
ajlm-2816	49	24	blood	blood	NOUN
ajlm-2816	49	25	culture	culture	NOUN
ajlm-2816	49	26	positivity	positivity	NOUN
ajlm-2816	49	27	,	,	PUNCT
ajlm-2816	49	28	volume	volume	NOUN
ajlm-2816	49	29	of	of	ADP
ajlm-2816	49	30	blood	blood	NOUN
ajlm-2816	49	31	sampled	sample	VERB
ajlm-2816	49	32	for	for	ADP
ajlm-2816	49	33	microbiology	microbiology	NOUN
ajlm-2816	49	34	investigation	investigation	NOUN
ajlm-2816	49	35	,	,	PUNCT
ajlm-2816	49	36	antibiotic	antibiotic	ADJ
ajlm-2816	49	37	susceptibility	susceptibility	NOUN
ajlm-2816	49	38	,	,	PUNCT
ajlm-2816	49	39	and	and	CCONJ
ajlm-2816	49	40	patient	patient	ADJ
ajlm-2816	49	41	outcome	outcome	NOUN
ajlm-2816	49	42	.	.	PUNCT
ajlm-2816	50	1	discrepancies	discrepancy	NOUN
ajlm-2816	50	2	in	in	ADP
ajlm-2816	50	3	the	the	DET
ajlm-2816	50	4	data	datum	NOUN
ajlm-2816	50	5	extracted	extract	VERB
ajlm-2816	50	6	were	be	AUX
ajlm-2816	50	7	corrected	correct	VERB
ajlm-2816	50	8	by	by	ADP
ajlm-2816	50	9	referring	refer	VERB
ajlm-2816	50	10	to	to	ADP
ajlm-2816	50	11	the	the	DET
ajlm-2816	50	12	original	original	ADJ
ajlm-2816	50	13	studies	study	NOUN
ajlm-2816	50	14	.	.	PUNCT
ajlm-2816	51	1	data	datum	NOUN
ajlm-2816	51	2	analysis	analysis	NOUN
ajlm-2816	51	3	the	the	DET
ajlm-2816	51	4	data	datum	NOUN
ajlm-2816	51	5	on	on	ADP
ajlm-2816	51	6	isolates	isolate	NOUN
ajlm-2816	51	7	and	and	CCONJ
ajlm-2816	51	8	antibiotic	antibiotic	ADJ
ajlm-2816	51	9	susceptibility	susceptibility	NOUN
ajlm-2816	51	10	patterns	pattern	NOUN
ajlm-2816	51	11	were	be	AUX
ajlm-2816	51	12	aggregated	aggregate	VERB
ajlm-2816	51	13	from	from	ADP
ajlm-2816	51	14	the	the	DET
ajlm-2816	51	15	selected	select	VERB
ajlm-2816	51	16	articles	article	NOUN
ajlm-2816	51	17	and	and	CCONJ
ajlm-2816	51	18	presented	present	VERB
ajlm-2816	51	19	in	in	ADP
ajlm-2816	51	20	proportions	proportion	NOUN
ajlm-2816	51	21	.	.	PUNCT
ajlm-2816	52	1	risk	risk	NOUN
ajlm-2816	52	2	factors	factor	NOUN
ajlm-2816	52	3	for	for	ADP
ajlm-2816	52	4	fn	fn	NOUN
ajlm-2816	52	5	were	be	AUX
ajlm-2816	52	6	not	not	PART
ajlm-2816	52	7	included	include	VERB
ajlm-2816	52	8	in	in	ADP
ajlm-2816	52	9	this	this	DET
ajlm-2816	52	10	study	study	NOUN
ajlm-2816	52	11	,	,	PUNCT
ajlm-2816	52	12	because	because	SCONJ
ajlm-2816	52	13	of	of	ADP
ajlm-2816	52	14	the	the	DET
ajlm-2816	52	15	varied	varied	ADJ
ajlm-2816	52	16	study	study	NOUN
ajlm-2816	52	17	designs	design	NOUN
ajlm-2816	52	18	of	of	ADP
ajlm-2816	52	19	the	the	DET
ajlm-2816	52	20	eligible	eligible	ADJ
ajlm-2816	52	21	articles	article	NOUN
ajlm-2816	52	22	with	with	ADP
ajlm-2816	52	23	non	non	ADJ
ajlm-2816	52	24	-	-	ADJ
ajlm-2816	52	25	comparable	comparable	ADJ
ajlm-2816	52	26	study	study	NOUN
ajlm-2816	52	27	outcomes	outcome	NOUN
ajlm-2816	52	28	.	.	PUNCT
ajlm-2816	53	1	ethical	ethical	ADJ
ajlm-2816	53	2	considerations	consideration	NOUN
ajlm-2816	53	3	this	this	DET
ajlm-2816	53	4	article	article	NOUN
ajlm-2816	53	5	followed	follow	VERB
ajlm-2816	53	6	all	all	DET
ajlm-2816	53	7	ethical	ethical	ADJ
ajlm-2816	53	8	standards	standard	NOUN
ajlm-2816	53	9	for	for	ADP
ajlm-2816	53	10	research	research	NOUN
ajlm-2816	53	11	without	without	ADP
ajlm-2816	53	12	direct	direct	ADJ
ajlm-2816	53	13	contact	contact	NOUN
ajlm-2816	53	14	with	with	ADP
ajlm-2816	53	15	human	human	ADJ
ajlm-2816	53	16	or	or	CCONJ
ajlm-2816	53	17	animal	animal	NOUN
ajlm-2816	53	18	subjects	subject	NOUN
ajlm-2816	53	19	.	.	PUNCT
ajlm-2816	54	1	results	result	VERB
ajlm-2816	54	2	description	description	NOUN
ajlm-2816	54	3	of	of	ADP
ajlm-2816	54	4	eligible	eligible	ADJ
ajlm-2816	54	5	articles	article	NOUN
ajlm-2816	54	6	the	the	DET
ajlm-2816	54	7	article	article	NOUN
ajlm-2816	54	8	search	search	NOUN
ajlm-2816	54	9	done	do	VERB
ajlm-2816	54	10	in	in	ADP
ajlm-2816	54	11	february	february	PROPN
ajlm-2816	54	12	2024	2024	NUM
ajlm-2816	54	13	and	and	CCONJ
ajlm-2816	54	14	yielded	yield	VERB
ajlm-2816	54	15	a	a	DET
ajlm-2816	54	16	total	total	NOUN
ajlm-2816	54	17	of	of	ADP
ajlm-2816	54	18	16	16	NUM
ajlm-2816	54	19	637	637	NUM
ajlm-2816	54	20	articles	article	NOUN
ajlm-2816	54	21	from	from	ADP
ajlm-2816	54	22	the	the	DET
ajlm-2816	54	23	three	three	NUM
ajlm-2816	54	24	databases	database	NOUN
ajlm-2816	54	25	(	(	PUNCT
ajlm-2816	54	26	google	google	PROPN
ajlm-2816	54	27	scholar	scholar	NOUN
ajlm-2816	54	28	[	[	X
ajlm-2816	54	29	n	n	X
ajlm-2816	54	30	=	=	SYM
ajlm-2816	54	31	16	16	NUM
ajlm-2816	54	32	500	500	NUM
ajlm-2816	54	33	;	;	PUNCT
ajlm-2816	54	34	pubmed	pubmed	PROPN
ajlm-2816	54	35	[	[	X
ajlm-2816	54	36	n	n	X
ajlm-2816	54	37	=	=	SYM
ajlm-2816	54	38	103	103	NUM
ajlm-2816	54	39	]	]	PUNCT
ajlm-2816	54	40	;	;	PUNCT
ajlm-2816	55	1	african	african	ADJ
ajlm-2816	55	2	journals	journal	NOUN
ajlm-2816	55	3	online	online	VERB
ajlm-2816	56	1	[	[	X
ajlm-2816	56	2	n	n	X
ajlm-2816	56	3	=	=	SYM
ajlm-2816	56	4	34	34	NUM
ajlm-2816	56	5	]	]	PUNCT
ajlm-2816	56	6	)	)	PUNCT
ajlm-2816	56	7	,	,	PUNCT
ajlm-2816	56	8	of	of	ADP
ajlm-2816	56	9	which	which	PRON
ajlm-2816	56	10	13	13	NUM
ajlm-2816	56	11	eligible	eligible	ADJ
ajlm-2816	56	12	original	original	ADJ
ajlm-2816	56	13	articles	article	NOUN
ajlm-2816	56	14	were	be	AUX
ajlm-2816	56	15	selected	select	VERB
ajlm-2816	56	16	for	for	ADP
ajlm-2816	56	17	analysis	analysis	NOUN
ajlm-2816	56	18	.	.	PUNCT
ajlm-2816	57	1	an	an	DET
ajlm-2816	57	2	additional	additional	ADJ
ajlm-2816	57	3	two	two	NUM
ajlm-2816	57	4	articles17,18	articles17,18	NOUN
ajlm-2816	57	5	were	be	AUX
ajlm-2816	57	6	included	include	VERB
ajlm-2816	57	7	after	after	ADP
ajlm-2816	57	8	a	a	DET
ajlm-2816	57	9	manual	manual	ADJ
ajlm-2816	57	10	search	search	NOUN
ajlm-2816	57	11	of	of	ADP
ajlm-2816	57	12	the	the	DET
ajlm-2816	57	13	references	reference	NOUN
ajlm-2816	57	14	of	of	ADP
ajlm-2816	57	15	the	the	DET
ajlm-2816	57	16	13	13	NUM
ajlm-2816	57	17	eligible	eligible	ADJ
ajlm-2816	57	18	articles	article	NOUN
ajlm-2816	57	19	,	,	PUNCT
ajlm-2816	57	20	resulting	result	VERB
ajlm-2816	57	21	in	in	ADP
ajlm-2816	57	22	a	a	DET
ajlm-2816	57	23	total	total	NOUN
ajlm-2816	57	24	of	of	ADP
ajlm-2816	57	25	15	15	NUM
ajlm-2816	57	26	articles	article	NOUN
ajlm-2816	57	27	for	for	ADP
ajlm-2816	57	28	the	the	DET
ajlm-2816	57	29	synthesis	synthesis	NOUN
ajlm-2816	57	30	after	after	SCONJ
ajlm-2816	57	31	the	the	DET
ajlm-2816	57	32	selection	selection	NOUN
ajlm-2816	57	33	criteria	criterion	NOUN
ajlm-2816	57	34	were	be	AUX
ajlm-2816	57	35	applied	apply	VERB
ajlm-2816	57	36	.	.	PUNCT
ajlm-2816	58	1	the	the	DET
ajlm-2816	58	2	15	15	NUM
ajlm-2816	58	3	eligible	eligible	ADJ
ajlm-2816	58	4	studies	study	NOUN
ajlm-2816	58	5	were	be	AUX
ajlm-2816	58	6	from	from	ADP
ajlm-2816	58	7	nine	nine	NUM
ajlm-2816	58	8	countries	country	NOUN
ajlm-2816	58	9	,	,	PUNCT
ajlm-2816	58	10	including	include	VERB
ajlm-2816	58	11	egypt	egypt	PROPN
ajlm-2816	58	12	(	(	PUNCT
ajlm-2816	58	13	5	5	NUM
ajlm-2816	58	14	)	)	PUNCT
ajlm-2816	58	15	,	,	PUNCT
ajlm-2816	58	16	south	south	PROPN
ajlm-2816	58	17	africa	africa	PROPN
ajlm-2816	58	18	(	(	PUNCT
ajlm-2816	58	19	3	3	NUM
ajlm-2816	58	20	)	)	PUNCT
ajlm-2816	58	21	,	,	PUNCT
ajlm-2816	58	22	kenya	kenya	PROPN
ajlm-2816	58	23	(	(	PUNCT
ajlm-2816	58	24	1	1	NUM
ajlm-2816	58	25	)	)	PUNCT
ajlm-2816	58	26	,	,	PUNCT
ajlm-2816	58	27	sudan	sudan	PROPN
ajlm-2816	58	28	(	(	PUNCT
ajlm-2816	58	29	1	1	NUM
ajlm-2816	58	30	)	)	PUNCT
ajlm-2816	58	31	,	,	PUNCT
ajlm-2816	58	32	tunisia	tunisia	NOUN
ajlm-2816	58	33	(	(	PUNCT
ajlm-2816	58	34	1	1	NUM
ajlm-2816	58	35	)	)	PUNCT
ajlm-2816	58	36	,	,	PUNCT
ajlm-2816	58	37	ghana	ghana	PROPN
ajlm-2816	58	38	(	(	PUNCT
ajlm-2816	58	39	1	1	NUM
ajlm-2816	58	40	)	)	PUNCT
ajlm-2816	58	41	,	,	PUNCT
ajlm-2816	58	42	morocco	morocco	PROPN
ajlm-2816	58	43	(	(	PUNCT
ajlm-2816	58	44	1	1	NUM
ajlm-2816	58	45	)	)	PUNCT
ajlm-2816	58	46	,	,	PUNCT
ajlm-2816	58	47	ethiopia	ethiopia	PROPN
ajlm-2816	58	48	(	(	PUNCT
ajlm-2816	58	49	1	1	NUM
ajlm-2816	58	50	)	)	PUNCT
ajlm-2816	58	51	,	,	PUNCT
ajlm-2816	58	52	and	and	CCONJ
ajlm-2816	58	53	uganda	uganda	PROPN
ajlm-2816	58	54	(	(	PUNCT
ajlm-2816	58	55	1	1	NUM
ajlm-2816	58	56	)	)	PUNCT
ajlm-2816	58	57	(	(	PUNCT
ajlm-2816	58	58	figure	figure	NOUN
ajlm-2816	58	59	2	2	NUM
ajlm-2816	58	60	)	)	PUNCT
ajlm-2816	58	61	.	.	PUNCT
ajlm-2816	59	1	the	the	DET
ajlm-2816	59	2	studies	study	NOUN
ajlm-2816	59	3	were	be	AUX
ajlm-2816	59	4	conducted	conduct	VERB
ajlm-2816	59	5	between	between	ADP
ajlm-2816	59	6	1991	1991	NUM
ajlm-2816	59	7	and	and	CCONJ
ajlm-2816	59	8	2013	2013	NUM
ajlm-2816	59	9	(	(	PUNCT
ajlm-2816	59	10	figure	figure	NOUN
ajlm-2816	59	11	2	2	NUM
ajlm-2816	59	12	)	)	PUNCT
ajlm-2816	59	13	.	.	PUNCT
ajlm-2816	60	1	figure	figure	VERB
ajlm-2816	60	2	2	2	NUM
ajlm-2816	60	3	:	:	PUNCT
ajlm-2816	60	4	distribution	distribution	NOUN
ajlm-2816	60	5	and	and	CCONJ
ajlm-2816	60	6	number	number	NOUN
ajlm-2816	60	7	of	of	ADP
ajlm-2816	60	8	eligible	eligible	ADJ
ajlm-2816	60	9	articles	article	NOUN
ajlm-2816	60	10	about	about	ADP
ajlm-2816	60	11	febrile	febrile	NOUN
ajlm-2816	60	12	neutropenia	neutropenia	NOUN
ajlm-2816	60	13	in	in	ADP
ajlm-2816	60	14	africa	africa	PROPN
ajlm-2816	60	15	(	(	PUNCT
ajlm-2816	60	16	january	january	PROPN
ajlm-2816	60	17	1991	1991	NUM
ajlm-2816	60	18	to	to	ADP
ajlm-2816	60	19	december	december	PROPN
ajlm-2816	60	20	2024	2024	NUM
ajlm-2816	60	21	)	)	PUNCT
ajlm-2816	60	22	across	across	ADP
ajlm-2816	60	23	african	african	PROPN
ajlm-2816	60	24	union	union	PROPN
ajlm-2816	60	25	member	member	NOUN
ajlm-2816	60	26	states	state	NOUN
ajlm-2816	60	27	.	.	PUNCT
ajlm-2816	61	1	regions	region	NOUN
ajlm-2816	61	2	shown	show	VERB
ajlm-2816	61	3	are	be	AUX
ajlm-2816	61	4	as	as	ADP
ajlm-2816	61	5	defined	define	VERB
ajlm-2816	61	6	in	in	ADP
ajlm-2816	61	7	the	the	DET
ajlm-2816	61	8	organisation	organisation	NOUN
ajlm-2816	61	9	of	of	ADP
ajlm-2816	61	10	african	african	PROPN
ajlm-2816	61	11	union	union	NOUN
ajlm-2816	61	12	in	in	ADP
ajlm-2816	61	13	1976	1976	NUM
ajlm-2816	61	14	(	(	PUNCT
ajlm-2816	61	15	cm	cm	NOUN
ajlm-2816	61	16	/	/	SYM
ajlm-2816	61	17	res	re	NOUN
ajlm-2816	61	18	.	.	PUNCT
ajlm-2816	62	1	464qcxvi	464qcxvi	NOUN
ajlm-2816	62	2	)	)	PUNCT
ajlm-2816	62	3	.	.	PUNCT
ajlm-2816	63	1	the	the	DET
ajlm-2816	63	2	majority	majority	NOUN
ajlm-2816	63	3	of	of	ADP
ajlm-2816	63	4	the	the	DET
ajlm-2816	63	5	studies	study	NOUN
ajlm-2816	63	6	were	be	AUX
ajlm-2816	63	7	prospective	prospective	ADJ
ajlm-2816	63	8	(	(	PUNCT
ajlm-2816	63	9	10	10	NUM
ajlm-2816	63	10	studies	study	NOUN
ajlm-2816	63	11	;	;	PUNCT
ajlm-2816	63	12	66.7	66.7	NUM
ajlm-2816	63	13	%	%	NOUN
ajlm-2816	63	14	)	)	PUNCT
ajlm-2816	63	15	(	(	PUNCT
ajlm-2816	63	16	supplementary	supplementary	ADJ
ajlm-2816	63	17	table	table	NOUN
ajlm-2816	63	18	1	1	NUM
ajlm-2816	63	19	)	)	PUNCT
ajlm-2816	63	20	,	,	PUNCT
ajlm-2816	63	21	conducted	conduct	VERB
ajlm-2816	63	22	at	at	ADP
ajlm-2816	63	23	a	a	DET
ajlm-2816	63	24	single	single	ADJ
ajlm-2816	63	25	centre	centre	NOUN
ajlm-2816	63	26	(	(	PUNCT
ajlm-2816	63	27	14	14	NUM
ajlm-2816	63	28	studies	study	NOUN
ajlm-2816	63	29	;	;	PUNCT
ajlm-2816	63	30	93.3	93.3	NUM
ajlm-2816	63	31	%	%	NOUN
ajlm-2816	63	32	)	)	PUNCT
ajlm-2816	63	33	(	(	PUNCT
ajlm-2816	63	34	data	datum	NOUN
ajlm-2816	63	35	not	not	PART
ajlm-2816	63	36	shown	show	VERB
ajlm-2816	63	37	in	in	ADP
ajlm-2816	63	38	table	table	NOUN
ajlm-2816	63	39	)	)	PUNCT
ajlm-2816	63	40	.	.	PUNCT
ajlm-2816	64	1	many	many	ADJ
ajlm-2816	64	2	of	of	ADP
ajlm-2816	64	3	the	the	DET
ajlm-2816	64	4	eligible	eligible	ADJ
ajlm-2816	64	5	articles	article	NOUN
ajlm-2816	64	6	had	have	VERB
ajlm-2816	64	7	university	university	NOUN
ajlm-2816	64	8	teaching	teaching	NOUN
ajlm-2816	64	9	hospitals	hospital	NOUN
ajlm-2816	64	10	as	as	ADP
ajlm-2816	64	11	study	study	NOUN
ajlm-2816	64	12	locations	location	NOUN
ajlm-2816	64	13	(	(	PUNCT
ajlm-2816	64	14	seven	seven	NUM
ajlm-2816	64	15	studies	study	NOUN
ajlm-2816	64	16	;	;	PUNCT
ajlm-2816	64	17	46.7	46.7	NUM
ajlm-2816	64	18	%	%	NOUN
ajlm-2816	64	19	)	)	PUNCT
ajlm-2816	64	20	.	.	PUNCT
ajlm-2816	65	1	four	four	NUM
ajlm-2816	65	2	studies	study	NOUN
ajlm-2816	65	3	(	(	PUNCT
ajlm-2816	65	4	26.7	26.7	NUM
ajlm-2816	65	5	%	%	NOUN
ajlm-2816	65	6	)	)	PUNCT
ajlm-2816	65	7	were	be	AUX
ajlm-2816	65	8	from	from	ADP
ajlm-2816	65	9	cancer	cancer	NOUN
ajlm-2816	65	10	institutes	institute	NOUN
ajlm-2816	65	11	and	and	CCONJ
ajlm-2816	65	12	specialist	specialist	NOUN
ajlm-2816	65	13	hospitals	hospital	NOUN
ajlm-2816	65	14	.	.	PUNCT
ajlm-2816	66	1	six	six	NUM
ajlm-2816	66	2	studies	study	NOUN
ajlm-2816	66	3	(	(	PUNCT
ajlm-2816	66	4	40	40	NUM
ajlm-2816	66	5	%	%	NOUN
ajlm-2816	66	6	)	)	PUNCT
ajlm-2816	66	7	were	be	AUX
ajlm-2816	66	8	conducted	conduct	VERB
ajlm-2816	66	9	among	among	ADP
ajlm-2816	66	10	paediatric	paediatric	ADJ
ajlm-2816	66	11	patients	patient	NOUN
ajlm-2816	66	12	only	only	ADV
ajlm-2816	66	13	,	,	PUNCT
ajlm-2816	66	14	and	and	CCONJ
ajlm-2816	66	15	among	among	ADP
ajlm-2816	66	16	both	both	CCONJ
ajlm-2816	66	17	paediatric	paediatric	ADJ
ajlm-2816	66	18	and	and	CCONJ
ajlm-2816	66	19	adult	adult	NOUN
ajlm-2816	66	20	patients	patient	NOUN
ajlm-2816	66	21	,	,	PUNCT
ajlm-2816	66	22	while	while	SCONJ
ajlm-2816	66	23	two	two	NUM
ajlm-2816	66	24	studies	study	NOUN
ajlm-2816	66	25	(	(	PUNCT
ajlm-2816	66	26	13.3	13.3	NUM
ajlm-2816	66	27	%	%	NOUN
ajlm-2816	66	28	)	)	PUNCT
ajlm-2816	66	29	were	be	AUX
ajlm-2816	66	30	conducted	conduct	VERB
ajlm-2816	66	31	among	among	ADP
ajlm-2816	66	32	adult	adult	NOUN
ajlm-2816	66	33	patients	patient	NOUN
ajlm-2816	66	34	alone	alone	ADV
ajlm-2816	66	35	.	.	PUNCT
ajlm-2816	67	1	nine	nine	NUM
ajlm-2816	67	2	studies	study	NOUN
ajlm-2816	67	3	(	(	PUNCT
ajlm-2816	67	4	60.0	60.0	NUM
ajlm-2816	67	5	%	%	NOUN
ajlm-2816	67	6	)	)	PUNCT
ajlm-2816	67	7	were	be	AUX
ajlm-2816	67	8	conducted	conduct	VERB
ajlm-2816	67	9	among	among	ADP
ajlm-2816	67	10	a	a	DET
ajlm-2816	67	11	patient	patient	ADJ
ajlm-2816	67	12	population	population	NOUN
ajlm-2816	67	13	with	with	ADP
ajlm-2816	67	14	both	both	CCONJ
ajlm-2816	67	15	haematological	haematological	ADJ
ajlm-2816	67	16	and	and	CCONJ
ajlm-2816	67	17	solid	solid	ADJ
ajlm-2816	67	18	tumours	tumour	NOUN
ajlm-2816	67	19	,	,	PUNCT
ajlm-2816	67	20	and	and	CCONJ
ajlm-2816	67	21	two	two	NUM
ajlm-2816	67	22	studies	study	NOUN
ajlm-2816	67	23	(	(	PUNCT
ajlm-2816	67	24	13.3	13.3	NUM
ajlm-2816	67	25	%	%	NOUN
ajlm-2816	67	26	)	)	PUNCT
ajlm-2816	67	27	were	be	AUX
ajlm-2816	67	28	from	from	ADP
ajlm-2816	67	29	a	a	DET
ajlm-2816	67	30	population	population	NOUN
ajlm-2816	67	31	of	of	ADP
ajlm-2816	67	32	patients	patient	NOUN
ajlm-2816	67	33	with	with	ADP
ajlm-2816	67	34	stem	stem	NOUN
ajlm-2816	67	35	cell	cell	NOUN
ajlm-2816	67	36	transplantation	transplantation	NOUN
ajlm-2816	67	37	.	.	PUNCT
ajlm-2816	68	1	medical	medical	ADJ
ajlm-2816	68	2	microbiology	microbiology	NOUN
ajlm-2816	68	3	laboratory	laboratory	NOUN
ajlm-2816	68	4	methods	method	NOUN
ajlm-2816	68	5	the	the	DET
ajlm-2816	68	6	medical	medical	ADJ
ajlm-2816	68	7	microbiology	microbiology	NOUN
ajlm-2816	68	8	laboratory	laboratory	NOUN
ajlm-2816	68	9	methods	method	NOUN
ajlm-2816	68	10	used	use	VERB
ajlm-2816	68	11	were	be	AUX
ajlm-2816	68	12	stated	state	VERB
ajlm-2816	68	13	in	in	ADP
ajlm-2816	68	14	many	many	ADJ
ajlm-2816	68	15	of	of	ADP
ajlm-2816	68	16	the	the	DET
ajlm-2816	68	17	studies	study	NOUN
ajlm-2816	68	18	;	;	PUNCT
ajlm-2816	68	19	10	10	NUM
ajlm-2816	68	20	studies	study	NOUN
ajlm-2816	68	21	stated	state	VERB
ajlm-2816	68	22	the	the	DET
ajlm-2816	68	23	blood	blood	NOUN
ajlm-2816	68	24	culture	culture	NOUN
ajlm-2816	68	25	system	system	NOUN
ajlm-2816	68	26	used	use	VERB
ajlm-2816	68	27	(	(	PUNCT
ajlm-2816	68	28	automated	automate	VERB
ajlm-2816	68	29	blood	blood	NOUN
ajlm-2816	68	30	culture	culture	NOUN
ajlm-2816	68	31	system	system	NOUN
ajlm-2816	68	32	bactec	bactec	ADJ
ajlm-2816	68	33	/	/	SYM
ajlm-2816	68	34	bact	bact	NOUN
ajlm-2816	68	35	alert	alert	NOUN
ajlm-2816	68	36	,	,	PUNCT
ajlm-2816	68	37	n	n	NOUN
ajlm-2816	68	38	=	=	SYM
ajlm-2816	68	39	7	7	NUM
ajlm-2816	68	40	,	,	PUNCT
ajlm-2816	68	41	and	and	CCONJ
ajlm-2816	68	42	manual	manual	ADJ
ajlm-2816	68	43	/	/	SYM
ajlm-2816	68	44	conventional	conventional	ADJ
ajlm-2816	68	45	,	,	PUNCT
ajlm-2816	68	46	n	n	NOUN
ajlm-2816	68	47	=	=	SYM
ajlm-2816	68	48	3	3	NUM
ajlm-2816	68	49	)	)	PUNCT
ajlm-2816	68	50	.	.	PUNCT
ajlm-2816	69	1	ten	ten	NUM
ajlm-2816	69	2	studies	study	NOUN
ajlm-2816	69	3	stated	state	VERB
ajlm-2816	69	4	bacterial	bacterial	ADJ
ajlm-2816	69	5	identification	identification	NOUN
ajlm-2816	69	6	methods	method	NOUN
ajlm-2816	69	7	used	use	VERB
ajlm-2816	69	8	(	(	PUNCT
ajlm-2816	69	9	conventional	conventional	ADJ
ajlm-2816	69	10	biochemical	biochemical	ADJ
ajlm-2816	69	11	method	method	NOUN
ajlm-2816	69	12	only	only	ADV
ajlm-2816	69	13	,	,	PUNCT
ajlm-2816	69	14	n	n	PROPN
ajlm-2816	69	15	=	=	SYM
ajlm-2816	69	16	1	1	NUM
ajlm-2816	69	17	;	;	PUNCT
ajlm-2816	69	18	vitek	vitek	PROPN
ajlm-2816	69	19	,	,	PUNCT
ajlm-2816	69	20	n	n	NOUN
ajlm-2816	69	21	=	=	SYM
ajlm-2816	69	22	2	2	NUM
ajlm-2816	69	23	;	;	PUNCT
ajlm-2816	69	24	phoenix	phoenix	PROPN
ajlm-2816	69	25	,	,	PUNCT
ajlm-2816	69	26	n	n	NOUN
ajlm-2816	69	27	=	=	SYM
ajlm-2816	69	28	1	1	NUM
ajlm-2816	69	29	;	;	PUNCT
ajlm-2816	69	30	analytical	analytical	ADJ
ajlm-2816	69	31	profile	profile	NOUN
ajlm-2816	69	32	index	index	NOUN
ajlm-2816	70	1	[	[	X
ajlm-2816	70	2	api	api	NOUN
ajlm-2816	70	3	]	]	X
ajlm-2816	70	4	,	,	PUNCT
ajlm-2816	70	5	n	n	PROPN
ajlm-2816	70	6	=	=	SYM
ajlm-2816	70	7	2	2	NUM
ajlm-2816	70	8	;	;	PUNCT
ajlm-2816	70	9	sensititre	sensititre	NOUN
ajlm-2816	70	10	,	,	PUNCT
ajlm-2816	70	11	n	n	NOUN
ajlm-2816	70	12	=	=	SYM
ajlm-2816	70	13	1	1	NUM
ajlm-2816	70	14	;	;	PUNCT
ajlm-2816	70	15	microscan	microscan	ADJ
ajlm-2816	70	16	,	,	PUNCT
ajlm-2816	70	17	n	n	NOUN
ajlm-2816	70	18	=	=	SYM
ajlm-2816	70	19	2	2	NUM
ajlm-2816	70	20	;	;	PUNCT
ajlm-2816	70	21	bbl	bbl	PROPN
ajlm-2816	71	1	[	[	X
ajlm-2816	71	2	becton	becton	PROPN
ajlm-2816	71	3	dickinson	dickinson	PROPN
ajlm-2816	71	4	bioscience	bioscience	PROPN
ajlm-2816	71	5	]	]	PUNCT
ajlm-2816	71	6	crystal	crystal	PROPN
ajlm-2816	72	1	i	i	PROPN
ajlm-2816	72	2	d	d	PROPN
ajlm-2816	72	3	,	,	PUNCT
ajlm-2816	72	4	n	n	NOUN
ajlm-2816	72	5	=	=	SYM
ajlm-2816	72	6	1	1	NUM
ajlm-2816	72	7	)	)	PUNCT
ajlm-2816	72	8	.	.	PUNCT
ajlm-2816	73	1	antibiotic	antibiotic	ADJ
ajlm-2816	73	2	susceptibility	susceptibility	NOUN
ajlm-2816	73	3	testing	testing	NOUN
ajlm-2816	73	4	in	in	ADP
ajlm-2816	73	5	40	40	NUM
ajlm-2816	73	6	%	%	NOUN
ajlm-2816	73	7	(	(	PUNCT
ajlm-2816	73	8	6/11	6/11	NOUN
ajlm-2816	73	9	)	)	PUNCT
ajlm-2816	73	10	of	of	ADP
ajlm-2816	73	11	the	the	DET
ajlm-2816	73	12	studies	study	NOUN
ajlm-2816	73	13	was	be	AUX
ajlm-2816	73	14	by	by	ADP
ajlm-2816	73	15	disc	disc	NOUN
ajlm-2816	73	16	diffusion	diffusion	NOUN
ajlm-2816	73	17	methods	method	NOUN
ajlm-2816	73	18	(	(	PUNCT
ajlm-2816	73	19	supplementary	supplementary	ADJ
ajlm-2816	73	20	table	table	NOUN
ajlm-2816	73	21	1	1	NUM
ajlm-2816	73	22	)	)	PUNCT
ajlm-2816	73	23	.	.	PUNCT
ajlm-2816	74	1	bacteria	bacteria	NOUN
ajlm-2816	74	2	agents	agent	NOUN
ajlm-2816	74	3	the	the	DET
ajlm-2816	74	4	review	review	NOUN
ajlm-2816	74	5	included	include	VERB
ajlm-2816	74	6	2062	2062	NUM
ajlm-2816	74	7	patients	patient	NOUN
ajlm-2816	74	8	,	,	PUNCT
ajlm-2816	74	9	2106	2106	NUM
ajlm-2816	74	10	febrile	febrile	NOUN
ajlm-2816	74	11	episodes	episode	NOUN
ajlm-2816	74	12	and	and	CCONJ
ajlm-2816	74	13	a	a	DET
ajlm-2816	74	14	positive	positive	ADJ
ajlm-2816	74	15	blood	blood	NOUN
ajlm-2816	74	16	culture	culture	NOUN
ajlm-2816	74	17	rate	rate	NOUN
ajlm-2816	74	18	of	of	ADP
ajlm-2816	74	19	22.3	22.3	NUM
ajlm-2816	74	20	%	%	NOUN
ajlm-2816	74	21	(	(	PUNCT
ajlm-2816	74	22	1270/5675	1270/5675	NUM
ajlm-2816	74	23	)	)	PUNCT
ajlm-2816	74	24	(	(	PUNCT
ajlm-2816	74	25	table	table	NOUN
ajlm-2816	74	26	1	1	NUM
ajlm-2816	74	27	)	)	PUNCT
ajlm-2816	74	28	.	.	PUNCT
ajlm-2816	75	1	a	a	DET
ajlm-2816	75	2	total	total	NOUN
ajlm-2816	75	3	of	of	ADP
ajlm-2816	75	4	1216	1216	NUM
ajlm-2816	75	5	non	non	ADJ
ajlm-2816	75	6	-	-	ADJ
ajlm-2816	75	7	duplicate	duplicate	ADJ
ajlm-2816	75	8	isolates	isolate	NOUN
ajlm-2816	75	9	were	be	AUX
ajlm-2816	75	10	recovered	recover	VERB
ajlm-2816	75	11	from	from	ADP
ajlm-2816	75	12	the	the	DET
ajlm-2816	75	13	selected	select	VERB
ajlm-2816	75	14	studies	study	NOUN
ajlm-2816	75	15	,	,	PUNCT
ajlm-2816	75	16	of	of	ADP
ajlm-2816	75	17	which	which	PRON
ajlm-2816	75	18	57.0	57.0	NUM
ajlm-2816	75	19	%	%	NOUN
ajlm-2816	75	20	(	(	PUNCT
ajlm-2816	75	21	698/1225	698/1225	NUM
ajlm-2816	75	22	)	)	PUNCT
ajlm-2816	75	23	were	be	AUX
ajlm-2816	75	24	gram	gram	NOUN
ajlm-2816	75	25	-	-	PUNCT
ajlm-2816	75	26	positive	positive	ADJ
ajlm-2816	75	27	and	and	CCONJ
ajlm-2816	75	28	43.0	43.0	NUM
ajlm-2816	75	29	%	%	NOUN
ajlm-2816	75	30	(	(	PUNCT
ajlm-2816	75	31	527/1225	527/1225	NUM
ajlm-2816	75	32	)	)	PUNCT
ajlm-2816	75	33	were	be	AUX
ajlm-2816	75	34	gram	gram	NOUN
ajlm-2816	75	35	-	-	PUNCT
ajlm-2816	75	36	negative	negative	ADJ
ajlm-2816	75	37	isolates	isolate	NOUN
ajlm-2816	75	38	.	.	PUNCT
ajlm-2816	76	1	the	the	DET
ajlm-2816	76	2	most	most	ADV
ajlm-2816	76	3	common	common	ADJ
ajlm-2816	76	4	isolates	isolate	NOUN
ajlm-2816	76	5	were	be	AUX
ajlm-2816	76	6	coagulase	coagulase	ADJ
ajlm-2816	76	7	-	-	PUNCT
ajlm-2816	76	8	negative	negative	ADJ
ajlm-2816	76	9	staphylococcus	staphylococcus	NOUN
ajlm-2816	76	10	spp	spp	NOUN
ajlm-2816	76	11	.	.	PUNCT
ajlm-2816	77	1	(	(	PUNCT
ajlm-2816	77	2	cons	con	NOUN
ajlm-2816	77	3	;	;	PUNCT
ajlm-2816	77	4	n	n	PROPN
ajlm-2816	77	5	=	=	SYM
ajlm-2816	77	6	281	281	NUM
ajlm-2816	77	7	;	;	PUNCT
ajlm-2816	77	8	2.9	2.9	NUM
ajlm-2816	77	9	%	%	NOUN
ajlm-2816	77	10	)	)	PUNCT
ajlm-2816	77	11	;	;	PUNCT
ajlm-2816	77	12	staphylococcus	staphylococcus	NOUN
ajlm-2816	77	13	aureus	aureus	NOUN
ajlm-2816	77	14	(	(	PUNCT
ajlm-2816	77	15	n	n	NOUN
ajlm-2816	77	16	=	=	SYM
ajlm-2816	77	17	153	153	NUM
ajlm-2816	77	18	;	;	PUNCT
ajlm-2816	77	19	12.5	12.5	NUM
ajlm-2816	77	20	%	%	NOUN
ajlm-2816	77	21	)	)	PUNCT
ajlm-2816	77	22	;	;	PUNCT
ajlm-2816	77	23	klebsiella	klebsiella	PROPN
ajlm-2816	77	24	spp	spp	PROPN
ajlm-2816	77	25	.	.	PUNCT
ajlm-2816	78	1	(	(	PUNCT
ajlm-2816	78	2	n	n	NOUN
ajlm-2816	78	3	=	=	SYM
ajlm-2816	78	4	126	126	NUM
ajlm-2816	78	5	;	;	PUNCT
ajlm-2816	78	6	10.3	10.3	NUM
ajlm-2816	78	7	%	%	NOUN
ajlm-2816	78	8	)	)	PUNCT
ajlm-2816	78	9	;	;	PUNCT
ajlm-2816	78	10	escherichia	escherichia	NOUN
ajlm-2816	78	11	coli	coli	NOUN
ajlm-2816	78	12	(	(	PUNCT
ajlm-2816	78	13	n	n	NOUN
ajlm-2816	78	14	=	=	SYM
ajlm-2816	78	15	99	99	NUM
ajlm-2816	78	16	;	;	PUNCT
ajlm-2816	78	17	8.1	8.1	NUM
ajlm-2816	78	18	%	%	NOUN
ajlm-2816	78	19	)	)	PUNCT
ajlm-2816	78	20	;	;	PUNCT
ajlm-2816	78	21	streptococcus	streptococcus	VERB
ajlm-2816	78	22	spp	spp	NOUN
ajlm-2816	78	23	.	.	PUNCT
ajlm-2816	79	1	(	(	PUNCT
ajlm-2816	79	2	n	n	NOUN
ajlm-2816	79	3	=	=	SYM
ajlm-2816	79	4	87	87	NUM
ajlm-2816	79	5	;	;	PUNCT
ajlm-2816	79	6	7.1	7.1	NUM
ajlm-2816	79	7	%	%	NOUN
ajlm-2816	79	8	)	)	PUNCT
ajlm-2816	79	9	;	;	PUNCT
ajlm-2816	79	10	acinetobacter	acinetobacter	PROPN
ajlm-2816	79	11	spp	spp	NOUN
ajlm-2816	79	12	.	.	PUNCT
ajlm-2816	80	1	(	(	PUNCT
ajlm-2816	80	2	n	n	NOUN
ajlm-2816	80	3	=	=	SYM
ajlm-2816	80	4	74	74	NUM
ajlm-2816	80	5	;	;	PUNCT
ajlm-2816	80	6	6.0	6.0	NUM
ajlm-2816	80	7	%	%	NOUN
ajlm-2816	80	8	)	)	PUNCT
ajlm-2816	80	9	and	and	CCONJ
ajlm-2816	80	10	pseudomonas	pseudomona	VERB
ajlm-2816	80	11	spp	spp	NOUN
ajlm-2816	80	12	.	.	PUNCT
ajlm-2816	81	1	(	(	PUNCT
ajlm-2816	81	2	n	n	NOUN
ajlm-2816	81	3	=	=	SYM
ajlm-2816	81	4	69	69	NUM
ajlm-2816	81	5	;	;	PUNCT
ajlm-2816	81	6	5.6	5.6	NUM
ajlm-2816	81	7	%	%	NOUN
ajlm-2816	81	8	)	)	PUNCT
ajlm-2816	81	9	.	.	PUNCT
ajlm-2816	82	1	table	table	NOUN
ajlm-2816	82	2	1	1	NUM
ajlm-2816	82	3	:	:	PUNCT
ajlm-2816	82	4	 	 	SPACE
ajlm-2816	82	5	blood	blood	NOUN
ajlm-2816	82	6	culture	culture	NOUN
ajlm-2816	82	7	isolates	isolate	NOUN
ajlm-2816	82	8	from	from	ADP
ajlm-2816	82	9	15	15	NUM
ajlm-2816	82	10	studies	study	NOUN
ajlm-2816	82	11	on	on	ADP
ajlm-2816	82	12	febrile	febrile	NOUN
ajlm-2816	82	13	neutropaenia	neutropaenia	NOUN
ajlm-2816	82	14	in	in	ADP
ajlm-2816	82	15	africa	africa	PROPN
ajlm-2816	82	16	,	,	PUNCT
ajlm-2816	82	17	1991–2024	1991–2024	NUM
ajlm-2816	82	18	.	.	PUNCT
ajlm-2816	83	1	antibiotic	antibiotic	ADJ
ajlm-2816	83	2	susceptibility	susceptibility	NOUN
ajlm-2816	83	3	patterns	pattern	VERB
ajlm-2816	83	4	antibiotic	antibiotic	ADJ
ajlm-2816	83	5	susceptibility	susceptibility	NOUN
ajlm-2816	83	6	patterns	pattern	NOUN
ajlm-2816	83	7	were	be	AUX
ajlm-2816	83	8	reported	report	VERB
ajlm-2816	83	9	in	in	ADP
ajlm-2816	83	10	11	11	NUM
ajlm-2816	83	11	studies	study	NOUN
ajlm-2816	83	12	(	(	PUNCT
ajlm-2816	83	13	supplementary	supplementary	ADJ
ajlm-2816	83	14	table	table	NOUN
ajlm-2816	83	15	2	2	NUM
ajlm-2816	83	16	)	)	PUNCT
ajlm-2816	83	17	.	.	PUNCT
ajlm-2816	84	1	of	of	ADP
ajlm-2816	84	2	these	these	DET
ajlm-2816	84	3	studies	study	NOUN
ajlm-2816	84	4	,	,	PUNCT
ajlm-2816	84	5	four	four	NUM
ajlm-2816	84	6	reported	report	VERB
ajlm-2816	84	7	the	the	DET
ajlm-2816	84	8	antibiotic	antibiotic	ADJ
ajlm-2816	84	9	susceptibility	susceptibility	NOUN
ajlm-2816	84	10	patterns	pattern	NOUN
ajlm-2816	84	11	based	base	VERB
ajlm-2816	84	12	on	on	ADP
ajlm-2816	84	13	the	the	DET
ajlm-2816	84	14	isolated	isolated	ADJ
ajlm-2816	84	15	organisms	organism	NOUN
ajlm-2816	84	16	tested,18,20,25,27	tested,18,20,25,27	VERB
ajlm-2816	84	17	four	four	NUM
ajlm-2816	84	18	articles	article	NOUN
ajlm-2816	84	19	reported	report	VERB
ajlm-2816	84	20	the	the	DET
ajlm-2816	84	21	antibiotic	antibiotic	ADJ
ajlm-2816	84	22	susceptibility	susceptibility	NOUN
ajlm-2816	84	23	based	base	VERB
ajlm-2816	84	24	on	on	ADP
ajlm-2816	84	25	gram	gram	NOUN
ajlm-2816	84	26	reactions	reaction	NOUN
ajlm-2816	84	27	of	of	ADP
ajlm-2816	84	28	the	the	DET
ajlm-2816	84	29	isolated	isolated	ADJ
ajlm-2816	84	30	organisms,17,19,24,28	organisms,17,19,24,28	NOUN
ajlm-2816	84	31	and	and	CCONJ
ajlm-2816	84	32	three	three	NUM
ajlm-2816	84	33	studies	study	NOUN
ajlm-2816	84	34	reported	report	VERB
ajlm-2816	84	35	the	the	DET
ajlm-2816	84	36	proportion	proportion	NOUN
ajlm-2816	84	37	of	of	ADP
ajlm-2816	84	38	resistance	resistance	NOUN
ajlm-2816	84	39	to	to	ADP
ajlm-2816	84	40	tested	test	VERB
ajlm-2816	84	41	antibiotics	antibiotic	NOUN
ajlm-2816	84	42	only	only	ADV
ajlm-2816	84	43	without	without	ADP
ajlm-2816	84	44	disaggregation	disaggregation	NOUN
ajlm-2816	84	45	-	-	PUNCT
ajlm-2816	84	46	based	base	VERB
ajlm-2816	84	47	isolated	isolate	VERB
ajlm-2816	84	48	organisms.22,23,29	organisms.22,23,29	ADV
ajlm-2816	84	49	the	the	DET
ajlm-2816	84	50	overall	overall	ADJ
ajlm-2816	84	51	rates	rate	NOUN
ajlm-2816	84	52	of	of	ADP
ajlm-2816	84	53	antibiotic	antibiotic	ADJ
ajlm-2816	84	54	resistance	resistance	NOUN
ajlm-2816	84	55	to	to	ADP
ajlm-2816	84	56	antibiotics	antibiotic	NOUN
ajlm-2816	84	57	used	use	VERB
ajlm-2816	84	58	for	for	ADP
ajlm-2816	84	59	gram	gram	NOUN
ajlm-2816	84	60	-	-	PUNCT
ajlm-2816	84	61	negative	negative	ADJ
ajlm-2816	84	62	bacteria	bacteria	NOUN
ajlm-2816	84	63	included	include	VERB
ajlm-2816	84	64	ertapenem	ertapenem	PROPN
ajlm-2816	84	65	(	(	PUNCT
ajlm-2816	84	66	1.9	1.9	NUM
ajlm-2816	84	67	%	%	NOUN
ajlm-2816	84	68	;	;	PUNCT
ajlm-2816	84	69	1/52	1/52	NUM
ajlm-2816	84	70	)	)	PUNCT
ajlm-2816	84	71	,	,	PUNCT
ajlm-2816	84	72	meropenem	meropenem	PROPN
ajlm-2816	84	73	(	(	PUNCT
ajlm-2816	84	74	2.1	2.1	NUM
ajlm-2816	84	75	%	%	NOUN
ajlm-2816	84	76	;	;	PUNCT
ajlm-2816	84	77	3/142	3/142	NUM
ajlm-2816	84	78	)	)	PUNCT
ajlm-2816	84	79	,	,	PUNCT
ajlm-2816	84	80	cefepime	cefepime	X
ajlm-2816	84	81	(	(	PUNCT
ajlm-2816	84	82	32.8	32.8	NUM
ajlm-2816	84	83	%	%	NOUN
ajlm-2816	84	84	;	;	PUNCT
ajlm-2816	84	85	141/430	141/430	PROPN
ajlm-2816	84	86	)	)	PUNCT
ajlm-2816	84	87	,	,	PUNCT
ajlm-2816	84	88	piperacillin	piperacillin	NOUN
ajlm-2816	84	89	/	/	SYM
ajlm-2816	84	90	tazobactam	tazobactam	NOUN
ajlm-2816	84	91	(	(	PUNCT
ajlm-2816	84	92	40.9	40.9	NUM
ajlm-2816	84	93	%	%	NOUN
ajlm-2816	84	94	;	;	PUNCT
ajlm-2816	84	95	133/325	133/325	PROPN
ajlm-2816	84	96	)	)	PUNCT
ajlm-2816	84	97	,	,	PUNCT
ajlm-2816	84	98	tobramycin	tobramycin	NOUN
ajlm-2816	84	99	(	(	PUNCT
ajlm-2816	84	100	4.8	4.8	NUM
ajlm-2816	84	101	%	%	NOUN
ajlm-2816	84	102	;	;	PUNCT
ajlm-2816	84	103	3/63	3/63	NUM
ajlm-2816	84	104	)	)	PUNCT
ajlm-2816	84	105	,	,	PUNCT
ajlm-2816	84	106	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2816	84	107	(	(	PUNCT
ajlm-2816	84	108	35.5	35.5	NUM
ajlm-2816	84	109	%	%	NOUN
ajlm-2816	84	110	;	;	PUNCT
ajlm-2816	84	111	184/519	184/519	NUM
ajlm-2816	84	112	)	)	PUNCT
ajlm-2816	84	113	,	,	PUNCT
ajlm-2816	84	114	and	and	CCONJ
ajlm-2816	84	115	colistin	colistin	NOUN
ajlm-2816	84	116	(	(	PUNCT
ajlm-2816	84	117	12.5	12.5	NUM
ajlm-2816	84	118	%	%	NOUN
ajlm-2816	84	119	;	;	PUNCT
ajlm-2816	84	120	7/56	7/56	NUM
ajlm-2816	84	121	)	)	PUNCT
ajlm-2816	84	122	.	.	PUNCT
ajlm-2816	85	1	the	the	DET
ajlm-2816	85	2	pulled	pull	VERB
ajlm-2816	85	3	antibiotic	antibiotic	ADJ
ajlm-2816	85	4	resistance	resistance	NOUN
ajlm-2816	85	5	rate	rate	NOUN
ajlm-2816	85	6	for	for	ADP
ajlm-2816	85	7	antibiotics	antibiotic	NOUN
ajlm-2816	85	8	used	use	VERB
ajlm-2816	85	9	for	for	ADP
ajlm-2816	85	10	gram	gram	NOUN
ajlm-2816	85	11	-	-	PUNCT
ajlm-2816	85	12	positive	positive	ADJ
ajlm-2816	85	13	bacteria	bacteria	NOUN
ajlm-2816	85	14	included	include	VERB
ajlm-2816	85	15	amoxicillin	amoxicillin	PROPN
ajlm-2816	85	16	/	/	SYM
ajlm-2816	85	17	clavulanic	clavulanic	ADJ
ajlm-2816	85	18	acid	acid	NOUN
ajlm-2816	85	19	(	(	PUNCT
ajlm-2816	85	20	71.8	71.8	NUM
ajlm-2816	85	21	%	%	NOUN
ajlm-2816	85	22	;	;	PUNCT
ajlm-2816	85	23	163/227	163/227	NUM
ajlm-2816	85	24	)	)	PUNCT
ajlm-2816	85	25	,	,	PUNCT
ajlm-2816	85	26	vancomycin	vancomycin	PROPN
ajlm-2816	85	27	(	(	PUNCT
ajlm-2816	85	28	2.8	2.8	NUM
ajlm-2816	85	29	%	%	NOUN
ajlm-2816	85	30	;	;	PUNCT
ajlm-2816	85	31	7/321	7/321	NUM
ajlm-2816	85	32	)	)	PUNCT
ajlm-2816	85	33	,	,	PUNCT
ajlm-2816	85	34	clindamycin	clindamycin	NOUN
ajlm-2816	85	35	(	(	PUNCT
ajlm-2816	85	36	50.7	50.7	NUM
ajlm-2816	85	37	%	%	NOUN
ajlm-2816	85	38	;	;	PUNCT
ajlm-2816	85	39	37/73	37/73	NUM
ajlm-2816	85	40	)	)	PUNCT
ajlm-2816	85	41	,	,	PUNCT
ajlm-2816	85	42	and	and	CCONJ
ajlm-2816	85	43	linezolid	linezolid	NOUN
ajlm-2816	85	44	(	(	PUNCT
ajlm-2816	85	45	2.8	2.8	NUM
ajlm-2816	85	46	%	%	NOUN
ajlm-2816	85	47	;	;	PUNCT
ajlm-2816	85	48	1/30	1/30	NUM
ajlm-2816	85	49	)	)	PUNCT
ajlm-2816	85	50	.	.	PUNCT
ajlm-2816	86	1	antibiotic	antibiotic	ADJ
ajlm-2816	86	2	resistance	resistance	NOUN
ajlm-2816	86	3	profile	profile	NOUN
ajlm-2816	86	4	for	for	ADP
ajlm-2816	86	5	the	the	DET
ajlm-2816	86	6	most	most	ADV
ajlm-2816	86	7	prevalent	prevalent	ADJ
ajlm-2816	86	8	bacteria	bacteria	NOUN
ajlm-2816	86	9	to	to	ADP
ajlm-2816	86	10	the	the	DET
ajlm-2816	86	11	tested	test	VERB
ajlm-2816	86	12	antibiotics	antibiotic	NOUN
ajlm-2816	86	13	,	,	PUNCT
ajlm-2816	86	14	66.7	66.7	NUM
ajlm-2816	86	15	%	%	NOUN
ajlm-2816	86	16	(	(	PUNCT
ajlm-2816	86	17	8/12	8/12	NUM
ajlm-2816	86	18	)	)	PUNCT
ajlm-2816	86	19	of	of	ADP
ajlm-2816	86	20	cons	con	NOUN
ajlm-2816	86	21	isolates	isolate	NOUN
ajlm-2816	86	22	were	be	AUX
ajlm-2816	86	23	resistant	resistant	ADJ
ajlm-2816	86	24	to	to	ADP
ajlm-2816	86	25	oxacillin	oxacillin	PROPN
ajlm-2816	86	26	/	/	SYM
ajlm-2816	86	27	methicillin	methicillin	NOUN
ajlm-2816	86	28	,	,	PUNCT
ajlm-2816	86	29	mostly	mostly	ADV
ajlm-2816	86	30	susceptible	susceptible	ADJ
ajlm-2816	86	31	to	to	ADP
ajlm-2816	86	32	vancomycin	vancomycin	PROPN
ajlm-2816	86	33	(	(	PUNCT
ajlm-2816	86	34	resistance	resistance	NOUN
ajlm-2816	86	35	rate	rate	NOUN
ajlm-2816	86	36	5.3	5.3	NUM
ajlm-2816	86	37	%	%	NOUN
ajlm-2816	86	38	;	;	PUNCT
ajlm-2816	86	39	2/38	2/38	NUM
ajlm-2816	86	40	)	)	PUNCT
ajlm-2816	86	41	,	,	PUNCT
ajlm-2816	86	42	and	and	CCONJ
ajlm-2816	86	43	susceptible	susceptible	ADJ
ajlm-2816	86	44	to	to	ADP
ajlm-2816	86	45	linezolid	linezolid	NOUN
ajlm-2816	86	46	(	(	PUNCT
ajlm-2816	86	47	table	table	NOUN
ajlm-2816	86	48	2	2	NUM
ajlm-2816	86	49	)	)	PUNCT
ajlm-2816	86	50	.	.	PUNCT
ajlm-2816	87	1	in	in	ADP
ajlm-2816	87	2	the	the	DET
ajlm-2816	87	3	same	same	ADJ
ajlm-2816	87	4	manner	manner	NOUN
ajlm-2816	87	5	,	,	PUNCT
ajlm-2816	87	6	s.	s.	PROPN
ajlm-2816	87	7	aureus	aureus	PROPN
ajlm-2816	87	8	isolates	isolate	NOUN
ajlm-2816	87	9	were	be	AUX
ajlm-2816	87	10	highly	highly	ADV
ajlm-2816	87	11	resistant	resistant	ADJ
ajlm-2816	87	12	to	to	ADP
ajlm-2816	87	13	oxacillin	oxacillin	PROPN
ajlm-2816	87	14	/	/	SYM
ajlm-2816	87	15	methicillin	methicillin	NOUN
ajlm-2816	87	16	(	(	PUNCT
ajlm-2816	87	17	68.8	68.8	NUM
ajlm-2816	87	18	%	%	NOUN
ajlm-2816	87	19	;	;	PUNCT
ajlm-2816	87	20	22/32	22/32	NUM
ajlm-2816	87	21	)	)	PUNCT
ajlm-2816	87	22	,	,	PUNCT
ajlm-2816	87	23	and	and	CCONJ
ajlm-2816	87	24	were	be	AUX
ajlm-2816	87	25	mostly	mostly	ADV
ajlm-2816	87	26	susceptible	susceptible	ADJ
ajlm-2816	87	27	to	to	ADP
ajlm-2816	87	28	vancomycin	vancomycin	PROPN
ajlm-2816	87	29	(	(	PUNCT
ajlm-2816	87	30	10.0	10.0	NUM
ajlm-2816	87	31	%	%	NOUN
ajlm-2816	87	32	;	;	PUNCT
ajlm-2816	87	33	1/10	1/10	NUM
ajlm-2816	87	34	)	)	PUNCT
ajlm-2816	87	35	.	.	PUNCT
ajlm-2816	88	1	klebsiella	klebsiella	PROPN
ajlm-2816	88	2	spp	spp	PROPN
ajlm-2816	88	3	.	.	PUNCT
ajlm-2816	89	1	isolates	isolate	NOUN
ajlm-2816	89	2	were	be	AUX
ajlm-2816	89	3	mostly	mostly	ADV
ajlm-2816	89	4	resistant	resistant	ADJ
ajlm-2816	89	5	to	to	ADP
ajlm-2816	89	6	ampicillin	ampicillin	NOUN
ajlm-2816	89	7	(	(	PUNCT
ajlm-2816	89	8	93.8	93.8	NUM
ajlm-2816	89	9	%	%	NOUN
ajlm-2816	89	10	;	;	PUNCT
ajlm-2816	89	11	15/16	15/16	NUM
ajlm-2816	89	12	)	)	PUNCT
ajlm-2816	89	13	,	,	PUNCT
ajlm-2816	89	14	piperacillin	piperacillin	NOUN
ajlm-2816	89	15	/	/	SYM
ajlm-2816	89	16	tazobactam	tazobactam	NOUN
ajlm-2816	89	17	(	(	PUNCT
ajlm-2816	89	18	85.7	85.7	NUM
ajlm-2816	89	19	%	%	NOUN
ajlm-2816	89	20	;	;	PUNCT
ajlm-2816	89	21	6/7	6/7	NUM
ajlm-2816	89	22	)	)	PUNCT
ajlm-2816	89	23	,	,	PUNCT
ajlm-2816	89	24	and	and	CCONJ
ajlm-2816	89	25	third	third	ADJ
ajlm-2816	89	26	-	-	PUNCT
ajlm-2816	89	27	generation	generation	NOUN
ajlm-2816	89	28	cephalosporins	cephalosporin	NOUN
ajlm-2816	89	29	(	(	PUNCT
ajlm-2816	89	30	75.9	75.9	NUM
ajlm-2816	89	31	%	%	NOUN
ajlm-2816	89	32	;	;	PUNCT
ajlm-2816	89	33	22/29	22/29	NUM
ajlm-2816	89	34	)	)	PUNCT
ajlm-2816	89	35	,	,	PUNCT
ajlm-2816	89	36	and	and	CCONJ
ajlm-2816	89	37	a	a	DET
ajlm-2816	89	38	quarter	quarter	NOUN
ajlm-2816	89	39	(	(	PUNCT
ajlm-2816	89	40	4/16	4/16	NUM
ajlm-2816	89	41	)	)	PUNCT
ajlm-2816	89	42	showed	show	VERB
ajlm-2816	89	43	resistance	resistance	NOUN
ajlm-2816	89	44	to	to	ADP
ajlm-2816	89	45	the	the	DET
ajlm-2816	89	46	carbapenems	carbapenem	NOUN
ajlm-2816	89	47	.	.	PUNCT
ajlm-2816	90	1	escherichia	escherichia	NOUN
ajlm-2816	90	2	coli	coli	NOUN
ajlm-2816	90	3	showed	show	VERB
ajlm-2816	90	4	similar	similar	ADJ
ajlm-2816	90	5	high	high	ADJ
ajlm-2816	90	6	resistance	resistance	NOUN
ajlm-2816	90	7	to	to	ADP
ajlm-2816	90	8	ceftazidime	ceftazidime	NOUN
ajlm-2816	90	9	(	(	PUNCT
ajlm-2816	90	10	72.7	72.7	NUM
ajlm-2816	90	11	%	%	NOUN
ajlm-2816	90	12	;	;	PUNCT
ajlm-2816	90	13	8/11	8/11	NUM
ajlm-2816	90	14	)	)	PUNCT
ajlm-2816	90	15	,	,	PUNCT
ajlm-2816	90	16	and	and	CCONJ
ajlm-2816	90	17	other	other	ADJ
ajlm-2816	90	18	third	third	ADJ
ajlm-2816	90	19	-	-	PUNCT
ajlm-2816	90	20	generation	generation	NOUN
ajlm-2816	90	21	cephalosporins	cephalosporin	NOUN
ajlm-2816	90	22	(	(	PUNCT
ajlm-2816	90	23	66.7	66.7	NUM
ajlm-2816	90	24	%	%	NOUN
ajlm-2816	90	25	;	;	PUNCT
ajlm-2816	90	26	24/36	24/36	NUM
ajlm-2816	90	27	)	)	PUNCT
ajlm-2816	90	28	.	.	PUNCT
ajlm-2816	91	1	non	non	NOUN
ajlm-2816	91	2	-	-	NOUN
ajlm-2816	91	3	fermenters	fermenter	NOUN
ajlm-2816	91	4	such	such	ADJ
ajlm-2816	91	5	as	as	ADP
ajlm-2816	91	6	acinetobacter	acinetobacter	ADJ
ajlm-2816	91	7	spp	spp	NOUN
ajlm-2816	91	8	.	.	PUNCT
ajlm-2816	91	9	showed	show	VERB
ajlm-2816	91	10	resistance	resistance	NOUN
ajlm-2816	91	11	rates	rate	NOUN
ajlm-2816	91	12	of	of	ADP
ajlm-2816	91	13	between	between	ADP
ajlm-2816	91	14	50	50	NUM
ajlm-2816	91	15	%	%	NOUN
ajlm-2816	91	16	and	and	CCONJ
ajlm-2816	91	17	100	100	NUM
ajlm-2816	91	18	%	%	NOUN
ajlm-2816	91	19	to	to	ADP
ajlm-2816	91	20	tested	test	VERB
ajlm-2816	91	21	antibiotics	antibiotic	NOUN
ajlm-2816	91	22	,	,	PUNCT
ajlm-2816	91	23	including	include	VERB
ajlm-2816	91	24	gentamicin	gentamicin	NOUN
ajlm-2816	91	25	and	and	CCONJ
ajlm-2816	91	26	ciprofloxacin	ciprofloxacin	NOUN
ajlm-2816	91	27	.	.	PUNCT
ajlm-2816	92	1	however	however	ADV
ajlm-2816	92	2	,	,	PUNCT
ajlm-2816	92	3	pseudomonas	pseudomonas	PROPN
ajlm-2816	92	4	spp	spp	NOUN
ajlm-2816	92	5	.	.	PUNCT
ajlm-2816	92	6	showed	show	VERB
ajlm-2816	92	7	low	low	ADJ
ajlm-2816	92	8	resistance	resistance	NOUN
ajlm-2816	92	9	to	to	ADP
ajlm-2816	92	10	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2816	92	11	(	(	PUNCT
ajlm-2816	92	12	7.7	7.7	NUM
ajlm-2816	92	13	%	%	NOUN
ajlm-2816	92	14	;	;	PUNCT
ajlm-2816	92	15	1/13	1/13	NUM
ajlm-2816	92	16	)	)	PUNCT
ajlm-2816	92	17	.	.	PUNCT
ajlm-2816	93	1	table	table	NOUN
ajlm-2816	93	2	2	2	NUM
ajlm-2816	93	3	:	:	PUNCT
ajlm-2816	93	4	 	 	SPACE
ajlm-2816	93	5	antibiotic	antibiotic	ADJ
ajlm-2816	93	6	resistance	resistance	NOUN
ajlm-2816	93	7	to	to	ADP
ajlm-2816	93	8	commonest	commonest	NOUN
ajlm-2816	93	9	isolates	isolate	NOUN
ajlm-2816	93	10	in	in	ADP
ajlm-2816	93	11	febrile	febrile	NOUN
ajlm-2816	93	12	neutropaenia	neutropaenia	NOUN
ajlm-2816	93	13	in	in	ADP
ajlm-2816	93	14	africa	africa	PROPN
ajlm-2816	93	15	,	,	PUNCT
ajlm-2816	93	16	january	january	PROPN
ajlm-2816	93	17	1991	1991	NUM
ajlm-2816	93	18	to	to	ADP
ajlm-2816	93	19	december	december	PROPN
ajlm-2816	93	20	2024	2024	NUM
ajlm-2816	93	21	.	.	PUNCT
ajlm-2816	94	1	discussion	discussion	NOUN
ajlm-2816	94	2	febrile	febrile	NOUN
ajlm-2816	94	3	neutropaenia	neutropaenia	NOUN
ajlm-2816	94	4	is	be	AUX
ajlm-2816	94	5	a	a	DET
ajlm-2816	94	6	medical	medical	ADJ
ajlm-2816	94	7	emergency	emergency	NOUN
ajlm-2816	94	8	with	with	ADP
ajlm-2816	94	9	attending	attend	VERB
ajlm-2816	94	10	consequences	consequence	NOUN
ajlm-2816	94	11	of	of	ADP
ajlm-2816	94	12	morbidity	morbidity	NOUN
ajlm-2816	94	13	,	,	PUNCT
ajlm-2816	94	14	mortality	mortality	NOUN
ajlm-2816	94	15	and	and	CCONJ
ajlm-2816	94	16	economic	economic	ADJ
ajlm-2816	94	17	burden	burden	NOUN
ajlm-2816	94	18	on	on	ADP
ajlm-2816	94	19	both	both	CCONJ
ajlm-2816	94	20	the	the	DET
ajlm-2816	94	21	patients	patient	NOUN
ajlm-2816	94	22	and	and	CCONJ
ajlm-2816	94	23	healthcare	healthcare	NOUN
ajlm-2816	94	24	systems	system	NOUN
ajlm-2816	94	25	globally	globally	ADV
ajlm-2816	94	26	.	.	PUNCT
ajlm-2816	95	1	the	the	DET
ajlm-2816	95	2	consequences	consequence	NOUN
ajlm-2816	95	3	of	of	ADP
ajlm-2816	95	4	fn	fn	NOUN
ajlm-2816	95	5	are	be	AUX
ajlm-2816	95	6	further	far	ADV
ajlm-2816	95	7	made	make	VERB
ajlm-2816	95	8	difficult	difficult	ADJ
ajlm-2816	95	9	to	to	PART
ajlm-2816	95	10	deal	deal	VERB
ajlm-2816	95	11	with	with	ADP
ajlm-2816	95	12	as	as	SCONJ
ajlm-2816	95	13	the	the	DET
ajlm-2816	95	14	evolution	evolution	NOUN
ajlm-2816	95	15	of	of	ADP
ajlm-2816	95	16	antimicrobial	antimicrobial	ADJ
ajlm-2816	95	17	resistance	resistance	NOUN
ajlm-2816	95	18	escalates	escalate	VERB
ajlm-2816	95	19	in	in	ADP
ajlm-2816	95	20	lmics	lmic	NOUN
ajlm-2816	95	21	amid	amid	ADP
ajlm-2816	95	22	a	a	DET
ajlm-2816	95	23	dilapidating	dilapidate	VERB
ajlm-2816	95	24	healthcare	healthcare	NOUN
ajlm-2816	95	25	system	system	NOUN
ajlm-2816	95	26	,	,	PUNCT
ajlm-2816	95	27	complicated	complicate	VERB
ajlm-2816	95	28	with	with	ADP
ajlm-2816	95	29	layered	layered	ADJ
ajlm-2816	95	30	drivers	driver	NOUN
ajlm-2816	95	31	of	of	ADP
ajlm-2816	95	32	antibiotic	antibiotic	ADJ
ajlm-2816	95	33	overuse	overuse	NOUN
ajlm-2816	95	34	and	and	CCONJ
ajlm-2816	95	35	limited	limited	ADJ
ajlm-2816	95	36	/	/	SYM
ajlm-2816	95	37	absolute	absolute	ADJ
ajlm-2816	95	38	access	access	NOUN
ajlm-2816	95	39	to	to	PART
ajlm-2816	95	40	recommended	recommend	VERB
ajlm-2816	95	41	newer	new	ADJ
ajlm-2816	95	42	antibiotics	antibiotic	NOUN
ajlm-2816	95	43	appropriate	appropriate	ADJ
ajlm-2816	95	44	for	for	ADP
ajlm-2816	95	45	treating	treat	VERB
ajlm-2816	95	46	mdr	mdr	PROPN
ajlm-2816	95	47	infections.31	infections.31	PROPN
ajlm-2816	95	48	while	while	SCONJ
ajlm-2816	95	49	various	various	ADJ
ajlm-2816	95	50	international	international	ADJ
ajlm-2816	95	51	guides	guide	NOUN
ajlm-2816	95	52	on	on	ADP
ajlm-2816	95	53	the	the	DET
ajlm-2816	95	54	management	management	NOUN
ajlm-2816	95	55	of	of	ADP
ajlm-2816	95	56	fn	fn	NOUN
ajlm-2816	95	57	have	have	AUX
ajlm-2816	95	58	been	be	AUX
ajlm-2816	95	59	published	publish	VERB
ajlm-2816	95	60	,	,	PUNCT
ajlm-2816	95	61	many	many	ADJ
ajlm-2816	95	62	lmics	lmic	NOUN
ajlm-2816	95	63	are	be	AUX
ajlm-2816	95	64	yet	yet	ADV
ajlm-2816	95	65	to	to	PART
ajlm-2816	95	66	develop	develop	VERB
ajlm-2816	95	67	their	their	PRON
ajlm-2816	95	68	local	local	ADJ
ajlm-2816	95	69	guidelines	guideline	NOUN
ajlm-2816	95	70	.	.	PUNCT
ajlm-2816	96	1	this	this	PRON
ajlm-2816	96	2	may	may	AUX
ajlm-2816	96	3	hamper	hamper	VERB
ajlm-2816	96	4	the	the	DET
ajlm-2816	96	5	management	management	NOUN
ajlm-2816	96	6	of	of	ADP
ajlm-2816	96	7	fn	fn	NOUN
ajlm-2816	96	8	in	in	ADP
ajlm-2816	96	9	these	these	DET
ajlm-2816	96	10	resource	resource	NOUN
ajlm-2816	96	11	-	-	PUNCT
ajlm-2816	96	12	constrained	constrain	VERB
ajlm-2816	96	13	settings	setting	NOUN
ajlm-2816	96	14	,	,	PUNCT
ajlm-2816	96	15	where	where	SCONJ
ajlm-2816	96	16	management	management	NOUN
ajlm-2816	96	17	of	of	ADP
ajlm-2816	96	18	fn	fn	NOUN
ajlm-2816	96	19	infections	infection	NOUN
ajlm-2816	96	20	depends	depend	VERB
ajlm-2816	96	21	largely	largely	ADV
ajlm-2816	96	22	on	on	ADP
ajlm-2816	96	23	empiric	empiric	ADJ
ajlm-2816	96	24	antibiotic	antibiotic	ADJ
ajlm-2816	96	25	therapy	therapy	NOUN
ajlm-2816	96	26	without	without	ADP
ajlm-2816	96	27	recourse	recourse	NOUN
ajlm-2816	96	28	to	to	ADP
ajlm-2816	96	29	the	the	DET
ajlm-2816	96	30	local	local	ADJ
ajlm-2816	96	31	epidemiological	epidemiological	ADJ
ajlm-2816	96	32	data	datum	NOUN
ajlm-2816	96	33	and	and	CCONJ
ajlm-2816	96	34	laboratory	laboratory	NOUN
ajlm-2816	96	35	diagnostic	diagnostic	ADJ
ajlm-2816	96	36	capacity	capacity	NOUN
ajlm-2816	96	37	.	.	PUNCT
ajlm-2816	97	1	the	the	DET
ajlm-2816	97	2	burden	burden	NOUN
ajlm-2816	97	3	of	of	ADP
ajlm-2816	97	4	fn	fn	PROPN
ajlm-2816	97	5	in	in	ADP
ajlm-2816	97	6	africa	africa	PROPN
ajlm-2816	97	7	might	might	AUX
ajlm-2816	97	8	not	not	PART
ajlm-2816	97	9	be	be	AUX
ajlm-2816	97	10	fully	fully	ADV
ajlm-2816	97	11	described	describe	VERB
ajlm-2816	97	12	because	because	SCONJ
ajlm-2816	97	13	of	of	ADP
ajlm-2816	97	14	the	the	DET
ajlm-2816	97	15	paucity	paucity	NOUN
ajlm-2816	97	16	of	of	ADP
ajlm-2816	97	17	data	datum	NOUN
ajlm-2816	97	18	from	from	ADP
ajlm-2816	97	19	this	this	DET
ajlm-2816	97	20	region	region	NOUN
ajlm-2816	97	21	.	.	PUNCT
ajlm-2816	98	1	this	this	DET
ajlm-2816	98	2	review	review	NOUN
ajlm-2816	98	3	highlighted	highlight	VERB
ajlm-2816	98	4	the	the	DET
ajlm-2816	98	5	low	low	ADJ
ajlm-2816	98	6	data	data	NOUN
ajlm-2816	98	7	output	output	NOUN
ajlm-2816	98	8	on	on	ADP
ajlm-2816	98	9	fn	fn	NOUN
ajlm-2816	98	10	compared	compare	VERB
ajlm-2816	98	11	to	to	ADP
ajlm-2816	98	12	other	other	ADJ
ajlm-2816	98	13	regions	region	NOUN
ajlm-2816	98	14	,	,	PUNCT
ajlm-2816	98	15	such	such	ADJ
ajlm-2816	98	16	as	as	ADP
ajlm-2816	98	17	high	high	ADJ
ajlm-2816	98	18	-	-	PUNCT
ajlm-2816	98	19	income	income	NOUN
ajlm-2816	98	20	countries	country	NOUN
ajlm-2816	98	21	,	,	PUNCT
ajlm-2816	98	22	where	where	SCONJ
ajlm-2816	98	23	oncology	oncology	NOUN
ajlm-2816	98	24	practice	practice	NOUN
ajlm-2816	98	25	is	be	AUX
ajlm-2816	98	26	more	more	ADV
ajlm-2816	98	27	advanced	advanced	ADJ
ajlm-2816	98	28	,	,	PUNCT
ajlm-2816	98	29	and	and	CCONJ
ajlm-2816	98	30	is	be	AUX
ajlm-2816	98	31	prioritised	prioritise	VERB
ajlm-2816	98	32	to	to	PART
ajlm-2816	98	33	be	be	AUX
ajlm-2816	98	34	included	include	VERB
ajlm-2816	98	35	in	in	ADP
ajlm-2816	98	36	their	their	PRON
ajlm-2816	98	37	health	health	NOUN
ajlm-2816	98	38	-	-	PUNCT
ajlm-2816	98	39	benefit	benefit	NOUN
ajlm-2816	98	40	package	package	NOUN
ajlm-2816	98	41	for	for	ADP
ajlm-2816	98	42	the	the	DET
ajlm-2816	98	43	public	public	ADJ
ajlm-2816	98	44	health	health	NOUN
ajlm-2816	98	45	sector	sector	NOUN
ajlm-2816	98	46	,	,	PUNCT
ajlm-2816	98	47	as	as	SCONJ
ajlm-2816	98	48	there	there	PRON
ajlm-2816	98	49	was	be	VERB
ajlm-2816	98	50	no	no	DET
ajlm-2816	98	51	eligible	eligible	ADJ
ajlm-2816	98	52	study	study	NOUN
ajlm-2816	98	53	for	for	ADP
ajlm-2816	98	54	this	this	DET
ajlm-2816	98	55	review	review	NOUN
ajlm-2816	98	56	in	in	ADP
ajlm-2816	98	57	the	the	DET
ajlm-2816	98	58	last	last	ADJ
ajlm-2816	98	59	decade	decade	NOUN
ajlm-2816	98	60	from	from	ADP
ajlm-2816	98	61	africa.32	africa.32	PROPN
ajlm-2816	98	62	in	in	ADP
ajlm-2816	98	63	addition	addition	NOUN
ajlm-2816	98	64	to	to	ADP
ajlm-2816	98	65	this	this	PRON
ajlm-2816	98	66	,	,	PUNCT
ajlm-2816	98	67	there	there	PRON
ajlm-2816	98	68	is	be	VERB
ajlm-2816	98	69	skewness	skewness	NOUN
ajlm-2816	98	70	to	to	ADP
ajlm-2816	98	71	the	the	DET
ajlm-2816	98	72	data	datum	NOUN
ajlm-2816	98	73	on	on	ADP
ajlm-2816	98	74	fn	fn	PROPN
ajlm-2816	98	75	in	in	ADP
ajlm-2816	98	76	africa	africa	PROPN
ajlm-2816	98	77	,	,	PUNCT
ajlm-2816	98	78	as	as	SCONJ
ajlm-2816	98	79	the	the	DET
ajlm-2816	98	80	north	north	PROPN
ajlm-2816	98	81	africa	africa	PROPN
ajlm-2816	98	82	region	region	PROPN
ajlm-2816	98	83	and	and	CCONJ
ajlm-2816	98	84	east	east	PROPN
ajlm-2816	98	85	and	and	CCONJ
ajlm-2816	98	86	southern	southern	PROPN
ajlm-2816	98	87	africa	africa	PROPN
ajlm-2816	98	88	were	be	AUX
ajlm-2816	98	89	equally	equally	ADV
ajlm-2816	98	90	represented	represent	VERB
ajlm-2816	98	91	with	with	ADP
ajlm-2816	98	92	seven	seven	NUM
ajlm-2816	98	93	eligible	eligible	ADJ
ajlm-2816	98	94	articles	article	NOUN
ajlm-2816	98	95	,	,	PUNCT
ajlm-2816	98	96	and	and	CCONJ
ajlm-2816	98	97	west	west	NOUN
ajlm-2816	98	98	and	and	CCONJ
ajlm-2816	98	99	central	central	PROPN
ajlm-2816	98	100	africa	africa	PROPN
ajlm-2816	98	101	region	region	PROPN
ajlm-2816	98	102	had	have	VERB
ajlm-2816	98	103	one	one	NUM
ajlm-2816	98	104	eligible	eligible	ADJ
ajlm-2816	98	105	article	article	NOUN
ajlm-2816	98	106	,	,	PUNCT
ajlm-2816	98	107	which	which	PRON
ajlm-2816	98	108	reflects	reflect	VERB
ajlm-2816	98	109	on	on	ADP
ajlm-2816	98	110	the	the	DET
ajlm-2816	98	111	quality	quality	NOUN
ajlm-2816	98	112	of	of	ADP
ajlm-2816	98	113	health	health	NOUN
ajlm-2816	98	114	investment	investment	NOUN
ajlm-2816	98	115	and	and	CCONJ
ajlm-2816	98	116	sophistication	sophistication	NOUN
ajlm-2816	98	117	in	in	ADP
ajlm-2816	98	118	healthcare	healthcare	NOUN
ajlm-2816	98	119	systems	system	NOUN
ajlm-2816	98	120	available	available	ADJ
ajlm-2816	98	121	from	from	ADP
ajlm-2816	98	122	these	these	DET
ajlm-2816	98	123	regions.1	regions.1	NOUN
ajlm-2816	98	124	this	this	DET
ajlm-2816	98	125	review	review	NOUN
ajlm-2816	98	126	also	also	ADV
ajlm-2816	98	127	corroborates	corroborate	VERB
ajlm-2816	98	128	the	the	DET
ajlm-2816	98	129	already	already	ADV
ajlm-2816	98	130	documented	document	VERB
ajlm-2816	98	131	health	health	NOUN
ajlm-2816	98	132	disparity	disparity	NOUN
ajlm-2816	98	133	divide	divide	NOUN
ajlm-2816	98	134	across	across	ADP
ajlm-2816	98	135	the	the	DET
ajlm-2816	98	136	human	human	PROPN
ajlm-2816	98	137	development	development	NOUN
ajlm-2816	98	138	index	index	NOUN
ajlm-2816	98	139	that	that	PRON
ajlm-2816	98	140	exists	exist	VERB
ajlm-2816	98	141	between	between	ADP
ajlm-2816	98	142	high	high	ADJ
ajlm-2816	98	143	-	-	PUNCT
ajlm-2816	98	144	income	income	NOUN
ajlm-2816	98	145	countries	country	NOUN
ajlm-2816	98	146	and	and	CCONJ
ajlm-2816	98	147	lmics	lmic	NOUN
ajlm-2816	98	148	in	in	ADP
ajlm-2816	98	149	healthcare	healthcare	NOUN
ajlm-2816	98	150	systems	system	NOUN
ajlm-2816	98	151	and	and	CCONJ
ajlm-2816	98	152	deliveries.32	deliveries.32	NOUN
ajlm-2816	98	153	there	there	PRON
ajlm-2816	98	154	is	be	VERB
ajlm-2816	98	155	a	a	DET
ajlm-2816	98	156	need	need	NOUN
ajlm-2816	98	157	for	for	ADP
ajlm-2816	98	158	more	more	ADJ
ajlm-2816	98	159	composite	composite	ADJ
ajlm-2816	98	160	data	datum	NOUN
ajlm-2816	98	161	on	on	ADP
ajlm-2816	98	162	fn	fn	PROPN
ajlm-2816	98	163	in	in	ADP
ajlm-2816	98	164	africa	africa	PROPN
ajlm-2816	98	165	through	through	ADP
ajlm-2816	98	166	research	research	NOUN
ajlm-2816	98	167	,	,	PUNCT
ajlm-2816	98	168	funding	funding	NOUN
ajlm-2816	98	169	,	,	PUNCT
ajlm-2816	98	170	and	and	CCONJ
ajlm-2816	98	171	improved	improve	VERB
ajlm-2816	98	172	transparent	transparent	ADJ
ajlm-2816	98	173	health	health	NOUN
ajlm-2816	98	174	systems	system	NOUN
ajlm-2816	98	175	,	,	PUNCT
ajlm-2816	98	176	in	in	ADP
ajlm-2816	98	177	addition	addition	NOUN
ajlm-2816	98	178	to	to	ADP
ajlm-2816	98	179	data	data	NOUN
ajlm-2816	98	180	infrastructures	infrastructure	NOUN
ajlm-2816	98	181	to	to	PART
ajlm-2816	98	182	bridge	bridge	VERB
ajlm-2816	98	183	the	the	DET
ajlm-2816	98	184	cancer	cancer	NOUN
ajlm-2816	98	185	care	care	NOUN
ajlm-2816	98	186	inequalities.1	inequalities.1	ADP
ajlm-2816	98	187	blood	blood	NOUN
ajlm-2816	98	188	cultures	culture	NOUN
ajlm-2816	98	189	are	be	AUX
ajlm-2816	98	190	a	a	DET
ajlm-2816	98	191	highly	highly	ADV
ajlm-2816	98	192	dependent	dependent	ADJ
ajlm-2816	98	193	test	test	NOUN
ajlm-2816	98	194	for	for	ADP
ajlm-2816	98	195	the	the	DET
ajlm-2816	98	196	investigation	investigation	NOUN
ajlm-2816	98	197	of	of	ADP
ajlm-2816	98	198	bloodstream	bloodstream	NOUN
ajlm-2816	98	199	infections	infection	NOUN
ajlm-2816	98	200	,	,	PUNCT
ajlm-2816	98	201	including	include	VERB
ajlm-2816	98	202	fn	fn	NOUN
ajlm-2816	98	203	in	in	ADP
ajlm-2816	98	204	clinical	clinical	ADJ
ajlm-2816	98	205	microbiology	microbiology	NOUN
ajlm-2816	98	206	laboratories.33,34	laboratories.33,34	NOUN
ajlm-2816	98	207	however	however	ADV
ajlm-2816	98	208	,	,	PUNCT
ajlm-2816	98	209	the	the	DET
ajlm-2816	98	210	procedure	procedure	NOUN
ajlm-2816	98	211	is	be	AUX
ajlm-2816	98	212	limited	limit	VERB
ajlm-2816	98	213	by	by	ADP
ajlm-2816	98	214	frequent	frequent	ADJ
ajlm-2816	98	215	contamination	contamination	NOUN
ajlm-2816	98	216	,	,	PUNCT
ajlm-2816	98	217	as	as	SCONJ
ajlm-2816	98	218	up	up	ADP
ajlm-2816	98	219	to	to	ADP
ajlm-2816	98	220	a	a	DET
ajlm-2816	98	221	third	third	ADJ
ajlm-2816	98	222	to	to	PART
ajlm-2816	98	223	half	half	NOUN
ajlm-2816	98	224	of	of	ADP
ajlm-2816	98	225	all	all	DET
ajlm-2816	98	226	blood	blood	NOUN
ajlm-2816	98	227	cultures	culture	NOUN
ajlm-2816	98	228	are	be	AUX
ajlm-2816	98	229	judged	judge	VERB
ajlm-2816	98	230	to	to	PART
ajlm-2816	98	231	be	be	AUX
ajlm-2816	98	232	contaminants	contaminant	NOUN
ajlm-2816	98	233	by	by	ADP
ajlm-2816	98	234	infectious	infectious	ADJ
ajlm-2816	98	235	diseases	disease	NOUN
ajlm-2816	98	236	physicians	physician	NOUN
ajlm-2816	98	237	.	.	PUNCT
ajlm-2816	99	1	the	the	DET
ajlm-2816	99	2	principal	principal	ADJ
ajlm-2816	99	3	source	source	NOUN
ajlm-2816	99	4	of	of	ADP
ajlm-2816	99	5	the	the	DET
ajlm-2816	99	6	contaminants	contaminant	NOUN
ajlm-2816	99	7	is	be	AUX
ajlm-2816	99	8	from	from	ADP
ajlm-2816	99	9	the	the	DET
ajlm-2816	99	10	dermis	dermis	NOUN
ajlm-2816	99	11	commensals	commensal	NOUN
ajlm-2816	99	12	such	such	ADJ
ajlm-2816	99	13	as	as	ADP
ajlm-2816	99	14	cons	con	NOUN
ajlm-2816	99	15	,	,	PUNCT
ajlm-2816	99	16	corynebacterium	corynebacterium	PROPN
ajlm-2816	99	17	spp	spp	PROPN
ajlm-2816	99	18	.	.	PROPN
ajlm-2816	99	19	,	,	PUNCT
ajlm-2816	99	20	bacillus	bacillus	NOUN
ajlm-2816	99	21	spp	spp	NOUN
ajlm-2816	99	22	,	,	PUNCT
ajlm-2816	99	23	micrococcus	micrococcus	NOUN
ajlm-2816	99	24	spp	spp	NOUN
ajlm-2816	99	25	.	.	PROPN
ajlm-2816	99	26	,	,	PUNCT
ajlm-2816	99	27	and	and	CCONJ
ajlm-2816	99	28	cutibacterium	cutibacterium	ADJ
ajlm-2816	99	29	spp	spp	NOUN
ajlm-2816	99	30	.	.	PUNCT
ajlm-2816	100	1	because	because	SCONJ
ajlm-2816	100	2	of	of	ADP
ajlm-2816	100	3	poor	poor	ADJ
ajlm-2816	100	4	disinfection	disinfection	NOUN
ajlm-2816	100	5	of	of	ADP
ajlm-2816	100	6	the	the	DET
ajlm-2816	100	7	skin.35	skin.35	NOUN
ajlm-2816	100	8	in	in	ADP
ajlm-2816	100	9	this	this	DET
ajlm-2816	100	10	review	review	NOUN
ajlm-2816	100	11	,	,	PUNCT
ajlm-2816	100	12	cons	con	NOUN
ajlm-2816	100	13	(	(	PUNCT
ajlm-2816	100	14	9	9	NUM
ajlm-2816	100	15	of	of	ADP
ajlm-2816	100	16	15	15	NUM
ajlm-2816	100	17	studies	study	NOUN
ajlm-2816	100	18	)	)	PUNCT
ajlm-2816	100	19	accounted	account	VERB
ajlm-2816	100	20	for	for	ADP
ajlm-2816	100	21	over	over	ADP
ajlm-2816	100	22	a	a	PRON
ajlm-2816	100	23	fifth	fifth	ADJ
ajlm-2816	100	24	(	(	PUNCT
ajlm-2816	100	25	23.1	23.1	NUM
ajlm-2816	100	26	%	%	NOUN
ajlm-2816	100	27	)	)	PUNCT
ajlm-2816	100	28	of	of	ADP
ajlm-2816	100	29	the	the	DET
ajlm-2816	100	30	total	total	ADJ
ajlm-2816	100	31	isolates	isolate	NOUN
ajlm-2816	100	32	,	,	PUNCT
ajlm-2816	100	33	which	which	PRON
ajlm-2816	100	34	is	be	AUX
ajlm-2816	100	35	similar	similar	ADJ
ajlm-2816	100	36	to	to	ADP
ajlm-2816	100	37	the	the	DET
ajlm-2816	100	38	contamination	contamination	NOUN
ajlm-2816	100	39	rate	rate	NOUN
ajlm-2816	100	40	(	(	PUNCT
ajlm-2816	100	41	23.0	23.0	NUM
ajlm-2816	100	42	%	%	NOUN
ajlm-2816	100	43	)	)	PUNCT
ajlm-2816	100	44	reported	report	VERB
ajlm-2816	100	45	by	by	ADP
ajlm-2816	100	46	rupp	rupp	PROPN
ajlm-2816	100	47	et	et	PROPN
ajlm-2816	100	48	al.36	al.36	NOUN
ajlm-2816	100	49	this	this	PRON
ajlm-2816	100	50	may	may	AUX
ajlm-2816	100	51	underscore	underscore	VERB
ajlm-2816	100	52	the	the	DET
ajlm-2816	100	53	issue	issue	NOUN
ajlm-2816	100	54	of	of	ADP
ajlm-2816	100	55	contamination	contamination	NOUN
ajlm-2816	100	56	,	,	PUNCT
ajlm-2816	100	57	which	which	PRON
ajlm-2816	100	58	is	be	AUX
ajlm-2816	100	59	a	a	DET
ajlm-2816	100	60	major	major	ADJ
ajlm-2816	100	61	problem	problem	NOUN
ajlm-2816	100	62	in	in	ADP
ajlm-2816	100	63	blood	blood	NOUN
ajlm-2816	100	64	culture	culture	NOUN
ajlm-2816	100	65	tests	test	NOUN
ajlm-2816	100	66	.	.	PUNCT
ajlm-2816	101	1	while	while	SCONJ
ajlm-2816	101	2	blood	blood	NOUN
ajlm-2816	101	3	culture	culture	NOUN
ajlm-2816	101	4	is	be	AUX
ajlm-2816	101	5	the	the	DET
ajlm-2816	101	6	‘	'	PUNCT
ajlm-2816	101	7	gold	gold	ADJ
ajlm-2816	101	8	standard	standard	NOUN
ajlm-2816	101	9	’	'	PUNCT
ajlm-2816	101	10	for	for	ADP
ajlm-2816	101	11	the	the	DET
ajlm-2816	101	12	investigation	investigation	NOUN
ajlm-2816	101	13	of	of	ADP
ajlm-2816	101	14	blood	blood	NOUN
ajlm-2816	101	15	stream	stream	NOUN
ajlm-2816	101	16	infections	infection	NOUN
ajlm-2816	101	17	,	,	PUNCT
ajlm-2816	101	18	its	its	PRON
ajlm-2816	101	19	accuracy	accuracy	NOUN
ajlm-2816	101	20	hinges	hinge	NOUN
ajlm-2816	101	21	on	on	ADP
ajlm-2816	101	22	effective	effective	ADJ
ajlm-2816	101	23	compliance	compliance	NOUN
ajlm-2816	101	24	with	with	ADP
ajlm-2816	101	25	the	the	DET
ajlm-2816	101	26	aseptic	aseptic	ADJ
ajlm-2816	101	27	techniques	technique	NOUN
ajlm-2816	101	28	through	through	ADP
ajlm-2816	101	29	the	the	DET
ajlm-2816	101	30	preand	preand	NOUN
ajlm-2816	101	31	analytical	analytical	ADJ
ajlm-2816	101	32	stages	stage	NOUN
ajlm-2816	101	33	of	of	ADP
ajlm-2816	101	34	the	the	DET
ajlm-2816	101	35	procedure	procedure	NOUN
ajlm-2816	101	36	(	(	PUNCT
ajlm-2816	101	37	i.e.	i.e.	X
ajlm-2816	101	38	the	the	DET
ajlm-2816	101	39	selection	selection	NOUN
ajlm-2816	101	40	of	of	ADP
ajlm-2816	101	41	body	body	NOUN
ajlm-2816	101	42	site	site	NOUN
ajlm-2816	101	43	for	for	ADP
ajlm-2816	101	44	sampling	sample	VERB
ajlm-2816	101	45	,	,	PUNCT
ajlm-2816	101	46	aseptic	aseptic	ADJ
ajlm-2816	101	47	cleaning	cleaning	NOUN
ajlm-2816	101	48	of	of	ADP
ajlm-2816	101	49	the	the	DET
ajlm-2816	101	50	venipuncture	venipuncture	NOUN
ajlm-2816	101	51	site	site	NOUN
ajlm-2816	101	52	,	,	PUNCT
ajlm-2816	101	53	use	use	NOUN
ajlm-2816	101	54	of	of	ADP
ajlm-2816	101	55	trained	train	VERB
ajlm-2816	101	56	phlebotomist	phlebotomist	NOUN
ajlm-2816	101	57	and	and	CCONJ
ajlm-2816	101	58	downing	downing	NOUN
ajlm-2816	101	59	of	of	ADP
ajlm-2816	101	60	personal	personal	ADJ
ajlm-2816	101	61	protective	protective	ADJ
ajlm-2816	101	62	equipment).35	equipment).35	NOUN
ajlm-2816	101	63	these	these	PRON
ajlm-2816	101	64	underpin	underpin	VERB
ajlm-2816	101	65	the	the	DET
ajlm-2816	101	66	need	need	NOUN
ajlm-2816	101	67	for	for	ADP
ajlm-2816	101	68	specialised	specialised	ADJ
ajlm-2816	101	69	training	training	NOUN
ajlm-2816	101	70	for	for	ADP
ajlm-2816	101	71	blood	blood	NOUN
ajlm-2816	101	72	culture	culture	NOUN
ajlm-2816	101	73	sample	sample	NOUN
ajlm-2816	101	74	collection	collection	NOUN
ajlm-2816	101	75	to	to	PART
ajlm-2816	101	76	improve	improve	VERB
ajlm-2816	101	77	the	the	DET
ajlm-2816	101	78	quality	quality	NOUN
ajlm-2816	101	79	of	of	ADP
ajlm-2816	101	80	diagnostic	diagnostic	ADJ
ajlm-2816	101	81	stewardship	stewardship	NOUN
ajlm-2816	101	82	in	in	ADP
ajlm-2816	101	83	the	the	DET
ajlm-2816	101	84	diagnoses	diagnosis	NOUN
ajlm-2816	101	85	of	of	ADP
ajlm-2816	101	86	fn	fn	NOUN
ajlm-2816	101	87	,	,	PUNCT
ajlm-2816	101	88	isolating	isolate	VERB
ajlm-2816	101	89	the	the	DET
ajlm-2816	101	90	pathogen	pathogen	NOUN
ajlm-2816	101	91	involved	involve	VERB
ajlm-2816	101	92	to	to	PART
ajlm-2816	101	93	ensure	ensure	VERB
ajlm-2816	101	94	targeted	targeted	ADJ
ajlm-2816	101	95	therapy	therapy	NOUN
ajlm-2816	101	96	for	for	ADP
ajlm-2816	101	97	the	the	DET
ajlm-2816	101	98	treatment	treatment	NOUN
ajlm-2816	101	99	and	and	CCONJ
ajlm-2816	101	100	improve	improve	VERB
ajlm-2816	101	101	treatment	treatment	NOUN
ajlm-2816	101	102	outcome	outcome	NOUN
ajlm-2816	101	103	in	in	ADP
ajlm-2816	101	104	fn	fn	PROPN
ajlm-2816	101	105	.	.	PUNCT
ajlm-2816	102	1	six	six	NUM
ajlm-2816	102	2	out	out	ADP
ajlm-2816	102	3	of	of	ADP
ajlm-2816	102	4	the	the	DET
ajlm-2816	102	5	10	10	NUM
ajlm-2816	102	6	eligible	eligible	ADJ
ajlm-2816	102	7	studies	study	NOUN
ajlm-2816	102	8	for	for	ADP
ajlm-2816	102	9	this	this	DET
ajlm-2816	102	10	review	review	NOUN
ajlm-2816	102	11	made	make	VERB
ajlm-2816	102	12	use	use	NOUN
ajlm-2816	102	13	of	of	ADP
ajlm-2816	102	14	an	an	DET
ajlm-2816	102	15	automated	automate	VERB
ajlm-2816	102	16	blood	blood	NOUN
ajlm-2816	102	17	culture	culture	NOUN
ajlm-2816	102	18	system	system	NOUN
ajlm-2816	102	19	,	,	PUNCT
ajlm-2816	102	20	while	while	SCONJ
ajlm-2816	102	21	the	the	DET
ajlm-2816	102	22	others	other	NOUN
ajlm-2816	102	23	(	(	PUNCT
ajlm-2816	102	24	four	four	NUM
ajlm-2816	102	25	studies	study	NOUN
ajlm-2816	102	26	)	)	PUNCT
ajlm-2816	102	27	used	use	VERB
ajlm-2816	102	28	‘	'	PUNCT
ajlm-2816	102	29	manual	manual	ADJ
ajlm-2816	102	30	’	'	PUNCT
ajlm-2816	102	31	blood	blood	NOUN
ajlm-2816	102	32	culture	culture	NOUN
ajlm-2816	102	33	systems	system	NOUN
ajlm-2816	102	34	.	.	PUNCT
ajlm-2816	103	1	the	the	DET
ajlm-2816	103	2	‘	'	PUNCT
ajlm-2816	103	3	manual	manual	ADJ
ajlm-2816	103	4	’	'	PUNCT
ajlm-2816	103	5	blood	blood	NOUN
ajlm-2816	103	6	culture	culture	NOUN
ajlm-2816	103	7	system	system	NOUN
ajlm-2816	103	8	reduces	reduce	VERB
ajlm-2816	103	9	the	the	DET
ajlm-2816	103	10	culture	culture	NOUN
ajlm-2816	103	11	yield	yield	NOUN
ajlm-2816	103	12	of	of	ADP
ajlm-2816	103	13	the	the	DET
ajlm-2816	103	14	investigation	investigation	NOUN
ajlm-2816	103	15	test	test	NOUN
ajlm-2816	103	16	and	and	CCONJ
ajlm-2816	103	17	negatively	negatively	ADV
ajlm-2816	103	18	impacts	impact	VERB
ajlm-2816	103	19	the	the	DET
ajlm-2816	103	20	promptness	promptness	NOUN
ajlm-2816	103	21	of	of	ADP
ajlm-2816	103	22	the	the	DET
ajlm-2816	103	23	isolation	isolation	NOUN
ajlm-2816	103	24	,	,	PUNCT
ajlm-2816	103	25	antibiotic	antibiotic	ADJ
ajlm-2816	103	26	susceptibility	susceptibility	NOUN
ajlm-2816	103	27	patterns	pattern	NOUN
ajlm-2816	103	28	,	,	PUNCT
ajlm-2816	103	29	including	include	VERB
ajlm-2816	103	30	timely	timely	ADJ
ajlm-2816	103	31	and	and	CCONJ
ajlm-2816	103	32	appropriate	appropriate	ADJ
ajlm-2816	103	33	commencement	commencement	NOUN
ajlm-2816	103	34	of	of	ADP
ajlm-2816	103	35	targeted	target	VERB
ajlm-2816	103	36	therapy	therapy	NOUN
ajlm-2816	103	37	,	,	PUNCT
ajlm-2816	103	38	as	as	ADV
ajlm-2816	103	39	well	well	ADV
ajlm-2816	103	40	as	as	ADP
ajlm-2816	103	41	epidemiological	epidemiological	ADJ
ajlm-2816	103	42	surveillance	surveillance	NOUN
ajlm-2816	103	43	of	of	ADP
ajlm-2816	103	44	pathogens	pathogen	NOUN
ajlm-2816	103	45	involved	involve	VERB
ajlm-2816	103	46	in	in	ADP
ajlm-2816	103	47	fn.34	fn.34	NOUN
ajlm-2816	103	48	the	the	DET
ajlm-2816	103	49	uses	use	NOUN
ajlm-2816	103	50	of	of	ADP
ajlm-2816	103	51	automated	automate	VERB
ajlm-2816	103	52	blood	blood	NOUN
ajlm-2816	103	53	culture	culture	NOUN
ajlm-2816	103	54	systems	system	NOUN
ajlm-2816	103	55	in	in	ADP
ajlm-2816	103	56	africa	africa	PROPN
ajlm-2816	103	57	are	be	AUX
ajlm-2816	103	58	usually	usually	ADV
ajlm-2816	103	59	restricted	restrict	VERB
ajlm-2816	103	60	to	to	ADP
ajlm-2816	103	61	major	major	ADJ
ajlm-2816	103	62	referral	referral	ADJ
ajlm-2816	103	63	centres	centre	NOUN
ajlm-2816	103	64	or	or	CCONJ
ajlm-2816	103	65	reference	reference	NOUN
ajlm-2816	103	66	laboratories	laboratory	NOUN
ajlm-2816	103	67	,	,	PUNCT
ajlm-2816	103	68	which	which	PRON
ajlm-2816	103	69	are	be	AUX
ajlm-2816	103	70	mostly	mostly	ADV
ajlm-2816	103	71	powered	power	VERB
ajlm-2816	103	72	by	by	ADP
ajlm-2816	103	73	external	external	ADJ
ajlm-2816	103	74	collaboration	collaboration	NOUN
ajlm-2816	103	75	from	from	ADP
ajlm-2816	103	76	high	high	ADJ
ajlm-2816	103	77	-	-	PUNCT
ajlm-2816	103	78	income	income	NOUN
ajlm-2816	103	79	countries	country	NOUN
ajlm-2816	103	80	.	.	PUNCT
ajlm-2816	104	1	while	while	SCONJ
ajlm-2816	104	2	the	the	DET
ajlm-2816	104	3	availability	availability	NOUN
ajlm-2816	104	4	of	of	ADP
ajlm-2816	104	5	the	the	DET
ajlm-2816	104	6	‘	'	PUNCT
ajlm-2816	104	7	automated	automated	ADJ
ajlm-2816	104	8	’	'	PUNCT
ajlm-2816	104	9	blood	blood	NOUN
ajlm-2816	104	10	culture	culture	NOUN
ajlm-2816	104	11	system	system	NOUN
ajlm-2816	104	12	had	have	AUX
ajlm-2816	104	13	significantly	significantly	ADV
ajlm-2816	104	14	helped	help	VERB
ajlm-2816	104	15	in	in	ADP
ajlm-2816	104	16	the	the	DET
ajlm-2816	104	17	investigation	investigation	NOUN
ajlm-2816	104	18	of	of	ADP
ajlm-2816	104	19	fn	fn	PROPN
ajlm-2816	104	20	in	in	ADP
ajlm-2816	104	21	lmics	lmic	NOUN
ajlm-2816	104	22	of	of	ADP
ajlm-2816	104	23	africa	africa	PROPN
ajlm-2816	104	24	,	,	PUNCT
ajlm-2816	104	25	its	its	PRON
ajlm-2816	104	26	sustainability	sustainability	NOUN
ajlm-2816	104	27	remains	remain	VERB
ajlm-2816	104	28	in	in	ADP
ajlm-2816	104	29	doubt	doubt	NOUN
ajlm-2816	104	30	after	after	ADP
ajlm-2816	104	31	the	the	DET
ajlm-2816	104	32	funders	funder	NOUN
ajlm-2816	104	33	’	’	PART
ajlm-2816	104	34	collaboration	collaboration	NOUN
ajlm-2816	104	35	because	because	SCONJ
ajlm-2816	104	36	of	of	ADP
ajlm-2816	104	37	the	the	DET
ajlm-2816	104	38	costly	costly	ADJ
ajlm-2816	104	39	required	require	VERB
ajlm-2816	104	40	regular	regular	ADJ
ajlm-2816	104	41	equipment	equipment	NOUN
ajlm-2816	104	42	maintenance	maintenance	NOUN
ajlm-2816	104	43	,	,	PUNCT
ajlm-2816	104	44	complicated	complicated	ADJ
ajlm-2816	104	45	consumable	consumable	ADJ
ajlm-2816	104	46	logistics	logistic	NOUN
ajlm-2816	104	47	,	,	PUNCT
ajlm-2816	104	48	and	and	CCONJ
ajlm-2816	104	49	supply	supply	NOUN
ajlm-2816	104	50	chain,37	chain,37	VERB
ajlm-2816	104	51	as	as	ADV
ajlm-2816	104	52	well	well	ADV
ajlm-2816	104	53	as	as	ADP
ajlm-2816	104	54	compatibility	compatibility	NOUN
ajlm-2816	104	55	of	of	ADP
ajlm-2816	104	56	this	this	DET
ajlm-2816	104	57	equipment	equipment	NOUN
ajlm-2816	104	58	with	with	ADP
ajlm-2816	104	59	the	the	DET
ajlm-2816	104	60	tropical	tropical	ADJ
ajlm-2816	104	61	environment	environment	NOUN
ajlm-2816	104	62	and	and	CCONJ
ajlm-2816	104	63	infrastructural	infrastructural	ADJ
ajlm-2816	104	64	architecture.1,34	architecture.1,34	PROPN
ajlm-2816	104	65	clinical	clinical	ADJ
ajlm-2816	104	66	laboratory	laboratory	NOUN
ajlm-2816	104	67	standards	standard	NOUN
ajlm-2816	104	68	institute	institute	PROPN
ajlm-2816	104	69	and	and	CCONJ
ajlm-2816	104	70	european	european	PROPN
ajlm-2816	104	71	committee	committee	PROPN
ajlm-2816	104	72	on	on	ADP
ajlm-2816	104	73	antimicrobial	antimicrobial	ADJ
ajlm-2816	104	74	susceptibility	susceptibility	NOUN
ajlm-2816	104	75	testing	test	VERB
ajlm-2816	104	76	guidelines	guideline	NOUN
ajlm-2816	104	77	on	on	ADP
ajlm-2816	104	78	antibiotic	antibiotic	ADJ
ajlm-2816	104	79	susceptibility	susceptibility	NOUN
ajlm-2816	104	80	have	have	AUX
ajlm-2816	104	81	stipulated	stipulate	VERB
ajlm-2816	104	82	specific	specific	ADJ
ajlm-2816	104	83	antibiotics	antibiotic	NOUN
ajlm-2816	104	84	that	that	PRON
ajlm-2816	104	85	are	be	AUX
ajlm-2816	104	86	relevant	relevant	ADJ
ajlm-2816	104	87	for	for	ADP
ajlm-2816	104	88	testing	test	VERB
ajlm-2816	104	89	against	against	ADP
ajlm-2816	104	90	specific	specific	ADJ
ajlm-2816	104	91	bacteria	bacteria	NOUN
ajlm-2816	104	92	.	.	PUNCT
ajlm-2816	105	1	however	however	ADV
ajlm-2816	105	2	,	,	PUNCT
ajlm-2816	105	3	this	this	PRON
ajlm-2816	105	4	was	be	AUX
ajlm-2816	105	5	not	not	PART
ajlm-2816	105	6	followed	follow	VERB
ajlm-2816	105	7	in	in	ADP
ajlm-2816	105	8	all	all	DET
ajlm-2816	105	9	cases	case	NOUN
ajlm-2816	105	10	.	.	PUNCT
ajlm-2816	106	1	this	this	PRON
ajlm-2816	106	2	could	could	AUX
ajlm-2816	106	3	be	be	AUX
ajlm-2816	106	4	because	because	SCONJ
ajlm-2816	106	5	of	of	ADP
ajlm-2816	106	6	the	the	DET
ajlm-2816	106	7	common	common	ADJ
ajlm-2816	106	8	use	use	NOUN
ajlm-2816	106	9	of	of	ADP
ajlm-2816	106	10	a	a	DET
ajlm-2816	106	11	generic	generic	ADJ
ajlm-2816	106	12	multidisc	multidisc	NOUN
ajlm-2816	106	13	–	–	PUNCT
ajlm-2816	106	14	a	a	DET
ajlm-2816	106	15	single	single	ADJ
ajlm-2816	106	16	-	-	PUNCT
ajlm-2816	106	17	paneled	panel	VERB
ajlm-2816	106	18	antibiotic	antibiotic	ADJ
ajlm-2816	106	19	disc	disc	NOUN
ajlm-2816	106	20	for	for	ADP
ajlm-2816	106	21	gram	gram	NOUN
ajlm-2816	106	22	-	-	PUNCT
ajlm-2816	106	23	negative	negative	ADJ
ajlm-2816	106	24	and	and	CCONJ
ajlm-2816	106	25	gram	gram	NOUN
ajlm-2816	106	26	-	-	PUNCT
ajlm-2816	106	27	positive	positive	ADJ
ajlm-2816	106	28	organisms	organism	NOUN
ajlm-2816	106	29	,	,	PUNCT
ajlm-2816	106	30	which	which	PRON
ajlm-2816	106	31	might	might	AUX
ajlm-2816	106	32	not	not	PART
ajlm-2816	106	33	accommodate	accommodate	VERB
ajlm-2816	106	34	the	the	DET
ajlm-2816	106	35	unique	unique	ADJ
ajlm-2816	106	36	approach	approach	NOUN
ajlm-2816	106	37	offered	offer	VERB
ajlm-2816	106	38	by	by	ADP
ajlm-2816	106	39	a	a	DET
ajlm-2816	106	40	single	single	ADJ
ajlm-2816	106	41	antibiotic	antibiotic	ADJ
ajlm-2816	106	42	disc	disc	NOUN
ajlm-2816	106	43	as	as	SCONJ
ajlm-2816	106	44	stipulated	stipulate	VERB
ajlm-2816	106	45	by	by	ADP
ajlm-2816	106	46	antibiotic	antibiotic	ADJ
ajlm-2816	106	47	susceptibility	susceptibility	NOUN
ajlm-2816	106	48	guidelines	guideline	NOUN
ajlm-2816	106	49	for	for	ADP
ajlm-2816	106	50	the	the	DET
ajlm-2816	106	51	testing	testing	NOUN
ajlm-2816	106	52	of	of	ADP
ajlm-2816	106	53	organisms	organism	NOUN
ajlm-2816	106	54	such	such	ADJ
ajlm-2816	106	55	as	as	ADP
ajlm-2816	106	56	acinetobacter	acinetobacter	ADJ
ajlm-2816	106	57	spp	spp	NOUN
ajlm-2816	106	58	,	,	PUNCT
ajlm-2816	106	59	pseudomonas	pseudomona	VERB
ajlm-2816	106	60	spp	spp	NOUN
ajlm-2816	106	61	.	.	PUNCT
ajlm-2816	106	62	and	and	CCONJ
ajlm-2816	106	63	streptococcus	streptococcus	VERB
ajlm-2816	106	64	spp.38	spp.38	NOUN
ajlm-2816	106	65	this	this	DET
ajlm-2816	106	66	review	review	NOUN
ajlm-2816	106	67	revealed	reveal	VERB
ajlm-2816	106	68	that	that	SCONJ
ajlm-2816	106	69	the	the	DET
ajlm-2816	106	70	clinical	clinical	ADJ
ajlm-2816	106	71	outcome	outcome	NOUN
ajlm-2816	106	72	of	of	ADP
ajlm-2816	106	73	fn	fn	NOUN
ajlm-2816	106	74	can	can	AUX
ajlm-2816	106	75	be	be	AUX
ajlm-2816	106	76	improved	improve	VERB
ajlm-2816	106	77	in	in	ADP
ajlm-2816	106	78	africa	africa	PROPN
ajlm-2816	106	79	by	by	ADP
ajlm-2816	106	80	increasing	increase	VERB
ajlm-2816	106	81	the	the	DET
ajlm-2816	106	82	diagnostic	diagnostic	ADJ
ajlm-2816	106	83	capacity	capacity	NOUN
ajlm-2816	106	84	of	of	ADP
ajlm-2816	106	85	the	the	DET
ajlm-2816	106	86	laboratories	laboratory	NOUN
ajlm-2816	106	87	infrastructures	infrastructure	NOUN
ajlm-2816	106	88	to	to	PART
ajlm-2816	106	89	isolate	isolate	VERB
ajlm-2816	106	90	bacterial	bacterial	ADJ
ajlm-2816	106	91	in	in	ADP
ajlm-2816	106	92	bloodstream	bloodstream	NOUN
ajlm-2816	106	93	infection	infection	NOUN
ajlm-2816	106	94	in	in	ADP
ajlm-2816	106	95	fn	fn	NOUN
ajlm-2816	106	96	,	,	PUNCT
ajlm-2816	106	97	continuous	continuous	ADJ
ajlm-2816	106	98	training	training	NOUN
ajlm-2816	106	99	of	of	ADP
ajlm-2816	106	100	the	the	DET
ajlm-2816	106	101	laboratory	laboratory	NOUN
ajlm-2816	106	102	staff	staff	NOUN
ajlm-2816	106	103	to	to	PART
ajlm-2816	106	104	improve	improve	VERB
ajlm-2816	106	105	their	their	PRON
ajlm-2816	106	106	competencies	competency	NOUN
ajlm-2816	106	107	to	to	PART
ajlm-2816	106	108	optimise	optimise	VERB
ajlm-2816	106	109	blood	blood	NOUN
ajlm-2816	106	110	culture	culture	NOUN
ajlm-2816	106	111	testing	testing	NOUN
ajlm-2816	106	112	,	,	PUNCT
ajlm-2816	106	113	accurate	accurate	ADJ
ajlm-2816	106	114	pathogen	pathogen	NOUN
ajlm-2816	106	115	identification	identification	NOUN
ajlm-2816	106	116	,	,	PUNCT
ajlm-2816	106	117	and	and	CCONJ
ajlm-2816	106	118	antibiotic	antibiotic	ADJ
ajlm-2816	106	119	susceptibility	susceptibility	NOUN
ajlm-2816	106	120	testing	testing	NOUN
ajlm-2816	106	121	to	to	PART
ajlm-2816	106	122	inform	inform	VERB
ajlm-2816	106	123	local	local	ADJ
ajlm-2816	106	124	policy	policy	NOUN
ajlm-2816	106	125	development	development	NOUN
ajlm-2816	106	126	as	as	ADV
ajlm-2816	106	127	well	well	ADV
ajlm-2816	106	128	as	as	ADP
ajlm-2816	106	129	adherence	adherence	NOUN
ajlm-2816	106	130	to	to	ADP
ajlm-2816	106	131	international	international	ADJ
ajlm-2816	106	132	guidelines	guideline	NOUN
ajlm-2816	106	133	for	for	ADP
ajlm-2816	106	134	comparable	comparable	ADJ
ajlm-2816	106	135	practice	practice	NOUN
ajlm-2816	106	136	and	and	CCONJ
ajlm-2816	106	137	result.39	result.39	VERB
ajlm-2816	106	138	the	the	DET
ajlm-2816	106	139	epidemiological	epidemiological	ADJ
ajlm-2816	106	140	distribution	distribution	NOUN
ajlm-2816	106	141	of	of	ADP
ajlm-2816	106	142	bacteria	bacteria	NOUN
ajlm-2816	106	143	in	in	ADP
ajlm-2816	106	144	fn	fn	PROPN
ajlm-2816	106	145	varies	varie	NOUN
ajlm-2816	106	146	with	with	ADP
ajlm-2816	106	147	geographical	geographical	ADJ
ajlm-2816	106	148	location	location	NOUN
ajlm-2816	106	149	,	,	PUNCT
ajlm-2816	106	150	medical	medical	ADJ
ajlm-2816	106	151	procedures	procedure	NOUN
ajlm-2816	106	152	,	,	PUNCT
ajlm-2816	106	153	and	and	CCONJ
ajlm-2816	106	154	antibiotic	antibiotic	ADJ
ajlm-2816	106	155	consumption	consumption	NOUN
ajlm-2816	106	156	in	in	ADP
ajlm-2816	106	157	the	the	DET
ajlm-2816	106	158	locality	locality	NOUN
ajlm-2816	106	159	.	.	PUNCT
ajlm-2816	107	1	in	in	ADP
ajlm-2816	107	2	this	this	DET
ajlm-2816	107	3	review	review	NOUN
ajlm-2816	107	4	,	,	PUNCT
ajlm-2816	107	5	the	the	DET
ajlm-2816	107	6	significant	significant	ADJ
ajlm-2816	107	7	variability	variability	NOUN
ajlm-2816	107	8	across	across	ADP
ajlm-2816	107	9	decades	decade	NOUN
ajlm-2816	107	10	was	be	AUX
ajlm-2816	107	11	not	not	PART
ajlm-2816	107	12	obvious	obvious	ADJ
ajlm-2816	107	13	.	.	PUNCT
ajlm-2816	108	1	gram	gram	NOUN
ajlm-2816	108	2	-	-	PUNCT
ajlm-2816	108	3	positive	positive	ADJ
ajlm-2816	108	4	bacteria	bacteria	NOUN
ajlm-2816	108	5	were	be	AUX
ajlm-2816	108	6	the	the	DET
ajlm-2816	108	7	most	most	ADV
ajlm-2816	108	8	isolated	isolated	ADJ
ajlm-2816	108	9	(	(	PUNCT
ajlm-2816	108	10	56.7	56.7	NUM
ajlm-2816	108	11	%	%	NOUN
ajlm-2816	108	12	)	)	PUNCT
ajlm-2816	108	13	organism	organism	NOUN
ajlm-2816	108	14	in	in	ADP
ajlm-2816	108	15	this	this	DET
ajlm-2816	108	16	review	review	NOUN
ajlm-2816	108	17	,	,	PUNCT
ajlm-2816	108	18	which	which	PRON
ajlm-2816	108	19	is	be	AUX
ajlm-2816	108	20	similar	similar	ADJ
ajlm-2816	108	21	to	to	ADP
ajlm-2816	108	22	the	the	DET
ajlm-2816	108	23	pattern	pattern	NOUN
ajlm-2816	108	24	documented	document	VERB
ajlm-2816	108	25	over	over	ADP
ajlm-2816	108	26	six	six	NUM
ajlm-2816	108	27	years	year	NOUN
ajlm-2816	108	28	(	(	PUNCT
ajlm-2816	108	29	1995–2000)40	1995–2000)40	NUM
ajlm-2816	108	30	in	in	ADP
ajlm-2816	108	31	the	the	DET
ajlm-2816	108	32	united	united	PROPN
ajlm-2816	108	33	states	states	PROPN
ajlm-2816	108	34	,	,	PUNCT
ajlm-2816	108	35	with	with	ADP
ajlm-2816	108	36	a	a	DET
ajlm-2816	108	37	gram	gram	NOUN
ajlm-2816	108	38	-	-	PUNCT
ajlm-2816	108	39	positive	positive	ADJ
ajlm-2816	108	40	bacteria	bacteria	NOUN
ajlm-2816	108	41	rate	rate	NOUN
ajlm-2816	108	42	of	of	ADP
ajlm-2816	108	43	61.0	61.0	NUM
ajlm-2816	108	44	%	%	NOUN
ajlm-2816	108	45	and	and	CCONJ
ajlm-2816	108	46	a	a	DET
ajlm-2816	108	47	significant	significant	ADJ
ajlm-2816	108	48	shift	shift	NOUN
ajlm-2816	108	49	from	from	ADP
ajlm-2816	108	50	gram	gram	NOUN
ajlm-2816	108	51	-	-	PUNCT
ajlm-2816	108	52	negative	negative	ADJ
ajlm-2816	108	53	to	to	ADP
ajlm-2816	108	54	gram	gram	NOUN
ajlm-2816	108	55	-	-	PUNCT
ajlm-2816	108	56	positive	positive	ADJ
ajlm-2816	108	57	bacteria	bacteria	NOUN
ajlm-2816	108	58	over	over	ADP
ajlm-2816	108	59	two	two	NUM
ajlm-2816	108	60	decades	decade	NOUN
ajlm-2816	108	61	in	in	ADP
ajlm-2816	108	62	europe	europe	PROPN
ajlm-2816	108	63	(	(	PUNCT
ajlm-2816	108	64	1985–2000).41	1985–2000).41	NUM
ajlm-2816	108	65	this	this	PRON
ajlm-2816	108	66	is	be	AUX
ajlm-2816	108	67	in	in	ADP
ajlm-2816	108	68	contrast	contrast	NOUN
ajlm-2816	108	69	to	to	ADP
ajlm-2816	108	70	what	what	PRON
ajlm-2816	108	71	was	be	AUX
ajlm-2816	108	72	documented	document	VERB
ajlm-2816	108	73	in	in	ADP
ajlm-2816	108	74	central	central	PROPN
ajlm-2816	108	75	america	america	PROPN
ajlm-2816	108	76	(	(	PUNCT
ajlm-2816	108	77	from	from	ADP
ajlm-2816	108	78	2012	2012	NUM
ajlm-2816	108	79	to	to	ADP
ajlm-2816	108	80	2014	2014	NUM
ajlm-2816	108	81	)	)	PUNCT
ajlm-2816	108	82	where	where	SCONJ
ajlm-2816	108	83	the	the	DET
ajlm-2816	108	84	most	most	ADV
ajlm-2816	108	85	isolated	isolated	ADJ
ajlm-2816	108	86	group	group	NOUN
ajlm-2816	108	87	of	of	ADP
ajlm-2816	108	88	bacteria	bacteria	NOUN
ajlm-2816	108	89	in	in	ADP
ajlm-2816	108	90	fn	fn	NOUN
ajlm-2816	108	91	were	be	AUX
ajlm-2816	108	92	gram	gram	NOUN
ajlm-2816	108	93	negative	negative	ADJ
ajlm-2816	108	94	(	(	PUNCT
ajlm-2816	108	95	78.0%),42	78.0%),42	INTJ
ajlm-2816	108	96	as	as	ADV
ajlm-2816	108	97	well	well	ADV
ajlm-2816	108	98	as	as	ADP
ajlm-2816	108	99	in	in	ADP
ajlm-2816	108	100	india	india	PROPN
ajlm-2816	108	101	(	(	PUNCT
ajlm-2816	108	102	from	from	ADP
ajlm-2816	108	103	2012	2012	NUM
ajlm-2816	108	104	to	to	ADP
ajlm-2816	108	105	2014	2014	NUM
ajlm-2816	108	106	;	;	PUNCT
ajlm-2816	108	107	57.8	57.8	NUM
ajlm-2816	108	108	%	%	NOUN
ajlm-2816	108	109	)	)	PUNCT
ajlm-2816	108	110	and	and	CCONJ
ajlm-2816	108	111	iran	iran	PROPN
ajlm-2816	108	112	(	(	PUNCT
ajlm-2816	108	113	from	from	ADP
ajlm-2816	108	114	2019	2019	NUM
ajlm-2816	108	115	to	to	ADP
ajlm-2816	108	116	2020	2020	NUM
ajlm-2816	108	117	;	;	PUNCT
ajlm-2816	108	118	66.7	66.7	NUM
ajlm-2816	108	119	%	%	NOUN
ajlm-2816	108	120	)	)	PUNCT
ajlm-2816	108	121	.	.	PUNCT
ajlm-2816	109	1	the	the	DET
ajlm-2816	109	2	reasons	reason	NOUN
ajlm-2816	109	3	for	for	ADP
ajlm-2816	109	4	the	the	DET
ajlm-2816	109	5	predominance	predominance	NOUN
ajlm-2816	109	6	of	of	ADP
ajlm-2816	109	7	gram	gram	NOUN
ajlm-2816	109	8	-	-	PUNCT
ajlm-2816	109	9	positive	positive	ADJ
ajlm-2816	109	10	bacteria	bacteria	NOUN
ajlm-2816	109	11	in	in	ADP
ajlm-2816	109	12	africa	africa	PROPN
ajlm-2816	109	13	in	in	ADP
ajlm-2816	109	14	this	this	DET
ajlm-2816	109	15	review	review	NOUN
ajlm-2816	109	16	are	be	AUX
ajlm-2816	109	17	unknown	unknown	ADJ
ajlm-2816	109	18	.	.	PUNCT
ajlm-2816	110	1	however	however	ADV
ajlm-2816	110	2	,	,	PUNCT
ajlm-2816	110	3	it	it	PRON
ajlm-2816	110	4	could	could	AUX
ajlm-2816	110	5	be	be	AUX
ajlm-2816	110	6	because	because	SCONJ
ajlm-2816	110	7	of	of	ADP
ajlm-2816	110	8	quinolone	quinolone	NOUN
ajlm-2816	110	9	prophylaxis43	prophylaxis43	NOUN
ajlm-2816	110	10	use	use	NOUN
ajlm-2816	110	11	in	in	ADP
ajlm-2816	110	12	this	this	DET
ajlm-2816	110	13	setting	setting	NOUN
ajlm-2816	110	14	,	,	PUNCT
ajlm-2816	110	15	choice	choice	NOUN
ajlm-2816	110	16	of	of	ADP
ajlm-2816	110	17	mucositis	mucositis	NOUN
ajlm-2816	110	18	-	-	PUNCT
ajlm-2816	110	19	producing	produce	VERB
ajlm-2816	110	20	chemotherapy	chemotherapy	NOUN
ajlm-2816	110	21	agents	agent	NOUN
ajlm-2816	110	22	,	,	PUNCT
ajlm-2816	110	23	as	as	ADV
ajlm-2816	110	24	well	well	ADV
ajlm-2816	110	25	as	as	ADP
ajlm-2816	110	26	use	use	NOUN
ajlm-2816	110	27	of	of	ADP
ajlm-2816	110	28	invasive	invasive	ADJ
ajlm-2816	110	29	devices	device	NOUN
ajlm-2816	110	30	such	such	ADJ
ajlm-2816	110	31	as	as	ADP
ajlm-2816	110	32	central	central	ADJ
ajlm-2816	110	33	-	-	PUNCT
ajlm-2816	110	34	line	line	NOUN
ajlm-2816	110	35	catheters	catheter	NOUN
ajlm-2816	110	36	and	and	CCONJ
ajlm-2816	110	37	significant	significant	ADJ
ajlm-2816	110	38	use	use	NOUN
ajlm-2816	110	39	of	of	ADP
ajlm-2816	110	40	antacids.44	antacids.44	NOUN
ajlm-2816	110	41	the	the	DET
ajlm-2816	110	42	use	use	NOUN
ajlm-2816	110	43	of	of	ADP
ajlm-2816	110	44	prophylactic	prophylactic	ADJ
ajlm-2816	110	45	antibiotics	antibiotic	NOUN
ajlm-2816	110	46	(	(	PUNCT
ajlm-2816	110	47	especially	especially	ADV
ajlm-2816	110	48	fluoroquinolone	fluoroquinolone	NOUN
ajlm-2816	110	49	)	)	PUNCT
ajlm-2816	110	50	has	have	AUX
ajlm-2816	110	51	reduced	reduce	VERB
ajlm-2816	110	52	the	the	DET
ajlm-2816	110	53	overall	overall	ADJ
ajlm-2816	110	54	mortality	mortality	NOUN
ajlm-2816	110	55	in	in	ADP
ajlm-2816	110	56	patients	patient	NOUN
ajlm-2816	110	57	with	with	ADP
ajlm-2816	110	58	an	an	DET
ajlm-2816	110	59	intermediate	intermediate	ADJ
ajlm-2816	110	60	-	-	PUNCT
ajlm-2816	110	61	to	to	ADP
ajlm-2816	110	62	-	-	PUNCT
ajlm-2816	110	63	high	high	ADJ
ajlm-2816	110	64	multinational	multinational	ADJ
ajlm-2816	110	65	association	association	NOUN
ajlm-2816	110	66	for	for	ADP
ajlm-2816	110	67	supportive	supportive	ADJ
ajlm-2816	110	68	care	care	NOUN
ajlm-2816	110	69	in	in	ADP
ajlm-2816	110	70	cancer	cancer	NOUN
ajlm-2816	110	71	fn	fn	PROPN
ajlm-2816	110	72	risk	risk	NOUN
ajlm-2816	110	73	index	index	NOUN
ajlm-2816	110	74	.	.	PUNCT
ajlm-2816	111	1	however	however	ADV
ajlm-2816	111	2	,	,	PUNCT
ajlm-2816	111	3	it	it	PRON
ajlm-2816	111	4	is	be	AUX
ajlm-2816	111	5	cautioned	caution	VERB
ajlm-2816	111	6	against	against	ADP
ajlm-2816	111	7	by	by	ADP
ajlm-2816	111	8	the	the	DET
ajlm-2816	111	9	european	european	PROPN
ajlm-2816	111	10	organisation	organisation	PROPN
ajlm-2816	111	11	for	for	ADP
ajlm-2816	111	12	research	research	NOUN
ajlm-2816	111	13	and	and	CCONJ
ajlm-2816	111	14	treatment	treatment	NOUN
ajlm-2816	111	15	of	of	ADP
ajlm-2816	111	16	cancer	cancer	NOUN
ajlm-2816	111	17	and	and	CCONJ
ajlm-2816	111	18	the	the	DET
ajlm-2816	111	19	american	american	ADJ
ajlm-2816	111	20	society	society	NOUN
ajlm-2816	111	21	of	of	ADP
ajlm-2816	111	22	clinical	clinical	ADJ
ajlm-2816	111	23	oncology	oncology	NOUN
ajlm-2816	111	24	,	,	PUNCT
ajlm-2816	111	25	especially	especially	ADV
ajlm-2816	111	26	in	in	ADP
ajlm-2816	111	27	cases	case	NOUN
ajlm-2816	111	28	with	with	ADP
ajlm-2816	111	29	a	a	DET
ajlm-2816	111	30	low	low	ADJ
ajlm-2816	111	31	multinational	multinational	ADJ
ajlm-2816	111	32	association	association	NOUN
ajlm-2816	111	33	for	for	ADP
ajlm-2816	111	34	supportive	supportive	ADJ
ajlm-2816	111	35	care	care	NOUN
ajlm-2816	111	36	in	in	ADP
ajlm-2816	111	37	cancer	cancer	NOUN
ajlm-2816	111	38	fn	fn	PROPN
ajlm-2816	111	39	risk	risk	NOUN
ajlm-2816	111	40	index	index	NOUN
ajlm-2816	111	41	(	(	PUNCT
ajlm-2816	111	42	≥	≥	NOUN
ajlm-2816	111	43	21	21	NUM
ajlm-2816	111	44	)	)	PUNCT
ajlm-2816	111	45	,	,	PUNCT
ajlm-2816	111	46	because	because	SCONJ
ajlm-2816	111	47	of	of	ADP
ajlm-2816	111	48	the	the	DET
ajlm-2816	111	49	risk	risk	NOUN
ajlm-2816	111	50	of	of	ADP
ajlm-2816	111	51	emergence	emergence	NOUN
ajlm-2816	111	52	of	of	ADP
ajlm-2816	111	53	mdr.45	mdr.45	ADJ
ajlm-2816	111	54	the	the	DET
ajlm-2816	111	55	aggregated	aggregate	VERB
ajlm-2816	111	56	resistance	resistance	NOUN
ajlm-2816	111	57	rate	rate	NOUN
ajlm-2816	111	58	to	to	ADP
ajlm-2816	111	59	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2816	111	60	and	and	CCONJ
ajlm-2816	111	61	amoxycillin	amoxycillin	NOUN
ajlm-2816	111	62	/	/	SYM
ajlm-2816	111	63	clavulanic	clavulanic	NOUN
ajlm-2816	111	64	acid	acid	NOUN
ajlm-2816	111	65	(	(	PUNCT
ajlm-2816	111	66	which	which	PRON
ajlm-2816	111	67	are	be	AUX
ajlm-2816	111	68	the	the	DET
ajlm-2816	111	69	initial	initial	ADJ
ajlm-2816	111	70	empiric	empiric	ADJ
ajlm-2816	111	71	antibiotics	antibiotic	NOUN
ajlm-2816	111	72	for	for	ADP
ajlm-2816	111	73	low	low	ADJ
ajlm-2816	111	74	-	-	PUNCT
ajlm-2816	111	75	risk	risk	NOUN
ajlm-2816	111	76	patients	patient	NOUN
ajlm-2816	111	77	with	with	ADP
ajlm-2816	111	78	fn	fn	NOUN
ajlm-2816	111	79	)	)	PUNCT
ajlm-2816	111	80	from	from	ADP
ajlm-2816	111	81	this	this	DET
ajlm-2816	111	82	review	review	NOUN
ajlm-2816	111	83	is	be	AUX
ajlm-2816	111	84	more	more	ADJ
ajlm-2816	111	85	than	than	ADP
ajlm-2816	111	86	a	a	DET
ajlm-2816	111	87	third	third	ADJ
ajlm-2816	111	88	(	(	PUNCT
ajlm-2816	111	89	ciprofloxacin	ciprofloxacin	PROPN
ajlm-2816	111	90	)	)	PUNCT
ajlm-2816	111	91	and	and	CCONJ
ajlm-2816	111	92	about	about	ADV
ajlm-2816	111	93	two	two	NUM
ajlm-2816	111	94	-	-	PUNCT
ajlm-2816	111	95	quarters	quarter	NOUN
ajlm-2816	111	96	(	(	PUNCT
ajlm-2816	111	97	amoxycillin	amoxycillin	NOUN
ajlm-2816	111	98	/	/	SYM
ajlm-2816	111	99	clavulanic	clavulanic	NOUN
ajlm-2816	111	100	acid	acid	NOUN
ajlm-2816	111	101	)	)	PUNCT
ajlm-2816	111	102	of	of	ADP
ajlm-2816	111	103	the	the	DET
ajlm-2816	111	104	isolates	isolate	NOUN
ajlm-2816	111	105	,	,	PUNCT
ajlm-2816	111	106	and	and	CCONJ
ajlm-2816	111	107	implies	imply	VERB
ajlm-2816	111	108	that	that	SCONJ
ajlm-2816	111	109	these	these	DET
ajlm-2816	111	110	antibiotics	antibiotic	NOUN
ajlm-2816	111	111	might	might	AUX
ajlm-2816	111	112	not	not	PART
ajlm-2816	111	113	be	be	AUX
ajlm-2816	111	114	effective	effective	ADJ
ajlm-2816	111	115	empiric	empiric	ADJ
ajlm-2816	111	116	therapy	therapy	NOUN
ajlm-2816	111	117	for	for	ADP
ajlm-2816	111	118	fn	fn	PROPN
ajlm-2816	111	119	in	in	ADP
ajlm-2816	111	120	many	many	ADJ
ajlm-2816	111	121	africa	africa	PROPN
ajlm-2816	111	122	settings	setting	NOUN
ajlm-2816	111	123	because	because	SCONJ
ajlm-2816	111	124	of	of	ADP
ajlm-2816	111	125	the	the	DET
ajlm-2816	111	126	prevailing	prevail	VERB
ajlm-2816	111	127	high	high	ADJ
ajlm-2816	111	128	antibiotic	antibiotic	ADJ
ajlm-2816	111	129	resistance	resistance	NOUN
ajlm-2816	111	130	situation	situation	NOUN
ajlm-2816	111	131	driven	drive	VERB
ajlm-2816	111	132	by	by	ADP
ajlm-2816	111	133	increasing	increase	VERB
ajlm-2816	111	134	antibiotic	antibiotic	ADJ
ajlm-2816	111	135	consumption	consumption	NOUN
ajlm-2816	111	136	in	in	ADP
ajlm-2816	111	137	the	the	DET
ajlm-2816	111	138	hospital	hospital	NOUN
ajlm-2816	111	139	and	and	CCONJ
ajlm-2816	111	140	community	community	NOUN
ajlm-2816	111	141	,	,	PUNCT
ajlm-2816	111	142	as	as	SCONJ
ajlm-2816	111	143	support	support	NOUN
ajlm-2816	111	144	for	for	ADP
ajlm-2816	111	145	a	a	DET
ajlm-2816	111	146	failing	failing	NOUN
ajlm-2816	111	147	,	,	PUNCT
ajlm-2816	111	148	fractured	fractured	ADJ
ajlm-2816	111	149	heath	heath	NOUN
ajlm-2816	111	150	system	system	NOUN
ajlm-2816	111	151	and	and	CCONJ
ajlm-2816	111	152	antibiotic	antibiotic	ADJ
ajlm-2816	111	153	stewardship	stewardship	NOUN
ajlm-2816	111	154	intervention.31,46	intervention.31,46	VERB
ajlm-2816	111	155	the	the	DET
ajlm-2816	111	156	use	use	NOUN
ajlm-2816	111	157	of	of	ADP
ajlm-2816	111	158	cefepime	cefepime	NOUN
ajlm-2816	111	159	and	and	CCONJ
ajlm-2816	111	160	piperacillin	piperacillin	NOUN
ajlm-2816	111	161	/	/	SYM
ajlm-2816	111	162	tazobactam	tazobactam	NOUN
ajlm-2816	111	163	as	as	ADP
ajlm-2816	111	164	a	a	DET
ajlm-2816	111	165	monotherapy	monotherapy	NOUN
ajlm-2816	111	166	or	or	CCONJ
ajlm-2816	111	167	as	as	ADP
ajlm-2816	111	168	part	part	NOUN
ajlm-2816	111	169	of	of	ADP
ajlm-2816	111	170	combined	combined	ADJ
ajlm-2816	111	171	antibiotics	antibiotic	NOUN
ajlm-2816	111	172	for	for	ADP
ajlm-2816	111	173	initial	initial	ADJ
ajlm-2816	111	174	empiric	empiric	ADJ
ajlm-2816	111	175	therapy	therapy	NOUN
ajlm-2816	111	176	in	in	ADP
ajlm-2816	111	177	high	high	ADJ
ajlm-2816	111	178	-	-	PUNCT
ajlm-2816	111	179	risk	risk	NOUN
ajlm-2816	111	180	patients	patient	NOUN
ajlm-2816	111	181	with	with	ADP
ajlm-2816	111	182	fn	fn	PROPN
ajlm-2816	111	183	needs	need	VERB
ajlm-2816	111	184	caution	caution	NOUN
ajlm-2816	111	185	when	when	SCONJ
ajlm-2816	111	186	escalating	escalate	VERB
ajlm-2816	111	187	for	for	ADP
ajlm-2816	111	188	treatment	treatment	NOUN
ajlm-2816	111	189	of	of	ADP
ajlm-2816	111	190	fn	fn	NOUN
ajlm-2816	111	191	,	,	PUNCT
ajlm-2816	111	192	as	as	SCONJ
ajlm-2816	111	193	two	two	NUM
ajlm-2816	111	194	-	-	PUNCT
ajlm-2816	111	195	fifths	fifth	NOUN
ajlm-2816	111	196	of	of	ADP
ajlm-2816	111	197	the	the	DET
ajlm-2816	111	198	isolates	isolate	NOUN
ajlm-2816	111	199	were	be	AUX
ajlm-2816	111	200	resistant	resistant	ADJ
ajlm-2816	111	201	to	to	ADP
ajlm-2816	111	202	piperacillin	piperacillin	NOUN
ajlm-2816	111	203	/	/	SYM
ajlm-2816	111	204	tazobactam	tazobactam	NOUN
ajlm-2816	111	205	and	and	CCONJ
ajlm-2816	111	206	a	a	DET
ajlm-2816	111	207	third	third	NOUN
ajlm-2816	111	208	to	to	PART
ajlm-2816	111	209	cefepime	cefepime	VERB
ajlm-2816	111	210	.	.	PUNCT
ajlm-2816	112	1	this	this	PRON
ajlm-2816	112	2	underscores	underscore	VERB
ajlm-2816	112	3	the	the	DET
ajlm-2816	112	4	need	need	NOUN
ajlm-2816	112	5	for	for	ADP
ajlm-2816	112	6	optimised	optimise	VERB
ajlm-2816	112	7	medical	medical	ADJ
ajlm-2816	112	8	microbiology	microbiology	NOUN
ajlm-2816	112	9	support	support	NOUN
ajlm-2816	112	10	for	for	ADP
ajlm-2816	112	11	appropriate	appropriate	ADJ
ajlm-2816	112	12	blood	blood	NOUN
ajlm-2816	112	13	culture	culture	NOUN
ajlm-2816	112	14	,	,	PUNCT
ajlm-2816	112	15	pathogen	pathogen	NOUN
ajlm-2816	112	16	isolation	isolation	NOUN
ajlm-2816	112	17	and	and	CCONJ
ajlm-2816	112	18	determination	determination	NOUN
ajlm-2816	112	19	of	of	ADP
ajlm-2816	112	20	antibiotic	antibiotic	ADJ
ajlm-2816	112	21	susceptibility	susceptibility	NOUN
ajlm-2816	112	22	patterns	pattern	NOUN
ajlm-2816	112	23	to	to	PART
ajlm-2816	112	24	guide	guide	VERB
ajlm-2816	112	25	the	the	DET
ajlm-2816	112	26	escalation	escalation	NOUN
ajlm-2816	112	27	and	and	CCONJ
ajlm-2816	112	28	de	de	NOUN
ajlm-2816	112	29	-	-	NOUN
ajlm-2816	112	30	escalation	escalation	NOUN
ajlm-2816	112	31	of	of	ADP
ajlm-2816	112	32	antibiotic	antibiotic	ADJ
ajlm-2816	112	33	use	use	NOUN
ajlm-2816	112	34	in	in	ADP
ajlm-2816	112	35	fn.47,48	fn.47,48	NOUN
ajlm-2816	112	36	commonly	commonly	ADV
ajlm-2816	112	37	isolated	isolate	VERB
ajlm-2816	112	38	gram	gram	NOUN
ajlm-2816	112	39	-	-	PUNCT
ajlm-2816	112	40	negatives	negative	NOUN
ajlm-2816	112	41	in	in	ADP
ajlm-2816	112	42	fn	fn	NOUN
ajlm-2816	112	43	in	in	ADP
ajlm-2816	112	44	this	this	DET
ajlm-2816	112	45	review	review	NOUN
ajlm-2816	112	46	,	,	PUNCT
ajlm-2816	112	47	such	such	ADJ
ajlm-2816	112	48	as	as	ADP
ajlm-2816	112	49	klebsiella	klebsiella	PROPN
ajlm-2816	112	50	spp	spp	PROPN
ajlm-2816	112	51	,	,	PUNCT
ajlm-2816	112	52	and	and	CCONJ
ajlm-2816	112	53	e.	e.	PROPN
ajlm-2816	112	54	coli	coli	PROPN
ajlm-2816	112	55	,	,	PUNCT
ajlm-2816	112	56	had	have	VERB
ajlm-2816	112	57	high	high	ADJ
ajlm-2816	112	58	resistance	resistance	NOUN
ajlm-2816	112	59	to	to	ADP
ajlm-2816	112	60	piperazilin	piperazilin	NOUN
ajlm-2816	112	61	/	/	SYM
ajlm-2816	112	62	tazobactam	tazobactam	NOUN
ajlm-2816	112	63	,	,	PUNCT
ajlm-2816	112	64	third	third	ADJ
ajlm-2816	112	65	-	-	PUNCT
ajlm-2816	112	66	generation	generation	NOUN
ajlm-2816	112	67	cephalosporins	cephalosporin	NOUN
ajlm-2816	112	68	,	,	PUNCT
ajlm-2816	112	69	and	and	CCONJ
ajlm-2816	112	70	even	even	ADV
ajlm-2816	112	71	last	last	ADJ
ajlm-2816	112	72	-	-	PUNCT
ajlm-2816	112	73	result	result	NOUN
ajlm-2816	112	74	drugs	drug	NOUN
ajlm-2816	112	75	such	such	ADJ
ajlm-2816	112	76	as	as	ADP
ajlm-2816	112	77	carbapenems	carbapenem	NOUN
ajlm-2816	112	78	.	.	PUNCT
ajlm-2816	113	1	in	in	ADP
ajlm-2816	113	2	addition	addition	NOUN
ajlm-2816	113	3	,	,	PUNCT
ajlm-2816	113	4	there	there	PRON
ajlm-2816	113	5	is	be	VERB
ajlm-2816	113	6	a	a	DET
ajlm-2816	113	7	high	high	ADJ
ajlm-2816	113	8	prevalence	prevalence	NOUN
ajlm-2816	113	9	of	of	ADP
ajlm-2816	113	10	methicillin	methicillin	NOUN
ajlm-2816	113	11	resistance	resistance	NOUN
ajlm-2816	113	12	in	in	ADP
ajlm-2816	113	13	gram	gram	NOUN
ajlm-2816	113	14	-	-	PUNCT
ajlm-2816	113	15	positive	positive	ADJ
ajlm-2816	113	16	cocci	cocci	NOUN
ajlm-2816	113	17	;	;	PUNCT
ajlm-2816	113	18	however	however	ADV
ajlm-2816	113	19	,	,	PUNCT
ajlm-2816	113	20	vancomycin	vancomycin	PROPN
ajlm-2816	113	21	is	be	AUX
ajlm-2816	113	22	still	still	ADV
ajlm-2816	113	23	effective	effective	ADJ
ajlm-2816	113	24	,	,	PUNCT
ajlm-2816	113	25	as	as	ADP
ajlm-2816	113	26	only	only	ADV
ajlm-2816	113	27	about	about	ADP
ajlm-2816	113	28	10	10	NUM
ajlm-2816	113	29	%	%	NOUN
ajlm-2816	113	30	of	of	ADP
ajlm-2816	113	31	s.	s.	PROPN
ajlm-2816	113	32	aureus	aureus	PROPN
ajlm-2816	113	33	isolates	isolate	NOUN
ajlm-2816	113	34	,	,	PUNCT
ajlm-2816	113	35	and	and	CCONJ
ajlm-2816	113	36	about	about	ADV
ajlm-2816	113	37	20	20	NUM
ajlm-2816	113	38	%	%	NOUN
ajlm-2816	113	39	of	of	ADP
ajlm-2816	113	40	cons	con	NOUN
ajlm-2816	113	41	,	,	PUNCT
ajlm-2816	113	42	are	be	AUX
ajlm-2816	113	43	resistant	resistant	ADJ
ajlm-2816	113	44	to	to	ADP
ajlm-2816	113	45	vancomycin	vancomycin	PROPN
ajlm-2816	113	46	.	.	PUNCT
ajlm-2816	114	1	the	the	DET
ajlm-2816	114	2	pattern	pattern	NOUN
ajlm-2816	114	3	of	of	ADP
ajlm-2816	114	4	antibiotic	antibiotic	ADJ
ajlm-2816	114	5	resistance	resistance	NOUN
ajlm-2816	114	6	distributed	distribute	VERB
ajlm-2816	114	7	across	across	ADP
ajlm-2816	114	8	the	the	DET
ajlm-2816	114	9	spectrum	spectrum	NOUN
ajlm-2816	114	10	of	of	ADP
ajlm-2816	114	11	bacterial	bacterial	ADJ
ajlm-2816	114	12	pathogens	pathogen	NOUN
ajlm-2816	114	13	isolated	isolate	VERB
ajlm-2816	114	14	in	in	ADP
ajlm-2816	114	15	the	the	DET
ajlm-2816	114	16	fn	fn	NOUN
ajlm-2816	114	17	from	from	ADP
ajlm-2816	114	18	this	this	DET
ajlm-2816	114	19	review	review	NOUN
ajlm-2816	114	20	revealed	reveal	VERB
ajlm-2816	114	21	that	that	SCONJ
ajlm-2816	114	22	antibiotic	antibiotic	ADJ
ajlm-2816	114	23	resistance	resistance	NOUN
ajlm-2816	114	24	,	,	PUNCT
ajlm-2816	114	25	especially	especially	ADV
ajlm-2816	114	26	to	to	ADP
ajlm-2816	114	27	last	last	ADJ
ajlm-2816	114	28	-	-	PUNCT
ajlm-2816	114	29	resort	resort	NOUN
ajlm-2816	114	30	antibiotics	antibiotic	NOUN
ajlm-2816	114	31	such	such	ADJ
ajlm-2816	114	32	as	as	ADP
ajlm-2816	114	33	carbapenems	carbapenem	NOUN
ajlm-2816	114	34	in	in	ADP
ajlm-2816	114	35	gram	gram	NOUN
ajlm-2816	114	36	-	-	PUNCT
ajlm-2816	114	37	negative	negative	ADJ
ajlm-2816	114	38	bacilli	bacilli	NOUN
ajlm-2816	114	39	organisms	organism	NOUN
ajlm-2816	114	40	,	,	PUNCT
ajlm-2816	114	41	is	be	AUX
ajlm-2816	114	42	more	more	ADV
ajlm-2816	114	43	widespread	widespread	ADJ
ajlm-2816	114	44	.	.	PUNCT
ajlm-2816	115	1	this	this	PRON
ajlm-2816	115	2	is	be	AUX
ajlm-2816	115	3	a	a	DET
ajlm-2816	115	4	huge	huge	ADJ
ajlm-2816	115	5	concern	concern	NOUN
ajlm-2816	115	6	that	that	SCONJ
ajlm-2816	115	7	the	the	DET
ajlm-2816	115	8	mdr	mdr	PROPN
ajlm-2816	115	9	organisms	organism	NOUN
ajlm-2816	115	10	are	be	AUX
ajlm-2816	115	11	increasingly	increasingly	ADV
ajlm-2816	115	12	being	be	AUX
ajlm-2816	115	13	implicated	implicate	VERB
ajlm-2816	115	14	in	in	ADP
ajlm-2816	115	15	fn	fn	NOUN
ajlm-2816	115	16	,	,	PUNCT
ajlm-2816	115	17	and	and	CCONJ
ajlm-2816	115	18	this	this	PRON
ajlm-2816	115	19	poses	pose	VERB
ajlm-2816	115	20	a	a	DET
ajlm-2816	115	21	significant	significant	ADJ
ajlm-2816	115	22	challenge	challenge	NOUN
ajlm-2816	115	23	to	to	ADP
ajlm-2816	115	24	treatment	treatment	NOUN
ajlm-2816	115	25	in	in	ADP
ajlm-2816	115	26	such	such	ADJ
ajlm-2816	115	27	patients	patient	NOUN
ajlm-2816	115	28	.	.	PUNCT
ajlm-2816	116	1	in	in	ADP
ajlm-2816	116	2	the	the	DET
ajlm-2816	116	3	light	light	NOUN
ajlm-2816	116	4	of	of	ADP
ajlm-2816	116	5	this	this	PRON
ajlm-2816	116	6	,	,	PUNCT
ajlm-2816	116	7	especially	especially	ADV
ajlm-2816	116	8	with	with	ADP
ajlm-2816	116	9	increasing	increase	VERB
ajlm-2816	116	10	morbidity	morbidity	NOUN
ajlm-2816	116	11	and	and	CCONJ
ajlm-2816	116	12	mortality	mortality	NOUN
ajlm-2816	116	13	because	because	SCONJ
ajlm-2816	116	14	of	of	ADP
ajlm-2816	116	15	carbapenem	carbapenem	PROPN
ajlm-2816	116	16	resistance	resistance	NOUN
ajlm-2816	116	17	in	in	ADP
ajlm-2816	116	18	enterobacterales	enterobacterale	NOUN
ajlm-2816	116	19	and	and	CCONJ
ajlm-2816	116	20	non	non	ADJ
ajlm-2816	116	21	-	-	ADJ
ajlm-2816	116	22	glucose	glucose	NOUN
ajlm-2816	116	23	-	-	PUNCT
ajlm-2816	116	24	fermenting	ferment	VERB
ajlm-2816	116	25	gram	gram	NOUN
ajlm-2816	116	26	-	-	PUNCT
ajlm-2816	116	27	negative	negative	ADJ
ajlm-2816	116	28	bacilli	bacilli	NOUN
ajlm-2816	116	29	,	,	PUNCT
ajlm-2816	116	30	there	there	PRON
ajlm-2816	116	31	is	be	VERB
ajlm-2816	116	32	an	an	DET
ajlm-2816	116	33	increasing	increase	VERB
ajlm-2816	116	34	role	role	NOUN
ajlm-2816	116	35	in	in	ADP
ajlm-2816	116	36	the	the	DET
ajlm-2816	116	37	use	use	NOUN
ajlm-2816	116	38	of	of	ADP
ajlm-2816	116	39	beta	beta	NOUN
ajlm-2816	116	40	-	-	PUNCT
ajlm-2816	116	41	lactams	lactam	NOUN
ajlm-2816	116	42	(	(	PUNCT
ajlm-2816	116	43	and	and	CCONJ
ajlm-2816	116	44	non	non	ADJ
ajlm-2816	116	45	-	-	ADJ
ajlm-2816	116	46	beta	beta	ADJ
ajlm-2816	116	47	-	-	PUNCT
ajlm-2816	116	48	lactams	lactam	NOUN
ajlm-2816	116	49	)	)	PUNCT
ajlm-2816	116	50	in	in	ADP
ajlm-2816	116	51	combination	combination	NOUN
ajlm-2816	116	52	with	with	ADP
ajlm-2816	116	53	beta	beta	NOUN
ajlm-2816	116	54	-	-	PUNCT
ajlm-2816	116	55	lactam	lactam	NOUN
ajlm-2816	116	56	-	-	PUNCT
ajlm-2816	116	57	inhibitors	inhibitor	NOUN
ajlm-2816	116	58	such	such	ADJ
ajlm-2816	116	59	as	as	ADP
ajlm-2816	116	60	ceftazidime	ceftazidime	NOUN
ajlm-2816	116	61	-	-	PUNCT
ajlm-2816	116	62	avibactam	avibactam	NOUN
ajlm-2816	116	63	,	,	PUNCT
ajlm-2816	116	64	ceftolozane	ceftolozane	NOUN
ajlm-2816	116	65	-	-	PUNCT
ajlm-2816	116	66	tazobactam	tazobactam	NOUN
ajlm-2816	116	67	,	,	PUNCT
ajlm-2816	116	68	imipenem	imipenem	PROPN
ajlm-2816	116	69	/	/	SYM
ajlm-2816	116	70	relebactam	relebactam	NOUN
ajlm-2816	116	71	,	,	PUNCT
ajlm-2816	116	72	and	and	CCONJ
ajlm-2816	116	73	others	other	NOUN
ajlm-2816	116	74	.	.	PUNCT
ajlm-2816	117	1	there	there	PRON
ajlm-2816	117	2	is	be	VERB
ajlm-2816	117	3	,	,	PUNCT
ajlm-2816	117	4	however	however	ADV
ajlm-2816	117	5	,	,	PUNCT
ajlm-2816	117	6	a	a	DET
ajlm-2816	117	7	challenge	challenge	NOUN
ajlm-2816	117	8	regarding	regard	VERB
ajlm-2816	117	9	access	access	NOUN
ajlm-2816	117	10	to	to	ADP
ajlm-2816	117	11	this	this	DET
ajlm-2816	117	12	newer	new	ADJ
ajlm-2816	117	13	combination	combination	NOUN
ajlm-2816	117	14	of	of	ADP
ajlm-2816	117	15	antibiotics	antibiotic	NOUN
ajlm-2816	117	16	in	in	ADP
ajlm-2816	117	17	lmics	lmic	NOUN
ajlm-2816	117	18	because	because	SCONJ
ajlm-2816	117	19	of	of	ADP
ajlm-2816	117	20	their	their	PRON
ajlm-2816	117	21	high	high	ADJ
ajlm-2816	117	22	cost	cost	NOUN
ajlm-2816	117	23	,	,	PUNCT
ajlm-2816	117	24	and	and	CCONJ
ajlm-2816	117	25	limited	limited	ADJ
ajlm-2816	117	26	data	datum	NOUN
ajlm-2816	117	27	on	on	ADP
ajlm-2816	117	28	their	their	PRON
ajlm-2816	117	29	use	use	NOUN
ajlm-2816	117	30	for	for	ADP
ajlm-2816	117	31	fn	fn	NOUN
ajlm-2816	117	32	in	in	ADP
ajlm-2816	117	33	such	such	ADJ
ajlm-2816	117	34	climes.46	climes.46	PROPN
ajlm-2816	117	35	therefore	therefore	ADV
ajlm-2816	117	36	,	,	PUNCT
ajlm-2816	117	37	it	it	PRON
ajlm-2816	117	38	is	be	AUX
ajlm-2816	117	39	imperative	imperative	ADJ
ajlm-2816	117	40	to	to	PART
ajlm-2816	117	41	prioritise	prioritise	VERB
ajlm-2816	117	42	prevention	prevention	NOUN
ajlm-2816	117	43	of	of	ADP
ajlm-2816	117	44	infection	infection	NOUN
ajlm-2816	117	45	in	in	ADP
ajlm-2816	117	46	patients	patient	NOUN
ajlm-2816	117	47	with	with	ADP
ajlm-2816	117	48	neutropaenia	neutropaenia	NOUN
ajlm-2816	117	49	by	by	ADP
ajlm-2816	117	50	modification	modification	NOUN
ajlm-2816	117	51	of	of	ADP
ajlm-2816	117	52	intensity	intensity	NOUN
ajlm-2816	117	53	of	of	ADP
ajlm-2816	117	54	cytotoxic	cytotoxic	ADJ
ajlm-2816	117	55	medication	medication	NOUN
ajlm-2816	117	56	,	,	PUNCT
ajlm-2816	117	57	addition	addition	NOUN
ajlm-2816	117	58	of	of	ADP
ajlm-2816	117	59	myeloid	myeloid	ADJ
ajlm-2816	117	60	-	-	PUNCT
ajlm-2816	117	61	growth	growth	NOUN
ajlm-2816	117	62	-	-	PUNCT
ajlm-2816	117	63	factor	factor	NOUN
ajlm-2816	117	64	,	,	PUNCT
ajlm-2816	117	65	systematic	systematic	ADJ
ajlm-2816	117	66	selection	selection	NOUN
ajlm-2816	117	67	of	of	ADP
ajlm-2816	117	68	patients	patient	NOUN
ajlm-2816	117	69	for	for	ADP
ajlm-2816	117	70	chemoprophylaxis	chemoprophylaxis	NOUN
ajlm-2816	117	71	,	,	PUNCT
ajlm-2816	117	72	colonisation	colonisation	NOUN
ajlm-2816	117	73	surveillance	surveillance	NOUN
ajlm-2816	117	74	for	for	ADP
ajlm-2816	117	75	mdr	mdr	PROPN
ajlm-2816	117	76	,	,	PUNCT
ajlm-2816	117	77	and	and	CCONJ
ajlm-2816	117	78	proper	proper	ADJ
ajlm-2816	117	79	infection	infection	NOUN
ajlm-2816	117	80	prevention	prevention	NOUN
ajlm-2816	117	81	and	and	CCONJ
ajlm-2816	117	82	control.46,47,49	control.46,47,49	PROPN
ajlm-2816	117	83	limitations	limitation	NOUN
ajlm-2816	117	84	there	there	PRON
ajlm-2816	117	85	is	be	VERB
ajlm-2816	117	86	an	an	DET
ajlm-2816	117	87	inherent	inherent	ADJ
ajlm-2816	117	88	limitation	limitation	NOUN
ajlm-2816	117	89	with	with	ADP
ajlm-2816	117	90	systematic	systematic	ADJ
ajlm-2816	117	91	review	review	NOUN
ajlm-2816	117	92	,	,	PUNCT
ajlm-2816	117	93	as	as	SCONJ
ajlm-2816	117	94	its	its	PRON
ajlm-2816	117	95	outcome	outcome	NOUN
ajlm-2816	117	96	is	be	AUX
ajlm-2816	117	97	based	base	VERB
ajlm-2816	117	98	on	on	ADP
ajlm-2816	117	99	an	an	DET
ajlm-2816	117	100	aggregation	aggregation	NOUN
ajlm-2816	117	101	of	of	ADP
ajlm-2816	117	102	the	the	DET
ajlm-2816	117	103	secondary	secondary	ADJ
ajlm-2816	117	104	data	datum	NOUN
ajlm-2816	117	105	from	from	ADP
ajlm-2816	117	106	synthesised	synthesise	VERB
ajlm-2816	117	107	original	original	ADJ
ajlm-2816	117	108	articles	article	NOUN
ajlm-2816	117	109	.	.	PUNCT
ajlm-2816	118	1	it	it	PRON
ajlm-2816	118	2	was	be	AUX
ajlm-2816	118	3	observed	observe	VERB
ajlm-2816	118	4	that	that	SCONJ
ajlm-2816	118	5	some	some	DET
ajlm-2816	118	6	eligible	eligible	ADJ
ajlm-2816	118	7	articles	article	NOUN
ajlm-2816	118	8	did	do	AUX
ajlm-2816	118	9	not	not	PART
ajlm-2816	118	10	follow	follow	VERB
ajlm-2816	118	11	the	the	DET
ajlm-2816	118	12	antibiotic	antibiotic	ADJ
ajlm-2816	118	13	susceptibility	susceptibility	NOUN
ajlm-2816	118	14	guidelines	guideline	NOUN
ajlm-2816	118	15	to	to	PART
ajlm-2816	118	16	select	select	VERB
ajlm-2816	118	17	the	the	DET
ajlm-2816	118	18	antibiotics	antibiotic	NOUN
ajlm-2816	118	19	tested	test	VERB
ajlm-2816	118	20	on	on	ADP
ajlm-2816	118	21	the	the	DET
ajlm-2816	118	22	bacterial	bacterial	ADJ
ajlm-2816	118	23	agents	agent	NOUN
ajlm-2816	118	24	.	.	PUNCT
ajlm-2816	119	1	moreover	moreover	ADV
ajlm-2816	119	2	,	,	PUNCT
ajlm-2816	119	3	in	in	ADP
ajlm-2816	119	4	some	some	DET
ajlm-2816	119	5	cases	case	NOUN
ajlm-2816	119	6	,	,	PUNCT
ajlm-2816	119	7	the	the	DET
ajlm-2816	119	8	breakpoints	breakpoint	NOUN
ajlm-2816	119	9	,	,	PUNCT
ajlm-2816	119	10	the	the	DET
ajlm-2816	119	11	panels	panel	NOUN
ajlm-2816	119	12	of	of	ADP
ajlm-2816	119	13	antibiotics	antibiotic	NOUN
ajlm-2816	119	14	for	for	ADP
ajlm-2816	119	15	some	some	DET
ajlm-2816	119	16	bacteria	bacteria	NOUN
ajlm-2816	119	17	,	,	PUNCT
ajlm-2816	119	18	had	have	AUX
ajlm-2816	119	19	changed	change	VERB
ajlm-2816	119	20	over	over	ADP
ajlm-2816	119	21	time	time	NOUN
ajlm-2816	119	22	.	.	PUNCT
ajlm-2816	120	1	these	these	PRON
ajlm-2816	120	2	made	make	VERB
ajlm-2816	120	3	the	the	DET
ajlm-2816	120	4	articles	article	NOUN
ajlm-2816	120	5	heterogeneous	heterogeneous	ADJ
ajlm-2816	120	6	and	and	CCONJ
ajlm-2816	120	7	presented	present	VERB
ajlm-2816	120	8	challenges	challenge	NOUN
ajlm-2816	120	9	to	to	ADP
ajlm-2816	120	10	getting	get	VERB
ajlm-2816	120	11	a	a	DET
ajlm-2816	120	12	common	common	ADJ
ajlm-2816	120	13	denominator	denominator	NOUN
ajlm-2816	120	14	for	for	ADP
ajlm-2816	120	15	the	the	DET
ajlm-2816	120	16	antibiotic	antibiotic	ADJ
ajlm-2816	120	17	susceptibility	susceptibility	NOUN
ajlm-2816	120	18	results	result	VERB
ajlm-2816	120	19	for	for	ADP
ajlm-2816	120	20	some	some	DET
ajlm-2816	120	21	analyses	analysis	NOUN
ajlm-2816	120	22	.	.	PUNCT
ajlm-2816	121	1	however	however	ADV
ajlm-2816	121	2	,	,	PUNCT
ajlm-2816	121	3	these	these	DET
ajlm-2816	121	4	limitations	limitation	NOUN
ajlm-2816	121	5	did	do	AUX
ajlm-2816	121	6	not	not	PART
ajlm-2816	121	7	nullify	nullify	VERB
ajlm-2816	121	8	the	the	DET
ajlm-2816	121	9	essence	essence	NOUN
ajlm-2816	121	10	of	of	ADP
ajlm-2816	121	11	this	this	DET
ajlm-2816	121	12	study	study	NOUN
ajlm-2816	121	13	to	to	PART
ajlm-2816	121	14	report	report	VERB
ajlm-2816	121	15	the	the	DET
ajlm-2816	121	16	situation	situation	NOUN
ajlm-2816	121	17	analysis	analysis	NOUN
ajlm-2816	121	18	on	on	ADP
ajlm-2816	121	19	the	the	DET
ajlm-2816	121	20	state	state	NOUN
ajlm-2816	121	21	of	of	ADP
ajlm-2816	121	22	fn	fn	PROPN
ajlm-2816	121	23	in	in	ADP
ajlm-2816	121	24	africa	africa	PROPN
ajlm-2816	121	25	in	in	ADP
ajlm-2816	121	26	the	the	DET
ajlm-2816	121	27	context	context	NOUN
ajlm-2816	121	28	of	of	ADP
ajlm-2816	121	29	antibiotic	antibiotic	ADJ
ajlm-2816	121	30	resistance	resistance	NOUN
ajlm-2816	121	31	.	.	PUNCT
ajlm-2816	122	1	conclusion	conclusion	NOUN
ajlm-2816	122	2	this	this	DET
ajlm-2816	122	3	review	review	NOUN
ajlm-2816	122	4	highlighted	highlight	VERB
ajlm-2816	122	5	the	the	DET
ajlm-2816	122	6	paucity	paucity	NOUN
ajlm-2816	122	7	of	of	ADP
ajlm-2816	122	8	data	datum	NOUN
ajlm-2816	122	9	on	on	ADP
ajlm-2816	122	10	fn	fn	PROPN
ajlm-2816	122	11	in	in	ADP
ajlm-2816	122	12	africa	africa	PROPN
ajlm-2816	122	13	,	,	PUNCT
ajlm-2816	122	14	which	which	PRON
ajlm-2816	122	15	corroborated	corroborate	VERB
ajlm-2816	122	16	the	the	DET
ajlm-2816	122	17	health	health	NOUN
ajlm-2816	122	18	disparity	disparity	NOUN
ajlm-2816	122	19	in	in	ADP
ajlm-2816	122	20	cancer	cancer	NOUN
ajlm-2816	122	21	treatment	treatment	NOUN
ajlm-2816	122	22	across	across	ADP
ajlm-2816	122	23	the	the	DET
ajlm-2816	122	24	economic	economic	ADJ
ajlm-2816	122	25	divide	divide	NOUN
ajlm-2816	122	26	of	of	ADP
ajlm-2816	122	27	the	the	DET
ajlm-2816	122	28	nations	nation	NOUN
ajlm-2816	122	29	.	.	PUNCT
ajlm-2816	123	1	our	our	PRON
ajlm-2816	123	2	findings	finding	NOUN
ajlm-2816	123	3	underscore	underscore	VERB
ajlm-2816	123	4	the	the	DET
ajlm-2816	123	5	need	need	NOUN
ajlm-2816	123	6	for	for	ADP
ajlm-2816	123	7	good	good	ADJ
ajlm-2816	123	8	laboratory	laboratory	NOUN
ajlm-2816	123	9	infrastructures	infrastructure	NOUN
ajlm-2816	123	10	as	as	ADV
ajlm-2816	123	11	well	well	ADV
ajlm-2816	123	12	as	as	ADP
ajlm-2816	123	13	correct	correct	ADJ
ajlm-2816	123	14	blood	blood	NOUN
ajlm-2816	123	15	culture	culture	NOUN
ajlm-2816	123	16	technique	technique	NOUN
ajlm-2816	123	17	in	in	ADP
ajlm-2816	123	18	investigating	investigate	VERB
ajlm-2816	123	19	fn	fn	NOUN
ajlm-2816	123	20	to	to	PART
ajlm-2816	123	21	ensure	ensure	VERB
ajlm-2816	123	22	isolation	isolation	NOUN
ajlm-2816	123	23	of	of	ADP
ajlm-2816	123	24	true	true	ADJ
ajlm-2816	123	25	pathogens	pathogen	NOUN
ajlm-2816	123	26	and	and	CCONJ
ajlm-2816	123	27	appropriate	appropriate	ADJ
ajlm-2816	123	28	‘	'	PUNCT
ajlm-2816	123	29	drug	drug	NOUN
ajlm-2816	123	30	-	-	PUNCT
ajlm-2816	123	31	bug	bug	NOUN
ajlm-2816	123	32	’	'	PUNCT
ajlm-2816	123	33	combinations	combination	NOUN
ajlm-2816	123	34	based	base	VERB
ajlm-2816	123	35	on	on	ADP
ajlm-2816	123	36	standard	standard	ADJ
ajlm-2816	123	37	antibiotic	antibiotic	ADJ
ajlm-2816	123	38	susceptibility	susceptibility	NOUN
ajlm-2816	123	39	guidelines	guideline	NOUN
ajlm-2816	123	40	to	to	PART
ajlm-2816	123	41	reflect	reflect	VERB
ajlm-2816	123	42	the	the	DET
ajlm-2816	123	43	appropriate	appropriate	ADJ
ajlm-2816	123	44	epidemiological	epidemiological	ADJ
ajlm-2816	123	45	picture	picture	NOUN
ajlm-2816	123	46	for	for	ADP
ajlm-2816	123	47	the	the	DET
ajlm-2816	123	48	development	development	NOUN
ajlm-2816	123	49	of	of	ADP
ajlm-2816	123	50	local	local	ADJ
ajlm-2816	123	51	guidelines	guideline	NOUN
ajlm-2816	123	52	in	in	ADP
ajlm-2816	123	53	managing	manage	VERB
ajlm-2816	123	54	fn	fn	NOUN
ajlm-2816	123	55	in	in	ADP
ajlm-2816	123	56	africa	africa	PROPN
ajlm-2816	123	57	.	.	PUNCT
ajlm-2816	124	1	there	there	PRON
ajlm-2816	124	2	is	be	VERB
ajlm-2816	124	3	a	a	DET
ajlm-2816	124	4	high	high	ADJ
ajlm-2816	124	5	level	level	NOUN
ajlm-2816	124	6	of	of	ADP
ajlm-2816	124	7	mdr	mdr	PROPN
ajlm-2816	124	8	strains	strain	VERB
ajlm-2816	124	9	among	among	ADP
ajlm-2816	124	10	the	the	DET
ajlm-2816	124	11	organisms	organism	NOUN
ajlm-2816	124	12	isolated	isolate	VERB
ajlm-2816	124	13	in	in	ADP
ajlm-2816	124	14	fn	fn	NOUN
ajlm-2816	124	15	in	in	ADP
ajlm-2816	124	16	this	this	DET
ajlm-2816	124	17	review	review	NOUN
ajlm-2816	124	18	,	,	PUNCT
ajlm-2816	124	19	which	which	PRON
ajlm-2816	124	20	makes	make	VERB
ajlm-2816	124	21	a	a	DET
ajlm-2816	124	22	case	case	NOUN
ajlm-2816	124	23	for	for	ADP
ajlm-2816	124	24	continuous	continuous	ADJ
ajlm-2816	124	25	need	need	NOUN
ajlm-2816	124	26	for	for	ADP
ajlm-2816	124	27	antimicrobial	antimicrobial	ADJ
ajlm-2816	124	28	resistance	resistance	NOUN
ajlm-2816	124	29	surveillance	surveillance	NOUN
ajlm-2816	124	30	,	,	PUNCT
ajlm-2816	124	31	improved	improve	VERB
ajlm-2816	124	32	laboratory	laboratory	NOUN
ajlm-2816	124	33	capacity	capacity	NOUN
ajlm-2816	124	34	and	and	CCONJ
ajlm-2816	124	35	stewardship	stewardship	NOUN
ajlm-2816	124	36	.	.	PUNCT
ajlm-2816	125	1	there	there	PRON
ajlm-2816	125	2	is	be	VERB
ajlm-2816	125	3	also	also	ADV
ajlm-2816	125	4	a	a	DET
ajlm-2816	125	5	need	need	NOUN
ajlm-2816	125	6	for	for	ADP
ajlm-2816	125	7	the	the	DET
ajlm-2816	125	8	review	review	NOUN
ajlm-2816	125	9	of	of	ADP
ajlm-2816	125	10	international	international	ADJ
ajlm-2816	125	11	guidelines	guideline	NOUN
ajlm-2816	125	12	and	and	CCONJ
ajlm-2816	125	13	suggested	suggest	VERB
ajlm-2816	125	14	antibiotic	antibiotic	ADJ
ajlm-2816	125	15	prophylaxis	prophylaxis	ADJ
ajlm-2816	125	16	and	and	CCONJ
ajlm-2816	125	17	empiric	empiric	ADJ
ajlm-2816	125	18	therapy	therapy	NOUN
ajlm-2816	125	19	for	for	ADP
ajlm-2816	125	20	fn	fn	PROPN
ajlm-2816	125	21	in	in	ADP
ajlm-2816	125	22	the	the	DET
ajlm-2816	125	23	light	light	NOUN
ajlm-2816	125	24	of	of	ADP
ajlm-2816	125	25	local	local	ADJ
ajlm-2816	125	26	epidemiological	epidemiological	ADJ
ajlm-2816	125	27	findings	finding	NOUN
ajlm-2816	125	28	.	.	PUNCT
ajlm-2816	126	1	there	there	PRON
ajlm-2816	126	2	might	might	AUX
ajlm-2816	126	3	be	be	AUX
ajlm-2816	126	4	a	a	DET
ajlm-2816	126	5	need	need	NOUN
ajlm-2816	126	6	for	for	ADP
ajlm-2816	126	7	improved	improved	ADJ
ajlm-2816	126	8	access	access	NOUN
ajlm-2816	126	9	to	to	ADP
ajlm-2816	126	10	newer	new	ADJ
ajlm-2816	126	11	agents	agent	NOUN
ajlm-2816	126	12	,	,	PUNCT
ajlm-2816	126	13	such	such	ADJ
ajlm-2816	126	14	as	as	ADP
ajlm-2816	126	15	beta	beta	NOUN
ajlm-2816	126	16	-	-	PUNCT
ajlm-2816	126	17	lactam	lactam	NOUN
ajlm-2816	126	18	-	-	PUNCT
ajlm-2816	126	19	beta	beta	NOUN
ajlm-2816	126	20	-	-	PUNCT
ajlm-2816	126	21	lactamase	lactamase	NOUN
ajlm-2816	126	22	inhibitors	inhibitor	NOUN
ajlm-2816	126	23	,	,	PUNCT
ajlm-2816	126	24	in	in	ADP
ajlm-2816	126	25	africa	africa	PROPN
ajlm-2816	126	26	to	to	PART
ajlm-2816	126	27	treat	treat	VERB
ajlm-2816	126	28	fn	fn	NOUN
ajlm-2816	126	29	caused	cause	VERB
ajlm-2816	126	30	by	by	ADP
ajlm-2816	126	31	mdr	mdr	PROPN
ajlm-2816	126	32	,	,	PUNCT
ajlm-2816	126	33	causing	cause	VERB
ajlm-2816	126	34	resistance	resistance	NOUN
ajlm-2816	126	35	to	to	ADP
ajlm-2816	126	36	last	last	ADJ
ajlm-2816	126	37	-	-	PUNCT
ajlm-2816	126	38	resort	resort	NOUN
ajlm-2816	126	39	antibiotics	antibiotic	NOUN
ajlm-2816	126	40	(	(	PUNCT
ajlm-2816	126	41	such	such	ADJ
ajlm-2816	126	42	as	as	ADP
ajlm-2816	126	43	carbapenems	carbapenem	NOUN
ajlm-2816	126	44	)	)	PUNCT
ajlm-2816	126	45	for	for	ADP
ajlm-2816	126	46	improved	improved	ADJ
ajlm-2816	126	47	outcomes	outcome	NOUN
ajlm-2816	126	48	in	in	ADP
ajlm-2816	126	49	fn	fn	NOUN
ajlm-2816	126	50	patients	patient	NOUN
ajlm-2816	126	51	.	.	PUNCT
ajlm-2816	127	1	this	this	DET
ajlm-2816	127	2	review	review	NOUN
ajlm-2816	127	3	should	should	AUX
ajlm-2816	127	4	encourage	encourage	VERB
ajlm-2816	127	5	further	further	ADJ
ajlm-2816	127	6	studies	study	NOUN
ajlm-2816	127	7	on	on	ADP
ajlm-2816	127	8	bacterial	bacterial	ADJ
ajlm-2816	127	9	agents	agent	NOUN
ajlm-2816	127	10	of	of	ADP
ajlm-2816	127	11	fn	fn	NOUN
ajlm-2816	127	12	in	in	ADP
ajlm-2816	127	13	this	this	DET
ajlm-2816	127	14	clime	clime	NOUN
ajlm-2816	127	15	to	to	PART
ajlm-2816	127	16	generate	generate	VERB
ajlm-2816	127	17	needed	needed	ADJ
ajlm-2816	127	18	pieces	piece	NOUN
ajlm-2816	127	19	of	of	ADP
ajlm-2816	127	20	evidence	evidence	NOUN
ajlm-2816	127	21	to	to	PART
ajlm-2816	127	22	support	support	VERB
ajlm-2816	127	23	improvement	improvement	NOUN
ajlm-2816	127	24	in	in	ADP
ajlm-2816	127	25	medical	medical	ADJ
ajlm-2816	127	26	microbiology	microbiology	NOUN
ajlm-2816	127	27	laboratory	laboratory	NOUN
ajlm-2816	127	28	capacity	capacity	NOUN
ajlm-2816	127	29	for	for	ADP
ajlm-2816	127	30	the	the	DET
ajlm-2816	127	31	diagnosis	diagnosis	NOUN
ajlm-2816	127	32	of	of	ADP
ajlm-2816	127	33	infections	infection	NOUN
ajlm-2816	127	34	in	in	ADP
ajlm-2816	127	35	fn	fn	NOUN
ajlm-2816	127	36	to	to	PART
ajlm-2816	127	37	inform	inform	VERB
ajlm-2816	127	38	local	local	ADJ
ajlm-2816	127	39	empirical	empirical	ADJ
ajlm-2816	127	40	guidelines	guideline	NOUN
ajlm-2816	127	41	and	and	CCONJ
ajlm-2816	127	42	definitive	definitive	ADJ
ajlm-2816	127	43	therapy	therapy	NOUN
ajlm-2816	127	44	for	for	ADP
ajlm-2816	127	45	optimised	optimise	VERB
ajlm-2816	127	46	management	management	NOUN
ajlm-2816	127	47	of	of	ADP
ajlm-2816	127	48	cancer	cancer	NOUN
ajlm-2816	127	49	patients	patient	NOUN
ajlm-2816	127	50	.	.	PUNCT
ajlm-2816	128	1	acknowledgements	acknowledgement	NOUN
ajlm-2816	128	2	we	we	PRON
ajlm-2816	128	3	acknowledge	acknowledge	VERB
ajlm-2816	128	4	taiwo	taiwo	PROPN
ajlm-2816	128	5	ogunbiyi	ogunbiyi	PROPN
ajlm-2816	128	6	for	for	ADP
ajlm-2816	128	7	his	his	PRON
ajlm-2816	128	8	role	role	NOUN
ajlm-2816	128	9	in	in	ADP
ajlm-2816	128	10	facilitating	facilitate	VERB
ajlm-2816	128	11	the	the	DET
ajlm-2816	128	12	logistics	logistic	NOUN
ajlm-2816	128	13	during	during	ADP
ajlm-2816	128	14	the	the	DET
ajlm-2816	128	15	data	data	NOUN
ajlm-2816	128	16	collection	collection	NOUN
ajlm-2816	128	17	and	and	CCONJ
ajlm-2816	128	18	literature	literature	NOUN
ajlm-2816	128	19	search	search	NOUN
ajlm-2816	128	20	for	for	ADP
ajlm-2816	128	21	this	this	DET
ajlm-2816	128	22	manuscript	manuscript	NOUN
ajlm-2816	128	23	.	.	PUNCT
ajlm-2816	129	1	competing	compete	VERB
ajlm-2816	129	2	interests	interest	NOUN
ajlm-2816	129	3	the	the	DET
ajlm-2816	129	4	authors	author	NOUN
ajlm-2816	129	5	declare	declare	VERB
ajlm-2816	129	6	that	that	SCONJ
ajlm-2816	129	7	they	they	PRON
ajlm-2816	129	8	have	have	VERB
ajlm-2816	129	9	no	no	DET
ajlm-2816	129	10	financial	financial	ADJ
ajlm-2816	129	11	or	or	CCONJ
ajlm-2816	129	12	personal	personal	ADJ
ajlm-2816	129	13	relationships	relationship	NOUN
ajlm-2816	129	14	that	that	PRON
ajlm-2816	129	15	may	may	AUX
ajlm-2816	129	16	have	have	AUX
ajlm-2816	129	17	inappropriately	inappropriately	ADV
ajlm-2816	129	18	influenced	influence	VERB
ajlm-2816	129	19	them	they	PRON
ajlm-2816	129	20	in	in	ADP
ajlm-2816	129	21	writing	write	VERB
ajlm-2816	129	22	this	this	DET
ajlm-2816	129	23	article	article	NOUN
ajlm-2816	129	24	.	.	PUNCT
ajlm-2816	130	1	authors	author	NOUN
ajlm-2816	130	2	’	’	PART
ajlm-2816	130	3	contributions	contribution	NOUN
ajlm-2816	130	4	t.o.o	t.o.o	NOUN
ajlm-2816	130	5	.	.	PROPN
ajlm-2816	130	6	and	and	CCONJ
ajlm-2816	130	7	o.i.a	o.i.a	NOUN
ajlm-2816	130	8	.	.	PUNCT
ajlm-2816	130	9	conceived	conceive	VERB
ajlm-2816	130	10	and	and	CCONJ
ajlm-2816	130	11	conceptualised	conceptualise	VERB
ajlm-2816	130	12	this	this	DET
ajlm-2816	130	13	review	review	NOUN
ajlm-2816	130	14	.	.	PUNCT
ajlm-2816	131	1	t.o.o	t.o.o	PROPN
ajlm-2816	131	2	.	.	PROPN
ajlm-2816	131	3	,	,	PUNCT
ajlm-2816	131	4	a.t.a	a.t.a	PROPN
ajlm-2816	131	5	.	.	PROPN
ajlm-2816	131	6	,	,	PUNCT
ajlm-2816	131	7	n.o.s	n.o.s	ADP
ajlm-2816	131	8	.	.	PROPN
ajlm-2816	131	9	,	,	PUNCT
ajlm-2816	131	10	and	and	CCONJ
ajlm-2816	131	11	o.a.i	o.a.i	PROPN
ajlm-2816	131	12	.	.	PROPN
ajlm-2816	131	13	searched	search	VERB
ajlm-2816	131	14	the	the	DET
ajlm-2816	131	15	literature	literature	NOUN
ajlm-2816	131	16	,	,	PUNCT
ajlm-2816	131	17	and	and	CCONJ
ajlm-2816	131	18	collated	collate	VERB
ajlm-2816	131	19	the	the	DET
ajlm-2816	131	20	data	datum	NOUN
ajlm-2816	131	21	.	.	PUNCT
ajlm-2816	132	1	the	the	DET
ajlm-2816	132	2	article	article	NOUN
ajlm-2816	132	3	was	be	AUX
ajlm-2816	132	4	drafted	draft	VERB
ajlm-2816	132	5	by	by	ADP
ajlm-2816	132	6	t.o.o	t.o.o	PROPN
ajlm-2816	132	7	.	.	PROPN
ajlm-2816	132	8	,	,	PUNCT
ajlm-2816	132	9	a.t.a	a.t.a	PROPN
ajlm-2816	132	10	.	.	PROPN
ajlm-2816	132	11	,	,	PUNCT
ajlm-2816	132	12	n.o.s	n.o.s	PROPN
ajlm-2816	132	13	.	.	PROPN
ajlm-2816	132	14	,	,	PUNCT
ajlm-2816	132	15	o.a.i	o.a.i	PROPN
ajlm-2816	132	16	.	.	PROPN
ajlm-2816	132	17	,	,	PUNCT
ajlm-2816	132	18	and	and	CCONJ
ajlm-2816	132	19	m.m.a	m.m.a	NOUN
ajlm-2816	132	20	.	.	PUNCT
ajlm-2816	133	1	o.i.a	o.i.a	NOUN
ajlm-2816	133	2	.	.	PUNCT
ajlm-2816	133	3	provided	provide	VERB
ajlm-2816	133	4	leadership	leadership	NOUN
ajlm-2816	133	5	and	and	CCONJ
ajlm-2816	133	6	critically	critically	ADV
ajlm-2816	133	7	reviewed	review	VERB
ajlm-2816	133	8	the	the	DET
ajlm-2816	133	9	article	article	NOUN
ajlm-2816	133	10	.	.	PUNCT
ajlm-2816	134	1	t.o.o	t.o.o	PROPN
ajlm-2816	134	2	.	.	PROPN
ajlm-2816	134	3	,	,	PUNCT
ajlm-2816	134	4	a.t.a	a.t.a	PROPN
ajlm-2816	134	5	.	.	PROPN
ajlm-2816	134	6	,	,	PUNCT
ajlm-2816	135	1	o.a.i	o.a.i	PROPN
ajlm-2816	135	2	.	.	PROPN
ajlm-2816	135	3	,	,	PUNCT
ajlm-2816	135	4	n.o.s	n.o.s	PROPN
ajlm-2816	135	5	.	.	PROPN
ajlm-2816	135	6	,	,	PUNCT
ajlm-2816	135	7	m.m.a	m.m.a	NOUN
ajlm-2816	135	8	.	.	PUNCT
ajlm-2816	135	9	,	,	PUNCT
ajlm-2816	135	10	and	and	CCONJ
ajlm-2816	135	11	o.i.a	o.i.a	NOUN
ajlm-2816	135	12	.	.	PUNCT
ajlm-2816	136	1	agreed	agree	VERB
ajlm-2816	136	2	on	on	ADP
ajlm-2816	136	3	the	the	DET
ajlm-2816	136	4	final	final	ADJ
ajlm-2816	136	5	draft	draft	NOUN
ajlm-2816	136	6	of	of	ADP
ajlm-2816	136	7	the	the	DET
ajlm-2816	136	8	article	article	NOUN
ajlm-2816	136	9	.	.	PUNCT
ajlm-2816	137	1	sources	source	NOUN
ajlm-2816	137	2	of	of	ADP
ajlm-2816	137	3	support	support	NOUN
ajlm-2816	137	4	this	this	DET
ajlm-2816	137	5	research	research	NOUN
ajlm-2816	137	6	received	receive	VERB
ajlm-2816	137	7	no	no	DET
ajlm-2816	137	8	specific	specific	ADJ
ajlm-2816	137	9	grant	grant	NOUN
ajlm-2816	137	10	from	from	ADP
ajlm-2816	137	11	any	any	DET
ajlm-2816	137	12	funding	funding	NOUN
ajlm-2816	137	13	agency	agency	NOUN
ajlm-2816	137	14	in	in	ADP
ajlm-2816	137	15	the	the	DET
ajlm-2816	137	16	public	public	ADJ
ajlm-2816	137	17	,	,	PUNCT
ajlm-2816	137	18	commercial	commercial	ADJ
ajlm-2816	137	19	or	or	CCONJ
ajlm-2816	137	20	not	not	PART
ajlm-2816	137	21	-	-	PUNCT
ajlm-2816	137	22	for	for	ADP
ajlm-2816	137	23	-	-	PUNCT
ajlm-2816	137	24	profit	profit	NOUN
ajlm-2816	137	25	sectors	sector	NOUN
ajlm-2816	137	26	.	.	PUNCT
ajlm-2816	138	1	data	datum	NOUN
ajlm-2816	138	2	availability	availability	NOUN
ajlm-2816	138	3	the	the	DET
ajlm-2816	138	4	authors	author	NOUN
ajlm-2816	138	5	confirm	confirm	VERB
ajlm-2816	138	6	that	that	SCONJ
ajlm-2816	138	7	the	the	DET
ajlm-2816	138	8	data	datum	NOUN
ajlm-2816	138	9	supporting	support	VERB
ajlm-2816	138	10	the	the	DET
ajlm-2816	138	11	findings	finding	NOUN
ajlm-2816	138	12	of	of	ADP
ajlm-2816	138	13	this	this	DET
ajlm-2816	138	14	study	study	NOUN
ajlm-2816	138	15	are	be	AUX
ajlm-2816	138	16	available	available	ADJ
ajlm-2816	138	17	within	within	ADP
ajlm-2816	138	18	the	the	DET
ajlm-2816	138	19	article	article	NOUN
ajlm-2816	138	20	and	and	CCONJ
ajlm-2816	138	21	its	its	PRON
ajlm-2816	138	22	supplementary	supplementary	ADJ
ajlm-2816	138	23	materials	material	NOUN
ajlm-2816	138	24	.	.	PUNCT
ajlm-2816	139	1	disclaimer	disclaimer	VERB
ajlm-2816	139	2	the	the	DET
ajlm-2816	139	3	views	view	NOUN
ajlm-2816	139	4	and	and	CCONJ
ajlm-2816	139	5	opinions	opinion	NOUN
ajlm-2816	139	6	expressed	express	VERB
ajlm-2816	139	7	in	in	ADP
ajlm-2816	139	8	this	this	DET
ajlm-2816	139	9	article	article	NOUN
ajlm-2816	139	10	are	be	AUX
ajlm-2816	139	11	those	those	PRON
ajlm-2816	139	12	of	of	ADP
ajlm-2816	139	13	the	the	DET
ajlm-2816	139	14	authors	author	NOUN
ajlm-2816	139	15	and	and	CCONJ
ajlm-2816	139	16	are	be	AUX
ajlm-2816	139	17	the	the	DET
ajlm-2816	139	18	product	product	NOUN
ajlm-2816	139	19	of	of	ADP
ajlm-2816	139	20	professional	professional	ADJ
ajlm-2816	139	21	research	research	NOUN
ajlm-2816	139	22	.	.	PUNCT
ajlm-2816	140	1	the	the	DET
ajlm-2816	140	2	article	article	NOUN
ajlm-2816	140	3	does	do	AUX
ajlm-2816	140	4	not	not	PART
ajlm-2816	140	5	necessarily	necessarily	ADV
ajlm-2816	140	6	reflect	reflect	VERB
ajlm-2816	140	7	the	the	DET
ajlm-2816	140	8	official	official	ADJ
ajlm-2816	140	9	policy	policy	NOUN
ajlm-2816	140	10	or	or	CCONJ
ajlm-2816	140	11	position	position	NOUN
ajlm-2816	140	12	of	of	ADP
ajlm-2816	140	13	any	any	DET
ajlm-2816	140	14	affiliated	affiliated	ADJ
ajlm-2816	140	15	institution	institution	NOUN
ajlm-2816	140	16	,	,	PUNCT
ajlm-2816	140	17	funder	funder	NOUN
ajlm-2816	140	18	,	,	PUNCT
ajlm-2816	140	19	agency	agency	NOUN
ajlm-2816	140	20	,	,	PUNCT
ajlm-2816	140	21	or	or	CCONJ
ajlm-2816	140	22	that	that	PRON
ajlm-2816	140	23	of	of	ADP
ajlm-2816	140	24	the	the	DET
ajlm-2816	140	25	publisher	publisher	NOUN
ajlm-2816	140	26	.	.	PUNCT
ajlm-2816	141	1	the	the	DET
ajlm-2816	141	2	authors	author	NOUN
ajlm-2816	141	3	are	be	AUX
ajlm-2816	141	4	responsible	responsible	ADJ
ajlm-2816	141	5	for	for	ADP
ajlm-2816	141	6	this	this	DET
ajlm-2816	141	7	article	article	NOUN
ajlm-2816	141	8	’s	’s	PART
ajlm-2816	141	9	results	result	NOUN
ajlm-2816	141	10	,	,	PUNCT
ajlm-2816	141	11	findings	finding	NOUN
ajlm-2816	141	12	,	,	PUNCT
ajlm-2816	141	13	and	and	CCONJ
ajlm-2816	141	14	content	content	NOUN
ajlm-2816	141	15	.	.	PUNCT
ajlm-2816	142	1	references	reference	NOUN
ajlm-2816	142	2	omotoso	omotoso	ADJ
ajlm-2816	142	3	o	o	PROPN
ajlm-2816	142	4	,	,	PUNCT
ajlm-2816	142	5	teibo	teibo	PROPN
ajlm-2816	142	6	jo	jo	PROPN
ajlm-2816	142	7	,	,	PUNCT
ajlm-2816	142	8	atiba	atiba	PROPN
ajlm-2816	142	9	fa	fa	PROPN
ajlm-2816	142	10	,	,	PUNCT
ajlm-2816	142	11	et	et	PROPN
ajlm-2816	142	12	al	al	PROPN
ajlm-2816	142	13	.	.	PUNCT
ajlm-2816	143	1	addressing	address	VERB
ajlm-2816	143	2	cancer	cancer	NOUN
ajlm-2816	143	3	care	care	NOUN
ajlm-2816	143	4	inequities	inequity	NOUN
ajlm-2816	143	5	in	in	ADP
ajlm-2816	143	6	sub	sub	ADJ
ajlm-2816	143	7	-	-	ADJ
ajlm-2816	143	8	saharan	saharan	ADJ
ajlm-2816	143	9	africa	africa	PROPN
ajlm-2816	143	10	:	:	PUNCT
ajlm-2816	143	11	current	current	ADJ
ajlm-2816	143	12	challenges	challenge	NOUN
ajlm-2816	143	13	and	and	CCONJ
ajlm-2816	143	14	proposed	propose	VERB
ajlm-2816	143	15	solutions	solution	NOUN
ajlm-2816	143	16	.	.	PUNCT
ajlm-2816	144	1	int	int	PROPN
ajlm-2816	144	2	j	j	PROPN
ajlm-2816	144	3	equity	equity	NOUN
ajlm-2816	144	4	health	health	NOUN
ajlm-2816	144	5	.	.	PUNCT
ajlm-2816	145	1	2023;22(1):1–14	2023;22(1):1–14	NUM
ajlm-2816	145	2	.	.	PUNCT
ajlm-2816	146	1	sharma	sharma	PROPN
ajlm-2816	146	2	r	r	PROPN
ajlm-2816	146	3	,	,	PUNCT
ajlm-2816	146	4	nanda	nanda	PROPN
ajlm-2816	146	5	m	m	PROPN
ajlm-2816	146	6	,	,	PUNCT
ajlm-2816	146	7	fronterre	fronterre	PROPN
ajlm-2816	146	8	c	c	NOUN
ajlm-2816	146	9	,	,	PUNCT
ajlm-2816	146	10	sewagudde	sewagudde	VERB
ajlm-2816	146	11	p	p	PRON
ajlm-2816	146	12	,	,	PUNCT
ajlm-2816	146	13	amponsah	amponsah	PROPN
ajlm-2816	146	14	-	-	PUNCT
ajlm-2816	146	15	manu	manu	PROPN
ajlm-2816	146	16	f	f	NOUN
ajlm-2816	146	17	,	,	PUNCT
ajlm-2816	146	18	ssentongo	ssentongo	NOUN
ajlm-2816	146	19	p.	p.	NOUN
ajlm-2816	146	20	mapping	mapping	NOUN
ajlm-2816	146	21	cancer	cancer	NOUN
ajlm-2816	146	22	in	in	ADP
ajlm-2816	146	23	africa	africa	PROPN
ajlm-2816	146	24	:	:	PUNCT
ajlm-2816	146	25	a	a	DET
ajlm-2816	146	26	comprehensive	comprehensive	ADJ
ajlm-2816	146	27	and	and	CCONJ
ajlm-2816	146	28	comparable	comparable	ADJ
ajlm-2816	146	29	characterization	characterization	NOUN
ajlm-2816	146	30	of	of	ADP
ajlm-2816	146	31	34	34	NUM
ajlm-2816	146	32	cancer	cancer	NOUN
ajlm-2816	146	33	types	type	NOUN
ajlm-2816	146	34	using	use	VERB
ajlm-2816	146	35	estimates	estimate	NOUN
ajlm-2816	146	36	from	from	ADP
ajlm-2816	146	37	globocan	globocan	PROPN
ajlm-2816	146	38	.	.	PUNCT
ajlm-2816	147	1	front	front	ADJ
ajlm-2816	147	2	public	public	ADJ
ajlm-2816	147	3	health	health	NOUN
ajlm-2816	147	4	.	.	PUNCT
ajlm-2816	148	1	2022;10(april):1–14	2022;10(april):1–14	PROPN
ajlm-2816	148	2	.	.	PUNCT
ajlm-2816	149	1	https://doi.org/10.3389/fpubh.2022.839835	https://doi.org/10.3389/fpubh.2022.839835	PROPN
ajlm-2816	149	2	larkin	larkin	PROPN
ajlm-2816	149	3	hd	hd	PROPN
ajlm-2816	149	4	.	.	PUNCT
ajlm-2816	150	1	cancer	cancer	NOUN
ajlm-2816	150	2	deaths	death	NOUN
ajlm-2816	150	3	may	may	AUX
ajlm-2816	150	4	double	double	VERB
ajlm-2816	150	5	by	by	ADP
ajlm-2816	150	6	2030	2030	NUM
ajlm-2816	150	7	in	in	ADP
ajlm-2816	150	8	sub	sub	ADJ
ajlm-2816	150	9	-	-	ADJ
ajlm-2816	150	10	saharan	saharan	ADJ
ajlm-2816	150	11	africa	africa	PROPN
ajlm-2816	150	12	.	.	PUNCT
ajlm-2816	151	1	jama	jama	PROPN
ajlm-2816	151	2	.	.	PUNCT
ajlm-2816	152	1	2022;327(23):2280	2022;327(23):2280	NUM
ajlm-2816	152	2	.	.	PUNCT
ajlm-2816	153	1	https://doi.org/10.1001/jama.2022.10019	https://doi.org/10.1001/jama.2022.10019	PROPN
ajlm-2816	153	2	brand	brand	PROPN
ajlm-2816	153	3	nr	nr	PROPN
ajlm-2816	153	4	,	,	PUNCT
ajlm-2816	153	5	qu	qu	PROPN
ajlm-2816	153	6	lg	lg	PROPN
ajlm-2816	153	7	,	,	PUNCT
ajlm-2816	153	8	chao	chao	PROPN
ajlm-2816	153	9	a	a	PROPN
ajlm-2816	153	10	,	,	PUNCT
ajlm-2816	153	11	ilbawi	ilbawi	NOUN
ajlm-2816	153	12	am	be	AUX
ajlm-2816	153	13	.	.	PUNCT
ajlm-2816	154	1	delays	delay	NOUN
ajlm-2816	154	2	and	and	CCONJ
ajlm-2816	154	3	barriers	barrier	NOUN
ajlm-2816	154	4	to	to	ADP
ajlm-2816	154	5	cancer	cancer	NOUN
ajlm-2816	154	6	care	care	NOUN
ajlm-2816	154	7	in	in	ADP
ajlm-2816	154	8	lowand	lowand	ADJ
ajlm-2816	154	9	middle	middle	ADJ
ajlm-2816	154	10	-	-	PUNCT
ajlm-2816	154	11	income	income	NOUN
ajlm-2816	154	12	countries	country	NOUN
ajlm-2816	154	13	:	:	PUNCT
ajlm-2816	154	14	a	a	DET
ajlm-2816	154	15	systematic	systematic	ADJ
ajlm-2816	154	16	review	review	NOUN
ajlm-2816	154	17	.	.	PUNCT
ajlm-2816	155	1	oncologist	oncologist	NOUN
ajlm-2816	155	2	.	.	PUNCT
ajlm-2816	156	1	2019;24(12):e1371	2019;24(12):e1371	NUM
ajlm-2816	156	2	–	–	PUNCT
ajlm-2816	156	3	e1380	e1380	NOUN
ajlm-2816	156	4	.	.	PUNCT
ajlm-2816	157	1	https://doi.org/10.1634/theoncologist.2019-0057	https://doi.org/10.1634/theoncologist.2019-0057	PROPN
ajlm-2816	157	2	stefan	stefan	PROPN
ajlm-2816	157	3	dc	dc	PROPN
ajlm-2816	157	4	.	.	PUNCT
ajlm-2816	158	1	cancer	cancer	NOUN
ajlm-2816	158	2	care	care	NOUN
ajlm-2816	158	3	in	in	ADP
ajlm-2816	158	4	africa	africa	PROPN
ajlm-2816	158	5	:	:	PUNCT
ajlm-2816	158	6	an	an	DET
ajlm-2816	158	7	overview	overview	NOUN
ajlm-2816	158	8	of	of	ADP
ajlm-2816	158	9	resouces	resouce	NOUN
ajlm-2816	158	10	.	.	PUNCT
ajlm-2816	159	1	am	be	AUX
ajlm-2816	159	2	soc	soc	PROPN
ajlm-2816	159	3	clin	clin	PROPN
ajlm-2816	159	4	oncol	oncol	PROPN
ajlm-2816	159	5	.	.	PUNCT
ajlm-2816	160	1	2023;1(1):1–5	2023;1(1):1–5	X
ajlm-2816	160	2	.	.	PUNCT
ajlm-2816	161	1	vanderpuye	vanderpuye	PROPN
ajlm-2816	161	2	v	v	PROPN
ajlm-2816	161	3	,	,	PUNCT
ajlm-2816	161	4	yarney	yarney	PROPN
ajlm-2816	161	5	j	j	PROPN
ajlm-2816	161	6	,	,	PUNCT
ajlm-2816	161	7	beecham	beecham	PROPN
ajlm-2816	161	8	k.	k.	PROPN
ajlm-2816	161	9	management	management	PROPN
ajlm-2816	161	10	of	of	ADP
ajlm-2816	161	11	febrile	febrile	NOUN
ajlm-2816	161	12	neutropenia	neutropenia	NOUN
ajlm-2816	161	13	in	in	ADP
ajlm-2816	161	14	patients	patient	NOUN
ajlm-2816	161	15	receiving	receive	VERB
ajlm-2816	161	16	chemotherapy	chemotherapy	NOUN
ajlm-2816	161	17	for	for	ADP
ajlm-2816	161	18	solid	solid	ADJ
ajlm-2816	161	19	tumors	tumor	NOUN
ajlm-2816	161	20	:	:	PUNCT
ajlm-2816	161	21	a	a	DET
ajlm-2816	161	22	retrospective	retrospective	ADJ
ajlm-2816	161	23	study	study	NOUN
ajlm-2816	161	24	of	of	ADP
ajlm-2816	161	25	twenty	twenty	NUM
ajlm-2816	161	26	cases	case	NOUN
ajlm-2816	161	27	from	from	ADP
ajlm-2816	161	28	the	the	DET
ajlm-2816	161	29	radiotherapy	radiotherapy	NOUN
ajlm-2816	161	30	centre	centre	NOUN
ajlm-2816	161	31	,	,	PUNCT
ajlm-2816	161	32	accra	accra	NOUN
ajlm-2816	161	33	,	,	PUNCT
ajlm-2816	161	34	ghana	ghana	PROPN
ajlm-2816	161	35	.	.	PUNCT
ajlm-2816	162	1	west	west	PROPN
ajlm-2816	162	2	afr	afr	PROPN
ajlm-2816	162	3	j	j	PROPN
ajlm-2816	162	4	med	med	PROPN
ajlm-2816	162	5	.	.	PUNCT
ajlm-2816	163	1	2010;29(5):303–308	2010;29(5):303–308	X
ajlm-2816	163	2	.	.	PUNCT
ajlm-2816	164	1	https://doi.org/10.4314/wajm.v29i5.68249	https://doi.org/10.4314/wajm.v29i5.68249	X
ajlm-2816	164	2	punnapuzha	punnapuzha	VERB
ajlm-2816	164	3	s	s	PROPN
ajlm-2816	164	4	,	,	PUNCT
ajlm-2816	164	5	pk	pk	NOUN
ajlm-2816	164	6	e	e	NOUN
ajlm-2816	164	7	,	,	PUNCT
ajlm-2816	164	8	elmoheen	elmoheen	VERB
ajlm-2816	164	9	a.	a.	PROPN
ajlm-2816	164	10	febrile	febrile	PROPN
ajlm-2816	164	11	neutropenia	neutropenia	PROPN
ajlm-2816	164	12	.	.	PUNCT
ajlm-2816	165	1	treasure	treasure	NOUN
ajlm-2816	165	2	island	island	NOUN
ajlm-2816	165	3	,	,	PUNCT
ajlm-2816	165	4	fl	fl	PROPN
ajlm-2816	165	5	:	:	PUNCT
ajlm-2816	165	6	statpearls	statpearl	NOUN
ajlm-2816	165	7	,	,	PUNCT
ajlm-2816	165	8	2022	2022	NUM
ajlm-2816	165	9	;	;	PUNCT
ajlm-2816	165	10	p.	p.	NOUN
ajlm-2816	165	11	1–7	1–7	NUM
ajlm-2816	165	12	.	.	PUNCT
ajlm-2816	165	13	lucas	lucas	PROPN
ajlm-2816	165	14	aj	aj	PROPN
ajlm-2816	165	15	,	,	PUNCT
ajlm-2816	165	16	olin	olin	PROPN
ajlm-2816	165	17	jl	jl	PROPN
ajlm-2816	165	18	,	,	PUNCT
ajlm-2816	165	19	coleman	coleman	PROPN
ajlm-2816	165	20	md	md	PROPN
ajlm-2816	165	21	.	.	PUNCT
ajlm-2816	166	1	management	management	PROPN
ajlm-2816	166	2	and	and	CCONJ
ajlm-2816	166	3	preventive	preventive	ADJ
ajlm-2816	166	4	measures	measure	NOUN
ajlm-2816	166	5	for	for	ADP
ajlm-2816	166	6	febrile	febrile	NOUN
ajlm-2816	166	7	neutropenia	neutropenia	NOUN
ajlm-2816	166	8	.	.	PUNCT
ajlm-2816	167	1	p	p	X
ajlm-2816	167	2	t.	t.	PROPN
ajlm-2816	167	3	2018;43(4):228–232	2018;43(4):228–232	PROPN
ajlm-2816	167	4	.	.	PUNCT
ajlm-2816	168	1	klastersky	klastersky	PROPN
ajlm-2816	168	2	j	j	PROPN
ajlm-2816	168	3	,	,	PUNCT
ajlm-2816	168	4	de	de	X
ajlm-2816	168	5	naurois	naurois	PROPN
ajlm-2816	168	6	j	j	PROPN
ajlm-2816	168	7	,	,	PUNCT
ajlm-2816	168	8	rolston	rolston	PROPN
ajlm-2816	168	9	k	k	PROPN
ajlm-2816	168	10	,	,	PUNCT
ajlm-2816	168	11	et	et	PROPN
ajlm-2816	168	12	al	al	PROPN
ajlm-2816	168	13	.	.	PUNCT
ajlm-2816	168	14	management	management	NOUN
ajlm-2816	168	15	of	of	ADP
ajlm-2816	168	16	febrile	febrile	NOUN
ajlm-2816	168	17	neutropaenia	neutropaenia	NOUN
ajlm-2816	168	18	:	:	PUNCT
ajlm-2816	168	19	esmo	esmo	VERB
ajlm-2816	168	20	clinical	clinical	ADJ
ajlm-2816	168	21	practice	practice	NOUN
ajlm-2816	168	22	guidelines	guideline	NOUN
ajlm-2816	168	23	.	.	PUNCT
ajlm-2816	169	1	ann	ann	PROPN
ajlm-2816	169	2	oncol	oncol	PROPN
ajlm-2816	169	3	.	.	PUNCT
ajlm-2816	170	1	2016;27(supplement	2016;27(supplement	NOUN
ajlm-2816	170	2	5):v111	5):v111	NUM
ajlm-2816	170	3	–	–	PUNCT
ajlm-2816	170	4	v118	v118	NUM
ajlm-2816	170	5	.	.	PUNCT
ajlm-2816	171	1	https://doi.org/10.1093/annonc/mdw325	https://doi.org/10.1093/annonc/mdw325	PROPN
ajlm-2816	171	2	schelenz	schelenz	PROPN
ajlm-2816	171	3	s	s	PART
ajlm-2816	171	4	,	,	PUNCT
ajlm-2816	171	5	giles	giles	PROPN
ajlm-2816	171	6	d	d	PROPN
ajlm-2816	171	7	,	,	PUNCT
ajlm-2816	171	8	abdallah	abdallah	PROPN
ajlm-2816	171	9	s.	s.	PROPN
ajlm-2816	171	10	epidemiology	epidemiology	PROPN
ajlm-2816	171	11	,	,	PUNCT
ajlm-2816	171	12	management	management	NOUN
ajlm-2816	171	13	and	and	CCONJ
ajlm-2816	171	14	economic	economic	ADJ
ajlm-2816	171	15	impact	impact	NOUN
ajlm-2816	171	16	of	of	ADP
ajlm-2816	171	17	febrile	febrile	NOUN
ajlm-2816	171	18	neutropenia	neutropenia	NOUN
ajlm-2816	171	19	in	in	ADP
ajlm-2816	171	20	oncology	oncology	NOUN
ajlm-2816	171	21	patients	patient	NOUN
ajlm-2816	171	22	receiving	receive	VERB
ajlm-2816	171	23	routine	routine	ADJ
ajlm-2816	171	24	care	care	NOUN
ajlm-2816	171	25	at	at	ADP
ajlm-2816	171	26	a	a	DET
ajlm-2816	171	27	regional	regional	ADJ
ajlm-2816	171	28	uk	uk	PROPN
ajlm-2816	171	29	cancer	cancer	NOUN
ajlm-2816	171	30	centre	centre	NOUN
ajlm-2816	171	31	.	.	PUNCT
ajlm-2816	172	1	ann	ann	PROPN
ajlm-2816	172	2	oncol	oncol	PROPN
ajlm-2816	172	3	.	.	PUNCT
ajlm-2816	173	1	2012;23(7):1889–1893	2012;23(7):1889–1893	NUM
ajlm-2816	173	2	.	.	PUNCT
ajlm-2816	174	1	https://doi.org/10.1093/annonc/mdr520	https://doi.org/10.1093/annonc/mdr520	ADJ
ajlm-2816	174	2	caggiano	caggiano	PROPN
ajlm-2816	174	3	v	v	PROPN
ajlm-2816	174	4	,	,	PUNCT
ajlm-2816	174	5	weiss	weiss	PROPN
ajlm-2816	174	6	rv	rv	PROPN
ajlm-2816	174	7	,	,	PUNCT
ajlm-2816	174	8	rickert	rickert	PROPN
ajlm-2816	174	9	ts	ts	PROPN
ajlm-2816	174	10	,	,	PUNCT
ajlm-2816	174	11	linde	linde	ADJ
ajlm-2816	174	12	-	-	PUNCT
ajlm-2816	174	13	zwirble	zwirble	ADJ
ajlm-2816	174	14	wt	wt	NOUN
ajlm-2816	174	15	.	.	NOUN
ajlm-2816	174	16	incidence	incidence	NOUN
ajlm-2816	174	17	,	,	PUNCT
ajlm-2816	174	18	cost	cost	NOUN
ajlm-2816	174	19	,	,	PUNCT
ajlm-2816	174	20	and	and	CCONJ
ajlm-2816	174	21	mortality	mortality	NOUN
ajlm-2816	174	22	of	of	ADP
ajlm-2816	174	23	neutropenia	neutropenia	NOUN
ajlm-2816	174	24	hospitalization	hospitalization	NOUN
ajlm-2816	174	25	associated	associate	VERB
ajlm-2816	174	26	with	with	ADP
ajlm-2816	174	27	chemotherapy	chemotherapy	NOUN
ajlm-2816	174	28	.	.	PUNCT
ajlm-2816	175	1	am	be	AUX
ajlm-2816	175	2	cancer	cancer	NOUN
ajlm-2816	175	3	soc	soc	NOUN
ajlm-2816	175	4	.	.	PUNCT
ajlm-2816	176	1	2005;103(9):1916–1924	2005;103(9):1916–1924	NUM
ajlm-2816	176	2	.	.	PUNCT
ajlm-2816	176	3	https://doi.org/10.1002/cncr.20983	https://doi.org/10.1002/cncr.20983	PROPN
ajlm-2816	176	4	rasmy	rasmy	PROPN
ajlm-2816	176	5	a	a	PRON
ajlm-2816	176	6	,	,	PUNCT
ajlm-2816	176	7	amal	amal	PROPN
ajlm-2816	176	8	a	a	PRON
ajlm-2816	176	9	,	,	PUNCT
ajlm-2816	176	10	fotih	fotih	NOUN
ajlm-2816	176	11	s	s	NOUN
ajlm-2816	176	12	,	,	PUNCT
ajlm-2816	176	13	selwi	selwi	ADJ
ajlm-2816	176	14	w.	w.	PROPN
ajlm-2816	176	15	febrile	febrile	PROPN
ajlm-2816	176	16	neutropenia	neutropenia	PROPN
ajlm-2816	176	17	in	in	ADP
ajlm-2816	176	18	cancer	cancer	NOUN
ajlm-2816	176	19	patient	patient	NOUN
ajlm-2816	176	20	:	:	PUNCT
ajlm-2816	176	21	epidemiology	epidemiology	NOUN
ajlm-2816	176	22	,	,	PUNCT
ajlm-2816	176	23	microbiology	microbiology	NOUN
ajlm-2816	176	24	,	,	PUNCT
ajlm-2816	176	25	pathophysiology	pathophysiology	NOUN
ajlm-2816	176	26	and	and	CCONJ
ajlm-2816	176	27	management	management	NOUN
ajlm-2816	176	28	.	.	PUNCT
ajlm-2816	177	1	j	j	PROPN
ajlm-2816	177	2	cancer	cancer	NOUN
ajlm-2816	177	3	prev	prev	PROPN
ajlm-2816	177	4	curr	curr	PROPN
ajlm-2816	177	5	res	re	NOUN
ajlm-2816	177	6	.	.	PUNCT
ajlm-2816	178	1	2016;5(3):273–278	2016;5(3):273–278	NUM
ajlm-2816	178	2	.	.	PUNCT
ajlm-2816	179	1	tong	tong	PROPN
ajlm-2816	179	2	d	d	PROPN
ajlm-2816	179	3	,	,	PUNCT
ajlm-2816	179	4	getahun	getahun	PROPN
ajlm-2816	179	5	h.	h.	PROPN
ajlm-2816	179	6	antimicrobial	antimicrobial	ADJ
ajlm-2816	179	7	stewardship	stewardship	NOUN
ajlm-2816	179	8	and	and	CCONJ
ajlm-2816	179	9	optimizing	optimize	VERB
ajlm-2816	179	10	antimicrobial	antimicrobial	ADJ
ajlm-2816	179	11	use	use	NOUN
ajlm-2816	179	12	in	in	ADP
ajlm-2816	179	13	the	the	DET
ajlm-2816	179	14	cancer	cancer	NOUN
ajlm-2816	179	15	community	community	NOUN
ajlm-2816	179	16	.	.	PUNCT
ajlm-2816	180	1	in	in	ADP
ajlm-2816	180	2	:	:	PUNCT
ajlm-2816	180	3	probart	probart	PROPN
ajlm-2816	180	4	t	t	PROPN
ajlm-2816	180	5	,	,	PUNCT
ajlm-2816	180	6	editor	editor	NOUN
ajlm-2816	180	7	.	.	PUNCT
ajlm-2816	181	1	amr	amr	PROPN
ajlm-2816	181	2	control	control	NOUN
ajlm-2816	181	3	supplements	supplement	NOUN
ajlm-2816	181	4	.	.	PUNCT
ajlm-2816	182	1	the	the	DET
ajlm-2816	182	2	challenge	challenge	NOUN
ajlm-2816	182	3	for	for	ADP
ajlm-2816	182	4	the	the	DET
ajlm-2816	182	5	cancer	cancer	NOUN
ajlm-2816	182	6	community	community	NOUN
ajlm-2816	182	7	.	.	PUNCT
ajlm-2816	183	1	geneva	geneva	NOUN
ajlm-2816	183	2	:	:	PUNCT
ajlm-2816	184	1	global	global	ADJ
ajlm-2816	184	2	health	health	NOUN
ajlm-2816	184	3	dynamics	dynamic	NOUN
ajlm-2816	184	4	,	,	PUNCT
ajlm-2816	184	5	2022	2022	NUM
ajlm-2816	184	6	;	;	PUNCT
ajlm-2816	184	7	p.	p.	PROPN
ajlm-2816	184	8	62–64	62–64	NUM
ajlm-2816	184	9	.	.	PUNCT
ajlm-2816	185	1	http://resistancecontrol.info/amr2022/	http://resistancecontrol.info/amr2022/	PROPN
ajlm-2816	185	2	naeem	naeem	PROPN
ajlm-2816	185	3	d	d	PROPN
ajlm-2816	185	4	,	,	PUNCT
ajlm-2816	185	5	alshamrani	alshamrani	PROPN
ajlm-2816	185	6	m	m	PROPN
ajlm-2816	185	7	,	,	PUNCT
ajlm-2816	185	8	aseeri	aseeri	PROPN
ajlm-2816	185	9	m	m	PROPN
ajlm-2816	185	10	,	,	PUNCT
ajlm-2816	185	11	khan	khan	PROPN
ajlm-2816	185	12	m.	m.	NOUN
ajlm-2816	185	13	prescribing	prescribing	NOUN
ajlm-2816	185	14	empiric	empiric	ADJ
ajlm-2816	185	15	antibiotics	antibiotic	NOUN
ajlm-2816	185	16	for	for	ADP
ajlm-2816	185	17	febrile	febrile	NOUN
ajlm-2816	185	18	neutropenia	neutropenia	NOUN
ajlm-2816	185	19	:	:	PUNCT
ajlm-2816	185	20	compliance	compliance	NOUN
ajlm-2816	185	21	with	with	ADP
ajlm-2816	185	22	institutional	institutional	ADJ
ajlm-2816	185	23	febrile	febrile	NOUN
ajlm-2816	185	24	neutropenia	neutropenia	NOUN
ajlm-2816	185	25	guidelines	guideline	NOUN
ajlm-2816	185	26	.	.	PUNCT
ajlm-2816	186	1	pharmacy	pharmacy	NOUN
ajlm-2816	186	2	.	.	PUNCT
ajlm-2816	187	1	2018;6(3):83	2018;6(3):83	X
ajlm-2816	187	2	.	.	X
ajlm-2816	187	3	https://doi.org/10.3390/pharmacy6030083	https://doi.org/10.3390/pharmacy6030083	PROPN
ajlm-2816	187	4	okello	okello	PROPN
ajlm-2816	187	5	cd	cd	PROPN
ajlm-2816	187	6	,	,	PUNCT
ajlm-2816	187	7	niyonzima	niyonzima	NOUN
ajlm-2816	187	8	n	n	CCONJ
ajlm-2816	187	9	,	,	PUNCT
ajlm-2816	187	10	ferraresso	ferraresso	NOUN
ajlm-2816	187	11	m	m	PROPN
ajlm-2816	187	12	,	,	PUNCT
ajlm-2816	187	13	et	et	PROPN
ajlm-2816	187	14	al	al	PROPN
ajlm-2816	187	15	.	.	PUNCT
ajlm-2816	188	1	haematological	haematological	PROPN
ajlm-2816	188	2	care	care	PROPN
ajlm-2816	188	3	priorities	priority	NOUN
ajlm-2816	188	4	in	in	ADP
ajlm-2816	188	5	sub	sub	ADJ
ajlm-2816	188	6	-	-	ADJ
ajlm-2816	188	7	saharan	saharan	ADJ
ajlm-2816	188	8	africa	africa	PROPN
ajlm-2816	188	9	3	3	NUM
ajlm-2816	188	10	haematological	haematological	ADJ
ajlm-2816	188	11	malignancies	malignancy	NOUN
ajlm-2816	188	12	in	in	ADP
ajlm-2816	188	13	sub	sub	ADJ
ajlm-2816	188	14	-	-	ADJ
ajlm-2816	188	15	saharan	saharan	ADJ
ajlm-2816	188	16	africa	africa	PROPN
ajlm-2816	188	17	:	:	PUNCT
ajlm-2816	188	18	east	east	PROPN
ajlm-2816	188	19	africa	africa	PROPN
ajlm-2816	188	20	as	as	ADP
ajlm-2816	188	21	an	an	DET
ajlm-2816	188	22	example	example	NOUN
ajlm-2816	188	23	for	for	ADP
ajlm-2816	188	24	improving	improve	VERB
ajlm-2816	188	25	care	care	NOUN
ajlm-2816	188	26	.	.	PUNCT
ajlm-2816	189	1	lancet	lancet	NOUN
ajlm-2816	189	2	haematol	haematol	NOUN
ajlm-2816	189	3	.	.	PUNCT
ajlm-2816	190	1	2021;8(10):e756	2021;8(10):e756	NUM
ajlm-2816	190	2	–	–	PUNCT
ajlm-2816	190	3	e769	e769	NUM
ajlm-2816	190	4	.	.	PUNCT
ajlm-2816	191	1	https://doi.org/10.1016/s2352-3026(21)00198-8	https://doi.org/10.1016/s2352-3026(21)00198-8	PROPN
ajlm-2816	191	2	moher	moher	PROPN
ajlm-2816	191	3	d	d	PROPN
ajlm-2816	191	4	,	,	PUNCT
ajlm-2816	191	5	liberati	liberati	PROPN
ajlm-2816	191	6	a	a	PRON
ajlm-2816	191	7	,	,	PUNCT
ajlm-2816	191	8	tetzlaff	tetzlaff	PROPN
ajlm-2816	191	9	j	j	PROPN
ajlm-2816	191	10	,	,	PUNCT
ajlm-2816	191	11	altman	altman	PROPN
ajlm-2816	191	12	dg	dg	PROPN
ajlm-2816	191	13	,	,	PUNCT
ajlm-2816	191	14	group	group	NOUN
ajlm-2816	191	15	tp	tp	PROPN
ajlm-2816	191	16	.	.	PUNCT
ajlm-2816	192	1	preferred	preferred	ADJ
ajlm-2816	192	2	reporting	reporting	NOUN
ajlm-2816	192	3	items	item	NOUN
ajlm-2816	192	4	for	for	ADP
ajlm-2816	192	5	systematic	systematic	ADJ
ajlm-2816	192	6	reviews	review	NOUN
ajlm-2816	192	7	and	and	CCONJ
ajlm-2816	192	8	meta	meta	NOUN
ajlm-2816	192	9	-	-	PUNCT
ajlm-2816	192	10	analyses	analysis	NOUN
ajlm-2816	192	11	:	:	PUNCT
ajlm-2816	192	12	the	the	DET
ajlm-2816	192	13	prisma	prisma	PROPN
ajlm-2816	192	14	statement	statement	NOUN
ajlm-2816	192	15	.	.	PUNCT
ajlm-2816	193	1	plos	plos	PROPN
ajlm-2816	193	2	med	med	PROPN
ajlm-2816	193	3	.	.	PUNCT
ajlm-2816	194	1	2009;6(7):e1000097	2009;6(7):e1000097	X
ajlm-2816	194	2	.	.	PUNCT
ajlm-2816	195	1	https://doi.org/10.1371/journal.pmed.1000097	https://doi.org/10.1371/journal.pmed.1000097	PROPN
ajlm-2816	195	2	el	el	PROPN
ajlm-2816	195	3	-	-	PROPN
ajlm-2816	195	4	mahallawy	mahallawy	PROPN
ajlm-2816	195	5	h	h	PROPN
ajlm-2816	195	6	,	,	PUNCT
ajlm-2816	195	7	samir	samir	PROPN
ajlm-2816	195	8	i	i	PROPN
ajlm-2816	195	9	,	,	PUNCT
ajlm-2816	195	10	abdel	abdel	PROPN
ajlm-2816	195	11	r	r	PROPN
ajlm-2816	195	12	,	,	PUNCT
ajlm-2816	195	13	kadry	kadry	PROPN
ajlm-2816	195	14	d.	d.	PROPN
ajlm-2816	195	15	source	source	PROPN
ajlm-2816	195	16	,	,	PUNCT
ajlm-2816	195	17	pattern	pattern	NOUN
ajlm-2816	195	18	and	and	CCONJ
ajlm-2816	195	19	antibiotic	antibiotic	ADJ
ajlm-2816	195	20	resistance	resistance	NOUN
ajlm-2816	195	21	of	of	ADP
ajlm-2816	195	22	blood	blood	NOUN
ajlm-2816	195	23	stream	stream	NOUN
ajlm-2816	195	24	infections	infection	NOUN
ajlm-2816	195	25	in	in	ADP
ajlm-2816	195	26	hematopoietic	hematopoietic	ADJ
ajlm-2816	195	27	stem	stem	NOUN
ajlm-2816	195	28	cell	cell	NOUN
ajlm-2816	195	29	transplant	transplant	NOUN
ajlm-2816	195	30	recipients	recipient	NOUN
ajlm-2816	195	31	.	.	PUNCT
ajlm-2816	196	1	j	j	PROPN
ajlm-2816	196	2	egypt	egypt	PROPN
ajlm-2816	196	3	natl	natl	PROPN
ajlm-2816	196	4	cancer	cancer	PROPN
ajlm-2816	196	5	inst	inst	PROPN
ajlm-2816	196	6	.	.	PUNCT
ajlm-2816	197	1	2014;26(2):73–77	2014;26(2):73–77	NUM
ajlm-2816	197	2	.	.	PUNCT
ajlm-2816	198	1	https://doi.org/10.1016/j.jnci.2013.12.001	https://doi.org/10.1016/j.jnci.2013.12.001	NOUN
ajlm-2816	198	2	nkrumah	nkrumah	PROPN
ajlm-2816	198	3	no	no	PROPN
ajlm-2816	198	4	,	,	PUNCT
ajlm-2816	198	5	labi	labi	PROPN
ajlm-2816	198	6	ak	ak	PROPN
ajlm-2816	198	7	,	,	PUNCT
ajlm-2816	198	8	acquah	acquah	VERB
ajlm-2816	198	9	me	i	PRON
ajlm-2816	198	10	,	,	PUNCT
ajlm-2816	198	11	donkor	donkor	PROPN
ajlm-2816	198	12	es	es	PROPN
ajlm-2816	198	13	.	.	PUNCT
ajlm-2816	199	1	bloodstream	bloodstream	NOUN
ajlm-2816	199	2	infections	infection	NOUN
ajlm-2816	199	3	in	in	ADP
ajlm-2816	199	4	patients	patient	NOUN
ajlm-2816	199	5	with	with	ADP
ajlm-2816	199	6	malignancies	malignancy	NOUN
ajlm-2816	199	7	:	:	PUNCT
ajlm-2816	200	1	i	i	PRON
ajlm-2816	200	2	m	m	VERB
ajlm-2816	200	3	plications	plication	NOUN
ajlm-2816	200	4	for	for	ADP
ajlm-2816	200	5	antibiotic	antibiotic	ADJ
ajlm-2816	200	6	treatment	treatment	NOUN
ajlm-2816	200	7	in	in	ADP
ajlm-2816	200	8	a	a	DET
ajlm-2816	200	9	ghanaian	ghanaian	ADJ
ajlm-2816	200	10	tertiary	tertiary	ADJ
ajlm-2816	200	11	setting	setting	NOUN
ajlm-2816	200	12	.	.	PUNCT
ajlm-2816	201	1	bmc	bmc	ADJ
ajlm-2816	201	2	res	re	NOUN
ajlm-2816	201	3	notes	note	NOUN
ajlm-2816	201	4	.	.	PUNCT
ajlm-2816	202	1	2015;8(742):1–11	2015;8(742):1–11	PROPN
ajlm-2816	202	2	.	.	PUNCT
ajlm-2816	203	1	el	el	PROPN
ajlm-2816	203	2	-	-	PROPN
ajlm-2816	203	3	mahallawy	mahallawy	PROPN
ajlm-2816	203	4	h	h	PROPN
ajlm-2816	203	5	,	,	PUNCT
ajlm-2816	203	6	sidhom	sidhom	PROPN
ajlm-2816	203	7	i	i	PROPN
ajlm-2816	203	8	,	,	PUNCT
ajlm-2816	203	9	el	el	PROPN
ajlm-2816	203	10	-	-	PUNCT
ajlm-2816	203	11	din	din	PROPN
ajlm-2816	203	12	nha	nha	NOUN
ajlm-2816	203	13	,	,	PUNCT
ajlm-2816	203	14	zamzam	zamzam	PROPN
ajlm-2816	203	15	m	m	PROPN
ajlm-2816	203	16	,	,	PUNCT
ajlm-2816	203	17	el	el	PROPN
ajlm-2816	203	18	-	-	PUNCT
ajlm-2816	203	19	lamie	lamie	VERB
ajlm-2816	203	20	mm	mm	PROPN
ajlm-2816	203	21	.	.	PUNCT
ajlm-2816	204	1	clinical	clinical	ADJ
ajlm-2816	204	2	and	and	CCONJ
ajlm-2816	204	3	microbiologic	microbiologic	ADJ
ajlm-2816	204	4	determinants	determinant	NOUN
ajlm-2816	204	5	of	of	ADP
ajlm-2816	204	6	serious	serious	ADJ
ajlm-2816	204	7	bloodstream	bloodstream	NOUN
ajlm-2816	204	8	infections	infection	NOUN
ajlm-2816	204	9	in	in	ADP
ajlm-2816	204	10	egyptian	egyptian	ADJ
ajlm-2816	204	11	pediatric	pediatric	ADJ
ajlm-2816	204	12	cancer	cancer	NOUN
ajlm-2816	204	13	patients	patient	NOUN
ajlm-2816	204	14	:	:	PUNCT
ajlm-2816	204	15	a	a	DET
ajlm-2816	204	16	one	one	NUM
ajlm-2816	204	17	-	-	PUNCT
ajlm-2816	204	18	year	year	NOUN
ajlm-2816	204	19	study	study	NOUN
ajlm-2816	204	20	.	.	PUNCT
ajlm-2816	205	1	int	int	PROPN
ajlm-2816	205	2	j	j	PROPN
ajlm-2816	205	3	infect	infect	VERB
ajlm-2816	205	4	dis	dis	PROPN
ajlm-2816	205	5	.	.	PUNCT
ajlm-2816	206	1	2005;9:43–51	2005;9:43–51	NUM
ajlm-2816	206	2	.	.	NOUN
ajlm-2816	206	3	https://doi.org/10.1016/j.ijid.2003.11.010	https://doi.org/10.1016/j.ijid.2003.11.010	PROPN
ajlm-2816	206	4	louw	louw	PROPN
ajlm-2816	206	5	vj	vj	PROPN
ajlm-2816	206	6	,	,	PUNCT
ajlm-2816	206	7	van	van	PROPN
ajlm-2816	206	8	der	der	PROPN
ajlm-2816	206	9	westhuizen	westhuizen	PROPN
ajlm-2816	206	10	j	j	PROPN
ajlm-2816	206	11	,	,	PUNCT
ajlm-2816	206	12	rautenbach	rautenbach	ADJ
ajlm-2816	206	13	w	w	PROPN
ajlm-2816	206	14	,	,	PUNCT
ajlm-2816	206	15	van	van	PROPN
ajlm-2816	206	16	der	der	PROPN
ajlm-2816	206	17	berg	berg	PROPN
ajlm-2816	206	18	e	e	PROPN
ajlm-2816	206	19	,	,	PUNCT
ajlm-2816	206	20	wamelink	wamelink	PROPN
ajlm-2816	206	21	m	m	PROPN
ajlm-2816	206	22	,	,	PUNCT
ajlm-2816	206	23	joubert	joubert	PROPN
ajlm-2816	206	24	g.	g.	PROPN
ajlm-2816	206	25	the	the	DET
ajlm-2816	206	26	antibiotic	antibiotic	ADJ
ajlm-2816	206	27	susceptibility	susceptibility	NOUN
ajlm-2816	206	28	of	of	ADP
ajlm-2816	206	29	bacteria	bacteria	NOUN
ajlm-2816	206	30	isolated	isolate	VERB
ajlm-2816	206	31	from	from	ADP
ajlm-2816	206	32	blood	blood	NOUN
ajlm-2816	206	33	cultures	culture	NOUN
ajlm-2816	206	34	during	during	ADP
ajlm-2816	206	35	episodes	episode	NOUN
ajlm-2816	206	36	of	of	ADP
ajlm-2816	206	37	neutropenic	neutropenic	ADJ
ajlm-2816	206	38	fever	fever	NOUN
ajlm-2816	206	39	in	in	ADP
ajlm-2816	206	40	patients	patient	NOUN
ajlm-2816	206	41	with	with	ADP
ajlm-2816	206	42	acute	acute	ADJ
ajlm-2816	206	43	myeloid	myeloid	ADJ
ajlm-2816	206	44	leukaemia	leukaemia	NOUN
ajlm-2816	206	45	.	.	PUNCT
ajlm-2816	207	1	south	south	PROPN
ajlm-2816	207	2	afr	afr	PROPN
ajlm-2816	207	3	j	j	PROPN
ajlm-2816	207	4	epidemiol	epidemiol	PROPN
ajlm-2816	207	5	infect	infect	PROPN
ajlm-2816	207	6	.	.	PUNCT
ajlm-2816	208	1	2010;25(2):9–11	2010;25(2):9–11	X
ajlm-2816	208	2	.	.	PUNCT
ajlm-2816	209	1	https://doi.org/10.1080/10158782.2010.11441380	https://doi.org/10.1080/10158782.2010.11441380	VERB
ajlm-2816	210	1	el	el	PROPN
ajlm-2816	210	2	-	-	PUNCT
ajlm-2816	210	3	mahallawy	mahallawy	PROPN
ajlm-2816	210	4	ha	ha	PROPN
ajlm-2816	210	5	,	,	PUNCT
ajlm-2816	210	6	el	el	PROPN
ajlm-2816	210	7	-	-	PUNCT
ajlm-2816	210	8	wakil	wakil	PROPN
ajlm-2816	210	9	m	m	PROPN
ajlm-2816	210	10	,	,	PUNCT
ajlm-2816	210	11	moneer	moneer	NOUN
ajlm-2816	210	12	mm	mm	NOUN
ajlm-2816	210	13	,	,	PUNCT
ajlm-2816	210	14	shalaby	shalaby	NOUN
ajlm-2816	210	15	l.	l.	PROPN
ajlm-2816	210	16	antibiotic	antibiotic	PROPN
ajlm-2816	210	17	resistance	resistance	NOUN
ajlm-2816	210	18	is	be	AUX
ajlm-2816	210	19	associated	associate	VERB
ajlm-2816	210	20	with	with	ADP
ajlm-2816	210	21	longer	long	ADJ
ajlm-2816	210	22	bacteremic	bacteremic	ADJ
ajlm-2816	210	23	episodes	episode	NOUN
ajlm-2816	210	24	and	and	CCONJ
ajlm-2816	210	25	worse	bad	ADJ
ajlm-2816	210	26	outcome	outcome	NOUN
ajlm-2816	210	27	in	in	ADP
ajlm-2816	210	28	febrile	febrile	NOUN
ajlm-2816	210	29	neutropenic	neutropenic	ADJ
ajlm-2816	210	30	children	child	NOUN
ajlm-2816	210	31	with	with	ADP
ajlm-2816	210	32	cancer	cancer	NOUN
ajlm-2816	210	33	.	.	PUNCT
ajlm-2816	211	1	pediatr	pediatr	ADJ
ajlm-2816	211	2	blood	blood	NOUN
ajlm-2816	211	3	cancer	cancer	NOUN
ajlm-2816	211	4	.	.	PUNCT
ajlm-2816	212	1	2011;57:283–288	2011;57:283–288	X
ajlm-2816	212	2	.	.	PUNCT
ajlm-2816	213	1	https://doi.org/10.1002/pbc.22926	https://doi.org/10.1002/pbc.22926	PROPN
ajlm-2816	213	2	jeddi	jeddi	PROPN
ajlm-2816	213	3	r	r	PROPN
ajlm-2816	213	4	,	,	PUNCT
ajlm-2816	213	5	achour	achour	NOUN
ajlm-2816	213	6	m	m	PROPN
ajlm-2816	213	7	,	,	PUNCT
ajlm-2816	213	8	ben	ben	PROPN
ajlm-2816	213	9	ar	ar	PROPN
ajlm-2816	213	10	,	,	PUNCT
ajlm-2816	213	11	et	et	PROPN
ajlm-2816	213	12	al	al	PROPN
ajlm-2816	213	13	.	.	PUNCT
ajlm-2816	213	14	factors	factor	NOUN
ajlm-2816	213	15	associated	associate	VERB
ajlm-2816	213	16	with	with	ADP
ajlm-2816	213	17	severe	severe	ADJ
ajlm-2816	213	18	sepsis	sepsis	NOUN
ajlm-2816	213	19	:	:	PUNCT
ajlm-2816	213	20	prospective	prospective	ADJ
ajlm-2816	213	21	study	study	NOUN
ajlm-2816	213	22	of	of	ADP
ajlm-2816	213	23	94	94	NUM
ajlm-2816	213	24	neutropenic	neutropenic	ADJ
ajlm-2816	213	25	febrile	febrile	NOUN
ajlm-2816	213	26	episodes	episode	NOUN
ajlm-2816	213	27	.	.	PUNCT
ajlm-2816	214	1	hematology	hematology	NOUN
ajlm-2816	214	2	.	.	PUNCT
ajlm-2816	215	1	2013;15(1):28–32	2013;15(1):28–32	X
ajlm-2816	215	2	.	.	PUNCT
ajlm-2816	216	1	mvalo	mvalo	PROPN
ajlm-2816	216	2	t	t	PROPN
ajlm-2816	216	3	,	,	PUNCT
ajlm-2816	216	4	eley	eley	PROPN
ajlm-2816	216	5	b	b	PROPN
ajlm-2816	216	6	,	,	PUNCT
ajlm-2816	216	7	bamford	bamford	PROPN
ajlm-2816	216	8	c	c	PROPN
ajlm-2816	216	9	,	,	PUNCT
ajlm-2816	216	10	et	et	PROPN
ajlm-2816	216	11	al	al	PROPN
ajlm-2816	216	12	.	.	PUNCT
ajlm-2816	217	1	bloodstream	bloodstream	NOUN
ajlm-2816	217	2	infections	infection	NOUN
ajlm-2816	217	3	in	in	ADP
ajlm-2816	217	4	oncology	oncology	NOUN
ajlm-2816	217	5	patients	patient	NOUN
ajlm-2816	217	6	at	at	ADP
ajlm-2816	217	7	red	red	PROPN
ajlm-2816	217	8	cross	cross	PROPN
ajlm-2816	217	9	war	war	PROPN
ajlm-2816	217	10	memorial	memorial	ADJ
ajlm-2816	217	11	children	child	NOUN
ajlm-2816	217	12	’s	’s	PART
ajlm-2816	217	13	hospital	hospital	NOUN
ajlm-2816	217	14	,	,	PUNCT
ajlm-2816	217	15	cape	cape	NOUN
ajlm-2816	217	16	town	town	NOUN
ajlm-2816	217	17	,	,	PUNCT
ajlm-2816	217	18	from	from	ADP
ajlm-2816	217	19	2012	2012	NUM
ajlm-2816	217	20	to	to	ADP
ajlm-2816	217	21	2014	2014	NUM
ajlm-2816	217	22	.	.	PUNCT
ajlm-2816	218	1	int	int	NOUN
ajlm-2816	218	2	j	j	PROPN
ajlm-2816	218	3	infect	infect	VERB
ajlm-2816	218	4	dis	dis	PROPN
ajlm-2816	218	5	.	.	PUNCT
ajlm-2816	219	1	2018;77:40–47	2018;77:40–47	NUM
ajlm-2816	219	2	.	.	X
ajlm-2816	220	1	https://doi.org/10.1016/j.ijid.2018.09.012	https://doi.org/10.1016/j.ijid.2018.09.012	PROPN
ajlm-2816	220	2	hagag	hagag	PROPN
ajlm-2816	220	3	aa	aa	PROPN
ajlm-2816	220	4	,	,	PUNCT
ajlm-2816	220	5	hassan	hassan	PROPN
ajlm-2816	220	6	sm	sm	PROPN
ajlm-2816	220	7	,	,	PUNCT
ajlm-2816	220	8	elgamasy	elgamasy	PROPN
ajlm-2816	220	9	ma	ma	PROPN
ajlm-2816	220	10	,	,	PUNCT
ajlm-2816	220	11	afifi	afifi	PROPN
ajlm-2816	220	12	ik	ik	PROPN
ajlm-2816	220	13	.	.	PROPN
ajlm-2816	220	14	study	study	NOUN
ajlm-2816	220	15	of	of	ADP
ajlm-2816	220	16	common	common	ADJ
ajlm-2816	220	17	bacterial	bacterial	ADJ
ajlm-2816	220	18	and	and	CCONJ
ajlm-2816	220	19	fungal	fungal	ADJ
ajlm-2816	220	20	pathogens	pathogen	NOUN
ajlm-2816	220	21	in	in	ADP
ajlm-2816	220	22	children	child	NOUN
ajlm-2816	220	23	with	with	ADP
ajlm-2816	220	24	hematological	hematological	ADJ
ajlm-2816	220	25	malignancies	malignancy	NOUN
ajlm-2816	220	26	during	during	ADP
ajlm-2816	220	27	febrile	febrile	NOUN
ajlm-2816	220	28	neutropenia	neutropenia	NOUN
ajlm-2816	220	29	:	:	PUNCT
ajlm-2816	220	30	single	single	ADJ
ajlm-2816	220	31	center	center	ADJ
ajlm-2816	220	32	egyptian	egyptian	ADJ
ajlm-2816	220	33	study	study	NOUN
ajlm-2816	220	34	.	.	PUNCT
ajlm-2816	221	1	infect	infect	VERB
ajlm-2816	221	2	disord	disord	NOUN
ajlm-2816	221	3	–	–	PUNCT
ajlm-2816	221	4	drug	drug	NOUN
ajlm-2816	221	5	targets	target	NOUN
ajlm-2816	221	6	.	.	PUNCT
ajlm-2816	222	1	2016;16(1):54–62	2016;16(1):54–62	NUM
ajlm-2816	222	2	.	.	NOUN
ajlm-2816	222	3	lubwama	lubwama	PROPN
ajlm-2816	222	4	m	m	PROPN
ajlm-2816	222	5	,	,	PUNCT
ajlm-2816	222	6	phipps	phipps	PROPN
ajlm-2816	222	7	w	w	PROPN
ajlm-2816	222	8	,	,	PUNCT
ajlm-2816	222	9	najjuka	najjuka	PROPN
ajlm-2816	222	10	cf	cf	NOUN
ajlm-2816	222	11	,	,	PUNCT
ajlm-2816	222	12	et	et	PROPN
ajlm-2816	222	13	al	al	PROPN
ajlm-2816	222	14	.	.	PROPN
ajlm-2816	222	15	bacteremia	bacteremia	NOUN
ajlm-2816	222	16	in	in	ADP
ajlm-2816	222	17	febrile	febrile	NOUN
ajlm-2816	222	18	cancer	cancer	NOUN
ajlm-2816	222	19	patients	patient	NOUN
ajlm-2816	222	20	in	in	ADP
ajlm-2816	222	21	uganda	uganda	PROPN
ajlm-2816	222	22	.	.	PUNCT
ajlm-2816	223	1	bmc	bmc	ADJ
ajlm-2816	223	2	res	re	NOUN
ajlm-2816	223	3	notes	note	NOUN
ajlm-2816	223	4	.	.	PUNCT
ajlm-2816	224	1	2019;12(1):464	2019;12(1):464	NOUN
ajlm-2816	224	2	.	.	PUNCT
ajlm-2816	225	1	https://doi.org/10.1186/s13104-019-4520-9	https://doi.org/10.1186/s13104-019-4520-9	NUM
ajlm-2816	225	2	depasse	depasse	PROPN
ajlm-2816	225	3	j	j	PROPN
ajlm-2816	225	4	,	,	PUNCT
ajlm-2816	225	5	caniza	caniza	PROPN
ajlm-2816	225	6	ma	ma	PROPN
ajlm-2816	225	7	,	,	PUNCT
ajlm-2816	225	8	quessar	quessar	VERB
ajlm-2816	225	9	a	a	PRON
ajlm-2816	225	10	,	,	PUNCT
ajlm-2816	225	11	et	et	PROPN
ajlm-2816	225	12	al	al	PROPN
ajlm-2816	225	13	.	.	PROPN
ajlm-2816	225	14	infections	infection	NOUN
ajlm-2816	225	15	in	in	ADP
ajlm-2816	225	16	hospitalized	hospitalize	VERB
ajlm-2816	225	17	children	child	NOUN
ajlm-2816	225	18	and	and	CCONJ
ajlm-2816	225	19	young	young	ADJ
ajlm-2816	225	20	adults	adult	NOUN
ajlm-2816	225	21	with	with	ADP
ajlm-2816	225	22	acute	acute	ADJ
ajlm-2816	225	23	leukemia	leukemia	NOUN
ajlm-2816	225	24	in	in	ADP
ajlm-2816	225	25	morocco	morocco	PROPN
ajlm-2816	225	26	.	.	PUNCT
ajlm-2816	226	1	pediatr	pediatr	ADJ
ajlm-2816	226	2	blood	blood	NOUN
ajlm-2816	226	3	cancer	cancer	NOUN
ajlm-2816	226	4	.	.	PUNCT
ajlm-2816	227	1	2013;60(february):916–922	2013;60(february):916–922	NUM
ajlm-2816	227	2	.	.	PUNCT
ajlm-2816	228	1	arega	arega	PROPN
ajlm-2816	228	2	b	b	PROPN
ajlm-2816	228	3	,	,	PUNCT
ajlm-2816	228	4	woldeamanuel	woldeamanuel	PROPN
ajlm-2816	228	5	y	y	PROPN
ajlm-2816	228	6	,	,	PUNCT
ajlm-2816	228	7	adane	adane	PROPN
ajlm-2816	228	8	k	k	PROPN
ajlm-2816	228	9	,	,	PUNCT
ajlm-2816	228	10	sherif	sherif	VERB
ajlm-2816	228	11	a	a	PRON
ajlm-2816	228	12	,	,	PUNCT
ajlm-2816	228	13	asrat	asrat	PROPN
ajlm-2816	228	14	d.	d.	PROPN
ajlm-2816	228	15	microbial	microbial	PROPN
ajlm-2816	228	16	spectrum	spectrum	PROPN
ajlm-2816	228	17	and	and	CCONJ
ajlm-2816	228	18	drug	drug	NOUN
ajlm-2816	228	19	-	-	PUNCT
ajlm-2816	228	20	resistance	resistance	NOUN
ajlm-2816	228	21	profile	profile	NOUN
ajlm-2816	228	22	of	of	ADP
ajlm-2816	228	23	isolates	isolate	NOUN
ajlm-2816	228	24	causing	cause	VERB
ajlm-2816	228	25	bloodstream	bloodstream	NOUN
ajlm-2816	228	26	infections	infection	NOUN
ajlm-2816	228	27	in	in	ADP
ajlm-2816	228	28	febrile	febrile	NOUN
ajlm-2816	228	29	cancer	cancer	NOUN
ajlm-2816	228	30	patients	patient	NOUN
ajlm-2816	228	31	at	at	ADP
ajlm-2816	228	32	a	a	DET
ajlm-2816	228	33	referral	referral	ADJ
ajlm-2816	228	34	hospital	hospital	NOUN
ajlm-2816	228	35	in	in	ADP
ajlm-2816	228	36	addis	addis	PROPN
ajlm-2816	228	37	microbial	microbial	ADJ
ajlm-2816	228	38	spectrum	spectrum	NOUN
ajlm-2816	228	39	and	and	CCONJ
ajlm-2816	228	40	drug	drug	NOUN
ajlm-2816	228	41	-	-	PUNCT
ajlm-2816	228	42	resistance	resistance	NOUN
ajlm-2816	228	43	profile	profile	NOUN
ajlm-2816	228	44	of	of	ADP
ajlm-2816	228	45	isolates	isolate	NOUN
ajlm-2816	228	46	causing	cause	VERB
ajlm-2816	228	47	bloodstream	bloodstream	NOUN
ajlm-2816	228	48	infections	infection	NOUN
ajlm-2816	228	49	in	in	ADP
ajlm-2816	228	50	febrile	febrile	NOUN
ajlm-2816	228	51	cance	cance	NOUN
ajlm-2816	228	52	.	.	PUNCT
ajlm-2816	229	1	infect	infect	VERB
ajlm-2816	229	2	drug	drug	NOUN
ajlm-2816	229	3	resist	resist	NOUN
ajlm-2816	229	4	.	.	PUNCT
ajlm-2816	230	1	2018;11:1511–1519	2018;11:1511–1519	NUM
ajlm-2816	230	2	.	.	PUNCT
ajlm-2816	231	1	https://doi.org/10.2147/idr.s168867	https://doi.org/10.2147/idr.s168867	X
ajlm-2816	231	2	zain	zain	PROPN
ajlm-2816	231	3	om	om	PROPN
ajlm-2816	231	4	,	,	PUNCT
ajlm-2816	231	5	elsayed	elsaye	VERB
ajlm-2816	231	6	my	my	PRON
ajlm-2816	231	7	,	,	PUNCT
ajlm-2816	231	8	abdelkhalig	abdelkhalig	NOUN
ajlm-2816	231	9	sm	sm	PROPN
ajlm-2816	231	10	,	,	PUNCT
ajlm-2816	231	11	abdelaziz	abdelaziz	PROPN
ajlm-2816	231	12	m.	m.	NOUN
ajlm-2816	231	13	bloodstream	bloodstream	NOUN
ajlm-2816	231	14	infection	infection	NOUN
ajlm-2816	231	15	in	in	ADP
ajlm-2816	231	16	cancer	cancer	NOUN
ajlm-2816	231	17	patients	patient	NOUN
ajlm-2816	231	18	;	;	PUNCT
ajlm-2816	231	19	susceptibility	susceptibility	NOUN
ajlm-2816	231	20	profiles	profile	NOUN
ajlm-2816	231	21	of	of	ADP
ajlm-2816	231	22	the	the	DET
ajlm-2816	231	23	isolated	isolate	VERB
ajlm-2816	231	24	pathogens	pathogen	NOUN
ajlm-2816	231	25	,	,	PUNCT
ajlm-2816	231	26	at	at	ADP
ajlm-2816	231	27	khartoum	khartoum	PROPN
ajlm-2816	231	28	oncology	oncology	NOUN
ajlm-2816	231	29	hospital	hospital	PROPN
ajlm-2816	231	30	,	,	PUNCT
ajlm-2816	231	31	sudan	sudan	PROPN
ajlm-2816	231	32	.	.	PUNCT
ajlm-2816	232	1	afr	afr	PROPN
ajlm-2816	232	2	health	health	PROPN
ajlm-2816	232	3	sci	sci	PROPN
ajlm-2816	232	4	.	.	PUNCT
ajlm-2816	233	1	2022;22(4):70–76	2022;22(4):70–76	X
ajlm-2816	233	2	.	.	PUNCT
ajlm-2816	233	3	kipchumba	kipchumba	PROPN
ajlm-2816	233	4	sk	sk	PROPN
ajlm-2816	233	5	.	.	PROPN
ajlm-2816	234	1	bacterial	bacterial	ADJ
ajlm-2816	234	2	isolates	isolate	NOUN
ajlm-2816	234	3	and	and	CCONJ
ajlm-2816	234	4	characteristics	characteristic	NOUN
ajlm-2816	234	5	of	of	ADP
ajlm-2816	234	6	children	child	NOUN
ajlm-2816	234	7	with	with	ADP
ajlm-2816	234	8	febrile	febrile	NOUN
ajlm-2816	234	9	neutropenia	neutropenia	NOUN
ajlm-2816	234	10	on	on	ADP
ajlm-2816	234	11	treatment	treatment	NOUN
ajlm-2816	234	12	for	for	ADP
ajlm-2816	234	13	cancer	cancer	NOUN
ajlm-2816	234	14	at	at	ADP
ajlm-2816	234	15	a	a	DET
ajlm-2816	234	16	tertiary	tertiary	ADJ
ajlm-2816	234	17	hospital	hospital	NOUN
ajlm-2816	234	18	in	in	ADP
ajlm-2816	234	19	western	western	ADJ
ajlm-2816	234	20	kenya	kenya	PROPN
ajlm-2816	234	21	.	.	PUNCT
ajlm-2816	235	1	jco	jco	PROPN
ajlm-2816	235	2	glob	glob	PROPN
ajlm-2816	235	3	oncol	oncol	PROPN
ajlm-2816	235	4	.	.	PUNCT
ajlm-2816	236	1	2024;10	2024;10	NUM
ajlm-2816	236	2	:	:	PUNCT
ajlm-2816	236	3	e2300313	e2300313	PROPN
ajlm-2816	236	4	.	.	PUNCT
ajlm-2816	237	1	https://doi.org/10.1200/go.23.00313	https://doi.org/10.1200/go.23.00313	PROPN
ajlm-2816	237	2	elgendy	elgendy	PROPN
ajlm-2816	237	3	sg	sg	PROPN
ajlm-2816	237	4	,	,	PUNCT
ajlm-2816	237	5	hameed	hameed	PROPN
ajlm-2816	237	6	mra	mra	PROPN
ajlm-2816	237	7	,	,	PUNCT
ajlm-2816	237	8	el	el	PROPN
ajlm-2816	237	9	-	-	PUNCT
ajlm-2816	237	10	mokhtar	mokhtar	PROPN
ajlm-2816	238	1	ma	ma	PROPN
ajlm-2816	238	2	.	.	PROPN
ajlm-2816	238	3	tigecycline	tigecycline	PROPN
ajlm-2816	238	4	resistance	resistance	NOUN
ajlm-2816	238	5	among	among	ADP
ajlm-2816	238	6	klebsiella	klebsiella	NOUN
ajlm-2816	238	7	pneumoniae	pneumoniae	NOUN
ajlm-2816	238	8	isolated	isolate	VERB
ajlm-2816	238	9	from	from	ADP
ajlm-2816	238	10	febrile	febrile	NOUN
ajlm-2816	238	11	neutropenic	neutropenic	ADJ
ajlm-2816	238	12	patients	patient	NOUN
ajlm-2816	238	13	.	.	PUNCT
ajlm-2816	239	1	j	j	PROPN
ajlm-2816	239	2	med	med	PROPN
ajlm-2816	239	3	microbiol	microbiol	PROPN
ajlm-2816	239	4	.	.	PUNCT
ajlm-2816	240	1	2018;67:972–975	2018;67:972–975	NUM
ajlm-2816	240	2	.	.	PUNCT
ajlm-2816	241	1	https://doi.org/10.1099/jmm.0.000770	https://doi.org/10.1099/jmm.0.000770	PROPN
ajlm-2816	242	1	kanan	kanan	PROPN
ajlm-2816	242	2	m	m	PROPN
ajlm-2816	242	3	,	,	PUNCT
ajlm-2816	242	4	ramadan	ramadan	PROPN
ajlm-2816	242	5	m	m	PROPN
ajlm-2816	242	6	,	,	PUNCT
ajlm-2816	242	7	haif	haif	PROPN
ajlm-2816	242	8	h	h	PROPN
ajlm-2816	242	9	,	,	PUNCT
ajlm-2816	242	10	et	et	PROPN
ajlm-2816	242	11	al	al	PROPN
ajlm-2816	242	12	.	.	PUNCT
ajlm-2816	243	1	empowering	empower	VERB
ajlm-2816	243	2	lowand	lowand	ADJ
ajlm-2816	243	3	middle	middle	ADJ
ajlm-2816	243	4	-	-	PUNCT
ajlm-2816	243	5	income	income	NOUN
ajlm-2816	243	6	countries	country	NOUN
ajlm-2816	243	7	to	to	PART
ajlm-2816	243	8	combat	combat	VERB
ajlm-2816	243	9	amr	amr	NOUN
ajlm-2816	243	10	by	by	ADP
ajlm-2816	243	11	minimal	minimal	ADJ
ajlm-2816	243	12	use	use	NOUN
ajlm-2816	243	13	of	of	ADP
ajlm-2816	243	14	antibiotics	antibiotic	NOUN
ajlm-2816	243	15	:	:	PUNCT
ajlm-2816	243	16	a	a	DET
ajlm-2816	243	17	way	way	NOUN
ajlm-2816	243	18	forward	forward	ADV
ajlm-2816	243	19	.	.	PUNCT
ajlm-2816	244	1	antibiotics	antibiotic	NOUN
ajlm-2816	244	2	.	.	PUNCT
ajlm-2816	245	1	2023;12(10):1–13	2023;12(10):1–13	X
ajlm-2816	245	2	.	.	PUNCT
ajlm-2816	246	1	who	who	PRON
ajlm-2816	246	2	.	.	PUNCT
ajlm-2816	247	1	who	who	PRON
ajlm-2816	247	2	global	global	ADJ
ajlm-2816	247	3	survey	survey	NOUN
ajlm-2816	247	4	on	on	ADP
ajlm-2816	247	5	the	the	DET
ajlm-2816	247	6	inclusion	inclusion	NOUN
ajlm-2816	247	7	of	of	ADP
ajlm-2816	247	8	cancer	cancer	NOUN
ajlm-2816	247	9	care	care	NOUN
ajlm-2816	247	10	in	in	ADP
ajlm-2816	247	11	health	health	NOUN
ajlm-2816	247	12	-	-	PUNCT
ajlm-2816	247	13	benefit	benefit	NOUN
ajlm-2816	247	14	packages	package	NOUN
ajlm-2816	247	15	2020–2021	2020–2021	NUM
ajlm-2816	247	16	.	.	PUNCT
ajlm-2816	248	1	geneva	geneva	NOUN
ajlm-2816	248	2	:	:	PUNCT
ajlm-2816	248	3	world	world	PROPN
ajlm-2816	248	4	health	health	NOUN
ajlm-2816	248	5	organization	organization	NOUN
ajlm-2816	248	6	(	(	PUNCT
ajlm-2816	248	7	who	who	PRON
ajlm-2816	248	8	)	)	PUNCT
ajlm-2816	248	9	,	,	PUNCT
ajlm-2816	248	10	2024	2024	NUM
ajlm-2816	248	11	;	;	PUNCT
ajlm-2816	248	12	p.	p.	NOUN
ajlm-2816	248	13	1–15	1–15	PROPN
ajlm-2816	249	1	lamy	lamy	PROPN
ajlm-2816	249	2	b	b	PROPN
ajlm-2816	249	3	,	,	PUNCT
ajlm-2816	249	4	dargère	dargère	NOUN
ajlm-2816	249	5	s	s	PROPN
ajlm-2816	249	6	,	,	PUNCT
ajlm-2816	249	7	arendrup	arendrup	PROPN
ajlm-2816	249	8	mc	mc	PROPN
ajlm-2816	249	9	,	,	PUNCT
ajlm-2816	249	10	parienti	parienti	PROPN
ajlm-2816	249	11	j	j	PROPN
ajlm-2816	249	12	-	-	PROPN
ajlm-2816	249	13	j	j	PROPN
ajlm-2816	249	14	,	,	PUNCT
ajlm-2816	249	15	tattevin	tattevin	PROPN
ajlm-2816	249	16	p.	p.	PROPN
ajlm-2816	249	17	how	how	SCONJ
ajlm-2816	249	18	to	to	PART
ajlm-2816	249	19	optimize	optimize	VERB
ajlm-2816	249	20	the	the	DET
ajlm-2816	249	21	use	use	NOUN
ajlm-2816	249	22	of	of	ADP
ajlm-2816	249	23	blood	blood	NOUN
ajlm-2816	249	24	cultures	culture	NOUN
ajlm-2816	249	25	for	for	ADP
ajlm-2816	249	26	the	the	DET
ajlm-2816	249	27	diagnosis	diagnosis	NOUN
ajlm-2816	249	28	of	of	ADP
ajlm-2816	249	29	bloodstream	bloodstream	NOUN
ajlm-2816	249	30	infections	infection	NOUN
ajlm-2816	249	31	?	?	PUNCT
ajlm-2816	250	1	a	a	DET
ajlm-2816	250	2	state	state	NOUN
ajlm-2816	250	3	-	-	PUNCT
ajlm-2816	250	4	of	of	ADP
ajlm-2816	250	5	-	-	PUNCT
ajlm-2816	250	6	the	the	DET
ajlm-2816	250	7	art	art	NOUN
ajlm-2816	250	8	.	.	PUNCT
ajlm-2816	251	1	front	front	ADJ
ajlm-2816	251	2	microbiol	microbiol	PROPN
ajlm-2816	251	3	.	.	PUNCT
ajlm-2816	252	1	2016;7(697):1–13	2016;7(697):1–13	X
ajlm-2816	252	2	.	.	PUNCT
ajlm-2816	253	1	https://doi.org/10.3389/fmicb.2016.00697	https://doi.org/10.3389/fmicb.2016.00697	PRON
ajlm-2816	253	2	ombelet	ombelet	PROPN
ajlm-2816	253	3	s	s	PROPN
ajlm-2816	253	4	,	,	PUNCT
ajlm-2816	253	5	barbé	barbé	PROPN
ajlm-2816	253	6	b	b	NOUN
ajlm-2816	253	7	,	,	PUNCT
ajlm-2816	253	8	affolabi	affolabi	NOUN
ajlm-2816	253	9	d	d	PROPN
ajlm-2816	253	10	,	,	PUNCT
ajlm-2816	253	11	ronat	ronat	PROPN
ajlm-2816	253	12	j.	j.	PROPN
ajlm-2816	253	13	best	good	ADJ
ajlm-2816	253	14	practices	practice	NOUN
ajlm-2816	253	15	of	of	ADP
ajlm-2816	253	16	blood	blood	NOUN
ajlm-2816	253	17	cultures	culture	NOUN
ajlm-2816	253	18	in	in	ADP
ajlm-2816	253	19	lowand	lowand	ADJ
ajlm-2816	253	20	middle	middle	ADJ
ajlm-2816	253	21	-	-	PUNCT
ajlm-2816	253	22	income	income	NOUN
ajlm-2816	253	23	countries	country	NOUN
ajlm-2816	253	24	.	.	PUNCT
ajlm-2816	254	1	front	front	PROPN
ajlm-2816	254	2	med	med	PROPN
ajlm-2816	254	3	.	.	PUNCT
ajlm-2816	255	1	2019;6(june):1–27	2019;6(june):1–27	NOUN
ajlm-2816	255	2	.	.	PUNCT
ajlm-2816	256	1	doern	doern	PROPN
ajlm-2816	256	2	gv	gv	PROPN
ajlm-2816	256	3	,	,	PUNCT
ajlm-2816	256	4	carroll	carroll	PROPN
ajlm-2816	256	5	kc	kc	PROPN
ajlm-2816	256	6	,	,	PUNCT
ajlm-2816	256	7	diekema	diekema	PROPN
ajlm-2816	256	8	dj	dj	PROPN
ajlm-2816	256	9	,	,	PUNCT
ajlm-2816	256	10	et	et	PROPN
ajlm-2816	256	11	al	al	PROPN
ajlm-2816	256	12	.	.	PUNCT
ajlm-2816	257	1	a	a	DET
ajlm-2816	257	2	comprehensive	comprehensive	ADJ
ajlm-2816	257	3	update	update	NOUN
ajlm-2816	257	4	on	on	ADP
ajlm-2816	257	5	the	the	DET
ajlm-2816	257	6	problem	problem	NOUN
ajlm-2816	257	7	of	of	ADP
ajlm-2816	257	8	blood	blood	NOUN
ajlm-2816	257	9	culture	culture	NOUN
ajlm-2816	257	10	contamination	contamination	NOUN
ajlm-2816	257	11	and	and	CCONJ
ajlm-2816	257	12	a	a	DET
ajlm-2816	257	13	discussion	discussion	NOUN
ajlm-2816	257	14	of	of	ADP
ajlm-2816	257	15	methods	method	NOUN
ajlm-2816	257	16	for	for	ADP
ajlm-2816	257	17	addressing	address	VERB
ajlm-2816	257	18	the	the	DET
ajlm-2816	257	19	problem	problem	NOUN
ajlm-2816	257	20	.	.	PUNCT
ajlm-2816	258	1	clin	clin	PROPN
ajlm-2816	258	2	microbiol	microbiol	PROPN
ajlm-2816	258	3	rev	rev	VERB
ajlm-2816	258	4	.	.	PROPN
ajlm-2816	258	5	2020;33(1):1–21	2020;33(1):1–21	NUM
ajlm-2816	258	6	.	.	PUNCT
ajlm-2816	259	1	https://doi.org/10.1128/cmr.00009-19	https://doi.org/10.1128/cmr.00009-19	PROPN
ajlm-2816	259	2	rupp	rupp	PROPN
ajlm-2816	259	3	me	i	PRON
ajlm-2816	259	4	,	,	PUNCT
ajlm-2816	259	5	cavalieri	cavalieri	PROPN
ajlm-2816	259	6	rj	rj	PROPN
ajlm-2816	259	7	,	,	PUNCT
ajlm-2816	259	8	marolf	marolf	PROPN
ajlm-2816	259	9	c	c	PROPN
ajlm-2816	259	10	,	,	PUNCT
ajlm-2816	259	11	lyden	lyden	PROPN
ajlm-2816	259	12	e.	e.	PROPN
ajlm-2816	259	13	reduction	reduction	NOUN
ajlm-2816	259	14	in	in	ADP
ajlm-2816	259	15	blood	blood	NOUN
ajlm-2816	259	16	culture	culture	NOUN
ajlm-2816	259	17	contamination	contamination	NOUN
ajlm-2816	259	18	through	through	ADP
ajlm-2816	259	19	use	use	NOUN
ajlm-2816	259	20	of	of	ADP
ajlm-2816	259	21	initial	initial	ADJ
ajlm-2816	259	22	specimen	speciman	NOUN
ajlm-2816	259	23	diversion	diversion	NOUN
ajlm-2816	259	24	device	device	NOUN
ajlm-2816	259	25	.	.	PUNCT
ajlm-2816	260	1	clin	clin	PROPN
ajlm-2816	260	2	infect	infect	PROPN
ajlm-2816	260	3	dis	dis	PROPN
ajlm-2816	260	4	.	.	PUNCT
ajlm-2816	261	1	2017;65(2):201–205	2017;65(2):201–205	X
ajlm-2816	261	2	.	.	PUNCT
ajlm-2816	261	3	ryder	ryder	PROPN
ajlm-2816	261	4	jh	jh	PROPN
ajlm-2816	261	5	,	,	PUNCT
ajlm-2816	261	6	van	van	PROPN
ajlm-2816	261	7	schooneveld	schooneveld	PROPN
ajlm-2816	261	8	tc	tc	PROPN
ajlm-2816	261	9	,	,	PUNCT
ajlm-2816	261	10	diekema	diekema	PROPN
ajlm-2816	261	11	dj	dj	PROPN
ajlm-2816	261	12	,	,	PUNCT
ajlm-2816	261	13	fabre	fabre	PROPN
ajlm-2816	261	14	v.	v.	ADP
ajlm-2816	261	15	every	every	DET
ajlm-2816	261	16	crisis	crisis	NOUN
ajlm-2816	261	17	is	be	AUX
ajlm-2816	261	18	an	an	DET
ajlm-2816	261	19	opportunity	opportunity	NOUN
ajlm-2816	261	20	:	:	PUNCT
ajlm-2816	261	21	advancing	advance	VERB
ajlm-2816	261	22	blood	blood	NOUN
ajlm-2816	261	23	culture	culture	NOUN
ajlm-2816	261	24	stewardship	stewardship	NOUN
ajlm-2816	261	25	during	during	ADP
ajlm-2816	261	26	a	a	DET
ajlm-2816	261	27	blood	blood	NOUN
ajlm-2816	261	28	culture	culture	NOUN
ajlm-2816	261	29	bottle	bottle	NOUN
ajlm-2816	261	30	shortage	shortage	NOUN
ajlm-2816	261	31	.	.	PUNCT
ajlm-2816	262	1	open	open	ADJ
ajlm-2816	262	2	forum	forum	PROPN
ajlm-2816	262	3	infect	infect	VERB
ajlm-2816	262	4	dis	dis	PROPN
ajlm-2816	262	5	.	.	PUNCT
ajlm-2816	263	1	2024;11(9):1–7	2024;11(9):1–7	X
ajlm-2816	263	2	.	.	PUNCT
ajlm-2816	264	1	hellen	hellen	VERB
ajlm-2816	264	2	g	g	PROPN
ajlm-2816	264	3	,	,	PUNCT
ajlm-2816	264	4	okeke	okeke	VERB
ajlm-2816	264	5	in	in	ADP
ajlm-2816	264	6	,	,	PUNCT
ajlm-2816	264	7	aboderin	aboderin	INTJ
ajlm-2816	264	8	ao	ao	PROPN
ajlm-2816	264	9	,	,	PUNCT
ajlm-2816	264	10	martinez	martinez	PROPN
ajlm-2816	264	11	e	e	PROPN
ajlm-2816	264	12	,	,	PUNCT
ajlm-2816	264	13	matu	matu	PROPN
ajlm-2816	264	14	m.	m.	PROPN
ajlm-2816	264	15	east	east	PROPN
ajlm-2816	264	16	africa	africa	PROPN
ajlm-2816	264	17	public	public	PROPN
ajlm-2816	264	18	health	health	PROPN
ajlm-2816	264	19	laboratory	laboratory	NOUN
ajlm-2816	264	20	networking	networking	NOUN
ajlm-2816	264	21	project	project	NOUN
ajlm-2816	264	22	strengthening	strengthen	VERB
ajlm-2816	264	23	the	the	DET
ajlm-2816	264	24	role	role	NOUN
ajlm-2816	264	25	of	of	ADP
ajlm-2816	264	26	laboratories	laboratory	NOUN
ajlm-2816	264	27	in	in	ADP
ajlm-2816	264	28	tracking	track	VERB
ajlm-2816	264	29	antimicrobial	antimicrobial	ADJ
ajlm-2816	264	30	drug	drug	NOUN
ajlm-2816	264	31	resistance	resistance	NOUN
ajlm-2816	264	32	in	in	ADP
ajlm-2816	264	33	east	east	PROPN
ajlm-2816	264	34	africa	africa	PROPN
ajlm-2816	264	35	.	.	PUNCT
ajlm-2816	265	1	washington	washington	PROPN
ajlm-2816	265	2	,	,	PUNCT
ajlm-2816	265	3	dc	dc	PROPN
ajlm-2816	265	4	:	:	PUNCT
ajlm-2816	265	5	center	center	NOUN
ajlm-2816	265	6	for	for	ADP
ajlm-2816	265	7	disease	disease	NOUN
ajlm-2816	265	8	dynamics	dynamic	NOUN
ajlm-2816	265	9	,	,	PUNCT
ajlm-2816	265	10	economics	economic	NOUN
ajlm-2816	265	11	&	&	CCONJ
ajlm-2816	265	12	policy	policy	NOUN
ajlm-2816	265	13	,	,	PUNCT
ajlm-2816	265	14	2016	2016	NUM
ajlm-2816	265	15	;	;	PUNCT
ajlm-2816	265	16	p.	p.	NOUN
ajlm-2816	265	17	40	40	NUM
ajlm-2816	265	18	.	.	PUNCT
ajlm-2816	266	1	https://onehealthtrust.org/wp-content/uploads/2017/06/wb_report_32-1.pdf	https://onehealthtrust.org/wp-content/uploads/2017/06/wb_report_32-1.pdf	PROPN
ajlm-2816	266	2	reddy	reddy	PROPN
ajlm-2816	266	3	ea	ea	PROPN
ajlm-2816	266	4	,	,	PUNCT
ajlm-2816	266	5	shaw	shaw	PROPN
ajlm-2816	266	6	av	av	PROPN
ajlm-2816	266	7	,	,	PUNCT
ajlm-2816	266	8	crump	crump	PROPN
ajlm-2816	266	9	ja	ja	PROPN
ajlm-2816	266	10	.	.	PUNCT
ajlm-2816	266	11	community	community	NOUN
ajlm-2816	266	12	-	-	PUNCT
ajlm-2816	266	13	acquired	acquire	VERB
ajlm-2816	266	14	bloodstream	bloodstream	NOUN
ajlm-2816	266	15	infections	infection	NOUN
ajlm-2816	266	16	in	in	ADP
ajlm-2816	266	17	africa	africa	PROPN
ajlm-2816	266	18	:	:	PUNCT
ajlm-2816	266	19	a	a	DET
ajlm-2816	266	20	systematic	systematic	ADJ
ajlm-2816	266	21	review	review	NOUN
ajlm-2816	266	22	and	and	CCONJ
ajlm-2816	266	23	meta	meta	ADJ
ajlm-2816	266	24	-	-	PUNCT
ajlm-2816	266	25	analysis	analysis	NOUN
ajlm-2816	266	26	.	.	PUNCT
ajlm-2816	267	1	lancet	lancet	PROPN
ajlm-2816	267	2	infect	infect	PROPN
ajlm-2816	267	3	dis	dis	PROPN
ajlm-2816	267	4	.	.	PUNCT
ajlm-2816	268	1	2010;10(6):417–432	2010;10(6):417–432	X
ajlm-2816	268	2	.	.	PUNCT
ajlm-2816	268	3	https://doi.org/10.1016/s1473-3099(10)70072-4	https://doi.org/10.1016/s1473-3099(10)70072-4	PROPN
ajlm-2816	268	4	wisplinghoff	wisplinghoff	PROPN
ajlm-2816	268	5	h	h	NOUN
ajlm-2816	268	6	,	,	PUNCT
ajlm-2816	268	7	seifert	seifert	PROPN
ajlm-2816	268	8	h	h	PROPN
ajlm-2816	268	9	,	,	PUNCT
ajlm-2816	268	10	wenzel	wenzel	PROPN
ajlm-2816	268	11	rp	rp	PROPN
ajlm-2816	268	12	,	,	PUNCT
ajlm-2816	268	13	edmond	edmond	PROPN
ajlm-2816	268	14	mb	mb	PROPN
ajlm-2816	268	15	.	.	PUNCT
ajlm-2816	269	1	current	current	ADJ
ajlm-2816	269	2	trends	trend	NOUN
ajlm-2816	269	3	in	in	ADP
ajlm-2816	269	4	the	the	DET
ajlm-2816	269	5	epidemiology	epidemiology	NOUN
ajlm-2816	269	6	of	of	ADP
ajlm-2816	269	7	nosocomial	nosocomial	ADJ
ajlm-2816	269	8	bloodstream	bloodstream	NOUN
ajlm-2816	269	9	infections	infection	NOUN
ajlm-2816	269	10	in	in	ADP
ajlm-2816	269	11	patients	patient	NOUN
ajlm-2816	269	12	with	with	ADP
ajlm-2816	269	13	hematological	hematological	ADJ
ajlm-2816	269	14	malignancies	malignancy	NOUN
ajlm-2816	269	15	and	and	CCONJ
ajlm-2816	269	16	solid	solid	ADJ
ajlm-2816	269	17	neoplasms	neoplasm	NOUN
ajlm-2816	269	18	in	in	ADP
ajlm-2816	269	19	hospitals	hospital	NOUN
ajlm-2816	269	20	in	in	ADP
ajlm-2816	269	21	the	the	DET
ajlm-2816	269	22	united	united	PROPN
ajlm-2816	269	23	states	states	PROPN
ajlm-2816	269	24	.	.	PUNCT
ajlm-2816	270	1	clin	clin	PROPN
ajlm-2816	270	2	infect	infect	PROPN
ajlm-2816	270	3	dis	dis	PROPN
ajlm-2816	270	4	.	.	PUNCT
ajlm-2816	271	1	2003;36:1103–1110	2003;36:1103–1110	PROPN
ajlm-2816	271	2	.	.	PUNCT
ajlm-2816	272	1	https://doi.org/10.1086/374339	https://doi.org/10.1086/374339	PROPN
ajlm-2816	272	2	viscoli	viscoli	PROPN
ajlm-2816	272	3	c	c	NOUN
ajlm-2816	272	4	,	,	PUNCT
ajlm-2816	272	5	varnier	varni	ADJ
ajlm-2816	272	6	o	o	NOUN
ajlm-2816	272	7	,	,	PUNCT
ajlm-2816	272	8	machetti	machetti	ADJ
ajlm-2816	272	9	m.	m.	NOUN
ajlm-2816	272	10	infections	infection	NOUN
ajlm-2816	272	11	in	in	ADP
ajlm-2816	272	12	patients	patient	NOUN
ajlm-2816	272	13	with	with	ADP
ajlm-2816	272	14	febrile	febrile	NOUN
ajlm-2816	272	15	neutropenia	neutropenia	NOUN
ajlm-2816	272	16	:	:	PUNCT
ajlm-2816	272	17	epidemiology	epidemiology	NOUN
ajlm-2816	272	18	,	,	PUNCT
ajlm-2816	272	19	microbiology	microbiology	NOUN
ajlm-2816	272	20	,	,	PUNCT
ajlm-2816	272	21	and	and	CCONJ
ajlm-2816	272	22	risk	risk	NOUN
ajlm-2816	272	23	stratification	stratification	NOUN
ajlm-2816	272	24	.	.	PUNCT
ajlm-2816	273	1	clin	clin	PROPN
ajlm-2816	273	2	infect	infect	PROPN
ajlm-2816	273	3	dis	dis	PROPN
ajlm-2816	273	4	.	.	PUNCT
ajlm-2816	274	1	2005;40(suppl	2005;40(suppl	NUM
ajlm-2816	274	2	4):1–6	4):1–6	NOUN
ajlm-2816	274	3	.	.	PUNCT
ajlm-2816	275	1	calvo	calvo	PROPN
ajlm-2816	275	2	-	-	PUNCT
ajlm-2816	275	3	lon	lon	PROPN
ajlm-2816	275	4	j	j	PROPN
ajlm-2816	275	5	,	,	PUNCT
ajlm-2816	275	6	landaverde	landaverde	PROPN
ajlm-2816	275	7	du	du	PROPN
ajlm-2816	275	8	,	,	PUNCT
ajlm-2816	275	9	ramos	ramos	PROPN
ajlm-2816	275	10	-	-	PROPN
ajlm-2816	275	11	esquivel	esquivel	PROPN
ajlm-2816	275	12	a	a	X
ajlm-2816	275	13	,	,	PUNCT
ajlm-2816	275	14	villalobos	villalobos	PROPN
ajlm-2816	275	15	jm	jm	PROPN
ajlm-2816	275	16	.	.	PROPN
ajlm-2816	275	17	epidemiology	epidemiology	NOUN
ajlm-2816	275	18	and	and	CCONJ
ajlm-2816	275	19	outcomes	outcome	NOUN
ajlm-2816	275	20	of	of	ADP
ajlm-2816	275	21	bloodstream	bloodstream	NOUN
ajlm-2816	275	22	infections	infection	NOUN
ajlm-2816	275	23	in	in	ADP
ajlm-2816	275	24	patients	patient	NOUN
ajlm-2816	275	25	with	with	ADP
ajlm-2816	275	26	solid	solid	ADJ
ajlm-2816	275	27	tumors	tumor	NOUN
ajlm-2816	275	28	in	in	ADP
ajlm-2816	275	29	a	a	DET
ajlm-2816	275	30	central	central	ADJ
ajlm-2816	275	31	american	american	ADJ
ajlm-2816	275	32	population	population	NOUN
ajlm-2816	275	33	at	at	ADP
ajlm-2816	275	34	mexico	mexico	PROPN
ajlm-2816	275	35	hospital	hospital	NOUN
ajlm-2816	275	36	,	,	PUNCT
ajlm-2816	275	37	san	san	PROPN
ajlm-2816	275	38	jose	jose	PROPN
ajlm-2816	275	39	.	.	PUNCT
ajlm-2816	276	1	j	j	PROPN
ajlm-2816	276	2	glob	glob	PROPN
ajlm-2816	276	3	oncol	oncol	PROPN
ajlm-2816	276	4	.	.	PUNCT
ajlm-2816	277	1	2018;4(4):1–6	2018;4(4):1–6	NUM
ajlm-2816	277	2	.	.	PUNCT
ajlm-2816	277	3	https://doi.org/10.1200/jgo.17.00058	https://doi.org/10.1200/jgo.17.00058	PROPN
ajlm-2816	277	4	israels	israels	PROPN
ajlm-2816	277	5	t	t	PROPN
ajlm-2816	277	6	,	,	PUNCT
ajlm-2816	277	7	afungchwi	afungchwi	PROPN
ajlm-2816	277	8	gm	gm	PROPN
ajlm-2816	277	9	,	,	PUNCT
ajlm-2816	277	10	klootwijk	klootwijk	PROPN
ajlm-2816	277	11	l	l	PROPN
ajlm-2816	277	12	,	,	PUNCT
ajlm-2816	277	13	et	et	PROPN
ajlm-2816	277	14	al	al	PROPN
ajlm-2816	277	15	.	.	PROPN
ajlm-2816	277	16	fever	fever	PROPN
ajlm-2816	277	17	and	and	CCONJ
ajlm-2816	277	18	neutropenia	neutropenia	NOUN
ajlm-2816	277	19	outcomes	outcome	NOUN
ajlm-2816	277	20	and	and	CCONJ
ajlm-2816	277	21	areas	area	NOUN
ajlm-2816	277	22	for	for	ADP
ajlm-2816	277	23	intervention	intervention	NOUN
ajlm-2816	277	24	:	:	PUNCT
ajlm-2816	277	25	a	a	DET
ajlm-2816	277	26	report	report	NOUN
ajlm-2816	277	27	from	from	ADP
ajlm-2816	277	28	succour	succour	ADJ
ajlm-2816	277	29	–	–	PUNCT
ajlm-2816	277	30	supportive	supportive	ADJ
ajlm-2816	277	31	care	care	NOUN
ajlm-2816	277	32	for	for	ADP
ajlm-2816	277	33	children	child	NOUN
ajlm-2816	277	34	with	with	ADP
ajlm-2816	277	35	cancer	cancer	NOUN
ajlm-2816	277	36	in	in	ADP
ajlm-2816	277	37	africa	africa	PROPN
ajlm-2816	277	38	.	.	PUNCT
ajlm-2816	278	1	pediartr	pediartr	PROPN
ajlm-2816	278	2	blood	blood	NOUN
ajlm-2816	278	3	cancer	cancer	NOUN
ajlm-2816	278	4	.	.	PUNCT
ajlm-2816	279	1	2021;68(9):e29224	2021;68(9):e29224	X
ajlm-2816	279	2	.	.	PUNCT
ajlm-2816	280	1	feld	feld	PROPN
ajlm-2816	280	2	r.	r.	PROPN
ajlm-2816	280	3	bloodstream	bloodstream	PROPN
ajlm-2816	280	4	infections	infection	NOUN
ajlm-2816	280	5	in	in	ADP
ajlm-2816	280	6	cancer	cancer	NOUN
ajlm-2816	280	7	patients	patient	NOUN
ajlm-2816	280	8	with	with	ADP
ajlm-2816	280	9	febrile	febrile	NOUN
ajlm-2816	280	10	neutropenia	neutropenia	PROPN
ajlm-2816	280	11	.	.	PUNCT
ajlm-2816	281	1	int	int	PROPN
ajlm-2816	281	2	j	j	PROPN
ajlm-2816	281	3	antimicrob	antimicrob	PROPN
ajlm-2816	281	4	agents	agent	NOUN
ajlm-2816	281	5	j.	j.	PROPN
ajlm-2816	281	6	2008;32s:30–33	2008;32s:30–33	PROPN
ajlm-2816	281	7	.	.	PUNCT
ajlm-2816	282	1	https://doi.org/10.1016/j.ijantimicag.2008.06.017	https://doi.org/10.1016/j.ijantimicag.2008.06.017	PROPN
ajlm-2816	282	2	villafuerte	villafuerte	NOUN
ajlm-2816	282	3	-	-	PUNCT
ajlm-2816	282	4	gutierrez	gutierrez	PROPN
ajlm-2816	282	5	p	p	PROPN
ajlm-2816	282	6	,	,	PUNCT
ajlm-2816	282	7	villalon	villalon	PROPN
ajlm-2816	282	8	l	l	PROPN
ajlm-2816	282	9	,	,	PUNCT
ajlm-2816	282	10	losa	losa	PROPN
ajlm-2816	282	11	je	je	PROPN
ajlm-2816	282	12	,	,	PUNCT
ajlm-2816	282	13	henriquez	henriquez	ADJ
ajlm-2816	282	14	-	-	PUNCT
ajlm-2816	282	15	camacho	camacho	PROPN
ajlm-2816	282	16	c.	c.	NOUN
ajlm-2816	282	17	treatment	treatment	NOUN
ajlm-2816	282	18	of	of	ADP
ajlm-2816	282	19	febrile	febrile	NOUN
ajlm-2816	282	20	neutropenia	neutropenia	NOUN
ajlm-2816	282	21	and	and	CCONJ
ajlm-2816	282	22	prophylaxis	prophylaxis	ADJ
ajlm-2816	282	23	in	in	ADP
ajlm-2816	282	24	hematologic	hematologic	ADJ
ajlm-2816	282	25	malignancies	malignancy	NOUN
ajlm-2816	282	26	:	:	PUNCT
ajlm-2816	282	27	a	a	DET
ajlm-2816	282	28	critical	critical	ADJ
ajlm-2816	282	29	review	review	NOUN
ajlm-2816	282	30	and	and	CCONJ
ajlm-2816	282	31	update	update	VERB
ajlm-2816	282	32	.	.	PUNCT
ajlm-2816	283	1	adv	adv	PROPN
ajlm-2816	283	2	hematol	hematol	NOUN
ajlm-2816	283	3	.	.	PUNCT
ajlm-2816	284	1	2014;2014(id	2014;2014(id	NOUN
ajlm-2816	284	2	986938):1–9	986938):1–9	NOUN
ajlm-2816	284	3	.	.	PUNCT
ajlm-2816	285	1	https://doi.org/10.1155/2014/986938	https://doi.org/10.1155/2014/986938	PROPN
ajlm-2816	285	2	kedzior	kedzior	ADJ
ajlm-2816	285	3	sk	sk	PROPN
ajlm-2816	285	4	,	,	PUNCT
ajlm-2816	285	5	ham	ham	PROPN
ajlm-2816	285	6	y	y	PROPN
ajlm-2816	285	7	,	,	PUNCT
ajlm-2816	285	8	bubalo	bubalo	NOUN
ajlm-2816	285	9	j.	j.	PROPN
ajlm-2816	285	10	overcoming	overcome	VERB
ajlm-2816	285	11	resistance	resistance	NOUN
ajlm-2816	285	12	:	:	PUNCT
ajlm-2816	285	13	antibiotic	antibiotic	ADJ
ajlm-2816	285	14	guidance	guidance	NOUN
ajlm-2816	285	15	for	for	ADP
ajlm-2816	285	16	multidrug	multidrug	NOUN
ajlm-2816	285	17	-	-	PUNCT
ajlm-2816	285	18	resistant	resistant	ADJ
ajlm-2816	285	19	febrile	febrile	NOUN
ajlm-2816	285	20	neutropenia	neutropenia	NOUN
ajlm-2816	285	21	in	in	ADP
ajlm-2816	285	22	patients	patient	NOUN
ajlm-2816	285	23	with	with	ADP
ajlm-2816	285	24	cancer	cancer	NOUN
ajlm-2816	285	25	.	.	PUNCT
ajlm-2816	286	1	j	j	PROPN
ajlm-2816	286	2	hematol	hematol	ADJ
ajlm-2816	286	3	oncol	oncol	ADJ
ajlm-2816	286	4	pharm	pharm	NOUN
ajlm-2816	286	5	.	.	PUNCT
ajlm-2816	287	1	2021;11(2):95–104	2021;11(2):95–104	X
ajlm-2816	287	2	.	.	PUNCT
ajlm-2816	288	1	zimmer	zimmer	PROPN
ajlm-2816	288	2	aj	aj	PROPN
ajlm-2816	288	3	,	,	PUNCT
ajlm-2816	288	4	freifeld	freifeld	PROPN
ajlm-2816	288	5	ag	ag	PROPN
ajlm-2816	288	6	.	.	PUNCT
ajlm-2816	288	7	optimal	optimal	ADJ
ajlm-2816	288	8	management	management	NOUN
ajlm-2816	288	9	of	of	ADP
ajlm-2816	288	10	neutropenic	neutropenic	ADJ
ajlm-2816	288	11	fever	fever	NOUN
ajlm-2816	288	12	in	in	ADP
ajlm-2816	288	13	patients	patient	NOUN
ajlm-2816	288	14	with	with	ADP
ajlm-2816	288	15	cancer	cancer	NOUN
ajlm-2816	288	16	.	.	PUNCT
ajlm-2816	289	1	j	j	PROPN
ajlm-2816	289	2	onchol	onchol	PROPN
ajlm-2816	289	3	pract	pract	PROPN
ajlm-2816	289	4	.	.	PUNCT
ajlm-2816	290	1	2019;15(1):19–25	2019;15(1):19–25	X
ajlm-2816	290	2	.	.	PUNCT
ajlm-2816	290	3	https://doi.org/10.1200/jop.18.00269	https://doi.org/10.1200/jop.18.00269	PROPN
ajlm-2816	290	4	de	de	PROPN
ajlm-2816	290	5	court	court	PROPN
ajlm-2816	290	6	jr	jr	PROPN
ajlm-2816	290	7	,	,	PUNCT
ajlm-2816	290	8	bruns	bruns	PROPN
ajlm-2816	290	9	ahw	ahw	PROPN
ajlm-2816	290	10	,	,	PUNCT
ajlm-2816	290	11	roukens	roukens	PROPN
ajlm-2816	290	12	ahe	ahe	PROPN
ajlm-2816	290	13	,	,	PUNCT
ajlm-2816	290	14	et	et	PROPN
ajlm-2816	290	15	al	al	PROPN
ajlm-2816	290	16	.	.	PUNCT
ajlm-2816	291	1	the	the	DET
ajlm-2816	291	2	dutch	dutch	PROPN
ajlm-2816	291	3	working	working	PROPN
ajlm-2816	291	4	party	party	NOUN
ajlm-2816	291	5	on	on	ADP
ajlm-2816	291	6	antibiotic	antibiotic	ADJ
ajlm-2816	291	7	policy	policy	NOUN
ajlm-2816	291	8	(	(	PUNCT
ajlm-2816	291	9	swab	swab	NOUN
ajlm-2816	291	10	)	)	PUNCT
ajlm-2816	291	11	recommendations	recommendation	NOUN
ajlm-2816	291	12	for	for	ADP
ajlm-2816	291	13	the	the	DET
ajlm-2816	291	14	diagnosis	diagnosis	NOUN
ajlm-2816	291	15	and	and	CCONJ
ajlm-2816	291	16	management	management	NOUN
ajlm-2816	291	17	of	of	ADP
ajlm-2816	291	18	febrile	febrile	NOUN
ajlm-2816	291	19	neutropenia	neutropenia	NOUN
ajlm-2816	291	20	in	in	ADP
ajlm-2816	291	21	patients	patient	NOUN
ajlm-2816	291	22	with	with	ADP
ajlm-2816	291	23	cancer	cancer	NOUN
ajlm-2816	291	24	.	.	PUNCT
ajlm-2816	292	1	infect	infect	VERB
ajlm-2816	292	2	dis	dis	PROPN
ajlm-2816	292	3	ther	ther	ADV
ajlm-2816	292	4	.	.	PUNCT
ajlm-2816	293	1	2022;11(6):2063–2098	2022;11(6):2063–2098	NOUN
ajlm-2816	293	2	.	.	PUNCT
ajlm-2816	294	1	https://doi.org/10.1007/s40121-022-00700-1	https://doi.org/10.1007/s40121-022-00700-1	PROPN
ajlm-2816	294	2	lyman	lyman	PROPN
ajlm-2816	294	3	gh	gh	PROPN
ajlm-2816	294	4	.	.	PROPN
ajlm-2816	295	1	febrile	febrile	PROPN
ajlm-2816	295	2	neutropenia	neutropenia	PROPN
ajlm-2816	295	3	:	:	PUNCT
ajlm-2816	295	4	an	an	DET
ajlm-2816	295	5	ounce	ounce	NOUN
ajlm-2816	295	6	of	of	ADP
ajlm-2816	295	7	prevention	prevention	NOUN
ajlm-2816	295	8	or	or	CCONJ
ajlm-2816	295	9	a	a	DET
ajlm-2816	295	10	pound	pound	NOUN
ajlm-2816	295	11	of	of	ADP
ajlm-2816	295	12	cure	cure	NOUN
ajlm-2816	295	13	.	.	PUNCT
ajlm-2816	296	1	j	j	PROPN
ajlm-2816	296	2	oncol	oncol	ADJ
ajlm-2816	296	3	pract	pract	NOUN
ajlm-2816	296	4	.	.	PUNCT
ajlm-2816	297	1	2019;15(1):27–29	2019;15(1):27–29	X
ajlm-2816	297	2	.	.	PUNCT
ajlm-2816	298	1	https://doi.org/10.1200/jop.18.00750	https://doi.org/10.1200/jop.18.00750	NOUN